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Abstract
This thesis concerns the characterisation of four Drosophila proteins that 
are involved in different steps of gene expression. The first protein, dMCRS2, is a 
nuclear Forkhead associated (FHA) domain protein. dMCRS2 is an essential protein 
required for growth during development. Drosophila and human MCRS2/MSP58 was 
previously reported to form a complex with the MOF histone acetyl transferase. My 
data reveal that in addition to MOF, dMCRS2 can be purified in complex with multiple 
RNAP II-associated proteins including Cdkll/Pitslre. Moreover, dMCRS2 co-localises 
with RNAP II complexes on polytene chromosomes in vivo. Thus, dMCRS2 might 
provide a physical link between the chromatin remodelling MOF complex and RNAP II 
via its ability to associate with Pitslre. Interestingly, the interaction between dMCRS2 
and Pitslre seems to be regulated in response to apoptotic stimuli.
The second and third proteins characterised here correspond to the 
Drosophila homologues of Prp38p (dPrp38), a tri-snRNP splicing factor, and 
Microfibril-Associated Protein 1 (dMFAPl), a previously uncharacterised protein found 
in some human spliceosomal fractions. I show here that dMFAPl binds directly to 
dPrp38 and is required for pre-mRNA processing. dMFAPl, like dPrp38, is essential 
for growth during development, and my in vivo data show that cells with reduced levels 
of dMFAPl or dPrp38 proliferate more slowly than control cells and undergo apoptosis. 
Consistent with this, dsRNA-mediated depletion of dPrp38 or dMFAPl causes cells to 
arrest in G2/M, and this is paralleled by a reduction in mRNA levels of the mitotic 
phosphatase string/cdc25. Interestingly dsRNA-mediated depletion of a wide range of 
core splicing factors elicits a similar phenotype, suggesting that the observed G2/M 
arrest might be a general consequence of interfering with spliceosome function.
The fourth protein, Pixie, can be isolated from cells in complex with eukaryotic 
initiation factor (elF) 3 and small ribosomal proteins and is required for the assembly of 
translation initiation competent ribosomes. Thus, depletion of Pixie results in the 
assembly of empty ribosomes lacking mRNAs and reduced levels of translation 
initiation. Moreover, Pixie associates with the 40S subunit in an ATP-dependent 
manner. These data are consistent with Pixie playing a catalytic role in the assembly of 
complexes required for translation initiation.
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Chapter 1 - Introduction
1.1 Introduction overview
This thesis concerns the characterisation of four Drosophila proteins that 
are implicated in different stages of gene expression. Our data show that two of the 
proteins, dPrp38 and dMFAPl, function in pre-mRNA processing, one, dMCRS2, 
might be implicated in transcriptional regulation, and one, Pixie, functions in translation 
initiation. This introduction is divided into four main sections and aims to provide an 
overview of three major stages of gene-expression: RNA polymerase II-dependent 
transcription, pre-mRNA processing, and translation. Section 1 one gives a very short 
introduction to Drosophila as a genetic tool. Section 2 describes various aspects of 
RNAP II transcription including pre-initiation complex assembly, transcription 
initiation and elongation, regulation of RNAP II transcription by activators/chromatin 
remodellers, and the interplay between RNAP II transcription and pre-mRNA 
processing. Section 2 also includes an update on previous research concerning dMCRS2 
and its human homologue MSP58. Section 3 aims to give relatively broad overview of 
the spliceosome. I have attempted to compile the mechanistic in vivo data obtained in 
yeast with the proteomic data from studies in mammalian cells to highlight similarities 
and differences between pre-mRNA processing in yeast and metazoans. The fourth and 
final section of the introduction is dedicated to translation with an emphasis on 
translation initation. I have included a brief introduction to insulin signalling, which 
regulates protein synthesis at several stages including translation initiation and 
elongation. The last part of section 4 provides an overview of previous data on Pixie 
and its human (RLI) and yeast (Rlilp) homologues.
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1.2 Drosophila as a model organism
Drosophila melanogaster (commonly known as the fruit fly) has served as 
a genetic tool to study developmental signalling processes for many years. The small 
size and the short life cycle (see below) make the fruit fly a convenient model organism. 
The ease of generating genetic mosaics in flies has been used extensively to induce loss 
of function (LOF) of genes in a spatially and temporally controlled manner (see below). 
The high level of conservation between key signalling pathways in flies and humans 
and the lack of redundancy among key regulatory genes in the fly genome facilitates the 
analysis of the phenotypic effects of gene LOF. With the completion of the Drosophila 
genome sequencing project in 2000, a foundation for a new era of functional studies has 
been laid.
1.2.1 The Drosophila life cycle
Drosophila has been used extensively as a model organism to study 
different aspects of development in higher eukaryotes. The relatively short generation 
time of flies make them a convenient tool for studying genetics. Thus, the life cycle of 
Drosophila from egg lay to adult is roughly 10 days at 25°C (Figure 1-1). Females lay 
hundreds of eggs (embryos) a day, which hatch as first instar larvae after approximately 
12-15 hours. The emerging first instar larvae enter a growth phase, where they increase 
in mass by about 400x. During the growth phase larvae moult twice into second- and 
third-instar larvae at about 24 and 48 hours after eclosion. 4-5 days after egg lay (AEL), 
third instar larvae pupate and undergo a 4-5 days long metamorphosis, after which the 
adults emerge. During metamorphosis the majority of the larval tissue breaks down with 
the exception of the imaginal discs. The imaginal discs are epithelial sheets that give 
rise to most of the structures of the adult fly including head, legs, wings, thorax and 
genetalia. They are set aside during embryogenesis, continue to grow during the larval 
stages, and undergo extensive morphological changes to form the adult structures 
during pupal stage. The wing and eye imaginal discs are commonly used tissues to 










Figure 1-1: The Drosophila life cycle. A fertilised female can lay hundreds of eggs (embryos) a 
day. The embryos develop over 12-15 hours, after which they hatch as first instar larvae. The first 
instar larvae moult twice into 2nd and 3rd instar larvae 24 and 48 hours after eclosure. Third instar 
larvae grow and accumulate mass, before they pupate 4-5 days AEL. During the pupal stage, 
which last about 4-5 days, extensive morphological changes take place. These involve break­
down of the majority of the larval tissue and the formation of adult structures. As a result, an adult 
flies emerge from their pupal case approximately 10 days AEL. Image taken from Flymove: 
http://flymove.uni-muenster.de.
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1.2.2 Genetic tools in Drosophila
1.2.2.1 P-elements as a tool for generating transgenic animals
P-elements belong to a family of naturally occurring transposable 
elements found in Drosophila, which have the ability to catalyse their own excision and 
transposition to a different region of the host genomic DNA (Engels, 1992). P-elements 
contain the coding sequence for the transposase enzyme, which catalyses the excision of 
the P-element, and are flanked by the recognition sequence elements that are targeted by 
the transposase. An engineered P-element vector, which contains the gene of interest, a 
visible marker, and recognitions sequence elements, but lack the region encoding the 
transposase, is a commonly used tool in Drosophila for generating transgenic animals 
(Rubin and Spradling, 1982; Spradling and Rubin, 1982). Micro-injection of P-element 
vectors into pre-blastoderm embryos in the presence of a transposase facilitates the 
integration of P-elements into the host genomic DNA. If inserted into the germline, this 
gives rise to a small percentage of transgenic animals in the progeny. The transposase 
activity is supplied in trans either by co-injection of DNA encoding the transposase or 
genetically. Thus, transgenic Drosophila lines exist that contain an engineered highly 
active version of the transposase (A2-3). The open reading frame (ORF) of the 
transposase is separated into four exons. The presence of the 2-3 intronic sequences in 
alternatively spliced messenger RNAs (mRNAs, the predominant mRNA species 
outside of the germline) results in the expression of a truncated version of the 
transposase, which is not fully active. The engineered transposase gene lacking the 2-3 
intronic sequence and the flanking sequence recognition elements efficiently mobilise 
P-element vectors in trans (Robertson et al., 1988). The lack of sequence recognition 
elements prevents the transposase from “jumping” around in the genome. To avoid 
continuous remobilisation of the inserted P-element, the transposase is crossed out in 
the next generation.
1.2.2.2 P-elements as a tool for generating L OF mutants
Injected P-element vectors will integrate randomly into the host genomic 
DNA including the coding regions of the genome. This provides a method for 
generating LOF mutations (Salz et al., 1987; Tsubota and Schedl, 1986). Moreover,
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mobilisation of P-elements inserted in the vicinity of a gene of interest, by reintroducing 
the A2-3 transposase, can facilitate the generation of LOF mutants. Thus, approximately 
2% of mobilised P-elements are imprecisely excised resulting in the deletion of DNA 
on either or both sides of the insertion point. A large collection of Drosophila lines 
carrying P-element insertion in or near most coding sequences exists, and mobilisation 
of P-elements has become the most frequent tool for generating LOF mutants in 
Drosophila (Bellen et al., 2004).
L 2.2.3 Generation of mosaic tissue using the FLP-FRT system
Inducing LOF in small areas of tissue (clones) provides a means of 
bypassing early lethality and studying phenotypes later in development (Perrimon, 
1998). The Flip recombinase (FLP)-Flip recombinase target (FRT) system provides a 
method for generating mosaics of wildtype (wt) and LOF tissue in heterozygous 
animals. Thus, FRT sequences have been inserted transgenetically near the centromere 
of each chromosome arm in Drosophila (Xu and Rubin, 1993). The expression of FLP 
in trans induces recombination between FRTs at identical sites on homologous 
chromosomes (Figure 1-2). Usually the mutation of interest is recombined onto a FRT- 
containing chromosome arm and transgenic flies are crossed to flies harbouring an FRT 
at an identical position and a visible marker such Green fluorescent protein (GFP) at a 
more distal position of the chromosome arm (Xu and Rubin, 1993). The FLP transgene 
is mostly supplied on another chromosome of the FRT-GFP line. Upon expression of 
FLP, a small number of cells undergo mitotic recombination, giving rise to mosaics of 
wt (two copies of GFP) and mutant (lack of GFP) tissue surrounded by heterozygous 
tissue (one copy of GFP) (Figure 1-2). Since, the mutant clones and neighbouring wt 
twin-spots arise at the same time from a single mitotic recombination event, the wt 
clones provide an internal control for studying the phenotype of their mutant twins. 
Moreover, the activity of FLP and therefore mitotic recombination can be temporally 
and spatially controlled by placing FLP under the control of a heat shock or tissue- 
specific promoter (Newsome et al., 2000; Xu and Rubin, 1993).
1.2.2.4 The GAL4/UAS system
The GAL4/UAS system is widely used in flies to study over-expression 
and LOF phenotypes. GAL4 binds to upstream activating sequence (UAS) promoter 

























Figure 1-2: FLP-FRT system. FLP induces recombination betw een FRT sites at identical 
positions on homologous chrom osom e arm s during mitosis. Usually, transgenic anim als carry the 
mutation of interest on one FRT-containing chrom osom e and a visible marker like GFP on the 
other. During S phase  each  chrom osom e arm is duplicated, and upon entry into mitosis FLP- 
dependent mitotic recombination can occur betw een FRT sites on homologous chrom osom e 
arms. Mitotic recombination followed by mitosis gives rise to three outcom es (depending on chro­
m osom e segregation). Cells can either have two copies of the mutation (mutant clones, marked 
by absence  of GFP), two copies of GFP (wt twin-spot) or one of each a s  before mitosis 
(heterozygous tissue, one copy of GFP). B ecause mutant clones and their neighbouring wt twin- 
spots are generated  from the sam e recombination event, the twin-spot functions a s  an internal 
control that allows the phenotype of mutant tissue to be a sse sse d . Adapted from (Tabata, 2001).
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Figure 1-3: The Gal4-UAS system and FLPout technique. Gal4 binds to UAS promoter 
elements and induces the expression of genes downstream from the promoter region (A). 
Usually, flies carrying the gal4 transgene under the control of a tissue-specific promoter are 
crossed to flies carrying the gene of interest (gene X) under the control of the UAS promoter. As 
a result, gene X  is expressed in a tissue-specific manner in the progeny. LOF phenotypes can be 
studied using the Gal4-UAS system if gene X  is replaced with an RNAi contruct. The GAL4-UAS 
system has been combined with the FLP-FRT technique to facilitate the temporally controlled 
expression of a transgenes in “FLP-out” clones (B). Thus, a casette containing a transcriptional 
stop signal with a FRT site on either side can be inserted between a constitutive promoter and the 
Gal4-encoding sequence. In the presence of a  FLPase, mitotic recombination results in excision 
of the stuffer and ubiquitous expression of Gal4 in a small number of cells. As a result, gain of 
function or LOF phenotypes can be studied in clones. Clones can be positively labelled if flies 
carry an UAS-GFP transgene. Moreover, Gal4 expression can be temporarily controlled if the 
FLPase is placed under the control of a heat shock promoter.
(Figure 1-3). Thus, a GAL4 transgene can be supplied in trans to control the expression 
of a UAS-containing transgene in a temporal or tissue-specific manner. This technique 
has been used extensively for studying over-expression phenotypes or to rescue LOF 
phenotypes. Since the construction of a genome-wide library of transgenic stocks 
containing RNAi constructs under the control of UAS, the GAL4-UAS system has also 
been used extensively to study LOF phenotypes (Dietzl et al., 2007). LOF phenotypes 
can be studied in specific tissues by driving the expression of double-stranded (ds)RNA 
in a tissue-specific manner.
The GAL4/UAS system has been combined with the FLP-FRT technique 
to facilitate the expression of a transgenes in “FLP-out” clones (Figure 1-3). In this 
system, the GAL4 gene is separated from a constitutive promoter by a “stuffer” 
composed of a stop codon flanked by two FRT sequences. Induction of FLP expression 
by heat shock results in excision of the “stuffer” and expression of GAL4 in a small 
percentage of cells. When the “FLP-out-GAL4” cassette is combined with a transgene 
under the control of UAS, the transgene of interest will express in GAL4 positive 
clones. UAS-GFP is usually present on the same chromosome as the FLP-out cassette, 
allowing clones to be positively marked (Blair, 2003).
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1.3 RNA polymerase (RNAP) II Transcription
In eukaryotes there are three RNA polymerases, RNAP I-III, all of which 
are closely related in structure. Thus, each RNAP complex consists of two large 
subunits and at least 8 additional subunits, some of which are common to two or all 
three RNA polymerases. Despite the similar structures, the RNA polymerases have non­
overlapping functions. RNAP I is responsible for transcription of rRNA precursors, 
RNAP II transcribes all protein-encoding genes and some small nuclear RNA genes, 
and RNAP III is mainly responsible for the transcription of 5S RNA and tRNAs. As 
previously mentioned, one of the four Drosophila protein characterised in my thesis 
(dMCRS2) is likely to be implicated in regulation of RNAP II transcription. Hence, this 
section has been dedicated to provide the reader with an overview of the various aspects 
of RNAP II transcription including pre-initiation complex assembly, transcription 
initiation and elongation, regulation of RNAP II transcription by activators/chromatin 
remodellers, and the interplay between RNAP II transcription and pre-mRNA 
processing.
1.3.1 Assembly of the RNA polymerase II pre-initiation complex
The initiation of mRNA transcription involves the assembly of a 
transcription pre-initiation complex (PIC) which as a minimum includes RNAP II, the 
Mediator, and six general transcription factors (GTFs) designated Transcription factor 
(TF) IIA, -B, -D, -E, -F, and -H  at the core promoter DNA region (Lee and Young, 
2000; Orphanides et al., 1996; Roeder, 1996). PIC assembly is initiated by binding of 
the TATA-box binding protein (TBP) subunit of TFIID to the promoter, which is 
stabilised in the presence of TFIIA and the Mediator (Figure 1-4). Subsequently, TFIIB 
binds to and stabilises the TFIIA-TFIIB-Mediator-DNA complex, and functions as an 
adaptor that recruits the pre-formed RNAP II-TFIIF complex to the promoter. TFIIE 
and TFIIH join at the end to form the complete PIC.
1.3.1.1 TFIID
TFIID consists of TBP and at least 14 TBP-associated factors (TAFs) 





















Figure 1-4: RNAP II PIC assembly. The first and rate-limiting step in PIC assembly is binding of 
TFIID via TBP to the TATA box. The TFIID complex is composed of TBP and at least 14 TBP- 
associated factors (TAFs), some of which interact with other promoter elements. The association 
of TBP with the TATA box is greatly stabilised in the presence of the GTFs TFIIA and TFIIB (A). 
TFIIB binds to TFIID and promoter DNA and functions as an adaptor to recruit the pre-formed 
TFIIF-RNAP II unit to the promoter-bound TFIID-TFIIA-TFIID complex (B). The Rpb1 subunit of 
the RNAP II complex contains an extended CTD, which consists of multiple heptapeptide repeats. 
Finally, TFIIF promotes the recruitment of TFIIE and TFIIH to form the complete RNAP II PIC (C). 
The kinase and helicase activities of TFIIH are absolutely essential for the subsequent events 
leading to transcription initiation.
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the rate-limiting step in PIC assembly (Ranish et al., 1999). Thus in many cases, 
activators increase the binding of TBP to promoters in direct proportion to their activity 
in transcription activation (Kuras and Struhl, 1999; Li et al., 1999). Binding of TBP to 
the promoter induces a sharp bend in the DNA of about 80 degrees, which results in 
partial unwinding of the TATA box DNA (Kim et al., 1993a; Kim et al., 1993b). TBP- 
induced bending of the promoter DNA is thought to occur by a two-step mechanism 
(Zhao and Herr, 2002). In the first step an unstable unbent TBP-TATA box complex is 
formed, and in a second much slower step the bent complex is formed (Zhao and Herr,
2002). The first step is rapid and reversible and most likely represents a non-committing 
association of TBP with a given promoter. The transition from an unbent TBP-TATA 
box complex to a bent complex is promoted by TFIIB and is likely to be a target of 
regulation (Zhao and Herr, 2002).
TBP alone can replace TFIID as nucleation factor for PIC assembly in 
vitro, but fails to support activator-dependent transcription (Dynlacht et al., 1991; 
Peterson et al., 1990; Pugh and Tjian, 1990). Consistent with this, several TAFs interact 
with transcription activators, and mutations in TAFs that disrupt their interactions with 
transcription activation domains (TADs) also result in failure to activate transcription 
((Gill et al., 1994), reviewed in (Sauer and Tjian, 1997)). Thus, a major function of 
individual TAFs might be to mediate interactions between the core promoter and 
specific subsets of activators bound to distant enhancer elements.
TAFs are also thought to play an important role in promoter recognition 
by forming multiple interactions between TFIID and promoter DNA (Figure 1-5) 
(Burke and Kadonaga, 1997; Kaufmann et al., 1998; Verrijzer et al., 1995; Verrijzer et 
al., 1994). This is important because TBP associates weakly with some TATA box- 
containing promoters and in the case of TATA-less promoters, binding of TBP to the 
promoter is critically dependent on the presence of factors bound to initiator elements 
(INRs) and downstream promoter elements (DPEs) (Burke and Kadonaga, 1996; 
Kaufmann and Smale, 1994; Purnell et al., 1994; Verrijzer et al., 1995). In humans, it 
has been estimated that more than 78% of promoters lack a TATA-box (Gershenzon 
and Ioshikhes, 2005). There are several lines of evidence that binding of TAFs to INRs 
and DPEs stabilises the interaction of TBP with the promoter region. First, human 
TAF6  and TAF9 exhibit DPE-specific binding activity (Shao et al., 2005). Second, 
human TAF1 and Drosophila dTAF2 bind directly to INRs, and human TAF2 was 
found to be an essential co-factor for TFIID-dependent transcription from INR-
28
TAF








BREU “  TATA “  BREd " Inr DPE
Figure 1-5: TFIIB and TAFs bind to promoter-specific elements. In addition to the TATA box, 
several other promoter elements have been identified that affect promoter strength. These 
include Inrs, DPEs, and TFIIB recognition elements (BREs) located upstream or downstream of 
the TATA box (BREU and BREd). TAF2, TAF6, and TAF9 are thought to stabilise the binding of 
TFIID to the promoter by interacting with Inrs and DPEs. This is especially important on TATA-less 
promoters. The association of TFIID with the promoter is further stabilised in the presence of 
TFIIB, which interacts with the BREuand BREd promoter elements. BREuand BREd seem  to 
behave antagonistically. Thus, the presence of either element stimulates transcription, but BREd 
appears negatively affect transcription in the presence of BREU. Adapted from (Thomas and 
Chiang, 2006).
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containing promoters (Kaufmann et al., 1998; Verrijzer et al., 1994). Third, TFIID binds 
cooperatively to INR and DPE since mutation in either of the two elements or variation 
in their spacing results in loss or decreased binding of TFIID to the core promoter and 
reduced levels of basal transcription (Burke and Kadonaga, 1996, 1997; Kutach and 
Kadonaga, 2000).
1.3.1.2 TFIIA
In yeast, TFIIA is composed of two subunits, TOA1 and TOA2 (Ranish et 
al., 1992). Human TFIIA consists of three subunits, TFIIAa, TFIIAp, and TFIIAy, 
where TFIIAy is the homologue of TOA2, and TFIIAa and TFIIAp are homologous to 
the N- and C-terminal region of TOA1. TFIIAa and TFIIAp are generated from the 
same polypeptide, TFIIAap, by proteolytic cleavage (DeJong and Roeder, 1993; Ma et 
al., 1993; Yokomori et al., 1993).
Binding of TFIIA to TBP increases the affinity of TBP for the TATA-box 
and accelerates this rate-limiting step of PIC assembly (Imbalzano et al., 1994). 
Surprisingly, TFIIA is not absolutely required for transcription in vitro. Thus, TFIIA 
was found to stimulate basal and activated transcription only when the TFIID but not 
TBP alone was used in reconstituted transcription reactions (reviewed in (Orphanides et 
al., 1996)). Consistent with this, TFIIA seems to derepress an inhibitory activity 
associated with TFIID (Ozer et al., 1998). The TFIID subunit TAF1 binds to TBP and 
inhibits the interaction of TBP with the TATA-box (Kokubo et al., 1993; Kokubo et al., 
1998; Verrijzer et al., 1995). TFIIA competes with the TAF1 subunit of TFIID for 
binding to TBP, and binding of TFIIA to TBP is thought to repress the transcriptional 
inhibitory activity of TAF 1 (Ozer et al., 1998). It is not clear how TFIIA competes with 
TAF1 for binding to TBP, given that TBP and TAF1 are already pre-assembled in the 
TFIID complex. It is well established that TFIIA is required for activator-mediated 
conformational changes in TFIID, which stimulates interactions of TFIID with 
sequences downstream of the transcriptional start site (Lieberman and Berk, 1994; Ozer 
et al., 1994). Thus, the conformational changes induced upon binding of TFIIA to 
TBP/TFIID might destabilise the association of TAF1 with TBP leading to 
transcriptional derepression (Ozer et al., 1998).
TFIIA may not solely derepress TBP inhibition by interfering with TAF1. 
Thus, TFIIA has been reported to compete with other negative factors for binding to 
TBP including Motl and NC2. Motl disrupt pre-formed TBP-TATA complexes in an
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ATP-dependent manner, and this is prevented by binding of TFIIA to the TBP-TATA 
complex (Auble and Hahn, 1993). NC2 binds to TBP after its association with the 
TATA box and blocks the interaction of this complex with TFIIB in vitro (Meisteremst 
and Roeder, 1991). TFIIA competes with NC2 for binding to TBP, and a recent study 
suggests that a TAF-dependent INR bound activity shifts the equilibrium in favour of 
TFIIA (Malecova et al., 2007). Thus, the presence of a functional INR provides 
resistance to NC2-mediated transcriptional repression (Malecova et al., 2007).
Studies carried out in vitro and in vivo indicate that TFIIA might be 
required for transcription of only a subset of TFIID-dependent genes (reviewed in 
(Thomas and Chiang, 2006)). However unlike TAFs, TFIIA is present at all promoters 
with an occupancy that strongly correlates with that of TBP (Kuras et al., 2000). Thus, 
it remains to be determined whether in addition to its function in derepression, TFIIA 
has a more general function in transcription.
1.3.1.3 TFIIB
TFIIB is composed of a single polypeptide, which interacts with TBP and 
forms multiple contacts with the core promoter, thereby stabilising the TBP/TFIID- 
TATA complex (Zhao and Herr, 2002). It binds to specific TFIIB recognition elements 
located either upstream (BREU) (Lagrange et al., 1998) or downstream (BREd)(Deng 
and Roberts, 2005, 2006) of the TATA box, and the presence of either element enhance 
TFIIB-TBP-TATA complex formation (Figure 1-5) (Deng and Roberts, 2005, 2006; 
Lagrange et a l, 1998). Interestingly, BREd can have either positive or negative effects 
on transcription in a promoter-dependent manner (Deng and Roberts, 2005). Thus, the 
negative effect of BREd appears to correlate with the presence of BREU suggesting that 
the two elements might act antagonistically (Deng and Roberts, 2005).
TFIIB plays a central role in PIC assembly by providing a bridge between 
promoter bound TBP/TFIID and RNAP II and is absolutely required for the recruitment 
of the pre-formed TFIIF-RNAP II complex (Buratowski et al., 1989; Reinberg and 
Roeder, 1987; Sawadogo and Roeder, 1985). Consistent with this, TFIIB forms multiple 
interactions with TBP, three subunits of RNAP II (RPB1, RPB2, and RPB9), both 
subunits of TFIIF (RAP30 and RAP74), and the TFIID subunit TAF9 (reviewed in 
(Deng and Roberts, 2007)). In addition to its crucial function in PIC assembly, TFIIB 
also interacts with multiple activators and plays a role in activated transcription 
(reviewed in (Deng and Roberts, 2007)).
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Upon transcription initiation, TFIIB dissociates from the PIC and does not 
continue along with elongating RNAP II (Roberts et al., 1995; Zawel et al., 1995). 
Mutations in TFIIB have been reported that are compatible with PIC assembly, but 
prevent transcription initiation, indicating that a step post-assembly is blocked in these 
mutants (reviewed in (Deng and Roberts, 2007)). It is possible that those mutations 
affect promoter clearance (discussed later) by interfering with TFIIB dissociation from 
the RNAP II complex.
13.1.4 TFIIF
TFIIF, which is composed of two subunits Rap30 and Rap74, enters the 
TFIIA-TFIID-TFIIB-TATA complex as a preformed TFIIF-RNAP II unit. The small 
subunit, Rap30, is sufficient for RNAP II recruitment and PIC assembly (Flores et al.,
1991). Consistent with this, Rap30 forms multiple interactions with TFIIB (Ha et al.,
1993), RNAP II (McCracken and Greenblatt, 1991), and DNA (Tan et al., 1994b). 
Importantly, a major function of TFIIF is to prevent RNAP II from binding non- 
specifically to DNA, and this requires both TFIIF subunits (Killeen and Greenblatt,
1992). Moreover, the large subunit, Rap74, has been implicated in transcription start 
site selection. Thus, a mutation in the yeast TFIIB gene that causes aberrant start site 
selection is suppressed by mutations in the gene encoding the yeast Rap74 homologue 
(Sun and Hampsey, 1995).
In addition to its function in PIC assembly, TFIIF is also required for the 
subsequent formation of an open complex catalysed by the TFIIH DNA helicase and for 
synthesis of the first phosphodiester bond of nascent transcripts. The requirement for 
TFIIF in these processes might be indirect, since TFIIF is needed for the recruitment of 
TFIIE and TFIIH into the PIC (Maxon et al., 1994). However, the ability of TFIIF to 
induce wrapping of promoter DNA around RNAP II could directly facilitate formation 
of an open complex (Robert et al., 1998). Moreover, TFIIF was found to function in 
promoter escape by increasing the processivity of very early RNAP II elongation 
intermediates, thus suppressing early abortive transcription, and by cooperating with 
TFIIH to prevent premature arrest of early RNAP II elongation intermediates (Yan et 
al., 1999). Finally, TFIIF cooperates with the elongation factor TFIIS to stimulate re­
initiation of paused elongation complexes at the 5’ end of the gene (Zhang and Burton,
2004).
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Following transcription initiation, TFIID remains promoter-bound 
whereas TFIIB rapidly dissociates from the PIC, followed by TFIIE dissociation prior
thto formation of the 10 phosphodiester bond, and TFIIH after the transcription complex 
reaches +30. TFIIB, TFIIE, TFIIE, and TFIIH re-associate with TFIID to form a new 
PIC nucleation site, whereas TFIIF appears to reversibly associate with the elongating 
RNAP II complex (Yudkovsky et al., 2000; Zawel et al., 1995). Consistent with this, 
TFIIF was found to increase the elongation rate of RNAP II in vitro (Cheng and Price, 
2007; Tan et al., 1994a). Moreover, positive transcription elongation factor b (P-TEFb)- 
mediated phosphorylation of the negative elongation factor (NELF) results in its 
dissociation from the RNAP II complex and allows TFIIF to associate with RNAP II to 
stimulate productive elongation in vitro (Cheng and Price, 2007). Intriguingly, TFIIF 
associates with promoter regions rather than open reading frames of genes in vivo 
(Krogan et al., 2002; Pokholok et al., 2002). Thus it is possible that like TFIIS, TFIIF 
only associates with coding regions under stress or suboptimal transcription-elongation 
conditions to facilitate release of RNAP II from a stalled state (Pokholok et al., 2002).
1.3.1.5 TFIIE
TFIIE enters the PIC after the TFIIF-RNAP II unit. Human TFIIE is a 
CX2 P2 hetero-tetramer composed of the two highly charged subunits TFIIEa and TFIIEp 
(Ohkuma et al., 1990). It interacts with TFIIB, the unphosphosphorylated form of 
RNAP II (RNAP I I a ) ,  both subunits of TFIIF, and TFIIH (reviewed in (Orphanides et 
al., 1996)). Moreover, it is required for the incorporation of TFIIH into the PIC and for 
regulation of its kinase and helicase activities (Lu et al., 1992; Ohkuma and Roeder, 
1994).
Like TFIIF, TFIIE has been implicated in early events of RNAP II 
elongation. Thus, TFIIF, TFIIE, and TFIIH are thought to function in a cooperative 
manner to suppress arrest of early RNAP II elongation intermediates by a mechanism 
that involves the DNA helicase activity of TFIIH (Dvir et al., 1996; Kugel and 
Goodrich, 1998; Kumar et al., 1998). Consistent with this, TFIIEa and TFIIEp both 
interact with the TFIIH-associated DNA helicase, xeroderma pigmentosum B (XPB) 
(Maxon et al., 1994). Intriguingly, the interaction of XPB with TFIIEa/p seems to be 
inhibitory (Drapkin et al., 1994), whereas TFIIEp alone is capable of stimulating the 
helicase activity of XPB (Lin and Gralla, 2005). Thus, the positive role of TFIIE in 
transcription initiation is best explained by structural rearrangements during
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transcription initiation that result in TFIIEp activation through TFIIEa repression. 
Moreover, TFIIE and TFIIH are both essential for promoter melting and transition from 
initiation to elongation (Holstege et al., 1996). Consistent with this, TFIIE is capable of 
binding to single stranded DNA, and TFIIE and TFIIH are dispensable for transcription 
from pre-melted promoters (Holstege et al., 1996; Kuldell and Buratowski, 1997; Pan 
and Greenblatt, 1994).
1.3.1.6 TFIIH
TFIIH is the final GTF to join the PIC and is absolutely required for 
transcription initation. TFIIH is composed of 6  core subunits including p34, p44, p52, 
p62, and the DNA and DNA-RNA helicases XPB and XPD. In addition, TFIIH contains 
three more loosely associated subunits, which make up the cyclin activating kinase 
(CAK) complex. The CAK complex consists of the cyclin-dependent kinase 7 
(Cdk7)/Kin28 (humans/yeast), its partner Cyclin H, and the MAT1 (menage-a-trois-1) 
protein (Devault et al., 1995; Fesquet et al., 1993; Fisher and Morgan, 1994; Tassan et 
al., 1995).
TFIIH has several functions in RNAP II transcription including mediating 
ATP-dependent promoter DNA opening (Holstege et al., 1997), phosphorylation of the 
RNAP II C-terminal domain (CTD) through its association with CAK (Feaver et al.,
1994), and suppression of transcription arrest of early RNAP II elongation complexes 
(Spangler et al., 2001). The XPB DNA helicase catalyses both the ATP-dependent 
formation of the open complex prior to transcription (Tirode et al., 1999) and the ATP- 
dependent suppression of arrest of early elongation intermediates prior to promoter 
escape (Bradsher et al., 2000; Moreland et al., 1999). In contrast, XPD activity appears 
to be dispensable for transcription initiation and promoter escape (Bradsher et al., 2000; 
Tirode et al., 1999). Instead, the ATP-dependent helicase activities of both XPB and 
XPD are involved in unwinding of DNA during nucleotide excision repair (NER). 
(Coin et al., 1998; Dubaele et al., 2003).
In the process of promoter clearance and early transcription elongation 
RNAP II becomes hyper-phosphorylated and pre-existing interactions with transcription 
initiation-specific factors are disrupted and new interactions with elongation-specific 
factors are established. The TFIIH-associated CAK activity plays a crucial role in this 
transition from initiating to elongating RNAP II. Thus, phosphorylation of the CTD of 
RNAP II by the CAK-associated kinase Cdk7 results in the dissociation of RNAP II
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from most of the basal transcription factors (Yudkovsky et al., 2000; Zawel et al.,
1995).
1.3.2 The Mediator complex
RNAP II transcription levels depend on the interaction of RNAP II with 
GFTs that regulate basal transcription from core promoters and a wide range of gene- 
specific transcription factors that bind to distant regulatory elements. A co-activator 
complex named the Mediator has been implicated in establishing a link between factors 
present at those distant regulatory elements and the basal RNAP II complex bound to 
the core promoter (Bjorklund and Gustafsson, 2005; Komberg, 2005; Thomas and 
Chiang, 2006).
1.3.2.1 Purification of the Mediator complex
The Mediator was originally purified from yeast and is composed of 
approximately 2 0  subunits that have been divided into head, middle, and tail sub- 
modules (reviewed in (Boube et al., 2002)). In addition, a sub-module, which contain 
the Cyclin C-Cdk8  pair, is associated with a subset of yeast Mediator complexes 
(reviewed in (Carlson, 1997)). Attempts to purify the mammalian Mediator initially led 
to the purification of a number of complexes with overlapping, but non-identical 
compositions (reviewed in (Boube et al., 2002)). Subsequently, a more sensitive 
proteomics method led to the purification of a 30 subunit mammalian Mediator 
complex, which contained all of the previously purified Mediator-like sub-complexes 
(Sato et al., 2004). Bioinformatic analyses revealed that all but three yeast Mediator 
subunits are conserved in the mammalian Mediator complex (reviewed in (Conaway et 
al., 2005a; Conaway et al., 2005b)).
1.3.2.2 The Mediator is required for basal and activated levels o f transcription
The Mediator is required for basal transcription, but also functions to 
activate transcription by mediating signals from transcription activators bound to distant 
enhancer elements to the RNAP II promoter (reviewed in (Conaway et al., 2005b)) 
(Figure 1-6). The requirement for Mediator in basal transcription is most likely 
explained by the cooperative binding of the Mediator and TBP to the core promoter 
(Johnson et al., 2002; Wu et al., 2003b). It has been proposed that transcriptional 










Figure 1-6: The Mediator and TAFs function as general transcriptional co-factors. The
Mediator is a multi-subunit complex, which plays a crucial role in basal and activated transcrip­
tion. Like TAFs, it stimulates basal transcription by stabilising the interaction of TBP with the 
promoter. Thus, TBP and the Mediator binds to the promoter in a cooperative manner. Moreover, 
the Mediator and TAFs interact with transcription activators bound to distal promoter elements. 
This provides a link between the general transcription machinery and gene-specific transcrip­
tional activators, and explains the requirement for TAFs and the Mediator in activated transcrip­
tion. Adapted from (Thomas and Chiang, 2006).
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which in turn stimulate the efficiency and/or rate of transcription initiation complex 
assembly. Consistent with this, the model activator GAL4-VP16, the Mediator and 
TFIID/TFIIA assemble onto the promoter in a cooperative manner in vitro (Johnson et 
al., 2 0 0 2 ), and the requirement for the activator can be bypassed by pre-assembly of 
saturating amounts of the Mediator-TFIID/TFIIA complex onto the promoter (Johnson 
and Carey, 2003). Moreover, under these conditions basal levels of transcription are 
increased to activated levels (Johnson and Carey, 2003).
1.3.2.3 The Mediator can function as a repressor of transcription
The various sub-complexes of the mammalian Mediator that were isolated 
in the original purifications are likely to represent distinct functional forms of the 
Mediator. Thus, the Cdk8  kinase module seems to associate with the Mediator in a 
reversible manner (Chadick and Asturias, 2005). Moreover, several lines of evidence 
suggest that the kinase module exerts a repressive function on transcription 
(Akoulitchev et al., 2000; Sun et al., 1998; Taatjes et al., 2002). Thus, Mediator 
complexes containing the Cdk 8  kinase module were found to inhibit transcriptional 
activation by VP 16, SREBP, Spl, and other TADs in vitro, whereas the Mediator 
complex lacking the kinase module supported strong activation of transcription by the 
same TADs (Taatjes et al., 2002). The molecular mechanism by which the kinase 
module exerts its repressive function is not clear, but there are some indications. First, 
the presence of the kinase module might disrupt the interaction between the Mediator 
and RNAP II. Thus, the Mediator binds to an immobilised Gluthionine S transferase 
(GST)-tagged CTD fusion protein in absence, but not in the presence, of the kinase 
module (Naar et al., 2002). Second, the Cdk8 -cyclin C complex is capable of 
phosphorylating the cyclin H subunit of mammalian TFIIH, thereby blocking CAK 
activity and transcription (Akoulitchev et al., 2000). Third, the kinase module appears to 
target some transcription activators for phosphorylation and degradation (Fryer et al.,
2004). Thus, it has been demonstrated that the Cdk8  kinase is recruited to the promoter 
of the Notch responsive HES1 gene shortly after its activation. Subsequently, Cdk8 - 
dependent phosphorylation of the Notch intracellular domain targets it for 
ubiquitination and degradation and shuts down transcription from the HES1 promoter 
(Fryer et al., 2004).
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1.3.3 The CTD
RNAP II is composed of 12 subunits. The two largest subunits, Rpbl and 
Rbp2, form the catalytic centre of the enzyme, and Rpb3-12 surround these two 
subunits to provide structural support and regulate RNAP II activity. RNAP II differs 
from the other two eukaryotic RNA polymerase in that Rpbl has an extended CTD, 
which is composed of multiple heptapeptide repeats with the consensus sequence Tyr- 
Ser-Pro-Thr-Ser-Pro-Ser (Y1S2P3T4S5P6 S7) (Dahmus, 1995). Due to its hydrophilic 
nature, the CTD is thought to adopt an extended flexible structure (Bienkiewicz et al., 
2000; Cagas and Corden, 1995) that serves as a platform to coordinate the assembly of 
multiple complexes associated with RNAP II transcription. These complexes not only 
include factors that are required for RNAP II transcription but also proteins involved in 
mRNA capping, pre-mRNA processing, and 3’ end cleavage and polyadenylation 
(Corden and Patturajan, 1997; Goldstrohm et al., 2001; Maniatis and Reed, 2002; 
Proudfoot et al., 2002). Thus, the CTD is likely to be implicated in multiple steps of 
mRNA synthesis. Consistent with this, in vitro studies of a truncated form of the CTD 
has been shown to affect not only RNAP II translation initiation and/or early elongation 
(Meininghaus et al., 2000) but also pre-mRNA processing (Hirose and Manley, 2000).
L3.3.1 Phosphorylation of the CTD
The RNAP II exists as two complexes with a non- (RNAP IIa) or hyper- 
phosphorylated (RNAP Ho) CTD subunit. The RNAP IIa complex is thought to engage 
in promoter binding and early events in the transcription cycle, whereas elongation 
requires hyper-phosphorylation of RNAP II. Thus, RNAP IlA-specific staining of 
Drosophila polytene chromosomes mostly coincides with inactive genes or polymerases 
paused at promoter-proximal sites, and RNAP Ilo-specific staining with sites of active 
transcription (O'Brien et al., 1994; Weeks et al., 1993).
The “IIo” designation does not refer to one hyper-phosphorylated RNAP II 
species, but rather to a heterogeneous group of RNAP IIs with different phosphorylation 
patterns. CTD phosphorylation occurs predominantly on Ser2 and Ser5 of the repeats, 
and the phosphorylation pattern changes as RNAP II progresses through the 
transcription cycle (Figure 1-7) (Dahmus, 1995, 1996). Phosphorylation of Ser5 takes 
place early on in the transition from pre-initiation to elongation and depends on the 
activity of the TFIIH-associated kinase Cdk7/Kin28 (Komamitsky et al., 2000; 
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Figure 1-7: The phosphorylation pattern of the CTD changes as RNAP II progresses 
through the transcription cycle. Transcription initiation requires the activity of the TFIIH- 
associated Cdk7/Kin28 kinase, which phosphorylates the RNAP II CTD on Ser5s. TFIIH associ­
ates with early elongating RNAP II complexes, but dissociates from RNAPII after about 30 nucle­
otides. The RNAP II enters a pausing phase that is thought to be linked with a capping check­
point. Proficient elongation requires the action of Cdk9/CTDK-1, which together with its partner 
cyclin T forms the DRB sensitive positive elongation factor b (P-TEFb). P-TEFb associates with 
elongating RNAP II and phosphorylates the CTD on Ser2s as  RNAP II progresses through the 
coding region. Towards the 3’end of the coding region, the CTD becom es dephosphorylated on 
Ser5s by Ser5-specific phosphatases like the yeast Fcp1 and Ssu72 proteins. This change in 
phosphorylation pattern coincide with the recruitment of 3’-end processing factors that preferen­
tially bind to the Ser2-phosporylated form of the CTD. Adapted from (Sims et al., 2004).
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kinase CTDK-1 (Cdk9 in metazoans) to generate elongation proficient RNAP Ho (Lee 
and Greenleaf, 1997; Marshall et al., 1996). Towards the 3’ end of the gene RNAP Ho 
appear to be phosphorylated mainly on Ser2s, indicating that a Ser5-specific 
phosphatase is involved at some stage (reviewed in (Meinhart et al., 2005)).
A number of CTD phosphatases that dephosphorylate Ser5 have been 
identified including human and yeast CTD phosphatase 1 (Fcpl) and yeast Ssu72 
(Chambers et al., 1995; Kong et al., 2005; Krishnamurthy et al., 2004). Fcpl associates 
with TFIIF and stimulates dephosphorylation of RNAP Ho Ser5 in vitro in a reaction 
that is stimulated by TFIIF and inhibited by TFIIB (reviewed in (Meinhart et al.,
2005))(Chambers et al., 1995; Kong et al., 2005)). Moreover, cells lacking Fcpl 
accumulates hyper-phosporylated RNAP II specifically in coding regions of genes (Cho 
et al., 2001; Kobor et al., 1999). Consistent with this, Fcpl associates with elongating 
RNAP II in vivo, and its phosphatase activity has been shown to stimulate RNAP II 
elongation in vitro (Kong et al., 2005; Mandal et al., 2002). Ssu72 is a component of the 
yeast cleavage/polyadenylation factor, and depletion of Ssu72 causes an elevation of 
CTD phospho-Ser5 levels in vivo and inhibits transcription in vitro (Krishnamurthy et 
al., 2004). Moreover, Ssu72 dephosphorylates recombinant CTD that has been 
phosphorylated by TFIIH in vitro, suggesting that it might counteract TFIIH function in 
vivo at the 3’ end of the gene (Krishnamurthy et al., 2004). Finally, Ssu72 and Fcpl 
have both been implicated in dephosphorylation and recycling of free RNAP II for 
subsequent rounds of transcription (reviewed in (Meinhart et al., 2005; Sims et al.,
2004)).
1.3.3.2 Changes in the phosphorylation pattern of the CTD coordinates 
transcription and RNA processing
It is now widely accepted that transcription and RNA processing are 
temporally and functionally linked. Towards the 5’ end of the gene, phosphorylation of 
Ser5s results in the recruitment of 5’end processing factors to the CTD including 
enzymes responsible for capping of the mRNA. Moreover, the activity of the 
guanylyltransferase, Cegl, was found to be stimulated by its binding to phosphorylated 
Ser5s in CTD repeats in vitro (Cho et al., 1998; Ho and Shuman, 1999), and genetic 
interactions between kin28 and cegl suggest that CTD phosphorylation regulates 
mRNA capping in vivo (Rodriguez et al., 2000). Interestingly, binding of capping 
enzymes to the CTD was found to stimulate early RNAP II elongation, possibly
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providing a checkpoint that ensures that the cap has been added before commitment to 
productive elongation (reviewed in (Bentley, 2005)). Towards the 3’ end of genes, the 
CTD is predominantly phosphorylated on Ser2s, and not Ser5s. This change in 
phosphorylation pattern correlates with the binding specificity of a number of 
processing factors that are recruited to the CTD towards the 3’ end of the gene, 
including cleavage and polyadenylation factors (Ahn et al., 2004; Licatalosi et al., 
2002).
In addition to serving as a platform for coupling 5’- and 3’-end processing 
with transcription, the CTD is likely to recruit factors required for pre-mRNA splicing. 
Thus, activation of RNAP II-dependent transcription re-localises splicing factors to sites 
of transcription, but this does not occur if RNAP II has a truncated CTD (Misteli and 
Spector, 1999). Moreover, various splicing related factors, including Precursor mRNA 
processing protein (Prp)40p (Morris and Greenleaf, 2000), U2 small nuclear 
ribonucleoprotein (snRNP) auxiliary factor 65 kDa (U2AF65) (Listerman et al., 2006), 
SAF-B (Nayler et al., 1998), PTB-associated splicing factor (PSF), UsnRNPs, and SR 
proteins (Yuryev et al., 1996) have been identified in large RNAP II complexes and/or 
bind directly to the CTD. In the case of U2AF65 and Prp40p, they were found to bind 
specifically to phosphorylated CTDs, suggesting that they are recruited to elongating 
RNAP II complexes (Listerman et al., 2006; Morris and Greenleaf, 2000). The 
association of splicing factors with the CTD is likely to be functionally relevant, since 
truncation of the CTD causes a defect in splicing (Misteli and Spector, 1999) and 
affects splice site selection (de la Mata and Komblihtt, 2006). Thus, truncation of the 
CTD abolishes SRp20-mediated exclusion of a fibronectin cassette exon, indicating that 
the CTD can regulate alternative splicing in vivo (de la Mata and Komblihtt, 2006). The 




Once the PIC has assembled onto the promoter, promoter escape and 
proximal pausing (discussed below) represent the main rate-limiting steps in gene 
expression. The promoter escape step is initiated by promoter opening, which involves 
unwinding of 11-15 base pairs (the transcription bubble) by the TFIIH-associated XPB
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DNA helicase (Tirode et al., 1999; Wang et al., 1992). The RNAP II complex is now 
referred to as the initially transcribing complex (ITC). Abortive initiation is relatively 
frequent during synthesis of the first one to four nucleotides, after which the ITC forms 
a meta-stable complex (Holstege et al., 1997; Kugel and Goodrich, 2000). This is often 
referred to as “escape commitment”. During the post commitment phase the ITC can 
still undergo upstream transcript slippage (Holstege et al., 1997; Pal and Luse, 2003). 
Promoter escape is completed during the transition from the 8th to the 9th nucleotide 
and coincides with a number of events. These include a reduction in upstream slippage, 
end of abortive transcript release, and collapse of the transcription bubble (reviewed in 
(Saunders et al., 2006)). Moreover, TFIIH activity is no longer required at this stage 
(Hieb et al., 2006). The RNAP II complex is now referred to as an early elongation 
complex (EEC). Promoter escape is followed by a transition to a pause region where 
transcript slippage is frequent until +23 nucleotides, and backtracking occurs until +30 
nucleotides (Pal and Luse, 2003). TFIIF cooperates with TFIIS to suppress pausing 
during this phase (Zhang and Burton, 2004).
1.3.4.2 Promoter proximal pausing
Promoter proximal pausing or stalling at the 5’ end of the gene is a rate- 
limiting step in the expression of many genes and is likely to represent a checkpoint 
before commitment to productive elongation. A number of proteins have been 
implicated in regulation of this step. 5, 6-Dichloro-l-bD-ribofuranosylbenzimidazole 
(DRB) sensitivity-inducing factor (DSIF) and NELP have both been found to inhibit 
elongation at this stage (Price, 2000). DSIF is composed of Spt4 and Spt5 and NELP of 
four subunits A, B, C/D, and E. Interestingly Spt5 interacts with the capping enzyme, 
and stimulates capping activity in vitro (Wen and Shatkin, 1999). Thus, it is possible 
that promoter proximal pausing both facilitates capping and provides a checkpoint to 
ensure that capping has taken place before commitment to productive elongation. 
Release from pausing requires the positive elongation factor P-TEFb, which is inhibited 
by DRB (Figure 1-8) (Price, 2000). P-TEFb consists of Cdk9/CTDK1 complexed with 
its partner cyclin T and phosphorylates DSIF, NELF, and the CTD on Ser2s (Fujinaga 
et al., 2004; Price, 2000; Yamada et al., 2006). As a result NELF dissociates from the 
RNAP II complex and productive elongation can take place (Fujinaga et al., 2004). 
DSIF stays associated with the elongating RNAP II and appears to stimulate elongation 
at this stage (Hartzog et al., 1998). Consistent with its crucial function in RNAP II
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Figure 1-8: P-TEFb activity is required for productive elongation. Escape from promoter 
proximal pausing is a rate-limiting step in the expression of many genes. The conversion of 
paused RNAP II complexes into productive elongating complexes requires the action of P-TEFb, 
which phosphorylates the CTD on Ser2s. P-TEFb also phoshorylates and derepresses the inhibi­
tory effect of the two negative elongation factors DSIF and NELF. Phosphorylation of NELF 
results in its displacement from the RNAP II complex and allows TFIIF to bind and stimulate 
RNAP II elongation rates. DSIF stays associated with elongating RNAP Ms and appears to stimu­
late elongation at this stage. Taken from (Cheng and Price, 2007).
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elongation, P-TEFb localises to active genes in vivo (Lis et al., 2000), and its depletion 
results in a global decrease in density of RNAP II on genes (Ni et al., 2004; Shim et al., 
2002).
1.3.5 Productive elongation
Once the RNAP II complex has cleared the promoter region, successful 
transcript elongation is dependent on a number of factors. These include elongation 
factors, which stimulate the processivity of the RNAP II complex, and chromatin 
remodellers, which “loosen up” the chromatin structure to facilitate RNAP II read 
through.
1.3.5.1 Elongation factors
A number of proteins have been identified that stimulate the rate of RNAP 
II elongation. These include TFIIF, eleven-nineteen lysine-rich in leukaemia (ELL), and 
elongin, all of which are thought to stimulate RNAP II elongation at least in part by 
repressing transient pausing (Conaway and Conaway, 1999). TFIIF is mainly localised 
at the 5’end of the gene, suggesting that its primary function might be to cooperate with 
TFIIS to re-initiate RNAP II complexes during the proximal promoter pausing phase 
(Yan et al., 1999). In addition, TFIIF might transiently associate with and release stalled 
RNAP II complexes in the coding region as has been described for TFIIS (Pokholok et 
al., 2002). This could be important for re-initiating transcription upon DNA damage or 
other cellular stresses. ELL and Elongin are both associated with hyper-phosphorylated 
RNAP II on polytene chromosomes, suggesting that they remain associated with RNAP 
II throughout the elongation phase (Gerber et al., 2001; Gerber et al., 2005). PaflC, 
another complex that associates with elongating RNAP II, forms a scaffold for 
recruitment of Histone modifiers and chromatin remodellers (discussed below, and 
reviewed in (Saunders et al., 2006)).
1.3.5.2 Histone modification factors
The tight wrapping of DNA around histones (nucleosomes) represents a 
barrier to the elongating RNAP II complex. Thus, active transcription requires 
remodelling and partial disassembly of nucleosomes to allow the RNAP II complex to 
read through. Modifications that result in remodelling of nucleosomes include
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acetylation, methylation, ubiquitylation and phosphorylation of histones (Figure 1-9) 
(reviewed in (Saunders et al., 2006)).
Histone acetylation is mostly associated with actively transcribing regions. 
The Elongin multi-factor complex contains a histone acetyl transferase (HAT) activity, 
and depletion of Elongin results in reduced levels of transcription in vivo. This suggests 
that Elongin might in part facilitate RNAP II elongation via its ability to modify the 
chromatin structure (Close et al., 2006).
Histone H3-K4 tri-methylation predominantly takes place at the 5’ end of 
actively transcribed genes and is catalysed by a number of Setl family members 
including MLL1, MLL2, and Setl (Pokholok et al., 2005). Consistent with this, some 
Setl family members preferentially bind to the Ser5-phosphorylated form of CTD, 
which dominates at the 5’ end of genes (Ng et al., 2003). In contrast, Set2 family 
members, which methylate histone H3 on K36 (reviewed in (Dillon et al., 2005)), bind 
the Ser2P-Ser5P form of RNAP II and associate with the entire transcribed region 
(Krogan et al., 2003b).
Mono-ubiquitylation of H2BK120 is catalysed by the H2B ubiquitylating 
complex and stimulates transcription in vitro (Pavri et al., 2006). The H2B 
ubiquitylating complex is present both at promoter regions and coding regions (Kao et 
al., 2004; Zhu et al., 2005), and H2BK120 ubiquitylation is required for correct 
methylation of H3-K4 and H3-K79 (Briggs et al., 2002; Sun and Allis, 2002). The 
elongation factor PaflC is required for the association of the H2B ubiquitylating 
complex with hyper-phosphorylated RNAP II and for the recruitment of Setl and Set2 
(Krogan et al., 2003a; Krogan et al., 2003b; Ng et al., 2003; Wood et al., 2003).
1.3.5.3 Chromatin remodellers
Chromatin remodellers are implicated in repositioning, disassembly and 
re-assembly of nucleosomes. There are four families of ATP-dependent chromatin 
remodellers: ISWI, SNF2, CHD, and INO80/SWR (Lusser and Kadonaga, 2003). These 
are thought to modify chromatin structure by repositioning nucleosomes in trans to 
another DNA molecule or in cis by displacing them upstream or downstream from their 
original position. The ISWI, SNF2, and CHD family members, ISWI, SWI/SNF, and 
CHD1, all associate with coding regions, but none of them are thought to function 
exclusively in elongation (reviewed in (Saunders et al., 2006)). Notably, depletion of
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Figure 1-9: Typical distribution pattern of histone modifications on active genes. The
nucleosomes represents a barrier to the elongating RNAP II complex, and extensive remodelling 
of the chromatin structure is required to allow RNAP II to read through. This is faciliated by acety­
lation, methylation, and ubiquitylation of histones, which results in partial diassembly of the 
nucleosomes. H3 and H4 acetylation by histone acetyl transferases is frequent towards the 
5’-end of actively transcribing regions. Histone methylation is carried out by members of the Setl 
and Set2 families. Wheras Setl-mediated tri-methylation of H3K4 predominantly takes place at 
the 5’-end, Set2-mediated di- and tri-methylation of H3-K36 is more frequent towards to 3’-end of 
transcribed regions. Ubiquitylation of H2B occurs within the entire transcribed region. Taken from 
(Saunders et al., 2006).
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ISWI, or SWI/SNF2 only affects a small number of genes in yeast (Lusser and 
Kadonaga, 2003; Tran et al., 2000).
The FACT (for FAcilitates Chromatin Transcription) complex and Spt6 
are major players in the disassembly and re-assembly of nucleosomes. The FACT 
complex, which consists of SSRP1 and Sptl6, facilitates displacement of H2A-H2B 
dimers and stimulate RNAP II elongation through chromatin in vitro 
((Belotserkovskaya et al., 2003) and reviewed in (Sims et al., 2004)). Spt6 interacts with 
H3 and H4 and seems function in nucleosome re-assembly (Bortvin and Winston, 1996; 
Kaplan et al., 2003). Thus, mutations in Spt6 result in increased sensitivity of chromatin 
to micrococcal nuclease digestion, indicating an open chromatin structure (Kaplan et al.,
2003). Consistent with their predicted functions, the FACT complex and Spt6 both 
localise at coding regions of actively transcribed genes (Andrulis et al., 2000; Saunders 
et al., 2003). Moreover, their co-localisation with elongating RNAP II depends on the 
presence of PaflC (Adelman et al., 2006). In the case of Spt6, the interaction appears to 
be co-dependent (Adelman et al., 2006; Kaplan et al., 2005).
1.3.6 Transcription termination
Whereas RNAP II transcription initiation and elongation have been 
subjects of intense study for a number of years, the mechanism for RNAP II 
transcription termination has only started to unravel. It has become clear that 
termination requires a functional polyadenylation (poly(A)) signal and correct 
processing of the 3’ end. Thus, mutations in the poly(A) signal or components of the 3’ 
end processing machinery results in failure to terminate transcription (reviewed in 
(Buratowski, 2005)). In mammals, additional termination signals downstream of the 
poly (A) signal are required for efficient termination (Gromak et al., 2006; West et al.,
2006). A model has been put forward to explain transcription termination in mammals, 
which is referred to as the “torpedo model” (Figure 1-10) (reviewed in (Buratowski,
2005)). According to the ’’torpedo model”, recognition of the poly(A) signal renders the 
RNAP II complex prone to termination. Subsequently, cleavage at the poly(A) site or 
further downstream generates a new 5’ end, which acts like an entry point for 
exonucleases and/or helicase to degrade nascent RNA associated with the elongating 
RNAP II complex. This eventually results in dissociation of the RNAP II complex from 
nascent RNA and template DNA (Buratowski, 2005). The torpedo model has gained 


















Figure 1-10: The “Torpedo Model”. A model (referred to as  the “torpedo model”) has been put 
forward to explain transcription termination in mammals. Termination is initiated by recognition of 
the poly(A) signal, which renders the RNAP II complex termination competent. Cleavage at the 
poly(A) site by 3’ poly(A)/cleavage factors or at terminator sequences downstream of the poly(A) 
site by a co-transcriptional cleavage event (CoTC) generates a new uncapped 5’-end. This acts 
as an entry point for “torpedoes” like the Xm2 5’->3’ exonuclease, which degrades nascent RNA 
associated with the elongating RNAP II complex. Dissociation of the ternary RNAP ll-RNA-DNA 
complex is thought to occur when Xm2 “catches up ” with the elongating RNAP II. Taken from 
(Komblihtt, 2004).
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First, they were able to show that poly(A) signal recognition occurs rapidly and is 
crucial to render the RNAP II complex termination competent. Second, 5’-3’ 
exonucleolytic degradation of cleaved nascent RNA precedes dissociation of the RNAP 
II complex from the DNA template. Third, in the presence of terminator sequences 
downstream of the poly(A) signal, cleavage occurs at those sites and poly(A) site 
cleavage and pre-mRNA dissociation takes place after template release. In the absence 
of terminator sequences, poly(A) signal cleavage takes place in the ternary RNAP II- 
template-pre-mRNA complex, and pre-mRNA release precedes degradation of nascent 
RNA and dissociation of RNAP II from the template (West et al., 2008). Recently, yeast 
Ratlp exonuclease and Senlp DEAD-box helicase were found to promote degradation 
of nascent RNA associated with RNAP II subsequent to 3’end processing (Kawauchi et 
al., 2008), suggesting that they play a key role in transcription termination. Consistent 
with this, Ratlp and Senlp are both required for termination in yeast (Kawauchi et al., 
2008), and depletion of the human Ratlp homologue, Xm2, from Hela cells results in a 
termination defect (West et al., 2004).
1.3.7 Regulation of RNAP II transcription by Cdks
Cdks belong to a large family of protein kinases that are activated upon 
complex formation with their respective Cyclin partners (reviewed in (Bregman et al., 
2000)). The Cyclin-Cdk complexes play pivotal roles in cell cycle progression and 
transcriptional regulation (Table 1-1). Thus, the cell cycle regulator Cyclins, which 
include Cyclin A 1-2, B, Dl-3, E, and F, function with their Cdk partners Cdkl-4, and -6 
to control cell cycle progression. In agreement with their functions at defined stages of 
the cell cycle, these Cyclins are synthesised and degraded in a cyclical fashion every 
cell division. The transcription regulator Cdks 7, 8, 9, and 11 function together with 
Cyclins C, H, K, L I-2 and Tl-2 and generally regulate RNAP II transcription. The 
levels of cyclins that are complexed with Cdks involved in transcriptional regulation 
remain constant during the cell cycle (reviewed in (Bregman et al., 2000)).
1.3.7.1 Cdk 7
As previously mentioned, Cdk7/Kin28 (humans/yeast) forms a trimeric 
CAK complex with its partner cyclin H and the MAT1 protein (Devault et al., 1995; 
Fesquet et al., 1993; Fisher and Morgan, 1994; Tassan et al., 1995). CAK regulates 
transcription through phosphorylation of the RNAP II CTD and a number of general
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Main activating cyclin 
(other cyclins)
Function
CDK1 100 PSTAIRE A1 ,A2, B1,B2(E , B3) Cell cycle (G2-M)
CDK2 65 PSTAIRE A1,A2, E 1 ,E 2 (D 1 ,D 2 , 
B1, B3)
Cell cycle (G1-S)
CDK3 63 PSTAIRE E 1,E2,A 1,A 2, C Cell cycle (G0-G1-S)
CDK4 42 PISTVRE D1.D2, D3 Cell cycle (G1-S)




CDK6 43 PLSTIRE D1.D2, D3 Cell cycle (G1-S)
CDK7 38 NRTALRE H RNAP II Transcription 
(initiation), DNA repair
CDK8 28 SMSACRE C (K?) RNAP II Transcription
CDK9 34 PITALRE T1.T2, K RNAP II Transcription 
(elongation)
CDK10 37 PISSLRE Unknown RNAP II Transcription, 
cell cycle (G2-M)
CDK11 26 SMSACRE L1, L2 (D) RNAP II Transcription, 
Splicing, cell cycle (M)
Table 1-1: Summary of Cdk-cyclin complexes and their functions. Cdks 1-4 and 6 function 
with their respective cyclin partners to control cell cycle progression. The activity of Cdks 1-4 and 
6 is controlled by the levels of their cyclin partners, which fluctuate during the cell cycle. Cdks 7-11 
function with a different set of cyclins to regulate RNAP II transcription. Contrary to what their 
names imply, the levels of cyclins that form complexes with Cdks 7-11 remain constant during the 
cell cycle. Adapted from (Malumbres and Barbacid, 2005).
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and regulatory transcription factors. These include TBP, TFIIEa, TFIIFa, p53, 
retinoblastoma protein (pRb), and retinoic receptor alpha (RARa) (Reviewed in 
(Oelgeschlager, 2002)). CAK can exist as a free complex or as part of TFIIH, and the 
association of CAK with TFIIH increases its substrate specificity for the RNAP II CTD 
(Yankulov and Bentley, 1997). Finally, CAK phosphorylates and presumably activates 
all cell cycle regulatory Cyclin/Cdk complexes (Harper and Elledge, 1998; Larochelle 
et al., 1998).
1.3.7.2 Cdk8
In contrast to Cdk7, Cyclin C-Cdk8 mediates transcriptional repression in 
vitro in both yeast and mammals (Pavri et al., 2005; Spahr et al., 2003; Sun et al., 1998; 
Taatjes et al., 2002). Cyclin C-Cdk8 forms a Cdk8 sub-complex with Medl2/Srb8 and 
Medl3/Srb9 (humans/yeast) (Bjorklund and Gustafsson, 2005; Borggrefe et al., 2002; 
Samuelsen et al., 2003), which negatively regulate transcription through its reversible 
association with the Mediator (Chadick and Asturias, 2005). In yeast, transcriptional 
repression of the Cyclin C-Cdk8-responsive genes is thought to occur by Cdk8- 
mediated phosphorylation of a set of transcription factors including Stel2, Gcn4, and 
Msn2 (Chi et al., 2001; Nelson et al., 2003). Moreover, the human Cyclin C/Cdk8 
complex is capable of repressing Cdk7 activity by phosphorylation of Cyclin H 
(Akoulitchev et al., 2000). Loss of any of the four subunits of the Cdk8 sub-module has 
little effect on viability in budding yeast (Holstege et al., 1998; van de Peppel et al.,
2005). In contrast, knock-out of Cdk8 in mice results in early embryonic lethality, 
indicating that Cdk8 function is required early in development (Westerling et al., 2007).
1.3.7.3 Cdk9
Cdk9 and its partner Cyclin T make up the positive elongation factor P- 
TEFb. P-TEFb kinase activity is absolutely crucial for the conversion of promoter 
proximal paused RNAP IIs into productive elongating complexes ((Marshall et al.,
1996) and reviewed in (Price, 2008)). In mammals, P-TEFb activity is negatively 
controlled by its reversible interaction with Methylphosphate capping enzyme 
(MEPCE), La-related protein 7 (LARP7), and the 7SK snRNP, which contains 
Hexamethylene bisacetamide-inducible protein (HEXIM)1 and HEXIM2 ((Jeronimo et 
al., 2007) and reviewed in (Peterlin and Price, 2006)). By analogy to studies of HIV 
transcriptional control, it has been suggested that P-TEFb release from 7SK snRNP and
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its recruitment to paused RNAP II complexes might be regulated by cellular factors 
bound to enhancer elements ((Sedore et al., 2007) and reviewed in (Peterlin and Price,
2006)). Cellular factors that have been implicated in recruiting P-TEFb to promoter 
regions include NF-kB, CIITA, and Brd4 (reviewed in (Peterlin and Price, 2006)).
1.3.7.4 C dkll
The Cdkl 1 protein kinases belong to a larger family of p34cdc2-related 
kinases and have been suggested to function as tumour supressors (Eipers et al., 1991). 
The two related genes, cdc2Ll and cdc2L2, encode at least 20 different Cdkl 1 isoforms. 
The larger C d k llpll° isoforms form complexes with at least four different cyclin L 
isoforms including cyclins LI a/p  and L2a/p (Loyer et al., 2008). C dk llpll° is thought 
to have dual functions in RNAP II transcription and pre-mRNA splicing and might 
provide a link between the two processes. Consistent with this, Cyclin L /C dkllpll° 
complexes localise to nuclear speckles, which are storage and assembly sites for 
splicing factors, and to the nucleoplasm (Hu et al., 2003; Yang et al., 2004). In 
agreement with a function in splicing, C dk llpll° and Cyclins LI a/p  and L2a/p 
associate with multiple splicing factors including the SR proteins SF2/ASF, SC35, 9G8, 
SRp75, SRp55, SRp40, SRp30a/b, and SRp20 and are required for normal splicing (Hu 
et al., 2003; Loyer et al., 2008; Yang et al., 2004). Over-expression of the Cyclin 
isoforms alone or in combination with C dk llpll° differentially affects alternative 
splicing, indicating that C dk llpll° can function as a regulator of alternative splicing 
(Loyer et al., 2008). Consistent with this, the alternative splicing factor 9G8 is a target 
of C d k llpll° phosphorylation, and depletion of C d k llpll° decreases 9G8 
phosphorylation and inhibits splicing (Hu et al., 2003).
There are several indications pointing to a role of C dk llpU0 in 
transcription. Thus, C d k llpl,° and its partner Cyclin L2 both bind to hyper- 
phosphorylated RNAP II (Trembley et al., 2002; Yang et al., 2004), and antibody- 
mediated repression of C dk llpU0 activity results in suppression of RNAP II 
transcription (Trembley et al., 2002). Moreover, C d k llpll° interacts with several 
proteins implicated in RNAP II elongation including ELL2, both subunits of TFIIF, 
TFIIS, and the FACT complex (Trembley et al., 2002). In contrast, Cdkl l pU0 does not 
co-purify with ELL, elongin A, or elongin B proteins, suggesting that C d k llpll° 
associates with a specific subset of RNAP II complexes (Trembley et al., 2002).
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Cdkl l p58 is a shorter isoform of Cdkl l pll°, and both are translated from a 
single transcript (Comelis et al., 2000). C dk llpll° is generated by classical cap- 
dependent translation, and C dkllp58 is produced by translation initiation from an 
internal ribosome entry site (IRES) (Comelis et al., 2000). Whereas Cdkl l pll° is present 
at constant levels throughout the cell cycle, C dkllp58 is expressed specifically during 
the G2/M transition (Comelis et al., 2000). Consistent with this, C dk llp58 is a 
centrosome-associated kinase that promotes centrosome maturation and bipolar spindle 
formation (Petretti et al., 2006). Thus, depletion of C dk llp58 results in diminished 
centrosomal levels of the protein kinases Polo-like kinase 1 (Plkl) and Aurora A that 
are known to function in microtubule nucleation and spindle stabilisation (Petretti et al.,
2006). Consistent with this, Cdkl l plI0/p58-deficient mice exhibit mitotic arrest and fail to 
develop beyond the blastocyst stage (Li et al., 2004).
The Cdkl 1 ^  isoform contains the catalytic kinase domain and is 
generated from the Cdkl l pU0 and Cdkl l p58 isoforms by proteolytic cleavage in response 
to apoptosis (Ariza et al., 1999; Tang et al., 1998). Thus, Fas-induced apoptosis or 
staurosporine treatment results in caspase-dependent cleavage of the longer Cdkll 
isoforms to generate C dk ll1’46 and is accompanied by Cdkll ^ -mediated 
phosphorylation of histone HI and apoptosis (Ariza et al., 1999; Lahti et al., 1995). 
Moreover, ectopic expression of Cdkl I1*46 is sufficient to induce apoptosis (Bunnell et 
al., 1990; Lahti et al., 1995). C dk ll1*46 interacts directly with eukaryotic translation 
initiation factor (elF) 3f, and this interaction is strengthened upon apoptotic stimuli (Shi 
et al., 2003). Moreover, Cdkl 11)46 phosphorylates eIF3f on Ser46 and inhibits translation 
in vitro (Shi et al., 2003). Thus, Cdkll ^ -mediated phopsphorylation of eIF3f could 
inhibit translation in vivo in response to apoptosis (Shi et al., 2003). Consistent with 
this, eIF3f is phosphorylated on Ser46 in apoptotic cells (Shi et al., 2003).
1.3.8 Casein Kinase 2 (CK2)
CK2 is a key regulator of multiple cellular processes and is thought to be 
an important mediator of cell survival. Thus, increased CK2 activity is associated with 
cellular stress responses, and loss of CK2 activity is associated with cell death 
(reviewed in (Ahmed et al., 2002)). Recent studies suggest that CK2 might function in 
the regulation of transcription. First, CK2 can be purified in complex with RNAP II, 
TFIIF and Cdkl 1 and is capable of phosphorylating these proteins (Egyhazi et al., 1999; 
Payne et al., 1989; Trembley et al., 2003). The importance of these phosphorylation
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events have not yet been addressed, but CK2-mediated phosphorylation of the CTD 
could potentially affect RNAP II elongation rates or the recruitment of specific cellular 
factors to the RNAP II complex (Trembley et al., 2003). Second, CK2 co-localise with 
TFIIF and elongating RNAP II complexes on Drosophila polytene chromosomes in 
vivo (Egyhazi et al., 1999). Third, CK2 phosphorylates and regulates the activity of the 
general splicing factor RNSP1, which is also associated with RNAP II complexes 
(Trembley et al., 2005). Thus, CK2 activity might be implicated in coordinating 
transcription and pre-mRNA processing
1.3.9 Males absent on the first (MOF)
The MOF proteins are of particular interest to my work, since Drosophila 
and human MOF were previously isolated in complex with my proteins of interest 
Microspherule protein 2 (dMCRS2)/Microspherule protein 58 (MSP58)
{Drosophila!humans) (Mendjan et al., 2006). The MOF histone acetyl transferase 
belongs to the MYST family (from founding members MOZ, Ybf2/Sas3, Sas2, and 
Tip60) (reviewed in (Yang, 2004)). In Drosophila, MOF is part of the male-specific 
lethal (MSL) complex, which is required for dosage compensation. Thus, the MSL 
complex binds to multiple sites along the male X chromosome and mediates a two-fold 
up-regulation of gene expression (Akhtar and Becker, 2000; Hilfiker et al., 1997; Smith 
et al., 2000). In addition to the MSL complex, MOF is part of another complex, which 
consists of dMCRS2 (my protein of interest), NSL1-3 (for non-specific lethal 1-3), 
WDS, and MBD-R2 (Mendjan et al., 2006). This complex is conserved in humans, and 
it has been speculated that it might have a more general function in transcription and/or 
chromatin remodelling (Mendjan et al., 2006). Consistent with this idea, MOF, but not 
MSL proteins, binds to the promoter region of genes on all four Drosophila 
chromosomes, and regulates transcription of both X-linked and autosomal genes (Kind 
et al., 2008).
Human MOF (hMOF) is thought to function in multiple processes 
including chromosome remodelling, transcriptional regulation, and DNA damage 
response. Thus, depletion of hMOF results in G2/M arrest, chromosomal aberrations, 
reduced transcription of a subset of genes, and impaired DNA repair (reviewed in (Rea 
et al., 2007)). hMOF specifically acetylates Histone 4 on lysine 16 (H4K16), and 
depletion of human MOF results in severely reduced levels or complete loss of 
H4K16Ac, suggesting that it is the main factor responsible for acetylation of H4K16
54
(Akhtar and Becker, 2000; Hilfiker et al., 1997; Smith et al., 2005; Smith et al., 2000; 
Taipale et al., 2005). Similarly, MOF-deficient mouse embryos fail to acetylate H4K16, 
but have normal acetylation on other N-terminal histone lysine residuces (Thomas et al., 
2008). As a result, M o /' embryonic cells exhibit abnormal chromatin structure, and 
MOF-deficient embryos do not develop beyond the blastocyst stage (Thomas et al., 
2008). Histone acetylation is often associated with regions of active transcription. Thus, 
hMOF has been proposed to cooperate with the methyl transferase MLL1, which binds 
to H4K16Ac and methylates H3K4, to stimulate transcription in vitro and in vivo (Dou 
et al., 2005).
Histone acetylation is also thought to play a role in DNA repair. Thus, 
generation of double-strand breaks induces H4 acetylation, including at K16, at the area 
surrounding the break (Tamburini and Tyler, 2005). Once DNA has been repaired, 
Histone deacetylases are recruited to the site of repair and Histone deacetylation takes 
place (Tamburini and Tyler, 2005; Utley et al., 2005). It has been proposed that 
acetylation and deacetylation might function to promote opening and closing of the 
chromatin structure to facilitate DNA repair or as a signal to attract the DNA repair 
machinery (Tamburini and Tyler, 2005). In accordance with this, hMOF is thought to 
function in DNA repair. First, hMOF-depleted cells exhibit a delay in the kinetics of the 
DNA repair process (Taipale et al., 2005), and expression of dominant-negative MOF 
results in inefficient repair of double-strand breaks (Gupta et al., 2005). Second, hMOF 
is activated in response to ionising radiation (IR)-induced DNA damage, and this is 
paralleled by an increase in H4K16Ac levels (Gupta et al., 2005). Third, yeast 2-hybrid 
data have shown that hMOF interacts with the ataxia-telangiectasia-mutated (ATM) 
protein, which is a key player in DNA damage response (Gupta et al., 2005). Moreover, 
inactivation of hMOF results in a decrease in ATM activity, and it has been proposed 
that hMOF might directly or indirectly regulate ATM in response to DNA damage 
(Gupta et al., 2005). Given that hMOF-mediated H4K16 acetylation occurs independent 
of ATM, it is possible that H4K16 acetylation rather than hMOF triggers ATM 
activation.
Interestingly, hMOF seems to have several independent functions in DNA 
damage response. Thus, hMOF was found to acetylate p53 on lysine 120 in response to 
DNA damage (Sykes et al., 2006). As a result, p53K120Ac accumulates specifically on 
promoters of pro-apoptotic genes rather than other target genes (Sykes et al., 2006).
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This suggests that hMOF-mediated acetylation of p53 makes cells prone to apoptosis 
rather than DNA repair.
1.3.10 MSP58 -  the human homologue of Drosophila dMCRS2
MSP58 (also known as p78/MCRSl), the human homologue of 
Drosophila dMCRS2, is a nuclear protein with a conserved forkhead-associated (FHA) 
domain at its C-terminus (Ren et al., 1998). FHA domains are found almost exclusively 
in nuclear proteins that function in transcription regulation, DNA repair, or cell cycle 
progression (Durocher et al., 1999; Hofmann and Bucher, 1995; Li et al., 2000). 
Consistent with this, there is some evidence that MSP58 is implicated in transcription 
regulation and possibly cell cycle progression (Hirohashi et al., 2006a; Shimono et al.,
2005).
Yeast 2-hybrid screens have identified several MSP58 binding partners 
including Mi-2(3, RET finger protein (RFP), and upstream binding factor (UBF) (Lin 
and Shih, 2002). Mi-2|3 is a component of a nucleosome remodelling and deacetylase 
(NuRD) complex (Tong et al., 1998; Wade et al., 1998; Zhang et al., 1998), RFP is a 
transcriptional regulator (Shimono et al., 2000; Shimono et al., 2003), and UBF is an 
essential component of the RNAP I initiation complex. Whereas the NuRD complex has 
mainly been associated with transcriptional repression, Mi-2|3 seems to function outside 
the NuRD complex as a transcriptional activator (Hirose et al., 2002; Shimono et al., 
2003; Williams et al., 2004). MSP58 was found to co-localise with Mi-2|3, RFP, and 
UBF in the nucleolus (Shimono et al., 2005), a sub-nuclear compartment in eukaryotic 
cells responsible for rRNA synthesis and ribosome biogenesis. Consistent with their 
localisation, MSP58, Mi-2j3, and RFP were found to bind to rDNA and up-regulate 
transcriptional activity from rDNA promoters (Shimono et al., 2005). Notably, the 
Drosophila homologue of MSP58, dMCRS2, is part of a MOF containing complex that 
has been proposed to function in chromatin remodelling and regulation of RNAP II 
transcription (Mendjan et al., 2006). Thus, a function of MSP58/dMCRS2 in 
chromosome remodelling and transcriptional regulation might be conserved between 
flies and humans.
MSP58 was also identified as a binding partner for the two centrosome- 
associated proteins Su48 and Ndel (Hirohashi et al., 2006a; Hirohashi et al., 2006b). 
Whereas the majority of MSP58 is found in the nucleus, a fraction of MSP58 was found 
to co-localise with Su48 and Ndel at centrosomes (Hirohashi et al., 2006a). Moreover,
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the association of MSP58 with Ndel seems to be regulated by phosphorylation. Thus, 
mutation of six putative phosphorylation sites in Ndel enhances its binding to MSP58 
(Hirohashi et al., 2006a). Depletion of MSP58 results in mitotic delay and apoptosis, 
suggesting that MSP58 might function in cell cycle progression (Hirohashi et al., 
2006a). Consistent with this, MSP58 expression levels fluctuate in a cell cycle 




As previously mentioned, this thesis concerns the characterisation of four 
Drosophila proteins, two of which (dPrp38 and dMFAPl) are required for pre-mRNA 
processing. In the following section, I have attempted to provide the reader with an 
overview of the different stages of the spliceosome cycle including spliceosome 
assembly, spliceosome activation, and the two catalytic reactions resulting in the 
excision of an intron from a pre-mRNA. I have compiled the mechanistic in vivo data 
obtained in yeast with the proteomic data from studies in mammalian cells to highlight 
similarities and differences between pre-mRNA processing in yeast and metazoans.
1.4.1 The spliceosome cycle
Splicing of pre-mRNA is a catalytic reaction that involves two successive 
trans-esterification steps. This process is carried out by a highly conserved 
ribonucleoprotein complex, named the spliceosome. The spliceosome consists of five 
small nuclear RNAs (snRNAs) (Ul, U2, U4, U5, and U6) and more than 200 proteins, 
making it one of the largest and most complex studied cellular machine (Jurica and 
Moore, 2003). Spliceosome assembly has traditionally been described as a sequential 
process that is initiated by the recruitment of the Ul snRNP to the 5’-splice donor site to 
form a “commitment complex” (E complex in mammals) (Figure 1-11) (Rosbash and 
Seraphin, 1991; Ruby and Abelson, 1988). Subsequently, recruitment of the U2 snRNP 
to the branch site by U2AF65 generates the “pre-spliceosome” (A complex in 
mammals) (Merendino et al., 1999; Singh et al., 2000; Wu et al., 1999; Zorio and 
Blumenthal, 1999). A preformed U4-U5-U6 tri-snRNP unit then binds to the U1-U2- 
pre-mRNA complex to form a “complete spliceosome” (B complex in mammals). In 
order to activate the spliceosome, several conformational rearrangements must take 
place (reviewed in (Brow, 2002)). These include unwinding of base-pairings between 
Ul and the 5’-splice site and between U6 and U4 and are accompanied by the formation 
of new base pair interaction between U6 and the 5’-splice site and U6 and U2. As a 
result, Ul and U4 snRNPs are released from the pre-spliceosome and an active 
spliceosome (B* complex in mammals) is formed (Madhani and Guthrie, 1994; Staley 
and Guthrie, 1998). The activated spliceosome promotes splicing of the pre-mRNA by 
two subsequent catalytic reactions. In the first catalytic reaction, a nucleophilic attack 
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Figure 1-11: Spliceosome assembly and catalysis. Spliceosome assembly is initiated by bind­
ing of the U1 snRNP to the 5’-splice site and U2AF65 to the branch site region to generate the 
commitment complex/E complex. Binding of U2AF65 to the branch site region promotes recruit­
ment of the U2 snRNP to the branch point and formation of the pre-spliceosome/A complex. 
Following recruitment of the tri-snRNP to generate the complete spliceosome/B complex, several 
conformational changes take place, which result in dissociation of the U1 and U4 snRNPs and 
activation of the spliceosome (referred to as the B* complex in mammals). The activated 
spliceosome catalyses the the first transesterification reaction, which involves a nucleophile 
attack by the 2‘ oxygen of the branch point adenosine on the phosphorous atom, which links the 
intron and exon 1. Additional structural rearrangements take place after the first catalytic reaction 
to generate a complex that is competent to carry out the second catalytic reaction. In mammals, 
this complex is referred to as the C complex. The second catalytic reaction involves a nucleophile 
attack of the hydroxyl group of the 3’ nucleotide of exon 1 on the phosphorous atom that links the 
intron with exon 2. As a result, the 3’-end of exon 1 is spliced to the 5’-end of exon 2, and the 
intron is released as a lariat structure. Adapted from (Schroeder et al., 2004).
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links the 5’ exon and the intron displaces the bond to the 5’ exon and forms the intron/3’ 
exon lariat intermediate. Next, a second nucleophilic attack of the 3’ hydroxyl group of 
the 5’ exon on the phosphorous atom, which links the intron with the 3’ exon, results in 
joining of exon 1 with exon 2 to form the mRNA. The intron is released as a lariat 
structure.
1.4.1.1 The “holospliceosome ” models
The assumption that spliceosome assembly occurs in sequential steps has 
partially been based on the isolation of Ul snRNP, U2 snRNP, and the U4-U5-U6 tri- 
snRNP in different complexes. Recently, this model has been challenged by the 
isolation of a penta-snRNP complex from yeast cell extract under low salt conditions 
(Stevens et al., 2002). This penta-snRNP complex also contained the nineteen complex 
(NTc) suggesting that an active spliceosome could form by binding of this pre­
assembled complex to the pre-mRNA. A few observations support this model. First, in 
mammals the association of U4 with U6 is stabilised in the presence of U2 (Brow and 
Vidaver, 1995). Second, in the absence of pre-mRNA a proportion of U2 snRNPs co­
purified with the U4-U5-U6 tri-snRNP in Hela cell extracts under mild salt conditions 
(Konarska and Sharp, 1988). Thus, an “holospliceosome” model for spliceosome 
assembly has been proposed in which a fully assembled spliceosome encounters an 
intron and undergoes ordered series of interactions and allosteric conformational 
changes resulting in catalysis of the first trans-esterification reaction (Brow, 2002). 
Consistent with this model, the reported isolation of Ul and U2 snRNPs as independent 
complexes might be explained by a loose association of these particles with the 
spliceosome during some of the conformational rearrangement steps leading to the 
activation of the spliceosome (Brow, 2002). In the following sections, I will refer the 
“sequential” model to describe the different steps in spliceosome assembly, but each 
step can equally well be interpreted as conformational changes in the 
“holospliceosome” model.
1.4.2 DExD/H-box RNA helicases
The unwinding of RNA-RNA duplexes during the spliceosome cycle 
requires energy and is facilitated by RNA helicases. RNA helicases predominantly 
belong to three highly conserved families of DEAD-box, DEAH-box, and ski2-like
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proteins commonly referred to as DExD/H-box RNA helicases (reviewed in (Bleichert 
and Baserga, 2007).
1.4.2. 1 Conserved domains in DExD/H RNA helicases
DExD/H-box RNA helicases have been classified based on eight 
conserved motifs that reside within two domains. Consistent with the general idea that 
RNA helicases promote unwinding of RNA helixes by hydrolysis of NTPs, most of 
these motifs have been implicated in NTP binding and hydrolysis and/or specifying 
binding of the helicase to its RNA substrate (Figure 1-12). Domain 1 contains motifs I 
(Walker A), la, lb, II (Walker B), III and Q (in DEAD-box proteins) (Tanner et al.,
2003), and domain 2 contains motifs IV, V, and VI. Walker A and B motifs are found in 
many NTP binding proteins and are required for ATP/NTP binding and hydrolysis, 
respectively (Caruthers and McKay, 2002; Cordin et al., 2006; Rocak and Linder,
2004). In DEAD-box helicases, the conserved DEAD consensus amino acid motif that 
gives name to the family resides within the Walker B motif. Motifs la, lb, IV, and V 
are involved in substrate RNA binding (Cordin et al., 2006), and motif III is thought to 
couple NTP hydrolysis with helicase activity (Silverman et al., 2003). There is some 
evidence that motif VI functions in both ATP hydrolysis and binding of substrate RNA 
suggesting that it might provide another link between NTP hydrolysis and helicase 
activity (Pause et al., 1993). Finally, the Q motif is thought to sense ATP binding and 
promote hydrolysis in DEAD-box proteins (Cordin et al., 2006).
1.4.2.2 DExD/H RNA helicases are required at multiple steps of the spliceosome 
cycle
In yeast, three DEAD-box (Sub2p, Prp28p, and Prp5p), four DEAH-box 
(Prp2p, Prpl6p, Prp22p, Prp43p), and one ski2-like (Brr2p) proteins have been 
implicated in the dynamic rearrangements that occurs during the processing of a pre- 
mRNA (de la Cruz et al., 1999; Silverman et al., 2003; Staley and Guthrie, 1998). 
Individual RNA helicases has been shown to function in different steps of the 
spliceosome cycle (Figure 1-13). Sub2p (UAP56 in humans) and Prp5p facilitate 
binding of U2 snRNP to the branch point (Kistler and Guthrie, 2001; O'Day et al., 
1996). The DEAD-box protein, Prp28p, and the ski2-like protein, Brr2p, both function 
in the activation step of the spliceosome (Staley and Guthrie, 1998). Prp28p is thought 
to be important for the unwinding of base-pairings between Ul and the 5’-splice site
61
Domain 1 Domain 2
c
W alker A W alker B
1 1 1  l l
ATP sensor; NTP binding 
regulation of 
A TPase activity;






-n v i- n n — i vi i-
i i







S ubstrate  
RNA binding







Figure 1-12: Domain structure of DExD/H Box RNA helicases. DexD/H Box RNA helicases 
contain eight highly conserved motifs, which reside in two domains. Each of the motifs has been 
assigned different functions including substrate binding, NTP-binding and hydrolysis, and/or 
helicase activity. DEAD-box RNA helicases contain an additional Q motif in the N-terminal of 







Figure 1-13: DExD/H Box RNA helicases function a different stages of the spliceosome cycle.
The yeast DeXD/H box RNA helicases Sub2p and Prp5p facilitate the recruitment of the U2 snRNP 
to the branch point region. Prp28p and Brr2p function during the activation step and are required for 
the release of U1 and U4 snRNPs, respectively. Prp2p is implicated in the structural rearrangements 
that take place prior to the first catalytic reaction. Prp16 functions before and during the second cata­
lytic reaction. Prp22, Prp43, and Brr2p are required for spliceosome disassembly and release of the 
spliced mRNA. Adapted from (Bleichert and Baserga, 2007).
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(Chen et al., 2001b) and Brr2p is implicated in unwinding the U4/U6 duplex, which is 
essential for the release of U4 snRNP (Raghunathan and Guthrie, 1998). Prp2 is 
implicated in structural rearrangements rendering the spliceosome active for the first 
catalytic reaction, and Prpl6 function before or during the second transesterification 
reaction. Finally, Brr2p, Prp43 and Prp22p are required for disassembly of the 
spliceosome and release of the spliced mRNA (Arenas and Abelson, 1997; Company et 
al., 1991; Schneider et al., 2004).
1.4.3 Splice site selection and assembly of the commitment/E complex
1.4.3.1 Assembly of the commitment/E complex
Binding of Ul snRNP to the 5’-splice site of the pre-mRNA occurs in an 
ATP-independent manner and is thought to commit the pre-mRNA to splicing (Rosbash 
and Seraphin, 1991; Ruby and Abelson, 1988). In addition to the Ul snRNP, the 
mammalian E complex contains SF1 (Bbpl in yeast) bound to the branch point 
(Abovich and Rosbash, 1997; Aming et al., 1996) and U2AF bound to the 
polypyrimidine tract (Singh et al., 2000) and to the 3’splice site (Wu et al., 1999). The 
human U2AF splicing factor is a heterodimer consisting of a small (U2AF35) and a 
large (U2AF65) subunit. U2AF65 (Mud2 in yeast) binds to the polypyrimidine tract and 
U2AF35 binds to the 3’-splice site. In humans, U2AF35 is required for splicing of pre- 
mRNAs with non-consensual or weak pyrimidine tracts (Guth et al., 1999). In budding 
yeast, there is no homologue of U2AF35, and the 3'-splice site is not required for the 
first catalytic reaction of splicing (Rymond and Rosbash, 1985). The E complex 
contains an additional set of factors that are required for its stabilisation. These belong 
to the family of SR proteins (see below) and are thought to stabilise the complex by 
generating an extensive network of interactions between the 5’-splice site and the 
branch point and 3’-splice site (Abovich and Rosbash, 1997; Boukis et al., 2004; Shen 
et al., 2004). Thus, the two SR proteins, SF2/ASF and SC35, have both been implicated 
in E complex assembly. SF2/ASF has been shown to increase U 1 snRNP binding to the 
5’-splice site (Eperon et al., 1993; Kohtz et al., 1994), and SC35, which bridges Ul 
snRNP and U2AF35, cross-links with the 3’-splice site (Staknis and Reed, 1994; Wu 
and Maniatis, 1993).
The yeast commitment complex has a less complex structure consisting of 
Ul snRNP bound to the 5’-splice site, Bbpl bound to the branch point, and Mud2p
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bound to the pyrimidine tract. In addition, the formation of a stable commitment 
complex requires cross-intron bridging of complexes at the 5’-splice site and the branch 
point sequence (BPS), which is accomplished by protein-protein interactions between 
Ul snRNP and Bbpl (Abovich and Rosbash, 1997).
1.4.3.2 Yeast and metazoan Ul snRNPs vary in size and composition
Interestingly, the yeast Ul snRNP is significantly larger than the 
vertebrate Ul snRNP. In addition to U1-70K, Ul-A, U1C and Sm proteins B/B’, D l, 
D2, D3, E, and F, which are found in both the yeast and vertebrate Ul snRNPs, the 
yeast U1 snRNP complex contains at least 8 proteins that are not stably associated with 
vertebrate Ul snRNPs. These include Snu71p, Snu65p, Snu56p, Prp39p, Prp40p, 
Prp42p, Nam8, and Luc7p (Fortes et al., 1999; Gottschalk et al., 1998). The reason for 
this difference in Ul snRNP composition might reflect different mechanisms for splice 
site selection in yeast and metazoans. In metazoans, the recruitment of the U1 snRNP 
“core activity44 to the pre-mRNA is thought to be regulated by the combinatorial 
association of a commonly used set of splicing factors with the 5’-splice site. Thus, the 
strength of a given splice site is determined by the combined affinity of the factors at a 
given site for the Ul snRNP core complex (discussed in “SR proteins” section below). 
The ability of the Ul snRNP complex to differentiate between different strengths of 
splice sites is crucial in higher eukaryotes, where regulated and alternative splicing is of 
major importance. Thus, a recent study estimates that at least 74% of multi-exon 
transcripts are alternatively spliced in humans (Johnson et al., 2003). In contrast, these 
processes are almost non-existent in yeast.
1.4.3.3 SR proteins
The splice site sequences in higher eukaryotes display a much higher 
variability than those in yeast. To compensate for this loss in sequence information, a 
family of SR proteins have evolved in higher eukaryotes that recognise and bind to 
weak consensus sequences within the pre-mRNA. The binding of SR proteins to splice 
site sequences generally leads to an increased affinity of the spliceosome for those sites 
(Figure 1-14). SR proteins are characterised by a C-terminal domain rich in 
arginine/serine di-peptides (RS domain), which mediates protein-protein (Wu and 
Maniatis, 1993) and protein-RNA interactions (Shen and Green, 2004; Shen et al., 
2004). In addition, SR proteins contain one or more N-terminal RNA recognition
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Figure 1-14: SR proteins affect the strength of a given splice site. SR proteins binds to exonic 
splicing enhancers (ESE) within exons and promote the recruitment of the U1 snRNP to the 
3’-splice site and U2AF65 and UAF35 (in mammals) to the branch site region and the 5’-splice 
site, respectively. Binding of U2AF65 to the branch site region facilitates the recruitment of the U2 
snRNP. SR proteins mediate cross-intron interactions by interacting with the pre-mRNA and splic­
ing factors bound to the 5’- and 3’-splice sites. Binding of SR proteins to ESEs also play a key role 
in cross-exon recognition by bridging interactions between the U1 snRNP bound at the upstream 
5’-splice site and the U2 snRNP bound at the branch point. Cross-exon recognition can affect the 
strength of the upstream 5’-splice site and is a major determinant in alternative splicing. Taken 
from (Maniatis and Tasic, 2002).
domains (RRMs) that are likely to increase their binding affinities for RNA. Several 
studies suggest that SR proteins bind to the pre-mRNA through their RMMs and RS 
domains and attract the spliceosome through RS domain-mediated protein-protein 
interactions (Crispino et al., 1994; Staknis and Reed, 1994; Wu and Maniatis, 1993; 
Zuo and Maniatis, 1996).
Consistent with the general idea that SR proteins are positive regulators of 
splicing, SF2/ASF and SC35 were shown to activate splicing in vitro (Expert-Bezancon 
et al., 2004). Moreover, they both behave antagonisticly to the inhibitory splicing factor, 
hnRNPAl, by competing for binding to the same sequence element (Expert-Bezancon 
et al., 2004). The antagonistic behaviours of SF2/ASF and hnRNPAl on splicing can be 
explained by their opposite effects on recruitment of Ul snRNP to the 5’-splice site 
(Eperon et al., 2000). SF2/ASF promotes and hnRNPAl inhibits binding of Ul snRNP 
to the 5’-splice site (Eperon et al., 2000). In addition to a function in constitutive 
splicing, SR proteins are thought to play a major role in regulation of alternative 
splicing. Consistent with this, SF2/ASF, SC35, and SRp20 are specifically recruited to 
tau transcription sites when exon 10 is included, but not when it is excluded (Mabon 
and Misteli, 2005).
1.4.3.4 SR protein kinases
SR proteins are extensively phosphorylated by kinases belonging to the 
two familes of SRPK and Clk/Sty proteins (Duncan et al., 1998; Gui et al., 1994; 
Kuroyanagi et al., 1998; Wang et al., 1998). Phosphorylation of SR proteins is thought 
to affect their substrate specificity and ability to regulate alternative splicing (Duncan et 
al., 1997; Prasad et al., 1999; Xiao and Manley, 1997). Thus, hypo- and hyper­
phosphorylation of SR proteins by the Clk/Sty kinase was found to affect both their 
constitutive and alternative splicing activities (Prasad et al., 1999). Phosphorylation of 
SR proteins also affects their intracellular localisation (Caceres et al., 1997; Lai et al., 
2003; Lin et al., 2005; Misteli and Spector, 1996). Thus, SRPK 1-mediated 
phosporylation of ASF/SF2 causes its redistribution from the cytoplasm to nuclear 
storage sites (speckles) (Ma et al., 2008; Ngo et al., 2005). Once inside the nucleus, SR 
proteins are further modified by Clk/Sty kinases, and this is thought to cause their re­
localisation from speckles to splicing sites (Colwill et al., 1996) (Ngo et al., 2005). 
Thus, SR protein kinases regulate both the localisation and the activity of SR proteins
and could potentially function as signal transmitters to modulate spliceosome activity 
according to cellular clues.
1.4.3.5 Heterogenous nuclear ribonuclearproteins
In contrast to SR proteins, some heterogenous nuclear ribonucleoproteins 
(hnRNPs) have been found to function as repressors of splicing. Thus, hnRNPAl 
functions as a general sequence-independent regulator of alternative splicing by 
antagonising the function of SR proteins like SF2/ASF (Eperon et al., 2000). The 
balance between binding of SR proteins and hnRNPs to a pre-mRNA can determine the 
strength of a given splice site provides a mechanism for regulating constitutive and 
alternative splicing in metazoans (reviewed in (Matlin et al., 2005)).
1.4.4 Stepwise assembly of the pre-catalytic spliceosome
1.4.4.1 Formation of the pre-spliceosome/A complex
In contrast to the formation of the commitment/E complex, which occurs 
in an ATP-dependent manner, addition of the U2 snRNP to the pre-mRNA requires 
energy. Consistent with this, two DEAD-box RNA helicases, Sub2p and Prp5p, have 
both been implicated in binding of U2 snRNP to the branch point (Kistler and Guthrie, 
2001; O'Day et al., 1996). Yeast genetics suggest that Sub2p is required for removal of 
Mud2p from the branch point to allow binding of the U2 snRNP. Thus, deletion of the 
MUD2 gene can bypass the requirement for the essential Sub2p RNA helicase (Kistler 
and Guthrie, 2001). Likewise, pre-spliceosome assembly requires Prp5p-dependent 
ATP hydrolysis (Xu et al., 2004), but occurs in an ATP independent manner in the 
absence of Cus2p, suggesting that Prp5p is required for the removal of Cus2p (Perriman 
and Ares, 2000; Perriman et al., 2003). Prp5p is, however, not dispensable in the 
absence of Cus2p, indicating that Prp5p activity is required in a later step (Perriman and 
Ares, 2000). Interestingly, a recent study suggests Prp5p-dependent ATP-hydrolysis 
links with a fidelity event related to base pairing between the branch region and U2 
RNA (Xu and Query, 2007). Xu and co-worker were able to show that reduced Prp5p 
ATPase activity in vitro correlated with improved splicing of substrates with suboptimal 
branch region in vivo, whereas complementary mutations in U2 that increased U2- 
branch region pairing abrogated this effect (Xu and Query, 2007). Thus, the ATP 
requirement for the recruitment of the U2 snRNP and the formation of the pre-
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spliceosome/A complex might provide kinetics that are compatible with a 
proofreading/check point event.
1.4.4.2 Formation of the complete spliceosome/B complex
Although U2/U4/U5/U6 and penta-snRNP complexes can be isolated under 
certain conditions, recent studies support the idea that the A complex is a functional 
intermediate, which can be converted into the B complex by addition of the tri-snRNP. 
Thus, the A complex assembles in vivo in the absence of U4 and U6 RNAs, and 
proceeds to form a functional spliceosome when added to extracts depleted of U2 
snRNPs (Behzadnia et al., 2006; Tardiff and Rosbash, 2006).
Protein-protein interactions between the U4/U5/U6 tri-snRNP and the Ul and 
U2 snRNP-associated proteins are thought to stabilise the complete/B complex and to 
link 3’- and 5’-splice site recognition with the recruitment of the tri-snRNP. Consistent 
with this, SPF30 was found to bridge an interaction between the E complex protein 
U2AF35 and the U4/U5/U6 tri-snRNP protein hPrp3 (Little and Jurica, 2008). Thus, 
SPF30 might provide a link between 3’-splice site recognition and B complex formation 
in metazoans (Little and Jurica, 2008). In yeast, the U5 snRNP proteins Prp8p and 
Brr2p interact with several components of the Ul snRNP including U1-70K, Prp39, and 
Prp40 (Abovich and Rosbash, 1997; Fromont-Racine et al., 1997; van Nues and Beggs, 
2001b). These interactions could provide a link between 5’-splice site recognition and 
the formation of the pre-spliceosome. Importantly, sustained association of the tri- 
snRNP with the pre-mRNA requires unwinding of base pairings between the 5’-splice 
site and the Ul snRNP and formation of new base pairs between the 5’splice site and 
U5 and U6 snRNPs (Lund and Kjems, 2002).
1.4.5 Activation of the spliceosome
The complete/B complex, which consists of all five snRNPs bound to the 
pre-mRNA, is catalytically inactive. Several conformational rearrangements must take 
place in order to generate a mature spliceosome. These include unwinding of the base 
pairings between the Ul snRNP and the 5’ splice site and between U4 snRNP and U6 
snRNP as well as formation of new base pairs between U5 and U6 snRNPs and the 
5’splice site and between U6 and U2 snRNPs. As a result Ul and U4 snRNPs are 
released and the catalytic core of the spliceosome is formed (Figure 1-15). The essential 
DExD/H-box RNA helicases, Prp28 and Brr2p are both implicated in the
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Figure 1-15: Activation of the spliceosome involves unwinding of pre-existing RNA 
duplexes and the formation of new base pairs. The yeast DexD/H-box RNA helicases Prp28p 
and Brr2p are both implicated in the activation step of spliceosome. Prp28p is thought to facilitate 
unwinding of basepairings between the U1 snRNA and the 5’-splice site, which results in the 
release of the U1 snRNP from the complete spliceosome. Brr2p promotes unwinding of the 
U4-U6 duplex and is required for release of the U4 snRNP and spliceosome activation. The small 
G protein, Snu114p, has also been implicated in maturation of the spliceosome and is thought to 
function upstream of Brr2p to regulate its activity. Unwinding of base pairings between U4 and U6 
allows U6 to form new base pairs with the 5’-splice site once the U1 snRNP has been released.
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rearrangements that occurs during activation of the spliceosome. Prp28p is thought to 
be important for the unwinding of base-pairings between Ul and the 5’-splice site 
(Chen et al., 2001b; Staley and Guthrie, 1999). Thus, genetics has shown that the 
requirement for Prp28p function in spliceosome activation can be bypassed by 
mutations that destabilise the interaction between Ul snRNP and the 5’-splice site 
(Chen et al., 2001b). Brr2p is likely to be responsible for unwinding the U4/U6 duplex 
(Raghunathan and Guthrie, 1998). First, U5-200kD, the human homologue of Brr2p, 
has been shown to unwind protein-free U4/U6 in vitro (Laggerbauer et al., 1998). 
Second, Brr2p is required for unwinding of the U4/U6 duplex, release of U4 snRNP, 
and activation of the spliceosome in vivo (Raghunathan and Guthrie, 1998). In addition 
to RNA helicases, several other proteins are required for maturation of the spliceosome 
(discussed below).
1.4.5.1 Prp8p
The integral U5 snRNP protein dPrp8/Prp8p (Lossky et al., 1987; Stevens 
et al., 2001) is thought to play a key role in the activation of the spliceosome. Prp8p is 
the largest known nuclear yeast protein and is thought to orchestrate many of the 
conformational changes that occur during spliceosome maturation by forming multiple 
and dynamic interactions with the pre-mRNA, snRNPs, and splicing factors, (reviewed 
in (Grainger and Beggs, 2005)). prp8 mutant alleles interact genetically with mutations 
in the two genes encoding the RNA helicases Brr2p and Prp28p. This suggests that 
Prp8p might regulate the activity of both DExD/H proteins. Consistent with a role of 
Prp8p in modulating Brr2p activity, genetics has demonstrated that Prp8p regulates 
unwinding of the U4/U6 duplex (Kuhn and Brow, 2000). Thus, 44 different prp8 single 
site mutant alleles were found to suppress a cold sensitive mutation in yeast U4 snRNP 
(U4-csl) (Kuhn and Brow, 2000). The U4-csl mutation results in hyper stabilisation of 
the U4/U6 duplex and the accumulation of pre-catalytic spliceosomes containing stable 
U4/U6 dimers (Kuhn et al., 1999; Murray and Jarrell, 1999; Staley and Guthrie, 1998, 
1999). The observed defect in pre-mRNA splicing in the U4-csl mutant is due to 
masking of a site in U6 that is required for its base pairing with the 5’-splice site (Li and 
Brow, 1996). These and other data lead Kuhn and Brow to propose a model in which 
Prp8p facilitate unwinding of the U4/U6 duplex only when U6 can correctly recognise 
the 5’-splice site (Kuhn and Brow, 2000). Thus, Prp8p might function as a control 
switch that negatively regulates the activity of Brr2p and possibly Prp28p until a signal
71
indicates that all factors are in place to support splicing (Reviewed in (Grainger and 
Beggs, 2005). In addition to Brr2p, the GTPase Snull4p (Bartels et al., 2002; Small et 
al., 2006) and the tri-snRNP proteins Prp38p and Spp381 (Lybarger et al., 1999; Xie et 
al., 1998) are all required for U4 snRNP release and spliceosome activation. Thus, these 
proteins are possible candidates for signalling upstream of Prp8p and/or Brr2p to 
promote Brr2p RNA helicase activity.
1.4.5.2 SnulUp
A recent study suggests that Snull4p acts as a classic regulatory G protein to 
regulate both spliceosome activation and disassembly (Small et al., 2006). Thus, 
unwinding of the U4/U6 helix and disassembly of the postsplicing U2/U6-U5-intron is 
repressed by Snull4p bound to GDP and derepressed by Snull4p bound to GTP or a 
non-hydrolysable GTP analogue (Small et al., 2006). Like Snull4p, Brr2p is also 
required for spliceosome activation and disassembly, and both are associated with the 
spliceosome throughout the splicing cycle (Lebaron et al., 2005; Ohi et al., 2002; 
Stevens et al., 2002). Moreover, Snul 14p and Brr2p both bind directly to Prp8p (Achsel 
et al., 1998; van Nues and Beggs, 2001a), and prp8 mutant alleles interact genetically 
with mutations in snul44 (Brenner and Guthrie, 2005) and brr2 (Kuhn et al., 2002; van 
Nues and Beggs, 2001a). This lead Small and co-workers to propose that changes in the 
guanine nucleotide state of Snullp regulates Brr2p activity required for unwinding of 
the U4/U6 duplex either directly or upstream of Prp8p (Small et al., 2006). The signal 
that induces the switching of Snul 14p from a GDP to a GTP bound state and vice versa 
remains to be identified.
1.4.5.3 Prp38p and Spp381
Prp38p was the first splicing factor reported to function in the activation 
of the spliceosome (Xie et al., 1998). Prp38p is a small acidic protein associated with 
the U4/U6-U5 tri-snRNP. Like Brr2p, Prp8p, and Snull4p, Prp38p activity is 
dispensable for the initial assembly of the spliceosome, but is required for the release of 
U4 snRNP and activation of the spliceosome (Xie et al., 1998). The molecular function 
of Prp38 in spliceosome activation is not clear, but it has been speculated that Prp38p 
might recruit (or activate) an RNA unwinding activity necessary for the release of U4 
snRNA and the integration of U6 snRNA into the active site of the spliceosome (Xie et 
al., 1998). As discussed above, Brr2p is likely to represent the RNA unwinding activity
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required for the release of U4 snRNP. The observation that Brr2p is stably associated 
with the spliceosome throughout the splicing cycle suggests that Prp38p is more likely 
to activate than recruit Brr2p (Ohi et al., 2002; Stevens et al., 2002).
The essential protein, Spp381, was identified in a dosage suppressor 
screen for proteins that function together with Prp38p (Lybarger et al., 1999). Like 
Prp38p, Spp381 is a small acidic protein associated with the U4/U6-U5 tri-snRNP. 
Spp381 interact directly with Prp38p and is required for splicing in vivo (Lybarger et 
al., 1999). Oddly, Spp381 does not appear to be required for splicing in vitro, and thus 
the splicing step at which Spp381 is required has not been determined (Lybarger et al., 
1999).
1.4.5.4 Nineteen-complex (NTc)
A pre-assembled Prpl9p-associated protein complex, named the NTc in 
yeast (Tam et al., 1994) and the Prpl9-CDC5 complex in humans (Ajuh et al., 2000; 
Makarova et al., 2004) plays an important role in the activation step of the spliceosome 
(Chan et al., 2003; Makarova et al., 2004). The budding yeast NTc consists of at least 
eleven tightly associated components most of which are evolutionary conserved. These 
include Ntc90/Syflp, Ntc85/Ceflp (Cdc5 in S. Pombe), Ntc77/Clflp, Ntc50/Prp46p, 
Ntc40/Cwc2p and Prpl9p encoded by essential genes, and Ntc31p/Syf2p, 
Ntc30p/Isylp, Ntc25p/Snt309p, and Ntc20p, which are not essential for growth (Chen 
et al., 2001a; Chen et al., 2002; Chen et al., 1998; Tsai et al., 1999). Prpl9p, due to its 
ability to form tetramers (Ohi et al., 2005), is thought to function as a main organiser of 
the NTc. Consistent with this, mutations in Prpl9p results in degradation of Ceflp and 
NTc instability (Ohi and Gould, 2002). The human Cdc5-Prpl9 complex consists of at 
least 8 components and possibly as many as 30 (Ajuh et al., 2000; Makarova et al.,
2004). Of these, Cdc5 and Prpl9 are the only proteins that share homology with 
components of the NTc (Makarova et al., 2004).
The NTc enters the spliceosome around the time of the release of U1 and 
U4 snRNPs (Tam et al., 1993). This led to the hypothesis that NTc might activate the 
spliceosome by promoting the release of U4 and/or U1 snRNPs (Tam et al., 1993). 
However, recent studies have demonstrated that the NTc complex associates with the 
spliceosome only after dissociation of U1 and U4 snRNPs, and therefore is not required 
for the release of U4 snRNP (Bessonov et al., 2008; Chan et al., 2003). Instead the NTc 
appear to function by stabilising the interactions of U5 and U6 snRNPs with the pre-
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mRNA after the release of U1 and U4 snRNPs (Chan and Cheng, 2005; Chan et al., 
2003). This stabilisation is achieved in part by specifying the interaction between U6 
and the 5’-splice site and between U5 and the pre-mRNA (Chan and Cheng, 2005; Chan 
et al., 2003). In humans, the Cdc5-Prpl9 complex joins the B-complex after addition of 
the tri-snRNP and prior to the first catalytic reaction (Makarova et al., 2004). Moreover, 
the Cdc5-Prpl9 complex is required for the first catalytic reaction to take place 
(Makarova et al., 2004). Thus, despite the striking difference in composition of the NTc 
and the Cdc5-Prpl9 complex, their function in spliceosome activation may be 
conserved between yeast and humans (Makarova et al., 2004).
Recently, an additional NTc component, Yju2, was discovered, which 
associates with the NTc in a dynamic manner (Liu et al., 2007). Thus, whereas NTc 
remains associated with the spliceosome throughout both catalytic reactions, Yju2 
dissociates from the NTc after the first catalytic step (Liu et al., 2007). Consistent with 
this, Yju2 was found to be required for pre-mRNA splicing in vivo and in vitro, and to 
promote the first catalytic reaction in concert with a heat resistant unknown factor (HP) 
(Liu et al., 2007).
In addition to a function in spliceosome activation, the NTc has also been 
implicated in U4/U6 biogenesis and spliceosome recycling (Chen et al., 2006a). Thus, 
cells depleted of NTc components accumulate free U4 snRNPs concomitant with 
reduced U4/U6 snRNP levels and exhibit impaired splicing and growth (Chen et al., 
2006a). The accumulation of U4 is a consequence of insufficient amounts of U6, since 
over-expression of U6 in NTc-depleted cells prevents accumulation of U4 and partially 
rescues the growth defect (Chen et al., 2006a).
Interestingly, Prpl9p contains a U-box at its N-terminus with structural 
similarity to RING finger domains (Ohi et al., 2003). Like many RING finger proteins, 
both human and budding yeast Prpl9 exhibit E3 ubiquitin ligase activity in vitro (Ohi et 
al, 2003). The importance of this activity for their function in splicing remains to be 
determined, but it is possible that the Prpl9 proteins regulate the activity of certain 
splicing factors via ubiquitylation. Thus, because Snull4p is ubiquitylated (Peng et al., 
2003), it has been proposed that Prpl9p might regulate the guanine bound state of 
Snul lp by reversible ubiquitylation (Small et al., 2006).
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1.4.6 Excision of an intron by a two step catalytic reaction
1.4.6.1 The first catalytic reaction
The DExD/H-box RNA helicase Prp2p is required subsequent to U4/U6 
unwinding, but prior to the first catalytic reaction (Kim and Lin, 1996). ATP hydrolysis 
by Prp2p is thought to induce structural rearrangements of the spliceosome required for 
the first catalytic reaction to take place (Kim and Lin, 1996). The essential gene 
encoding Spp2 interacts genetically with the Prp2-1 mutation and is thought to be 
required for Prp2p function, possibly by mediating Prp2p binding to the spliceosome. 
Upon ATP hydrolysis, both proteins appear to leave the spliceosome, and no further 
rearrangements are required prior to the first attack of the branch point on the 5’-splice 
site. The first catalytic reaction involves a nucleophile attack by the 2’ oxygen of the 
intronic branch point adenosine on the phosphorous atom that links the 5’exon and the 
intron. This results in the displacement of the phosphodiester bond between the intron 
and the 5’ exon and the formation of an intron/3’ exon lariat intermediate.
1.4.6.2 The second catalytic reaction
For the second catalytic reaction to occur, a 3’-splice site must be selected, 
and the phosphorous atom, which links the intron with the 3’ exon, must be positioned 
for attack by the 3’ hydroxyl group of the 5’ exon. Consistent with this idea, most 
second step factors have been implicated in 3’-splice site selection and/or restructuring 
of the spliceosome. The essential DExD/H-box RNA helicase Prpl6p binds to the 
spliceosome after lariat intermediate formation (Schwer and Guthrie, 1991), and its 
ATPase activity promotes the structural rearrangements that take place prior to the 
second catalytic reaction (Schwer and Guthrie, 1992). The association of Prpl6p with 
the spliceosome is transient, and its release upon ATP hydrolysis is required for the 
second catalytic reaction to occur (Schwer and Guthrie, 1991). Interestingly, the rate of 
Prpl6p-dependent ATP hydrolysis and release of Prpl6p from the spliceosome has 
implications for spliceosome fidelity (Villa and Guthrie, 2005). Thus, in prpl6  mutants 
with reduced ATPase activity, the release of Prpl6p is inhibited and as a result splicing 
of pre-mRNAs with mutated branch points occurs with increased frequency (Burgess 
and Guthrie, 1993). Splicing fidelity is restored in prpl6  mutants upon deletion of the 
gene encoding the NTc factor Isylp (Villa and Guthrie, 2005). Consistent with this, 
deletion of Isylp is found to promote the release of mutant Prpl6p, thereby allowing
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activation of the second step of splicing with normal kinetics (Villa and Guthrie, 2005). 
Moreover, in an ISY1 single mutant strain, fidelity of the 3’-splice site is reduced (Villa 
and Guthrie, 2005). Thus, Prpl6p and Isylp are likely to be part of a surveillance 
mechanism that ensures proper selection of the 3’-splice site before initiation of the 
second catalytic step.
The non-essential yeast protein Prpl7p is thought to join the spliceosome 
together with Prpl6p in an ATP-dependent manner (Jones et al., 1995). Consistent with 
it being non-essential, Prpl7p is only required for maximum efficiency of second 
catalytic step in vitro (Jones et al., 1995). The presence of Prpl7p at the 3’-splice 
suggests that it might affect splice site recognition (Umen and Guthrie, 1995a). Unlike 
Prpl6p, it remains associated with the 3’-splice site upon ATP hydrolysis (Umen and 
Guthrie, 1995a).
Subsequent to Prpl6p release, the catalytic reaction itself occurs in an 
ATP-independent manner. This step involves the essential factors Slu7p and Prp8p, and 
the non-essential factor Prpl8p (Grainger and Beggs, 2005; Umen and Guthrie, 1995c). 
Based on a number of studies, Prp8p is thought to be required for stabilisation of 
U5/exon interactions (Aronova et al., 2007; Teigelkamp et al., 1995). Thus, cross- 
linking studies have shown that Prp8p binds to U5 and to bases at the ends of both 
exons (Teigelkamp et al., 1995). A function of Prp8p in stabilising interactions between 
the 5’-splice site and U5 is further supported by the finding that the prp8-R1753 mutant 
allele, which is thought to weaken spliceosome/exon interactions, is suppressed by 
mutations in U5 that are thought to strengthen the interaction of U5 with the exons 
(Aronova et al., 2007).
Prpl8p is also thought to stabilise the interaction between U5 and the 
exons. Thus, gain of function mutations in prpl8  was found to suppress the prp8-Rl 753 
mutation (Aronova et al., 2007). This is consistent with previous studies carried out 
with another prpl8  mutant allele (Bacikova and Horowitz, 2005; Crotti et al., 2007), 
suggesting that Prpl8p function together with Prp8p to stabilise U5/exon interactions.
Consistent with its function after Prpl6p release, Slu7p crosslinks most 
strongly with the 3’-splice site after ATP hydrolysis and just before the second catalytic 
step (Umen and Guthrie, 1995b). In vitro studies suggest that Slu7p is required for 
proper positioning of the 3’ hydroxyl of exon 1 for its attack on the 3’-splice site 
phosphodiester bond (Chua and Reed, 1999). Consistent with this, Slu7p affects 3’- 
splice site selection in vitro in yeast (Frank and Guthrie, 1992) and humans (Chua and
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Reed, 1999). Moreover, gain-of-function mutations in prpl8  were found to suppress 
slu7 mutants, suggesting an additional role for Slu7p in U5/exon stabilisation (Aronova 
et al., 2007).
Prp8p, Prpl6p, Prpl7p, Prpl8p, and Slu7p are all evolutionary conserved, 
and previous studies suggest that the human proteins Prpl6, Prpl7, Prpl8, and Slu7 
function before or during the second catalytic reaction (Horowitz and Krainer, 1997; 
Umen and Guthrie, 1995a; Zhou and Reed, 1998). Thus, the mechanism underlying the 
second catalytic reaction is likely to be conserved between yeast and higher eukaryotes.
1.4.7 Disassembly of the spliceosome
Release of the spliced mRNA and disassembly of the spliceosome requires 
energy and involves the three DExD/H-box helicases Brr2p, Prp22p and Prp43p. 
Prp22p binds to the spliceosome at the stage of exon ligation (James et al., 2002b) and 
is required for release of the spliced mRNA (Schwer and Gross, 1998; Wagner et al., 
1998). Moreover, Prp22p was shown to provide an ATP-dependent proofreading 
activity that discriminates against splicing of pre-mRNAs containing intronic mutations 
(Mayas et al., 2006). Mayas and co-workers were able to show that the proofreading of 
intronic intermediates is disabled in prp22 mutants that are impaired in ATPase or RNA 
unwindase activity (Mayas et al., 2006). Thus, Prp22p is another example of a 
DExD/H-box helicase that confers fidelity to the spliceosome at the expense of ATP- 
hydrolysis. Prp43p replaces Prp22p (James et al., 2002b) and promotes release of the 
excised intron and disassembly of the spliceosome (Arenas and Abelson, 1997; Martin 
et al., 2002; Tsai et al., 2005; Tsai et al., 2007).
In addition to Prp43, Snull4p and Brr2p are both required for disassembly of 
the postsplicing U2/U6-U5-intron complex. Thus, intron release and spliceosome 
disassembly are blocked by mutations in prp43 (Small et al., 2006; Tsai et al., 2005), 
brr2 (Small et al., 2006), and snull4  (Small et al., 2006). As previously mentioned, 
spliceosome assembly is repressed by Snull4p bound to GDP and derepressed by 
Snul 14p bound to GTP or a non-hydrolysable GTP analogue (Small et al., 2006). This 
led Small et al to propose a model where spliceosome dynamics are regulated by the 
guanine nucleotide-bound state of Snull4p (Figure 1-16). According to this model, 
upon release of U4 snRNP and completion of spliceosome activation, a signal induces 
GTP hydrolysis switching Snul 14p to its GDP bound inactive state during the chemical 









Figure 1-16: Activation of the spliceosome by Snu114p. A model has been put forward, which 
proposes that the guanine nucleotide state of Snu114p might regulate Brr2p activity to control 
spliceosome activation and disassembly. According to this model, Snu114p switches between its 
GDP-bound inactive and GTP-bound active form during the spliceosome cycle. The GTP-bound 
form of Snu114p activates Brr2p, which in turn executes the RNA helicase activities required for 
spliceosome activation or disassembly. In between spliceosome activation and disassembly, 
Snu114p-mediated GTP hydrolysis results in Brr2p inactivation. The signal that triggers GTP 
hydrolysis remains to be identified. Taken from (Small et al., 2006).
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for GTP to activate Snull4p and promote intron release and spliceosome disassembly. 
Snull4p might then revert to its GDP bound inactive form until the next round of 
spliceosome activation (Small et al., 2006). Thus Snull4p could function as a 
regulatory switch to modulate the function of Brr2p, which in turn executes the RNA 
helicase activities required for spliceosome activation and disassembly.
1.4.8 The mammalian spliceosome
In yeast, biochemistry combined with the ease of genetics has contributed 
hugely to our understanding of the dynamic structure of the spliceosome. As discussed 
above, temperature-sensitive mutations in genes encoding splicing factors have been 
used extensively to study the function of individual splicing factors in vitro and in vivo. 
Moreover, conditional inactivation of splicing factors required at specific steps of the 
spliceosome cycle has facilitated the purification and characterisation of various 
spliceosome intermediates.
To date, the human spliceosome has almost exclusively been studied using 
proteomics. The isolation and comparison of different splicing intermediates have 
revealed that by and large, removal of an intron from a pre-mRNA occurs by the same 
sequential process in yeast and humans. The majority of the information concerning the 
dynamics of the spliceosome has been derived from proteomics studies comparing the 
compositions of the complete spliceosome (complex B), complex B lacking U1 snRNP, 
but still retaining base pairing between U4 and U6 (BA 1C), the activated spliceosome 
(B*), which is capable of catalysing the first step, and complex C, which catalyse the 
second step (Figure 1-17) (Bessonov et al., 2008; Deckert et al., 2006; Jurica et al., 
2002; Makarov et al., 2002; Makarova et al., 2004).
Mass spectrometry analysis of complexes B and C has revealed that the 
composition of the spliceosome changes substantially upon activation (Bessonov et al., 
2008). As expected, U1 and U4 snRNP proteins are lost in complex C, whereas factors 
required for the second catalytic step are enriched. Upon activation of the spliceosome, 
the Cdc5-Prpl9 complex appears to become more stably associated with the 
spliceosome. This is consistent with the reported association of the similar yeast NTc 
with the spliceosome during the activation step. Finally, proteins comprising the 
heterodimeric SF3a and SF3b complex are largely underrepresented in the C versus B 
complex. SF3a and SF3b complexes contact the pre-mRNA at and/or upstream of the 
BPS and stabilise the U2-BPS interaction (Gozani et al., 1996). Whereas this
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Figure 1-17: Purification of mammalian spliceosome intermediates. (A) The dynamics of the 
mammalian spliceosome has mainly been studied by comparing the composition of different 
splicing intermediates. Various methods have been employed to obtain highly homogenous purifi­
cations of trapped splicing intermediates. Purification of the A complex was accomplished by 
depletion of ATP, since assembly of the A complex, but not the B complex occurs in an ATP- 
independent manner. The BA1C complex was purified using an antibody directed against an 
U4/U6-specific 61K protein. The B* complex was isolated using an antibody against SKIP, which 
is not associated with the tri-snRNP or the B complex, but joins the spliceosome prior to the first 
catalytic reaction. B and later C complexes were assem bled onto PM5 pre-mRNAs containing 
the BPS and the pyrimidine tract, but lacking the 3’-splice site and 3’-exon (B). The coliphage coat 
protein MS2 was used to purify complexes assem bled onto the MP5 pre-mRNA at early (B com­
plex) and late (C complex) time points. The C complexes assem bled onto PM5 represent authen­
tic intermediates, since they are able to catalyse the second transesterification reaction when 
offered a 3’-splice site-containing RNA in trans. Figures adapted from (Bleichert and Baserga, 
2007) (A) and (Bessonov et al., 2008) (B).
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stabilisation is likely to be important for the formation of the B complex, the function of 
SF3a and SF3b complexes might not be important for the second catalytic step.
The activated form of the spliceosome required for the first catalytic 
reaction, complex B*, has been purified using an antibody against Ski oncogene 
interacting protein (SKIP). SKIP is neither associated with U4/U6-U5 tri-snRNPs 
(Neubauer et al., 1998) nor present in B complexes (Hartmuth et al., 2002), but is 
recruited to the spliceosome at a later stage before the first catalytic step (Makarov et 
al., 2002). Moreover, SKIP remains bound throughout both catalytic steps and 
ultimately is released with the spliced-out intron (Makarov et al., 2002). SKIP 
purifications were performed at a time point compatible with complex B* formation, 
but before the first catalytic step. Comparison of constituents of the B* complex with C 
complexes (Bessonov et al., 2008; Jurica et al., 2002) revealed that second step factors 
are absent in the B* complex. Thus, second step factors are recruited to the spliceosome 
concomitant or after the first catalytic step (Makarov et al., 2002). Moreover, all SF3a 
and SF3b subunit components are present in B* suggesting that they become more 
loosely associated with the spliceosome during or after the first catalytic step (Makarov 
et al., 2002). As expected, no U1 snRNP-specific proteins were present in the B* 
complex. Moreover, all U4 and U4/U6 snRNP-specific proteins and two tri-snRNP 
proteins were absent in the B* complex (Makarov et al., 2002). This is likely to be due 
to the dissociation of U4 from U6 and its subsequent release that takes place during the 
activation of the spliceosome. The Cdc5-Prpl9 complex is present in the B* complex 
and thus becomes stably associated with the spliceosome prior to the first catalytic step 
(Makarov et al., 2002).
In yeast, many conformational changes and structural rearrangements take 
place after the addition of the tri-snRNP and before the first catalytic step. To further 
investigate the dynamics during this process, Luhrmann and co-workers used an 
antibody that recognises the U4/U6-specific 61K protein to isolate a spliceosomal 
intermediate that contains an intact U4/U6-U5 snRNP, but lack the U1 snRNP (BA 1C) 
(Makarova et al., 2004). Cross-linking studies showed that U4 and U6 are still base 
paired in the BA 1C complex, indicating that this complex represents an intermediate 
step between the formation of the B and the B* complex. Consistent with this, the tri- 
snRNP is largely intact in the BA 1C complex, whereas all U4/U6 specific proteins are 
lost in the B* complex. Mass spectrometry analysis of the BA 1C complex revealed the
81
absence of the Cdc5-Prpl9 complex. Thus, the Cdc5-Prpl9 complex joins the 
spliceosome after the addition of the tri-snRNP, but before the first catalytic step 
(Makarov et al., 2002; Makarova et al., 2004). Consistent with this, Cdc5-Prpl9 
complex function is required for the first catalytic step (Makarova et al., 2004).
The above studies suggest that the majority of the information derived 
from functional studies of the spliceosome in yeast is relevant to spliceosome function 
in humans. Like in yeast, U1 and U4 snRNPs are lost during spliceosome activation, the 
Cdc5-Prpl9 complex joins the spliceosome after the addition of the tri-snRNP and prior 
to the first catalytic step, and a set of highly conserved second step factors are recruited 
to the spliceosome prior to the second catalytic step (Bessonov et al., 2008; Deckert et 
al., 2006; Jurica et al., 2002; Makarov et al., 2002; Makarova et al., 2004).
Significant progress in purification of splicing intermediates combined 
with proteomics has contributed a great deal to our understanding of the dynamics of 
the spliceosome. However, very little is known about its three-dimensional structure. 
This is mostly due to the highly complex and dynamic nature of the spliceosome and 
the difficulty of obtaining homogenous preparations of splicing intermediates. In spite 
of this, the recent years of research have seen advances in obtaining low-resolution 
images of different spliceosome intermediates using cryo-electron microscopy. 
Moreover, high-resolution studies have been carried out on a smaller scale (Deckert et 
al., 2006; Jurica et al., 2004; Sander et al., 2006; Schellenberg et al., 2006; Stark and 
Luhrmann, 2006). Thus, the future holds a promise that major advances will be made in 
understanding this highly complex cellular machine in the next few years.
1.4.9 Links between cell cycle and splicing
1.4.9.1 Yeast studies
The first clues that pointed to a link between splicing and cell cycle 
progression came from studies in yeast. A number of genes that were originally isolated 
in genetic screens for cell cycle regulators were later shown to function in splicing 
(Hwang and Murray, 1997; Johnston and Thomas, 1982; Lundgren et al., 1996; 
Nasmyth and Nurse, 1981; Potashkin et al., 1998; Shea et al., 1994; Takahashi et al., 
1994; Vaisman et al., 1995; Vijayraghavan et al., 1989). These include prp3, prp!7, 
prp8, cefl, prp22 (S. cerevisiae) (Boger-Nadjar et al., 1998; Hartwell et al., 1973; 
Hwang and Murray, 1997; Johnston and Thomas, 1982; Ohi et al., 1998; Shea et al.,
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1994; Vaisman et al., 1995) and prp2, cdc28/prp8, and cdc5 (S. pombe) (Lundgren et 
al., 1996; Nurse et al., 1976; Ohi et al., 1998; Takahashi et al., 1994). Whereas 
mutations in some of these genes cause cells to arrest heterogeneously throughout the 
cell cycle, cefl-13, prpl7A, andprp22-l mutants arrest homogenously in G2/M (Bums 
et al., 2002). The source of the variability in timing and cell cycle arrest phenotypes 
among splicing factor mutants is unclear. It is possible that the observed range of cell 
cycle arrest phenotypes reflects differences in the severity of splicing defects in those 
mutants. Moreover, a model has been put forward to explain the variability of the 
timing of cell cycle arrest, which suggests that splicing factors are differentially 
required for efficient splicing of single transcripts or a subset of transcripts (Bums et al., 
2002). Consistent with this idea, removal of a single intron from the a-tubulin-encoding 
gene TUB1 alleviates both the G2/M arrest and cell division defect observed in the cefl- 
13 mutant, but only partially rescues the cell division defect observed in theprpl7A  and 
prp22-l mutants (Bums et al., 2002; Chawla et al., 2003). Instead, the G2/M arrest and 
growth defect in the prpl 7A mutant can be rescued by removal of an intron from the 
ANC1 gene (Dahan and Kupiec, 2004). The molecular basis for this specificity remains 
unclear.
1.4.9.2 Mammalian studies
A number of studies carried out in vertebrate cells suggest that splicing 
and cell cycle progression are also connected in higher eukaryotes. For instance, the 
human homologue of Ceflp/Cdc5 (S. cerevisiae/S. pombe) was found to regulate G2 
progression and mitotic entry. Thus, over-expression of hCdc5 shortens G2, whereas 
expression of a dominant negative mutant of hCdc5 slows down G2 progression and 
delays entry into mitosis (Bernstein and Coughlin, 1998). ASF/SF2 is another splicing 
factor that is required for cell cycle progression. Conditional knockout of ASF/SF2 in 
chicken B-cells results in G2/M arrest and programmed cell death (Li et al., 2005a). A 
third example is U2AF35, which is required for splicing of pre-mRNAs with non- 
consensual or weak pyrimidine tracts (Guth et al., 1999). Depletion of human U2AF35 
results in reduced cell viability and mitotic arrest (Pacheco et al., 2006). The mitotic 
arrest might be a consequence of the strong effect that U2AF35 depletion has on Cdc25 
mRNA levels, since Cdc25 is required for progression through mitosis (Pacheco et al.,
2006).
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So far, studies of vertebrate splicing factors and their requirement for cell 
cycle progression are few and mostly concern splicing factors that are only required for 
processing of a subset of mRNAs. It still remains to be addressed whether inactivation 
of different core components of the metazoan spliceosome would give rise to the same 
variability in cell cycle phenotypes observed in yeast. In this context it is worth 
mentioning that a recent genome wide RNA interference screen in Hela cells for genes 
required for cell division identified a few, but far from all core components of the 
splicing machinery (Kittler et al., 2004).
1.4.10 Splicing defects as a primary cause of disease in higher eukaryotes
Mutations in c/s-acting elements can result in the disruption of splicing codes 
required for recruitment of the splicing machinery, the generation of cryptic splice sites, 
and the alteration of secondary structures within the pre-mRNA. Several studies suggest 
that mutations in ds-acting splicing elements are the primary cause of many human 
diseases. Thus, a recent study estimates that 60% of mutations that cause diseases do so 
by disrupting splicing (Lopez-Bigas et al., 2005).
Whereas mutations in cis-acting splicing elements are likely to affect just one 
transcript, mutations in splicing factors or proteins required for spliceosome function 
can potentially affect splicing of several transcripts. Consistent with key role of splicing 
factors in regulating gene expression, mutations in trans-acting factors have been 
reported for several diseases. Two examples are spinal muscular atrophy (SMA) and 
retinitis pigmentosa, the most common form of blindness (Mordes et al., 2006; Winkler 
et al., 2005). SMA is caused by loss of the survivor o f motor neuron-1 (smnl) gene 
product, which has been implicated in maturation of snRNPs (Winkler et al., 2005). 
Whereas a defect in maturation of snRNPs has not been proven to be the primary cause 
of SMA, spliceosome function is likely to be altered in this disease. Retinitis 
pigmentosa has in several cases been linked with mutations in three core components of 
the spliceosome, Prpf31, Prpf8, and hPrp3, suggesting that altered splicing patterns in 
some cases is the primary source of this disease (Chakarova et al., 2002; McKie et al., 
2001; Vithana et al., 2001).
There is clear evidence that mutations in cis-acting elements of oncogenes, 
tumor suppressors and other cancer-relevant genes or in trans-acting factors that 
regulate their splicing are a frequent source of cancer initiation and progression 
(reviewed in (Srebrow and Komblihtt, 2006)). Proteins belonging to the SR protein
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family constitute a group of trans-acting factors that are frequently mutated in various 
types of cancer (Ghigna et al., 2005; Kami et al., 2007; Sjoblom et al., 2006). As 
previously discussed, SR proteins function in splice site selection and have been 
implicated in regulated and alternative splicing. Thus, mutations in SR proteins are 
likely to affect the expression of only a subset of genes and could potentially target 
oncogenes or tumor suppressor genes specifically.
Genome-wide microarray assays to assess the splicing differences associated 
with normal variation or disease might prove useful for detecting alternative splicing 
signatures related with specific diseases and therefore may provide a future tool for 
diagnosing many diseases.
1.4.11 The spliceosome -  an evolutionary conserved splicing machine
Group II self-splicing introns catalyse auto-excision from pre-mRNAs by 
a strikingly similar chemical reaction to that catalysed by the spliceosome. This has led 
to the general belief that RNAs form the catalytic core of the spliceosome, and that 
RNAs are largely responsible for the excision of intronic sequences. In addition to five 
RNAs, the spliceosome comprises more than 200 splicing factors, making it one of the 
most complex cellular machineries. The vast number of splicing factors is thought to 
assist the conformational changes of the RNAs required for the catalytic reactions to 
take place.
So what are the advantages of having a macromolecular complex over 
group II self-splicing introns, given that both are capable of excising an intron from a 
pre-mRNA? First, the requirement for trans-acting factors means that splicing can be 
regulated by modulating the levels of individual splicing factors and/or their activities. 
This is particularly striking in metazoans where alternative splicing of multi-exon pre- 
mRNAs occurs frequently and in a highly regulated manner. Second, the presence of 
multiple weak consensus splicing sites within the same pre-mRNA puts a high demand 
on the spliceosome for splice site recognition. Consistent with this, additional splicing 
factors, including SR proteins, are required to ensure substrate specificity. The 
combinatorial binding of SR proteins and other factors to weak consensus sequences in 
the pre-mRNA is thought to determine the strength of a given splice site. Third, the 
substrate specificity of SR protein depends on their phosphorylation status, which in 
turn is regulated by SR protein kinases. Thus, reversible phosphorylation events 
regulates the recruitment of the spliceosome to a particular splice site and allows the
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temporal expressing of a subset of genes in response cellular signalling. Fourth, it has 
recently become clear that the spliceosome contains an intrinsic quality surveillance 
system. Thus, ATP-hydrolysis by DExD/H RNA helicases is thought to provide kinetics 
that are compatible with substrate proofreading at multiple steps of the spliceosome 
cycle. Prp5p dependent ATPase activity ensures that the U2 snRNP is base paired only 
with optimal branch point sequences. ATP hydrolysis by Prpl6p provides kinetics that 
are compatible with a proofreading event prior to the second catalytic reaction. Prp22p 
provides an ATP-dependent activity that discriminates against excision of mutated 
introns. Thus, the spliceosome has evolved to become a high-fidelity splicing 
machinery with a substrate specificity that can be fine-tuned according to the metabolic 
state of the cell. Future research will reveal more structural details of this highly 
dynamic and complex cellular machine.
86
1.5 Translation initiation
The fourth Drosophila protein characterised in my thesis, Pixie/RLI/Riip 
(Drasop/n/tf/humans/yeast), is required for normal levels of translation initiation in flies 
(shown here) and yeast (Dong et al., 2004; Kispal et al., 2005; Yarunin et al., 2005). 
Thus, in the fourth and final section of the introduction, I have attempted to provide the 
reader with an overview of translation with an emphasis on translation initation. This 
section also includes a brief introduction to insulin signalling, which regulates protein 
synthesis at several stages including translation initiation and elongation.
1.5.1 Assembly of a functional 80S ribosome
Translation initiation is a multi-step process involving the sequential 
assembly of various large pre-initiation complexes (PICs) (Figure 1-18). First, 
eukaryotic initiation factor (elF) 1, elFlA, eIF3, eIF5 and the ternary complex (TC), 
which consists of eIF2 bound to GTP and the initiator tRNAjMet, are recruited to the 
small 40S ribosomal subunit to form the 43 S PIC. Then, the 40S subunit binds to the 
capped 5’end of the mRNA in a reaction requiring eIF4E, eIF4G, eIF4A, and eIF4B. 
This complex scans the mRNA and positions itself on the correct initiation AUG codon, 
thereby forming the 48S PIC. Finally, the elFs are displaced by the large 60S ribosomal 
subunit in an eIF5B-dependent reaction to generate functional 80S ribosomes (Chen, 
2000; Hinnebusch, 2000).
1.5.1.1 eIF3
The eIF3 complex is composed of at least 13 different subunits in 
mammals (eIF3a-m) and flies (eIF3-Sl-13) ((Lasko, 2000) and reviewed in 
(Hinnebusch, 2006)). Only six of the 13 subunits are conserved in budding yeast. Thus, 
budding yeast eIF3 is composed of Tif32p/eIF3-S10/eIF3a, Niplp/eIF3-S8/eIF3b, 
Prtlp/eIF3-S9/eIF3c, Tif35p/eIF3S-4/eIF3g, Tif34p/eIF3-S2/eIF3i, and one loosely 
associated component, Hcrlp/Adam/eIF3j (yeast/flies/humans) (reviewed in 
(Hinnebusch, 2006)). Of these, Hcrlp is the only non-essential protein, suggesting that 
Hcrlp has a regulatory rather than a core function (Valasek et al., 1999). The other five 
yeast components are thought to make up the core eIF3 complex, and protein-protein 
interaction studies of yeast and mammalian eIF3 suggest that the architecture of the
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Figure 1-18: Translation initiation. elF3 binds to free 40S subunits and prevents the spon- 
tanous assembly of 40S and 60S subunits into empty 80S ribosomes lacking mRNA (1). 40S- 
bound elF3 promotes the recruitment of the TC and elFs 1,1 A, and 5 to the 40S subunit to gener­
ate the 43S PIC (2). Next, the mRNA is recruited to the 43S PIC (3). This is facilitated by an inter­
action between elF3 and the 5’-cap-binding complex, elF4F, which is composed of elF4E, elF4G, 
and elF4A. elF4E binds to the 5’-cap structure of the mRNA, elF4G bridges an interaction 
between elF4F and elF3, and the elF4A RNA helicase activity is thought to remove secondary 
structures in the mRNA that hinder 43S PIC recruitment (4). Once assembled onto the mRNA, 
elF1 and elF5 stimulates downstream scanning for a start site and positioning of the 43S PIC 
onto an AUG start codon to generate the 48S PIC (5). Base pairing between the Met-tRNAiMet and 
the AUG start codon stimulates elF5-dependent hydrolysis of elF2-bound GTP and the subse­
quent release of elF2-GDP (6). Finally, the elF5B GTPase promotes joining of the 40S and 60S 
subunits and release of the rest of the elFs (7). Taken from (Jackson, 2005).
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conserved part of mammalian eIF3 is similar to that of yeast eIF3 (reviewed in 
(Hinnebusch, 2006)).
eIF3 can bind the 40S subunit independent of other elFs (Benne and 
Hershey, 1976). Based on a cryo-EM model of the mammalian eIF3-40S complex, the 
bulk of eIF3 subunits are thought to bind to the solvent surface rather than the 60S 
subunit interface of the 40S subunit (Siridechadilok et al., 2005). Nevertheless, eIF3 is 
required to prevent the assembly of free 40S and 60S subunits into empty 80S 
ribosomes lacking mRNA (Thomas et al., 1980; Thompson et al., 1977; Trachsel and 
Staehelin, 1979). This is important since the 40S and 60S ribosomal subunits have 
strong affinities for each other, and their spontaneous assembly into empty 80S 
ribosomes represents an obstacle to translation initiation (Falvey and Staehelin, 1970; 
Henshaw et al., 1973). Importantly, the association of eIF3 with the 40S subunit alone is 
not sufficient to prevent premature 40S-60S subunit assembly, but requires 
simultaneous binding of the TC, eIF3, elFl, elFlA  and RNA nucleotides to the small 
ribosomal subunit (Chaudhuri et al., 1999; Kolupaeva et al., 2005; Majumdar et al.,
2003).
The size of eIF3 and its ability bind the 40S subunit independently of 
other elFs suggests that it might nucleate 43 S PIC assembly (Benne and Hershey, 
1976). Consistent with this, eIF3 stimulates 43S PIC assembly in vitro (reviewed in 
(Hinnebusch, 2006)), and mutations in yeast eIF3 result in reduced association of the 
TC with the 43S PIC in vivo (Valasek et al., 2002; Valasek et al., 2004). Moreover, 
mammalian and yeast eIF3s have both been implicated in the subsequent assembly of 
the 48 PIC. Thus, mammalian eIF3 stimulates mRNA recruitment and formation of the 
48S PIC in vitro (Chaudhuri et al., 1999; Kolupaeva et al., 2005; Majumdar et al.,
2003), and yeast eIF3 is required for optimal binding of mRNA to the 40S ribosomal 
subunit in vivo (Danaie et al., 1995; Phan et al., 1998). The exact mechanism by which 
eIF3 stimulates 48S PIC assembly is not clear, but there are a few indications. The eIF3 
complex forms multiple contacts with eIF4 and is likely to bridge an interaction 
between the eIF4-mRNA complex and the 40S subunit. Thus, mammalian eIF3 
interacts with eIF4B, eIF4G and the cap-binding subunit eIF4E in vitro ((Holz et al., 
2005; Methot et al., 1996) and reviewed in (Hinnebusch, 2006)). Interestingly, the eIF3- 
eIF4G interaction is stimulated by the mTOR pathway (Harris et al., 2006), suggesting 
that bridging between eIF3 and eIF4G might regulate the rate of 48S PIC assembly on 
mTOR-responsive mRNAs (Harris et al., 2006).
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In addition to a role in 43S and 48S PIC assembly, eIF3 has also been 
implicated in mRNA scanning and start site recognition. Thus, mutations in eIF3, which 
disrupt its interaction with elFl or eIF5, impair scanning and facilitate initiation at UUG 
codons in vivo (Valasek et al., 2004). This might be an indirect effect, since eIF3 is 
required for optimal recruitment of elFl and eIF5, both of which have defined functions 
in mRNA scanning. eIF5 promotes hydrolysis of eIF2-associated GTP, an event which 
is tightly linked with AUG start site selection (Das et al., 2001), and elFl promotes 
scanning and ensures that phosphate is released from eIF2-GDP-Pj only when the AUG 
start codon has been located in the peptidyl (P) site (Algire et al., 2005; Pestova and 
Kolupaeva, 2002). However, it has been shown that eIF3 and the eIF4F-m7GTP 
complex can restrain elF5-dependent GTP hydrolysis in the absence of an AUG start 
codon in the P site (Majumdar and Maitra, 2005). Thus, eIF3 might not only function as 
a scaffold for elFl and eIF5, but could directly regulate their activities.
With the exception of eIF3j, relatively little is known about the individual 
subunits of mammalian eIF3. Like its yeast homologue Hcrlp, eIF3j is loosely 
associated with the eIF3 complex (Fraser et al., 2004; Phan et al., 1998; Unbehaun et 
al., 2004; Valasek et al., 2001). Moreover, eIF3j binds to the 40S subunit independently 
of other eIF3 components and promotes the recruitment of the eIF3 complex to the 40S 
subunit in vitro and in vivo (Fraser et al., 2007; Fraser et al., 2004; Nielsen et al., 2006; 
Unbehaun et al., 2004). A recent study provided further insight into the function of 
eIF3j in PIC assembly (Fraser et al., 2007). The eIF3j binding site on the 40S subunit 
was mapped to the aminoacyl (A) site and the mRNA entry channel, placing eIF3 right 
in the decoding center of the small ribosomal subunit. Moreover, binding of eIF3j to the 
mRNA entry channel was found to reduce the affinity of the 40S subunit for mRNA. 
High affinity for mRNA was only restored upon recruitment of the TC and positioning 
of Met-tRNAjMet in the P site, suggesting that eIF3 might control the order of TC and 
mRNA recruitment (Fraser et al., 2007). Interestingly, the association of eIF3j with the 
40S subunit seems to be regulated in a mTOR-dependent manner, suggesting that eIF3j 
might stimulate the rate of eIF3-40S complex formation in accordance with the 
metabolic state of the cell (Miyamoto et al., 2005). Consistent with a regulatory 
function of eIF3j, yeast eIF3j (Hcrlp) is not essential for survival, though its depletion 
does result in a slow growth phenotype (Valasek et al., 1999).
90
1.5.1.2 eIF2
Recruitment of the TC to the 40S subunit is a key step in 43 S PIC 
assembly. In yeast, elFl and elFlA seem to play critical roles in promoting stable 
association of the TC with the 40S subunit in vitro (Algire et al., 2002; Maag et al.,
2005). Yeast eIF3 only minimally affects binding of the TC to the 40S subunit in vitro, 
but is required for efficient recruitment of the TC to the 40S subunit in vivo (Algire et 
al., 2002; Maag et al., 2005). The requirements for mammalian elFs 1, 1A, and 3 for 
stable association of the TC with the 40S subunit in vitro are controversial. Originally, 
eIF3 was found to promote recruitment of the TC to the 40S subunit in a reaction 
stimulated by elFs 1 and 1A. More recently using an identical in vitro system, elFs 1, 
1 A, and 3 appeared to be only minimally required for stable association of the TC with 
the 40S subunit (reviewed in (Kapp and Lorsch, 2004)). Either way, elFs 1, 1A, and 3 
might promote recruitment of the TC to the 40S subunit in vivo, like their yeast 
counterparts.
Translation initiation requires the assembly of 80S ribosomes onto 
mRNAs with a Met-tRNAjMet positioned in the P site and base-paired to the AUG start 
codon. Once positioned on the AUG start codon, hydrolysis of eIF2-bound GFP takes 
place in a reaction that requires the activity of the GTPase activating protein eIF5. This 
ultimately leads to dissociation of the eIF2-GDP complex from the 40S subunit before 
the 60S subunit joins to form the 80S ribosome (Hinnebusch, 2000). Importantly, the 
eIF2-GDP complex must be converted back to the eIF2-GTP form to render it available 
for another round of translation initiation. This is facilitated by the GDP dissociation 
factor eIF2B, which promote dissociation of GDP from eIF2-GDP and conversion of 
eIF2 into its GTP-bound form (Williams et al., 2001). The incorporation of eIF2-GTP 
into the TC is further promoted by the ATP-binding cassette protein 50 (ABC50) 
(Tyzack et al., 2000).
eIF2 is composed of the three subunits a , (3, and y, where the y subunit 
binds to GTP and the Met-tRNAjMet. The exchange of GDP for GTP, which is a key 
regulatory step in translation initiation, is regulated by phosphorylation of eIF2 
(reviewed in (Proud, 2005)). Thus, phosphorylation of the a  and/or p subunits of eIF2 
blocks its interaction with eIF2B and inhibits translation initiation (Rowlands et al., 
1988). In mammals, four different protein kinases have been identified that 
phosphorylate and inactivate eIF2 in response to cellular stress or low nutrient
91
conditions (Figure 1-19). These are the PEK (pancreatic eIF2a kinase), HRI (heme- 
regulated inhibitor), PKR (RNA-dependent protein kinase), and GCN2 (general amino 
acid control of gene expression non-derepressible-2) protein kinases (reviewed in 
(Dever, 2002; Proud, 2005)).
Finally, eIF2 activity might be regulated in accordance with its cellular 
localisation. In a recent study, yeast eIF2 and eIF2B were found to localise to discrete 
regions of the cytoplasm (Campbell et al., 2005). eIF2B seems to be a permanent 
component of these cytoplasmic foci, whereas eIF2 shuttles in and out of them. 
Mutations in eIF2B that reduce its Gunanin exchange factor (GEF) activity also inhibit 
shuttling of eIF2 into the cytoplasmic foci, suggesting that eIF2 activation take place 
within those discrete regions (Campbell et al., 2005).
1.5.1.3 Regulation of eIF2 activity in response to various types of stress
As previously mentioned, eIF2-GDP must be converted back to eIF2-GTP 
at the end of each round of translation to render it active for a new round of 43 S PIC 
assembly. This is a key regulatory step and is regulated by phosphorylation of eIF2 on 
its regulatory subunits. The PEK, PKR, HIR, and GCN2 protein kinases all negatively 
regulate eIF2 activity in response to various types of stress (Figure 1-19). PEK- 
mediated phosphorylation of eIF2 occurs in response to endoplasmic reticulum (ER) 
stress and blocks translation of new ER destined proteins. This allows the organelle to 
recover and deal with its existing load (Bertolotti et al., 2000; Harding et al., 2000b; 
Kaufman, 1999). PKR plays a major role in the stress response to viral infection. Thus, 
its expression is induced by interferons, and binding of double-stranded (ds)RNA to the 
N-terminal domain of PKR results in its activation and phosphorylation of eIF2, 
preventing translation of viral RNAs (Nanduri et al., 2000). HRI is activated in response 
to heme deprivation, oxidative stress and heat shock (Chen, 2000; Lu et al., 2001). 
GCN2 is activated in response to limited nutrient conditions. Thus, amino acid 
starvation leads to accumulation of uncharged tRNAs, which bind to and activate GCN2 
(reviewed in (Proud, 2005)). GCN2 activation results in eIF2 phosphorylation and a 
reduction in global levels of translation. Importantly, GCN2 activity also induces the 
expression of a small subset of genes encoding proteins involved in amino acid 
biosynthesis to compensate for the decrease in cellular amino acid uptake (reviewed in 
(Proud, 2005)). The implication of GCN2 in this type of stress response is clearly 











Figure 1-19: Regulation of elF2 activity in response stress. The PKR, HRI, PEK, and GCN2 
kinases phosporylate elF2 in response to different types of stress. Phosphorylation of elF2 
prevents its interaction with elF2B and keeps elF2 in its GDP-bound inactive form. As a result, 
translation initiation is blocked .
93
GCN2-deflcient mice are significantly less tolerant to amino acid deficiency (Zhang et 
al., 2002).
The mammalian transcriptional activator ATF4 belongs to another sub­
group of proteins that are synthesised in response to several types of cellular stress that 
affect eIF2-GFP levels (Harding et al., 2000a; Jiang et al., 2004; Vattem and Wek,
2004). This is facilitated by two upstream open reading frames (uORFs) in the ATF4 
mRNA (Vattem and Wek, 2004). uORFl, which encodes three amino acids, is a 
positively acting element that facilitate scanning and re-initiation at downstream coding 
regions (Vattem and Wek, 2004). uORF2 is 59 residues long and functions as an 
inhibitory element that blocks ATF4 expression (Vattem and Wek, 2004). Reduced 
levels of eIF2-GTP increase the time required for the scanning ribosome to become 
competent for re-initiation. This delay allows the ribosomes to scan through uORF2 and 
instead re-initiate at the ATF4-coding region. One of the transcriptional targets of AFT4 
is growth arrest and DNA-damage-inducible protein 34 (GADD34) (Ma and 
Hendershot, 2003). GADD34 binds to the catalytic subunit of protein phosphatase 1 
(PP1) and promotes PP1-dependent dephosphorylation of eIF2 (Brush et al., 2003). This 
generates a negative feedback loop, which is likely to be crucial for recovery of protein 
synthesis after exposure of the cell to stress (Ma and Hendershot, 2003; Novoa et al.,
2003).
1.5.1.4 elFl and elFlA
elFl (Suil for suppressor of initiation codon mutation in yeast) and elFl A 
function at multiple steps of translation initiation including 43 S PIC assembly, 
scanning, and start site selection. elFlA is thought to promote 43S PIC assembly by 
stabilising binding of eIF3, eIF5, and the TC to the 40S subunit in the absence of 
mRNA (Battiste et al., 2000; Chaudhuri et al., 1999; Fekete et al., 2005). Thus, a 
mutations in the central OB-fold of elFlA or a C-terminal truncation of elFlA 
(elFlAAC) results in reduced levels of 40S-bound eIF3, eIF5, and TC and inhibits 
translation in vivo (Fekete et al., 2005).
Mutations in the C-terminal domain of elFlA results in the assembly of 
aberrant 48S PIC in vitro and utilisation of non-AUG start sites in vivo (Fekete et al.,
2005). This indicates that elFlA is required not only for its function in 43S PIC 
assembly, but also later for start site recognition. Consistent with this, elFlA and elFl 
have both been implicated in downstream scanning for an initiation site (Battiste et al.,
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2000). Thus, an aberrant 43S PIC consisting of elFs 2, 3, 4B, and the cap-binding 
complex eIF4F, but lacking elFl and elFlA, is capable of assembling at promoter 
proximal positions, but fails to scan downstream to the initiation codon (Pestova et al.,
1998). Addition of elFs 1 and 1A together, but not individually, permits downstream 
scanning and 48S PIC assembly at the correct initiation codon (Pestova et al., 1998).
elFl prevents 48S PIC assembly at near-cognate triplets or at AUGs in 
poor initiation context (i.e. where the surrounding sequence deviates too far from an 
optimal Kozak sequence) in vitro (Pestova and Kolupaeva, 2002). Thus, elFl is thought 
to increase fidelity of start site selection by linking eIF2-GTP hydrolysis with base- 
pairing between the Met-tRNAiMet and the AUG start codon (Unbehaun et al., 2004). 
Consistent with this, eIF5 stimulates eIF2 GTP hydrolysis at similar rates in the 43 S and 
48S PICs in the absence of elFl (Unbehaun et al., 2004). Moreover, eIF5-dependent 
GTP hydrolysis is much slower in 43S PICs containing elFl than 43S and 48S PICs 
without elFl. Positioning of the Met-tRNAjMet in the P site and base pairing of the Met- 
tRNA;Met with the AUG start codon relieves the inhibitory effect of elFl on eIF5 and 
permits GTP hydrolysis (Unbehaun et al., 2004). In agreement with data obtained in 
vitro, mutations in yeast elFl (Suf) that reduce its interaction with the 40S subunit in 
vitro and in vivo and/or accelerate elFl dissociation and Pi release from PICs in vitro 
also increases initiation from non-AUG start codons in vivo (Cheung et al., 2007). 
Moreover, a hyper-accuracy mutation in elFl, which suppresses the Suf mutant, 
decreases the elFl off-rate (Cheung et al., 2007). Thus, one function of elFl seems to 
be to prevent premature GTP hydrolysis and ensure that the 48S PIC has been 
positioned on the AUG start codon, before events leading to the assembly of the 80S 
ribosome are initiated (Cheung et al., 2007; Unbehaun et al., 2004).
1.5.1.5 eIF5
In yeast, a pre-assembled multifactor complex (MFC) exists that consists 
of the TC and elFs 1, 3, and 5 (Asano et al., 2000). Binding of the pre-assembled MFC 
to the 40S subunit is likely to represent an alternative route to 43 S PIC formation 
(Asano et al., 2000). eIF5 interacts with elFl and the N-terminal domains (NTDs) of 
eIF3c and eIF2p and is thought to play a key role in the assembly of the MFC (Asano et 
al., 2000; Singh et al., 2005; Yamamoto et al., 2005). Moreover, genetic studies suggest 
that TC-eIF5 complex formation is rate-limiting for MFC assembly (Singh et al., 2005). 
Consistent with this, the affinity of eIF5 for eIF3c is greatly enhanced by pre-incubation
95
of eIF5 with the NTD of eIF2|3 (Singh et al., 2004). The interaction of eIF5 with eIF2 
does not seem to depend on the guanine state of eIF2, and a recent study suggests that 
about 40% of cellular eIF2 is bound to eIF5 (Algire et al., 2005; Singh et al., 2007). As 
previously mentioned, eIF2B activity is required to revert eIF2 into its GTP-bound state 
and for TC formation (reviewed in (Webb and Proud, 1997)). eIF5 appears to compete 
with the catalytic subunit of eIF2B, eIF2Be, for binding to eIF2 (Singh et al., 2006). 
Thus, over-expression of eIF5 prevents binding of eIF2B to eIF2, TC formation, and 
MFC assembly in vitro (Singh et al., 2006). Moreover, over-expression of wt eIF5, but 
not eIF5 mutated in the eIF2 interaction domain, results in a Gcd' (general control 
derepressed) phenotype indicative of impaired recruitment of the TC to the 40S subunit 
in vivo (Singh et al., 2006). Over-expression of the eIF2Bs subunit also gives a Gcd' 
phenotype, suggesting that excess binding of eIF2Be to eIF2 might prevent its 
association with eIF5. Consistent with this, the eIF2Be over-expression phenotype is 
exacerbated by mutations in the eIF2-binding interface of eIF5 (Singh et al., 2006). 
Thus, the eIF2-eIF2B to eIF2-eIF5 ratio needs to be kept in check to allow cycling of 
eIF2 between its GTP and GDP-bound states and efficient translation initiation.
eIF2 has no intrinsic GTPase activity, and the GTPase activating protein 
(GAP) eIF5 is required for hydrolysis of eIF2-bound GTP prior to joining of the 60S 
subunit (Das and Maitra, 2001). Importantly, eIF5 only stimulate GTP hydrolysis when 
the TC is bound to the 40S subunit, and yeast genetics suggest that GTP hydrolysis is 
tightly linked with AUG recognition (Das and Maitra, 2001; Huang et al., 1997; 
Raychaudhuri et al., 1985). Thus, mutations in eIF5, which increases its GAP activity or 
in eIF2 that increases its intrinsic GTPase activity, result in initiation at non-AUG 
codons (Huang et al., 1997). Moreover, a mutation in eIF2 that results in a higher rate of 
dissociation of charged Met-tRNAjMet from the TC in the absence of GTP hydrolysis 
elicits a similar phenotype (Huang et al., 1997).
1.5.1.6 elFSB
eIF5-induced hydrolysis of eIF2-bound GTP results in dissociation of 
eIF2-GDP, but not elFl, elFlA and eIF3 from the 40S subunit (Unbehaun et al., 2004). 
This occurs at a later step concomitant with joining of the 60S subunit and requires the 
GTPase eIF5B (Algire et al., 2002; Pestova et al., 2000; Shin et al., 2002). Thus, eIF5B 
promotes dissociation of elFl, elFlA and eIF3 from the 40S subunit only in the 
presence of the 60S subunit (Unbehaun et al., 2004). Whereas dissociation of elFl and
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eIF3 seems to occur concomitant with or after 40S/60S subunit joining, eIF5B GTP- 
hydrolysis is required for the release of elFlA and eIF5B (Fringer et al., 2007). Thus, a 
point mutation in eIF5B that disrupts its GTPase activity (eIF5B-T439) permits subunit 
joining in vitro, but elFl A and eIF5B are retained on the 80S ribosomes (Fringer et al., 
2007). A similar outcome is observed with wildtype eIF5B in the presence of a non- 
hydrolysable GTP analogue (Fringer et al., 2007). Consistent with a function of eIF5B 
in dissociation of elFlA from the 80S ribosome in vivo, the slow growth phenotype of 
eIF5B mutant cells is greatly enhanced by over-expression of elFl A (Choi et al., 2000).
Strains lacking eIF5B exhibit an extreme slow-growth phenotype and are 
severely affected under starved conditions (Choi et al., 1998). Nevertheless, yeast 
eIF5B is a non-essential protein, indicating that an eIF5B-independent pathway for 
ribosome assembly exists in yeast (Choi et al., 1998). In agreement with this, strains 
harbouring the dominant-negative eIF5B-T439 GTPase mutant exhibit a growth 
phenotype that is significantly more severe than cells lacking elFB (Fringer et al.,
2007). Moreover, the severe slow-growth defect of eIF5B-T439 mutant strains is 
suppressed by mutations in elFl A that disrupt elFlA-mediated recruitment of eIF5B to 
the 40S subunit (Fringer et al., 2007). This indicates that in the eIF5B-dependent 
pathway, dissociation of eIF5B from the 80S ribosome is crucial for translation 
initiation (Fringer et al., 2007).
1.5.1.7 eIF4
eIF4, which is a multifactor complex composed of elFs 4A, 4B, 4E, and 
4G, is dispensable for 43 S PIC assembly, but required for recruitment of mRNA and the 
formation of the 48S PIC (Figure 1-20). The presumed first step in 48S PIC assembly is 
binding of eIF4E to the m7GpppX (where X is any nucleotide) cap structure at the 5’- 
end. The importance of the eIF4E-5’-cap interaction is well established. Thus, 
translation levels are increased by 3-30 fold in reactions containing capped versus 
uncapped mRNA in both yeast and mammals (Iizuka et al., 1994; Preiss and Hentze, 
1998; Tarun and Sachs, 1995). Moreover, in the absence of eIF4E, translation of capped 
mRNAs proceeds at similar rates to that of uncapped mRNAs in vitro (Tarun and Sachs, 
1995). eIF4E binds to the large eIF4G subunit and together with eIF4A they form a sub­
complex, eIF4F, that plays a key role in translation initiation by binding to the 5’-cap 
structure and bridging interactions between the mRNA and the 40S subunit. Consistent
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Figure 1-20: The 48S PIC. 48S PIC assembly is thought to be initiated by binding of elF4E to the 
5’-cap structure of the mRNA. elF4E also binds to elF4G and together with elF4Athey form the 
elF4F sub-complex. elF4G is a large polypeptide and functions as a scaffold for48S PIC assem ­
bly. Thus, elF4G promotes 48S PIC formation by bridging an interaction between the mRNA (via 
elF4E and elF4A) and the 43S PIC (via elF3). Moreover, elF4G links the 5’-cap structure (via 
elF4E) with the poly(A) tail (via PABP), which results in circulisation of the mRNA. This further 
stimulates 48S PIC assembly and might provide a checkpoint for discriminating against 3’-end 
degraded mRNAs. The elF4A RNA helicase is thought to facilitate 48S PIC assembly by remov­
ing secondary structures in the 5’-end of the mRNA that hinder recruitment of the 43S PIC. 
Adapted from (Lopez-Lastra et al., 2005).
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with this, eIF4F complex assembly is the rate-limiting step in translation initiation and 
largely depends on the availability of eIF4E (reviewed in (Kapp and Lorsch, 2004)).
eIF4G functions as a scaffold that coordinates multiple interactions 
between the cap structure (via its RNA binding domain and eIF4E), the 40S subunit (via 
eIF3), and the polyadenylated (poly(A)) tail (via poly A binding protein (PABP)) 
(reviewed in (Kapp and Lorsch, 2004)). The 3’-end poly(A) tail positively regulates 
translation in vitro and in vivo (Gallie, 1991; Michel et al., 2000; Preiss and Hentze, 
1998; Tarun and Sachs, 1995) in a PABP-dependent manner (Tarun and Sachs, 1995). 
This can be explained by the ability of the poly(A) tail to interact with and stimulate the 
cap-binding and ATPase activities of eIF4F (via PABP) (reviewed in (Kapp and Lorsch,
2004)). Moreover, binding of eIF4G to the 5’-cap via eIF4E and to the poly(A) tail via 
PABP is sufficient to circularise the mRNA and might provide an important checkpoint 
for discriminating against 3’-end degraded mRNAs (Wells et al., 1998).
eIF4A is an RNA-dependent ATPase and ATP-dependent RNA helicase 
and the founding member of the family of DEAD-box proteins. In mammals, there are 
three different eIF4A isoforms: eIF4AI, eIF4AII, and eIF4AIII. eIF4I and eIF4II are 
highly homologous and can functionally substitute for each other, but vary with respect 
to their tissue distribution and temporal expression (reviewed in (Gingras et al., 1999)). 
In contrast, eIF4III cannot functionally replace eIF4AI and eIF4AII and was recently 
found to be part of the exon-junction complex (Chan et al., 2004). eIF4A RNA helicase 
activity is likely to facilitate 48S PIC assembly by unwinding secondary structures in 
the 5’-untranslated region (UTR) of the mRNA that hinder 43S PIC recruitment. First, 
its ATPase activity facilitates unwinding of RNA duplexes in vitro (Lawson et al., 
1989; Pause and Sonenberg, 1992; Ray et al., 1985; Rozen et al., 1990), and eIF4A is 
required for translation initiation in vivo (Blum et al., 1992). Second, a dominant 
negative eIF4A mutant lacking ATPase and RNA helicase activities inhibits the 
translation of structured mRNAs significantly more than that of unstructured mRNAs in 
vitro (Svitkin et al., 2001). Third, eIF4A is not required for translation of small mRNAs 
lacking secondary structures in their 5’ UTR, nor does it stimulate their translation 
(Algire et al., 2002; Benne and Hershey, 1978; Lorsch and Herschlag, 1999).
The enzymatic activity of eIF4A is stimulated by its incorporation into 
eIF4F (Rogers et al., 2001; Rozen et al., 1990), and its helicase activity by eIF4B and 
eIF4H (in mammals) (Richter-Cook et al., 1998; Rogers et al., 2001; Rogers et al.,
1999). eIF4B and eIF4H have no intrinsic catalytic activities and seem to play
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redundant roles with respect to stimulation of eIF4A activity (Richter-Cook et al., 
1998). The ability of eIF4B to stimulate eIF4A function is thought to be mediated at 
least in part by its stimulatory effect on eIF4A affinity for RNA and ATP (Abramson et 
al., 1988; Bi et al., 2000).
Two models have been proposed to explain how elFs, 4A, 4B, and 4H 
might function to unwind RNA duplexes. According to the first model, eIF4B and 
eIF4H bind to and stabilise the structure of single stranded RNA generated by the 
unwinding activity of the eIF4F-bound eIF4A RNA helicase. In the second model, 
eIF4F is proposed to function as a nucleation centre for the transient polymerisation of 
eIF4A along the mRNA resulting in the disruption of secondary structures (reviewed in 
(Kapp and Lorsch, 2004)). Consistent with this model, eIF4A is approximately 50 times 
as abundant as the other components of eIF4F, and an excess of eIF4A to RNA 
substrate of around 500:1 is required for efficient activation of translation in vitro 
(Duncan et al., 1987; von der Haar and McCarthy, 2002). The functions of eIF4B and 
eIF4H do not differ between the two models. Consistent with the idea that eIF4B and 
eIF4H seed the mRNA subsequent to the action of eIF4A, both proteins bind to the 
mRNA in an eIF4A- and ATP-dependent manner ((Lindqvist et al., 2008; Sonenberg, 
1981) and reviewed in (Cristofari and Darlix, 2002)), and a recent crosslinking study 
showed that eIF4B and eIF4H contact multiple positions downstream of the cap 
structure (Lindqvist et al., 2008).
1.5.2 Translation elongation/termination
1.5.2.1 Elongation
Translation elongation starts with a peptidyl-tRNA bound to the ribosomal 
P site and the recruitment of a ternary complex composed of an aminoacyl(aa)-tRNA, 
eukaryotic elongation factor 1A (eEFlA), and GTP to the acceptor (A) site (Figure 1- 
21). Both cognate and non-cognate aa-tRNAs can bind to the A site, but only the correct 
codon-anticodon recognition results in activation of eEFl A and peptide bond formation. 
Base pairings between the codon and anticodon in the A site leads to several 
conformational changes, which ultimately activates the eEFl A GTPase. eEFlA- 
mediated GTP hydrolysis results in dissociation of eEFl A-GDP from the ribosome and 
the release of aa-tRNA into the A site in a form that is competent to generate a peptide 
















Figure 1-21: Translation elongation. The translation elongation cycle starts with a peptidyl- 
tRNA positioned in the ribosomal P site and a vacant A site. An aa-tRNA is recruited to the A site 
as part of a ternary complex with eEFIAand GTP. Base pairing of the incoming aa-tRNA with the 
A site codon induces several conformational changes, which leads to activation of the eEF1A 
GTPase. GTP hydrolysis results in the relase of eEF1A-GDP from the ribosome and positioning 
of the aa-tRNA in the catalytic center of the ribosome (’’accommodation”). Next, the peptidyl trans­
ferase center catalyses the formation of a new peptide bond between the incoming amino acid 
and the 3’-end amino acid of the nascent peptide bound to its tRNA in the P site. This results in 
deacetylation of the tRNA in the P site, which is now positioned with its acceptor in the E site of 
the 60S subunit and its anticodon in the P site of the 40S subunit. The newly formed peptidyl- 
tRNA is positioned with its acceptor in the P site of the 60S subunit and its anticodon in the A site 
of the 40S subunit. eEF2-mediated GTP hydrolysis promotes mRNA translocation by three nucle­
otides and positions the peptidyl-tRNA in the P site and the deacetylated tRNA in the E site. This 






peptide bond between the incoming amino acid in the A site and the last amino acid of 
the nascent peptidyl chain bound to its tRNA in the P site. This results in deacetylation 
of the peptidyl-tRNA and positioning of the deacetylated tRNA with its acceptor in the 
exit (E) site of the 60S subunit and its anticodon in the P site of the 40S subunit. The 
newly generated peptidyl tRNA is positioned with its acceptor in the P site of the 60S 
subunit and its anticodon in the A site. eEF2-mediated GTP hydrolysis promotes 
translocation of the mRNA by three nucleotides, which positions the peptidyl-tRNA in 
the P site and the deacetylated tRNA in the E site. This leaves the A site available for 
the next incoming aa-tRNA (reviewed in (Kapp and Lorsch, 2004)).
eEFlA-GDP needs to be converted back to eEFlA-GTP for the next 
elongation cycle to take place. This requires the function of the multi-subunit complex 
eEFIB, which exhibits GEF activity (Sheu and Traugh, 1997). eEF2 also leaves the 
ribosome in its GDP-bound form and need to be converted back to eEF2-GTP. In 
contrast to eEFl A, this does not appear to require the activity of a GEF (reviewed in 
(Kapp and Lorsch, 2004)).
1.5.2.2 Termination
Elongation cycles continue until the translocating ribsome encounters a 
stop codon. The class I eukaryotic release factor eRFl binds to any of the three stop 
codons when positioned in the A site and promotes hydrolysis of the peptidyl-tRNA in 
the P site (Kisselev and Buckingham, 2000). eRFl contains three different domains 
(Song et al., 2000). Domain 1 harbours several conserved motifs that are implicated in 
stop codon recognition (Frolova et al., 2002; Ito et al., 2002; Kolosov et al., 2005). 
Domain 2 contains a highly conserved GGQ motif, which is required for hydrolysis of 
peptidyl-tRNA (Frolova et al., 1999; Song et al., 2000). Domain 3 interacts with the 
class II eukaryotic release factor 3 (eRF3) (Frolova et al., 2000; Merkulova et al., 1999).
Two mammalian (eRF3a and eRF3b) and one yeast (Sup35/eRF3p) class 
II release factors have been identified, all of which are required for termination in vivo 
((Chauvin et al., 2005) and reviewed in (Kisselev and Buckingham, 2000)). eRF3 
contains three domains: N, M, and C. The N and M domains are dispensable for 
viability and translation termination in yeast, whereas the C domain, which contains the 
GTPase fold and the binding site for eRFl, is essential for survival (Ter-Avanesyan et 
al., 1993). eRFl and GTP binds to eRF3 with strong cooperativity, and the GTP form of 
eRF3 is thought to predominantly exist in a long lived ternary complex with eRFl
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(Hauryliuk et al., 2006; Pisareva et al., 2006). eRF3 GTPase activity strictly requires the 
presence of both eRFl and the ribosome (Frolova et al., 1996), and yeast genetics 
suggest that eRF3’s GTPase activity might couple termination codon recognition by 
eRFl with efficient peptide release (Salas-Marco and Bedwell, 2004). Thus, mutations 
in eRF3 that reduce its GTPase activity also reduce the efficiency of termination at 
some, but not all stop codons (Salas-Marco and Bedwell, 2004). Importantly, the 
reduced efficiency of termination at specific stop codons is not simply a consequence of 
insufficient levels of eRF3 since lowering levels of eRFl and/or eRF3 reduce 
termination efficiency at all stop codons. Instead, the rate of eRF3-dependent GTP 
hydrolysis seems to affect stop codon recognition by eRFl (Salas-Marco and Bedwell,
2004).
Recently, Alkalaeva and co-workers used a reconstituted system to study 
translation termination in vitro (Alkalaeva et al., 2006). They were able to show that 
binding of eRFl and eRF3-GTP to pre-termination complexes induces a structural 
rearrangement, which manifests itself as a two-nucleotide shift of the toe print attributed 
to the termination complex. This structural rearrangement is followed by eRF3- 
mediated GTP hydrolysis and eRFl-dependent peptide release (Alkalaeva et al., 2006). 
eRF3-mediated GTP hydrolysis is likely to correctly position the GGQ motif of eRFl 
for it to induce the peptidyl-tRNA hydrolysis (Alkalaeva et al., 2006). Thus, eRF3 
functions prior to peptidyl-tRNA hydrolysis and is likely to link stop codon recognition 
with peptidyl-tRNA hydrolysis and peptide release (Alkalaeva et al., 2006; Salas-Marco 
and Bedwell, 2004).
1.5.3 Control of TOR activity
The nutrient-sensitive mammalian target of rapamycin (mTOR) kinase 
plays a crucial role in regulation of translation in response to insulin and/or amino acid 
deprivation (Figure 1-22). Signalling upstream of TOR in response to insulin 
stimulation has been studied extensively in mammalian cells and in flies using genetics 
(reviewed in (Averous and Proud, 2006)). In contrast, the mechanism by which mTOR 
is activated in response to nutrient deprivation remained poorly characterised until 
recently (see below).
mTOR exists in two different complexes that are referred to as mTORCl 
and mTORC2 (reviewed in (Sarbassov et al., 2005a)). The mTORCl complex is 
composed of mTOR, Raptor, mLST8, and the newly identified component proline-rich
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Figure 1-22: The insulin signalling pathway. The insulin signalling pathway stimulates transla­
tion and growth in response to insulin and growth factors. PIP3 is generated by PI3K in response 
to binding of insulin and growth factors to receptor tyrosine kinases. Increased levels of PIP3 
recruits AKT to the membrane, where it is phosphorylated and activated by PDK1 and mTOR 
bound to Rictor in the mT0RC2 complex. PI3K activity is counteracted by the lipid phosphatase 
PTEN, which converts PIP3 back to PIP2. AKT phosphorylates and inhibits TSC2 activity and 
thereby allows Rheb to activate mTOR bound to Raptor in the mTORCl complex. AKT also 
stimulates mTORCl activity via its effect on PRAS40, which associates with and inhibits mTOR 
activity in the absense of insulin signalling. In addition to growth factor signalling, mTORCl activ­
ity is also regulated by amino acid levels through the Rag GTPases. mTORCl signalling directly 
or indirectly (via S6K1) results in phosphorylation of the translational machinery and increased 
translation levels. Adapted from (Mamane et al., 2006).
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AKT/PKB substrate 40 kDa (PRAS40) (Vander Haar et al., 2007), and the mTORC2 
complex is composed of mTOR, Rictor, mLST8 , and Sinl (Frias et al., 2006; Jacinto et 
al., 2006). mTORCl regulates translation, cell size, and growth, whereas mTORC2 
functions in cytoskeleton organisation (reviewed in (Sarbassov et al., 2005a)). As 
discussed in more details in the next section, mTORCl stimulates translation in 
multiple ways by direct phosphorylation of the translational machinery or through 
activation of its target S6  kinase 1 (S6K1) (reviewed in (Proud, 2006) (Averous and 
Proud, 2006)).
1.5.3.1 Signalling upstream of mTORCl
The mTORCl, but not the mTORC2 complex, is inhibited by the drug 
rapamycin. Sensitivity to rapamycin has been used extensively as a tool to dissect the 
insulin-signalling network upstream of mTORCl using phosphorylation of its targets, 
eIF4B or S6K1, as readouts (reviewed in (Corradetti and Guan, 2006)). The insulin- 
signalling pathway is triggered by binding of insulin or insulin-like growth factors 
(IGFs) to the insulin receptor (IR) (reviewed in (Wullschleger et al., 2006b)). IR 
substrates (IRS), which bind to the activated form of the IR, serve as docking sites for 
phosphoinositide-3 kinase (PI3K). PI3K bound to IRS converts phosphatidylinositol- 
4,5-phosphate (PIP2) in the plasma membrane to phosphatidylinositol-3,4,5- 
triphosphate (PIP3). Increased levels of PIP3 recruit AKT (also known as PKB) to the 
plasma membrane, where it is activated by phosphorylation on T308 and S473 (Alessi 
et al., 1997; Sarbassov et al., 2005b). Phosphorylation on T308 is mediated by the 3- 
phosphoinositide-dependent kinase 1 (PDK1) (Alessi et al., 1997), and phosphorylation 
on S473 by the mTORC2 complex (Sarbassov et al., 2005b). Activation of AKT 
stimulates mTOR signalling via its inhibitory effect on TSC2 (Inoki et al., 2002; Potter 
et al., 2002). Thus, in the absense of AKT signalling, TSC2 in complex with its partner 
TSC1 inhibits mTOR-signalling via its effect on Rheb (Garami et al., 2003; Inoki et al., 
2003a; Tee et al., 2003). Rheb is a small GTPase (Saucedo et al., 2003; Stocker et al.,
2003), which in its GTP-bound form binds to and activates mTOR in vitro and in vivo 
(Long et al., 2005a; Long et al., 2005b; Urano et al., 2005). TSC2 functions as a GAP 
for Rheb to convert it into its GDP-bound form, which in turn inhibits mTORCl 
signalling (Garami et al., 2003; Inoki et al., 2003a; Tee et al., 2003). Hence, AKT- 
mediated inhibition of TSC2 relieves the inhibitory effect of TSC2 on Rheb activity and 
stimulates mTORCl signalling. AKT kinase also stimulates mTORCl-signalling
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independent of its effect on TSC2. Thus, phosphorylation of PRAS40 by AKT results in 
its dissociation from the mTORCl complex and relieves the inhibitory effect of 
PRAS40 on mTOR activity (Vander Haar et al., 2007).
As previously mentioned, the mechanism whereby amino acid levels 
regulate mTORCl activity remained elusive for many years. However, recently it was 
shown that the Ras-related GTP-binding Rag proteins regulate mTORCl-signalling in 
response to amino acid levels by affecting the localisation of mTOR (Sancak et al.,
2008). Thus, only when amino acids are not limited, mTOR co-localises with its 
activator Rheb (Sancak et al., 2008). Consistent with this, insulin signalling cannot 
activate mTOR-signalling when amino acids are in limited supply (reviewed in 
(Wullschleger et al., 2006).
In addition to insulin and amino acids levels, the mTORCl activity is also 
regulated by cellular energy levels via the AMP-activated kinase (AMPK) (reviewed in 
(Wullschleger et al., 2006). AMPK senses the energy status of the cell and is activated 
in response to low energy levels (high AMP/ATP ratio). Activated AMPK 
phosphorylates and stimulates the GAP activity of TSC2, which in turn decreases 
mTORCl activity (Inoki et al., 2003b). The tumour suppressor LKB1 has been 
identified as an upstream kinase for AMPK and functions in conjunction with AMP to 
regulate AMPK activity (reviewed in (Wullschleger et al., 2006).
1.5.3,2 Signalling downstream of mTORCl
There are two S6 Ks in mammals (S6K1 and S6K2) and one in Drosophila 
(S6 K) (Avruch et al., 2001). In mammals, Raptor mediates the binding of the mTORCl 
complex to S6K1, which is phosphorylated and activated in response to insulin 
signalling. S6K1 is directly phosphorylated by mTOR on Thr389, and this potentiates 
PDK1-mediated phosphorylation on Thr229 (Alessi et al., 1998; Pullen et al., 1998). 
Phosphorylation on Thr229 in the activation loop of S6K1 results in S6K1 activation 
(Avruch et al., 2001). Activated S6K1 phosphorylates eIF4B (Raught et al., 2004) and 
thereby increases the affinity of eIF4B for the translational machinery and stimulates 
translation initiation (Holz et al., 2005). S6K1 also phosphorylates the small ribosomal 
protein S6  on multiple sites, though the physiological relevance of this is not clear 
(reviewed in (Ruvinsky and Meyuhas, 2006)). Thus, mutating multiple S6  
phosphorylation sites to alanines in knock-in mice results in decreased cells size, but 
increased rates of protein synthesis (Ruvinsky et al., 2005). Chronic S6 K activation
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results in reduced expression and inhibition of IRS 1 (Harrington et al., 2004; Haruta et 
al., 2000; Shah et al., 2004). Since IRS1 functions as a positive transmitter of signalling 
between the insulin receptor and the phosphatidylinositol-3-kinase, this generates a 
negative feedback loop on the insulin pathway.
1.5.4 Regulation of translation by the insulin pathway
Protein synthesis and ribosome biogenesis are among the most 
energetically demanding cellular processes and must be kept in check and coordinated 
with cellular energy and nutrient levels. The insulin pathway represents a major node 
for the integration of multiple signals representing the metabolic state of the cell and 
regulates protein synthesis according to energy levels. The global effect on translation 
induced by insulin signalling can be divided into a rapid response, which depends on 
the pre-existing translational machinery, and a long-term effect, which involves the 
synthesis of additional ribosomal building blocks. The focus here will be on the rapid 
response of the translational machinery to insulin signalling (reviewed in (Proud,
2006)).
1.5.4.1 Multiple modes of regulation of translation initiation
Insulin signalling exerts its stimulatory effect on protein synthesis at 
different stages of translation including formation of the TC, recruitment of mRNA to 
the 43 S PIC, and translation elongation (Figure 1-23 and (reviewed in (Proud, 2006)). 
As previously mentioned, eIF2 leaves the ribosome in its GDP-bound form and needs to 
be converted back to its GTP-bound form to engage in the formation of the TC. This is 
a critical step in translation initiation and requires the GEF activity of eIF2B. The 
eIF2Bp subunit contains multiple phosphorylation sites, and its activity is negatively 
regulated by glycogen synthase kinase 3 (GSK3)-mediated phosphorylation (Welsh et 
al., 1998; Welsh and Proud, 1992). Thus, phosphorylation of a single residue near the 
catalytic domain of eIF2B impairs its GEF activity (Welsh et al., 1998). GSK3 itself is 
phosphorylated and inactivated by AKT/PKB in response insulin signalling and growth 
factors. As a result, insulin signalling relieves the inhibitory effect of GSK3 on eIF2B 
GEF activity and stimulates TC formation (reviewed in (Cohen and Frame, 2001)).
Assembly of eIF4E, eIF4G, and eIF4A into eIF4F is a rate-limiting step in 
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Figure 1-23: Regulation of translation by the insulin pathway. Insulin signalling regulates 
translation at multiple stages including TC formation, 48S PIC assembly, and translation elonga­
tion. TC formation is controlled by elF2B activity, which is required for the conversion of elF2-GDP 
into elF2-GTP at the end of each translation cycle. elF2B activity is inhibited by the GSK3 kinase, 
which itself is negatively regulated by AKT/PKB. Thus, insulin signalling derepresses the inhibi­
tory effect of GSK3 on elF2B and facilitates TC formation. mTORCl signalling stimulates transla­
tion initiation directely or indirectly via activation of its substrate S6K1. Thus, mTOR-dependent 
phosphorylation of 4E-BP relieves the inhibitory effect of 4E-BP on translation initiation. 4E-BP 
inhibits 48S PIC assembly by competing with elF4G for binding to the 5’-cap-binding protein 
elF4E. mTOR-dependent phosphorylation of 4E-BP results in its dissociation from elF4E and 
hence promotes 48S PIC assembly and translation initiation. S6K1 phosphorylates the 40S 
subunit ribosomal protein S6 and elF4B. Phosphorylation of elF4B promotes its recruitment to the 
translational machinery and stimulates translation initiation. mTORCl signalling also affects 
translation elongation rates. In the absense of mTORCl signalling, the elongation factor eEF2 is 
phosphorylated and inhibited by eEF2K. In response to insulin signalling, mTOR phosphorylates 
and inhibits eEF2K activity, and as a result activates eEF2 and stimulates translation elongation 
rates.
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eIF4E. Thus, eIF4G competes with 4E-BP, which is a negative regulator of translation 
initiation, for binding to eIF4E. The ability of 4E-BP to bind eIF4E depends on its 
phosphorylation status and is controlled by mTOR signalling. Thus, 4E-BP contains 
two N-terminal and two C-terminal phosphorylation sites that are responsive to mTOR 
signalling (Gingras et al., 2001; Mothe-Satney et al., 2000; Wang et al., 2005). 
Phosphorylation of the N-terminal sites seems to occur via an mTOR-dependent, but 
raptor/rictor-independent mechanism in response to modulation of amino acid levels 
(Wang et al., 2005). Phosphorylation of the two C-terminal sites of 4E-BP is rapamycin 
sensitive and depends on phosphorylation of the N-terminal sites and a target of 
rapamycin signalling (TOS) motif at the extreme C terminus (Gingras et al., 2001; 
Herbert et al., 2002; Mothe-Satney et al., 2000). The dependence on the TOS motif, 
which is bound by the mTORCl component raptor, and the sensitivity to rapamycin 
suggest that the mTORCl complex might be directly responsible for the 
phosphorylation of the C-terminal sites ((Nojima et al., 2003; Schalm et al., 2003) and 
reviewed in (Averous and Proud, 2006)). Thus, mTOR signalling can stimulate eIF4F 
assembly and translation initiation via its inhibitory effect on 4E-BP.
eIF4G is also subject to rapamycin sensitive phosphorylation on several 
sites, though the kinase responsible has not been identified (Raught et al., 2000). 
Consistent with this, insulin signalling stimulates the association of eIF3 with eIF4G in 
an mTOR-dependent manner, and this likely promotes binding of the 40S subunit to the 
mRNA and 48S PIC assembly (Harris et al., 2006).
The eIF3 subunit seems to provide a platform to coordinate a dynamic 
sequence of events in response to insulin signalling. Thus, in its inactive form, S6K1 is 
recruited to the translational machinery by the eIF3 complex (Holz et al., 2005). Insulin 
signalling results in the recruitment of the mTORCl complex to eIF3, leading to 
activation and release of S6K1 (Holz et al., 2005). Following activation and dissociation 
from the translational machinery, S6K1 phosphorylates and activates eIF4B. eIF4B 
phosphorylation promotes its recruitment to the translational machinery via its 
association with eIF3 (Holz et al., 2005). Thus, insulin signalling appears to stimulate 
48S PIC assembly by promoting eIF4F assembly via its effect on 4E-BP, by mRNA 
recruitment to the 40S subunit via its effect on eIF4G binding to eIF3 (as part of the 43 S 
PIC), and by recruitment of eIF4B to the translation machinery.
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1.5.4.2 Regulation of translation elongation
In mammals, insulin signalling not only regulates translation initiation, but 
also stimulates elongation rates (reviewed in (Averous and Proud, 2006)). 
Phosphorylation of eEF2 by the eEF2 kinase prevents its binding to ribosomes and 
inhibits translation elongation (Carlberg et al., 1990). Phosphorylated eEF2 exhibit 
decreased affinity for GTP, but not GDP, suggesting that phosphorylation inactivates 
eEF2 by shifting the balance in favour of the GDP-bound form (Dumont-Miscopein et 
al., 1994). The eEF2 kinase is itself regulated by insulin signalling (reviewed in (Proud,
2006)). Thus, mTOR signalling inhibits eEF2 kinase activity via three phosphorylation 
sites in eEF2 kinase (Browne and Proud, 2004; Knebel et al., 2001; Wang et al., 2001). 
S6K1 seems to be responsible for phosphorylation of at least one of these sites (Wang et 
al., 2001). Phosphorylation and inactivation of eEF2 kinase relieves its inhibitory effect 
on eEF2. Consistent with this, translation elongation rates are accelerated in response to 
mTOR signalling (Redpath et al., 1996)(reviewed in (Proud, 2006)).
1.5.5 Pixie -  the Drosophila homologue of RNAse L inhibitor (RLI)
Pixie, one of the four Drosophila proteins characterised in this thesis, was 
originally identified in a genetic interaction screen carried out in Leevers laboratory to 
identify molecules that regulate growth and interact with PI3K signalling (Coelho et al., 
2005b). Mutations in pixie have an unusual effect on fly growth that is similar to the 
effect of mutations in some genes encoding ribosomal proteins. For example, weak 
pixie mutant combinations and some heterozygous ribosomal protein mutants (termed 
Minute mutations) have slender bristles and show developmental delays, yet their final 
adult body size can be near normal (Coelho et al., 2005a; Lambertsson, 1998)(Marygold 
et al., 2007). In addition, pixie and ribosomal protein mutant wing imaginal discs show 
complex defects in growth and cell survival that vary spatially and temporally (Coelho 
et al., 2005a). Thus during the fast growing phase (early to mid third instar larvae),pixie 
and ribosomal protein function is required more in the fast growing region of the disc 
(the pouch), and in the slow growing phase (late third instar larvae), their function is 
required more in the slow growing region (the hinge) (Coelho et al., 2005a). So far, all 
but one of the known Minute loci were found to correspond to genes encoding 
ribosomal proteins, suggesting that the Minute phenotype arises from suboptimal 
protein synthesis (Marygold et al., 2007). Thus, the impact that mutating pixie has on
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growth might arise via an effect on translation. Consistent with this, dsRNAi-mediated 
depletion of Pixie reduces global translation (Coelho et al., 2005a).
Pixie is an exceptionally conserved protein found in all eukaryota and 
archaea sequenced so far (Gabaldon and Huynen, 2004). For example, Pixie and yeast 
Rlilp share 6 6 % amino acid identity, and yeast Rlilp and human RLI have 67% amino 
acid identity. Pixie belongs to the ABCE subfamily of ABC proteins, which contain two 
nucleotide-binding domains (NBDs) and two N-terminal iron sulfur (FeS) clusters. In 
contrast to most ABC domain proteins, members of this subfamily do not contain the 
membrane-spanning domains that would enable them to function as transporters (Kerr,
2004). The structure of Pyrococcus furiosus RLI lacking the FeS domain was recently 
solved and revealed some similarity to the structure of known ABC enzymes (Karcher 
et al., 2005). Binding of ATP to the interface of the two opposing NBDs in P. furiosus 
RLI is thought to induce a power stroke. Thus, RLI might function as an ATP-driven 
mechano-chemical enzyme to promote structural modulations of its substrates (Karcher 
et al., 2005). Consistent with this, mutations in the ATP binding regions of yeast Rlilp 
and Pixie are not viable (Coelho et al., 2005a; Dong et al., 2004; Karcher et al., 2005).
The human Pixie ortholog RLI, also known as ABCE1, was first 
characterised via its ability to inhibit the antiviral activity of RNAse L (Bisbal et al., 
1995; Martinand et al., 1999; Martinand et al., 1998). However, RNAse L is only found 
in mammals, so this function of RLI does not account for its conservation in non­
mammalian species (Gabaldon and Huynen, 2004). More recently, three independent 
studies have provided evidence that Pixie (shown here and (Andersen and Leevers,
2007)) and the yeast ortholog of Pixie, Rlilp, associate with translation initiation factors 
and the 40S ribosomal subunit and play a role in translation initiation (Dong et al., 
2004; Kispal et al., 2005; Yarunin et al., 2005). Additional data suggest that the 
vertebrate and Caenorhabditis elegans RLI orthologs also play roles in translation (Chen 
et al., 2006c; Le Roy et al., 2005; Zhao et al., 2004). These fundamental functions are 
likely to explain the high degree of conservation of the RLI/Pixie protein family and are 
consistent with the pixie mutant phenotypes observed in Drosophila (Coelho et al., 
2005a).
In addition to its role in translation initiation, Rlilp has also been shown to 
play a role in processing of the small and large ribosomal subunits (Dong et al., 2004; 
Kispal et al., 2005; Yarunin et al., 2005). Thus, depletion of Rlilp results in impaired 
processing and nuclear export of the 40S and 60S subunits (Kispal et al., 2005; Yarunin
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et al., 2005). Moreover, Rlilp interacts physically and genetically with the eIF3 
component, Hcrlp, which has also been implicated in ribosome biogenesis (Kispal et 
al., 2005; Yarunin et al., 2005).
1.5.6 Project Aims
The overall aim of my projects was to identify novel proteins that regulate 
growth during fly development. In Dr. Tapon’s laboratory, we used the rough-eye 
phenotype caused by excess Hpo signalling in a candidate-based genetic interaction 
screen for novel components of the Hpo pathway. In Dr. Leevers’ laboratory, we used 
the small-wing phenotype caused by reduced insulin signalling in the wing to screen for 
growth regulators that interact with insulin signalling. These two approaches led to the 
identification of the four Drosophila proteins characterised in this thesis. The data 
presented here show that all four proteins are indeed required for growth and 
proliferation during development. A more detailed functional study reveals that they are 
required at different stages of gene expression. One protein, dMCRS2, is likely to play a 
role in RNAP II transcription, two proteins, dPrp38 and dMFAPl are required for 
normal levels of pre-mRNA processing, and the fourth protein, Pixie, is required for 
normal levels of translation initiation. The results chapters have been organised in the 
same order as those three steps of gene expression: RNAP II transcription (dMCRS2), 
pre-mRNA processing (dPrp38 and dMFAPl), and translation initiation (Pixie).
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Chapter 2 - Materials and methods
2.1 Molecular biology and Biochemistry
2.1.1 Antibodies
Polyclonal rabbit antisera were raised against a N-terminal peptide of 
Adam (2T, aa 1-16), eIF3-S10 (5T, aa 1-19), and RpS25 (NT2 or NT1, aa 1-20) and a 
C-terminal peptide of eIF3-S2 (CT1, aa 312-326), eIF3-S8 (CT2, aa 892-910), and 
eIF3-S9 (CT1, aa 671-685) (Cancer Research UK). All peptides were coupled via 
cysteines in their N- or C-terminal aminoheaxanoic acid spacers (EAHX-Cys) to 
maleimide-activated keyhole limpet haemocyanin (KLH, Pierce) as directed. The anti- 
Pitslre (953), anti-eIF2-a (2396), anti-Rpsl3 (12), anti-dPrp38p_N and anti-dPrp38p_C 
rabbit antibodies and the anti-dMFAPl and anti-dMCRS2 guinea pig antibodies were 
generated and affinity-purified by Eurogentec SA (Seraing, Belgium) against peptides 
corresponding to amino acids 119-133 of dMCRS2, 884-898 of Pitslre, 4-14 and 314- 
328 of eIF2-a, 128-142 of Rpsl3, 1-15 and 315-330 of dPrp38, and 43-57 of dMFAPl 
(Eurogentec).
2.1.2 Cell culture
Drosophila S2 cells were grown in Schneider medium (Invitrogen) and 
S2R+ cells in Shields and Sang M3 Insect Medium (M3) (Sigma) supplemented with 
10% heat-inactivated Fetal Bovine Serum (Sigma), 50 U/ml penicillin, and 50 pg/ml 
streptomycin (Invitrogen, “Complete Medium”) at 25°C. S2 cells were transfected with 
pDA9-l, pDA9-2, and pDA10-l (see plasmids below) using a calcium phosphate 
transfection kit (Invitrogen). For all other plasmids, S2 and S2R+ cells were transfected 
using an effectene transfection kit (Qiagen). S2 cells stably expressing GTC-Pixie, 
GTC-PixieAABC, GTC-PixieE501Q, GTC-dMCRS2 or the GTC tag alone were 
selected in complete Schneider medium containing 300 p,g/ml hygromycin. For insulin 
treatment S2 cells were treated with 1 pM bovine insulin in complete medium.
2.1.3 dsRNA
dsRNAs were synthesised with a Megascript T7 kit (Ambion). DNA 
templates for dsRNA synthesis were PCR amplified from fly genomic DNA or plasmids
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using primers that contained 5'T7 RNA polymerase-binding sites followed by sense or 
anti-sense sequences (Table 2-4). The primers were designed using the E-RNAi web 
site at the DKFZ, Heidelberg http://www.dkfz-heidelberg.de/signaling/emai.html. For 
GFP, G FPR N A iS  and G FPR N A iA , for dmrs2, dMCRS2_RNAi_S and 
dMCRS2_RNAi_A, for pitslre, Pitslre_RNAi_S and P itslreRN A iA , for 
CG6049/cus2, CG6049/cus2_RNAi_S and CG6049/cus2_RNAi_A, for CG6905/cefl 
CG6905/cefl, CG6905/ceH_RNAi_S and CG6905/cefl_RNAi_A, for CG8877/prp8, 
CG8877/prp8_RNAi_S and CG8877/prp8_RNAi_A, for CG32604/prpl6, 
CG32604/prp 16_RNAi_S and CG32604/prpl6_RNAi_A, for CG6015/prpl7,
CG6015/prpl7_RNAi_S and CG6015/prpl7_RNAi_A, for CG601 l/prp!8,
CG6011 /prp 18_RN Ai_S and CG6011/prpl8_RNAi_A, for CG5519/prpl9,
CG5 519/prp 19_RNAi_S and CG5519/prpl9_RNAi_A, for CG8241/prp22,
CG8241/prp22_RNAi_S and CG8241/prp22_RNAi_A, for CG30342/dprp38, 
CG30342/dprp38_RNAi_S and CG30342/dprp38_RNAi_A, for CGI017/dmfapl, 
CG1017/dmfap 1 _RNAi_S and CGI017/dmfapl _RNAi_A, for pixie, Pixie_RNAi_S 
and Pixie_RNAi_A, for adam, Adam_RNAi_S and Adam_RNAi_A, for eIF3-S2, eIF3- 
S2_RNAi_S and eIF3-S2_RNAi_A, for eIF3-S8, eIF3-S8_RNAi_S and eIF3- 
S8 _RNAi_A, for eIF3-S9, eIF3-S9_RNAi_S and eIF3-S9_RNAi_A, for eIF3-S10, 
eIF3-S10_RNAi_S and eIF3-S10_RNAi_A, for rps25, Rps25_RNAi_S and 
Rps25_RNAi_A, for rpsl3, Rpsl3_RNAi_S and Rpsl3_RNAi_A.
2.1.4 Luciferase assay
S2R+ cells were seeded in a 96-well plate at a density of 2x105 cells/mL in 
60|iL serum-free medium (M3) containing 800 ng dsRNA targeting the relevant genes 
(Figure 3-3D). One hour later, 140pL complete M3 medium with transfection mix 
prepared according to the Qiagen effectene protocol was added to each well. The 
transfection mix contained the following amounts of plasmids:
UAS-Luc: 20 ng 
Yki-Gal4: 10 ng 
pIZ-Renilla: 10 ng 
and:
pAC-Hpo-Myc, pAC-Wts-Myc, pAC-Sav-Myc: 10 ng each 
or
empty pAC-Myc: 30 ng (control)
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The plate was spun at 1000 rpm for one minute and incubated at 25°C for 
72 hours. On day four, the medium was removed by aspiration, and for the subsequent 
steps the Dual-Luciferase® Reporter 1000 Assay System kit (Promega) was used. First, 
20pL Passive Lysis Buffer was added to each well. Plates were spun at 1000 rpm for 
one minute, and cells were lysed at room temperature with shaking for 2 0  minutes. 
Second, lOOpL LAR II reagent was added. Third, the luciferase signal was read on 
Perkin Elmer Envision. Finally, lOOpL of Stop&Glo reagent was added, and the Renilla 
signal was measured on the same reader. The Renilla signal functions as a read-out for 
transfection efficiency. To compare the Yki-luciferase activity between different 
samples (wells) the luciferase signal was normalised to the Renilla signal. For each 
condition, eight replicates were made.
2.1.5 DNA profiles
S2 cells were seeded in 35 mm wells at a density of 7x105 cells/ml in a 
total of 3 ml complete medium/well and treated with dsRNA (20 pg/well) targeting 
eGFP or genes encoding the relevant gene products for the indicated number of days 
(Figures 3-6A, 4-3A, and 4-10). Subsequently, cells were harvested, collected by 
centrifugation, washed two times in PBS (137 mM NaCl, 2.7 mM KC1, 4.3 mM 
Na2HP04, 1.47 mM KH2PO4 , pH=8 ), fixed in cold 70% ethanol and stored at 4°C. 
Subsequent steps were performed at room temperature. Fixed cells were washed twice 
in PBS, treated with 50 pi 100 pg/ml RNase A (Sigma-Aldrich) for 15 min and 250pl 
40pg/ml propidium iodide for a further 30 min, and then analysed by flow cytometry.
2.1.6 BrdU-pulse chase
S2 cells were seeded in 35 mm wells at a density of 7x105 cells/ml in a 
total of 3 ml complete medium/well and treated with dsRNA (20 pg/well) targeting 
eGFP, dprp38, or dmcrs2 for 4 (<dprp38, Figure 4-4) or 6  (<dmcrs2, Figure 3-7) days. 
After 3 (dprp38) or 5 (dmcrs2) days, cells were re-seeded in 35 mm wells at a density of 
2xl06 cells/mL. After 12 hours, 15pM BrdU (Sigma Aldrich) was added to the medium 
for 15 minutes, then cells were washed three times with PBS, and BrdU-free medium 
was added. Cells were harvested at the indicated time points, collected by 
centrifugation, washed two times in PBS, fixed in cold 70% ethanol, and stored at 4°C. 
Subsequent steps were performed at room temperature. Fixed cells were washed twice
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in PBS and once in PBS-BT (PBS + 0.1% BSA + 0.2% Tween-20). 2 \i\ monoclonal 
mouse anti-BrdU (Becton Dickinson) were added directly to the cell pellets, incubated 
for 20 minutes in the dark, then cells were washed twice in PBS-BT and incubated in 
50pl of FITC-conjugated rabbit anti-mouse F(ab’)2fragments (DAKO) diluted 1:10 in 
PBS-BT for 20 minutes. Cells were washed twice in PBSA, treated with 50 \i\ 100 
pg/ml RNaseA (Sigma-Aldrich) for 15 min and 250(0,1 40(ig/ml propidium iodide for a 
further 30 min and then analysed by flow cytometry.
2.1.7 Cloning
The plasmids to express recombinant Pixie or Pixie A ABC tagged at the N- 
terminus with glutathione-S-transferase (GST) followed by a tobacco etch virus (TEV) 
protease cleavage site and a Calmodulin binding peptide (CBP, ‘GTC’) was generated 
in three steps. First, the entire Pixie ORF or Pixie lacking the second ABC domain 
(PixieAABC), with EcoRV, Hindlll and EcoRI sites inserted before the start codon and 
with a Kpn I site inserted after the stop codon was PCR-amplified using the Pixie sense 
and Pixie anti (Pixie) or PixieAABC anti (PixieAABC) primers. The PCR fragments 
were inserted into pGEM-T (Promega) giving rise to the pDA3-l and pDA3-3 plasmids, 
and the insert DNA sequences were verified. Second, a cassette encoding the GTC-tag 
(Zachariou et al., 2003) was subcloned from pCN-GTCtag (gift from Pascal Meier) into 
pDA3-l and pDA3-3 using the Hindlll and EcoRI restriction sites, thereby generating 
pDA8 -l and pDA8-2, respectively. Third, N-terminally GTC-tagged Pixie and 
PixieAABC were inserted in front of the inducible MT promoter of the pMK33 vector 
using the unique EcoRV and Spel restriction sites to generate pDA9-l and pDA9-2, 
respectively. GTC-PixieE501Q (pDA9-3) was generated by introducing a point 
mutation in the second ABC domain of Pixie (G1483C) by three consecutive PCRs. 
First PixieE501Q_Sl and PixieE501Q_Al (PCR1) or PixieE501Q_S2 and 
PixieE501Q_A2 (PCR2) primers were used to produce two overlapping PCR fragments 
containing the desired point mutation. The final PCR fragment was amplified using the 
PCR1 and PCR2 fragments as template and the PixieE501Q_Sl and PixieE501Q_A2 
primers, which covers a unique BstEII restriction site 5’ of the point mutation, and 
inserts a Spel site 3’ of the stop codon, respectively. This PCR fragment was inserted 
into pCR®2.1-TOPO® (Invitrogen) generating pDA3-5, and the DNA sequence was 
verified. Finally, the Pixie fragment containing the point mutation was subcloned into
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pDA9-l using the unique BstEII and Spel restriction sites to generate pDA9-3. A 
control plasmid expressing the GTC-tag alone was generated by PCR amplification 
from pCN-GTCtag using primers that added a EcoRV site in front of the ATG and and 
a Spel site after the stop codon, respectively. This fragment was subcloned into pMK33 
to generate pDAlO-1. To generate GTC-dMCRS2, the entire dMCRS2 ORF, with an 
EcoRI site inserted before the start codon and with a Notl site inserted after the stop 
codon was PCR-amplified using the GTC_dMCRS2_S and GTC_dMCRS2_A primers. 
This PCR fragment was subcloned into pDA8 -l using the unique EcoRI and Notl sites. 
Next, N-terminally GTC-tagged dMCRS2 was inserted in front of the inducible MT 
promoter of the pMK33 vector using the unique EcoRV and Spel restriction sites to 
generate GTC-dMCRS2.
To generate His-dPrp38, the entire open reading frame of dPrp38 was 
PCR amplified with a Kpnl site inserted before the start codon and a Hindlll site 
inserted after the stop codon using dPrp38/pENTR-TOPO (see below) as a template and 
the dPrp38_GST_S and dPrp38_GST_A primers. Next, this PCR fragment was inserted 
into the pRSET A vector using the unique Kpnl and Hindlll sites. To generate GST- 
dMFAPl, the entire open reading frame of dMFAPl was PCR amplified with an EcoRI 
site inserted before the start codon and a Sal I site inserted after the stop codon using 
dMFAPl/pENTR-TOPO (see below) as a template and the dMFAPl_GST_S and 
dMFAPl_GST_A primers. Next, this PCR fragment was inserted into the pGEX 4T-1 
vector using the unique EcoRI and Sal I sites.
The construct used to generate the dmfapl D2-1 RNAi line was cloned by 
inserting two 400 bp inverted repeats of dmfapl into the pMF3 vector using the unique 
EcoRI and Xbal restriction sites. The 400 bp repeats were amplified from genomic 
DNA using a forward primer containing a Bgl II site at the 5’ end (dMFAPlForwBglll) 
and reverse primers containing an EcoRI (dMFAPlRevEco) or a Xbal 
(dMFAPlRevXba) site at the 3’ end. The two PCR products were digested with Bgl II 
and EcoRI or Bgl II and Xbal and cloned into the same pMF3 vector digested with 
EcoRI and Xbal.
dMCRS2-Flag, dMCRS2AFHA-Flag, HA-Pitslre, HA-PitslreK587R, 
MOF-HA, dMFAPl-Myc, HA-dMFAPlAN, HA-dMFAPlAC, HA-dPrp38p and 
dPrp38A were cloned using the Gateway system (Invitrogen). dMCRS2 was PCR 
amplified from an EST (1794) using the dMCRS2_S and dMCRS2_A primers, Pitslre
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was PCR amplified from an EST (39519) using the PitslreS and PitslreA  primers, 
dMFAPl was PCR amplified from an EST (7619) using the dMFAPI S and 
dMFAPl_A primers, dPrp38 was PCR amplified from an EST (13395) using the 
dPrp38_S and dPrp38_A primers, and MOF was PCR amplified from an EST (8841) 
using the MOF_S and MOF_A primers. PCR products were run on 1% agarose gels 
(TAE +1%  agarose (Invitrogen) + 1 pi of Ethidium Bromide (Roche)), and bands of 
the correct size were cut out, purified using the QIAquick gel extraction kit (Qiagen), 
and ligated into the pENTR-TOPO vector (Invitrogen) according to manufacturers 
instructions. dMCRS2AFHA was PCR amplified from dMCRS2/pENTR using the 
dMCRS2AFHA_S and dMCRS2AFHA_A primers, dMFAPlAN and dMFAPlAC were 
PCR amplified from dMFAPl/pENTR using dMFAPlAN_S and dMFAPlAN A or 
dMFAPlAC_S and dM FAPlACA primers, respectively, HA-dPrp38p and dPrp38A 
were PCR amplified from dPrp38/pENTR using dPrp38p_S and dPrp38p_A or 
dPrp38A_S and dPrp38A_A primers, respectively. PitslreK587R was generated by three 
consecutive PCRs. First Pitslre_S and PitslreK587R_A (PCR1) or PitslreK587R_S and 
and Pitslre_A (PCR2) primers were used to produce two overlapping PCR fragments 
containing the desired point mutation. Second, the final PCR fragment was amplified 
using PCR1 and PCR2 fragments as template and the Pitslre S and Pitslre A primers. 
All of the above PCR products were purified and cloned into pENTR-TOPO 
(Invitrogen). dMCRS2, dMCRS2AFHA, Pitslre, PitslreK587R, dMFAPl, dMFAPlAN, 
dMFAPlAC, HA-dPrp38p, dPrp38A, and MOF were then transferred from pENTR-topo 
to Gateway expression vectors by the LR reaction. These included pActin 3xHA, 
pActin 6 xMyc, and pActin 3xFlag for expression of tagged proteins in S2 cells and 
pUASP for generation of UAS-dprp38, UAS-dmfapl, and UAS~dmcrs2 transgenic lines. 
Midi-preps were made of all plasmids using the High-Speed Plasmid Midi Kit (Qiagen). 
The resulting plasmid DNs was quantified using the Nanodrop (Nanodrop) and stored at 
-20°C. All Gateway vectors were obtained from the Gateway Drosophila Vector 
Collection (Murphy lab, Carnegie Institution).
2.1.8 DNA Sequencing
DNA was sequenced by the Sequencing Service at Cancer Research UK 
using a 3730 DNA Analyzer (Applied Biosystems). Extension products were amplified
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and purified using the DyeEx Spin kit (Qiagen). Purified extension products were 
handed to the Sequencing Service for sequencing.
2.1.9 Polymerase chain reaction (PCR)
PCR products were amplified using the Taq PCR Master-mix kit (Qiagen) 
and a PTC-200 peltier thermal cycler (MJ Research). For cloning the PWO Master-mix 
(Roche), which contains a high-fidelity polymerase, was used. A typical PCR reaction 
of 50pil was set up as follows:
25^1 Master-mix 
lpl 5’-primer (20pM) 
lpl 3’-primer (20pM) 
lpl Template DNA (10-50ng)
2 2 ( j i1 distilled H2O
A typical PCR reaction was run on the following PCR program:
1) 95°C for 10 mins
2) 95°C for 40 seconds
3) 56°C for 30 seconds
4) 72°C for minute per kb of product
5) go to step (2) -  24 cycles
6 ) 72°C for 10 minutes
PCR products were run on 1% Agarose gels, and gels were photographed using an 
IMAGO compact imaging system.
2.1.10 Quantitative RT-PCR
S2 were treated with dsRNA (20 pg/well) targeting genes encoding the 
indicated gene products for three days. Total RNA was isolated from the cells using the 
RNeasy kit (Qiagen) and treated with RQ1 DNase (Promega). Total RNA (1.5 pg) was 
used for first-strand cDNA synthesis with AMV Reverse Transcriptase and oligo- 
p(dT)15 primer (mRNA) or oligo-p(dN) 6  (total RNA) (Roche). To measure pre-mRNA 
levels, quantitative PCRs (qPCRs) were performed on reverse-transcribed total RNA
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using one intron- and one exon-specific primer. To measure mRNA levels, qPCRs were 
carried out on reverse transcribed total mRNA using exon-specific primers. For stg 
mRNA, Stg_mRNA_S and Stg_mRNA_A, for y-tubulin(23C) pre-mRNA, y- 
tubulin_pre_mRNA_S and Y-tubulin_pre_mRNA_A, for y-tubulin(23C) mRNA, y- 
tubulin_mRNA_S and y-tubulinjnRNAA, for eIF3-S10 pre-mRNA, 
eIF3 S10_pre_mRNA_S and eIF3S10_pre_mRNA_A, for eIF3-S10 mRNA, 
eIF3S10_mRNA_S and eIF3S10_mRNA_A, for dmcrs2 pre-mRNA, 
dMCRS2_pre_mRNA_S and dMCRS2_pre_mRNA_A, for dmcrs2 mRNA, 
dMCRS2_mRNA_S and dMCRS2_mRNA_A, for hpo pre-mRNA, 
Hippo__pre_mRNA_S and Hippo_pre_mRNA_A, for hpo mRNA, Hippo mRNA S and 
Hippo mRNA A, and for his3, Histone3_transcript_S and Histone3_transcript_A 
primers were used. Real-time qPCR was performed with Platinum® SYBR® Green 
qPCR SuperMix-UDG (Invitrogen). PCR was carried out in 96-well plates using the 
Chromo 4 Real-time qPCR Detection System (MJ Research). All reactions were 
performed in four replicates. The relative amount of specific mRNAs and pre-mRNAs 
under each condition was calculated after normalization to the intronless histone 3 
(his3) transcript.
2.1.11 Tandem Affinity Purification
Two-step purifications were performed from lxlO10 S2 cells expressing 
recombinant GTC-Pixie, GTC-dMCRS2 or the GTC-tag alone. Cells were lysed in 
50ml Buffer A (50 mM Hepes-KOH, pH 8 , 100 mM KC1, 10 mM MgC12, 0.1% Triton 
X-100, 2 mM DTT, 10% glycerol, 10 mM NaF, 0.25 mM NaV04, 1 mM PMSF, 0.1 
mg/ml aprotinin, 1 0  pig/ml leupeptin), and cell extracts were cleared of nuclear and 
membranous material by centrifugation at 10,000 rpm for 15 min. In the first 
purification step, the cleared cell extracts were incubated with glutathionine sepharose 
beads (Amersham) for 2 hours at 4°C. Post incubation, beads were washed three times 
in 12 ml Buffer A and 3 times in Cleavage Buffer (CB; 10 mM TrisHCl pH 8 , 150 mM 
NaCl, 0.1% Triton X-100, 0.5 mM EDTA, 1 mM DTT). Beads were resuspended in 300 
\xl CB containing 50U of TEV protease (Invitrogen) and incubated at 16°C for two 
hours. After the first round of cleavage, the supernatant was recovered and a second 
round of cleavage was performed at 4°C overnight. In the second purification step, the 
supernatants from the two cleavage reactions were pooled and mixed with three
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volumes of Calmodulin (CaM) Binding Buffer (CaMBB; 10 mM TrisHCl pH 8 , 150 
mM NaCl, 0.1% Triton X-100, 1 mM Mg(CH3COO)2, 1 mM Imidazole, 2 mM CaCl2, 
10 mM p-mercaptoethanol), before incubation with CaM beads (SepharoseTM4B, 
Amersham) at 4°C for 4 hours. Subsequently, the beads were washed 6  times in 10 ml 
CaMBB and Pixie and Pixie-associated or dMCRS2 and dMCRS2-associated proteins 
were eluted in CaM elution Buffer (10 mM TrisHCl pH 8 , 150 mM NaCl, 0.1% Triton 
X-100, 1 mM Mg(CH3COO)2, 1 mM Imidazole, 2 mM EGTA, 10 mM (3- 
mercaptoethanol) at 4°C. Finally, the eluates from the CaM beads were concentrated by 
centrifugation in Microcon YM-10 concentrators (Millipore) and resolved by SDS- 
PAGE on 4-12% gradient gels (Invitrogen). Individual protein bands were visualized by 
Brilliant Blue G-colloidal concentrate (Sigma) staining, cut out and identified by 
MALDI-TOF mass spectrometry
2.1.12 Immunoprecipitation
Immunoprecipitations were performed from lx l0 9 (large-scale, Figures 4- 
5 and 4-7) or lxlO7 S2 cells. Cells were lysed in 10 ml (large-scale, Figures 4-5 and 4-
7) or 200 pi buffer B (50 mM Tris-HCl, pH 8 , 150 mM NaCl, 0.5% NP50, 1 mM 
EGTA, 0.5 M NaF, phosphatase inhibitor cocktail 2 (Sigma), Complete protease 
inhibitor cocktail (Roche)), and cell extracts were cleared of membranous material by 
centrifugation at 10,000 rpm for 15 min. Extracts were incubated with protein A- 
sepharose 4B beads (Amersham) for one hour to reduce unspecific binding of proteins 
to the beads in the subsequent purifications. Next, the pre-cleared extracts were 
incubated with 800 pi (large-scale, Figures 4-5 and 4-7) or 80 pi of protein A-sepharose 
beads and 10 pi (large-scale, Figures 4-5 and 4-7) or 1 pi of the relevant antibody for 
two hours. A rabbit anti-GFP antibody was used in the control purifications. 
Subsequently, beads were washed 3 times in buffer B, boiled in sample buffer 
(Invitrogen), and resolved by SDS-PAGE on 8-16% gradient gels (Biorad, Figure 4-7) 
or 4-12% Nupage Bis-Tris gels (Invitrogen). Individual protein bands were visualized 
by Brilliant Blue G-colloidal concentrate (Sigma) staining, cut out and identified by 
MALDI-TOF mass spectrometry at the Taplin Biological Mass Spectrometry Facility 
(large-scale, Figures 4-5 and 4-7).
121
2.1.13 GST pull-down
For the GST pull-downs, 1 pig bacterial-produced GST or GST-dMFAPl 
protein was incubated with 50ng bacterial-produced His-dPrp38 protein and 80pil pre­
washed Gluthionine-Sepharose beads (Pharmacia) in 250pl buffer B at 4°C (Figure 4- 
6 A). For the Histidine (His) pull-downs, 500ng of bacterial-produced His-dPrp38 or 
His-Peptide (control) was incubated with 800ng of cleaved GST-dMFAPl and 80pl 
pre-washed Ni-NTA agarose beads (Qiagen) in 250pl buffer B at 4°C (Figure 4-6B). 
After two hours, Gluthionine sepharose and Ni-NTA agarose beads were spun down at 
2 0 0  ref for two minutes, the supernatant was removed, and beads were washed three 
times for two minutes in buffer B at 4°C. After the final wash, beads were spun down 
and 18 pi of sample buffer (Invitrogen) and 3 pi of reducing buffer (Invitrogen) was 
added. Samples were incubated at 70°C for 10 minutes, and the supernatants resolved 
by SDS-PAGE on 4-16% Nupage Bis-Tris gels (Invitrogen).
2.1.14 Western blotting
Proteins were separated by SDS-PAGE using 12% gels or 4-12% gradient gels 
(Invitrogen) and transferred electrophoretically to polyvinylidene difluoride membranes 
(PDVF, Millipore or Amersham). For detection by the Odyssey Infrared Imaging 
System (LI-COR Biosciences), membranes were blocked for one hour in Blocking 
Buffer A (LI-COR Biosciences) supplemented with 0.1% Tween 20, and incubated 
overnight at 4°C in the same buffer containing primary antibodies at the indicated 
concentrations (Table 2-2). Membranes were washed three times in TBS-T (10 mM 
Tris-HCl pH 8 , 150 mM NaCl, 0.1% Tween-20) or PBS-T (PBS + 0.1% Tween-20), 
then probed with secondary antibodies labelled with Alexa Fluor 680 (Molecular 
Probes) or IRDyeTM 800 (Rockland Immunochemicals) diluted 1/6000 in a buffer 
containing 1/3 volume TBS-T or PBS-T, 2/3 volume Blocking Buffer A for one hour at 
room temperature. After washing in TBS-T or PBS-T, bands were detected using the 
Odyssey Infrared Imaging System (LI-COR Biosciences). For detection by 
chemiluminescence, membranes were blocked for one hour in Blocking Buffer B (PBS 
+ 5% milk) and incubated overnight at 4°C in the same buffer containing primary 
antibodies at the indicated concentrations (Table 2-2). Membranes were washed three 
times in PBS-T, blocked for one hour in Blocking Buffer B, then probed with 
Horseradish Peroxidase conjugated secondary antibodies diluted 1/5000 in blocking
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buffer B for one hour at room temperature. After three washes in PBS-T, 




To generate the data shown in Figures 4-12B and 5-6 to 5-13, 5x10 S2 
cells were treated with lOOpg/ml cycloheximide (Sigma) for 10 min and lysed in 0.6 ml 
50mM Hepes-KOH pH 7.2, lOOmM KC1, lOmM MgC12, 0.1% Triton X-100, 1 mg/ml 
Heparin, 2 mM DTT, lOOpg/ml cycloheximide, RNAguardTM (Amersham). Cell 
debris was removed via centrifugation for 1 0  min at 13,000 rpm, and extracts were 
resolved on 7.5-30% sucrose density gradients by centrifugation for 4.5 h at 39,000 rpm 
at 4°C using the SW41Ti rotor (Beckman). 600pi fractions were collected while 
recording the A254 profile using a single path UV monitor (Pharmacia).
o
To generate the data shown in Figure 4-12C, 5x10 S2 cells were lysed in 
0.6 ml lysis Buffer (25mM Hepes-KOH pH 7.6, 0.1 mM EDTA, 60mM KC1, 1% Triton 
X-100, ImM DTT, ImM PMSF, 0.5 M NaF, phosphatase inhibitor cocktail 2 (Sigma), 
Complete protease inhibitor cocktail (Roche)). Cell debris was removed via 
centrifugation for 10 min at 13,000 rpm, and extracts were resolved on 7.5-35% 
glycerol density gradients by centrifugation for 7 h at 37,000 rpm at 4°C using the 
SW41Ti rotor (Beckman). 600pl fractions were collected and stored at -20°C.
2.1.16 Polysome Profiles
To generate the data shown in Figure 5-5, S2 cells were seeded in 35 mm 
wells at a density of 7xl05 cells/ml in a total of 3 ml complete medium/well and treated 
with dsRNA (25 pg/well) targeting eGFP (control), pixie, or eIF3-S10, for 7-8 (Pixie) 
or 5 (eIF3-S10) days, and the effectiveness of the dsRNAi-mediated depletion was 
assessed by immunoblotting. To stimulate growth, cells were starved for an hour in PBS 
containing 2mg/ml glucose (Sigma) and subsequently stimulated in complete media 
containing lpM insulin (Sigma) for three hours. Cells were then treated with lOOpg/ml 
cycloheximide (Sigma) for 10 min and extracts were prepared from 3><107 cells as 
described above. The cleared extracts were resolved on 7.5-60% sucrose density 
gradients by centrifugation at 39,000 rpm for 2 hours at 4 °C using a SW41Ti rotor 
(Beckman). The A254 profiles were recorded as described above.
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2.2 Genetics and Immunohistochemistry
2.2.1 Immunohistochemistry
Mosaic tissues were obtained using the hs-Flp/FRT system (Xu and 
Rubin, 1993). Salivary glands and wing and eye imaginal discs were dissected from L3 
larvae (120 hr AEL) in lx  PBS. S2 cells were seeded at a density of 5xl06/mL on 
chamber slides (Nunc, Figure 4-11A-D). Tissues and S2 cells (Figure 4-11A-D) were 
fixed in 4% formaldehyde in PBS for 20 min at room temperature, washed four times in 
PBS containing 0.1% Triton X-100 (PBS-T), blocked for 2 hrs in PBS-T containing 
10% goat serum (PBS-TG), and incubated with primary antibodies diluted in PBS-TG 
overnight at 4°C. The dilutions of the primary antibodies are indicated in Table 2-2. The 
next day, tissues and cells were washed, blocked in PBS-TG, and incubated with 
secondary antibodies for two hours at room temperature. The dilutions of the secondary 
antibodies are indicated in Table 2-3. Hoechst (Sigma) was added to the secondary 
antibody mixture during the last 30 minutes of the incubation to stain DNA. After 
washes, cells and tissues were mounted in Vectashield. Fluorescence images were 
acquired using a Zeiss LSM510 Confocal Laser Scanning Microscope (25 x and 40x 
objectives) and processed using Adobe photoshop CS2.
2.2.2 Staining of Polysome Chromosome spreads
Salivary glands were dissected from third instar larvae in 1 x PBS, and 
fixed for 10 minutes in a droplet of fix (3.7% paraformaldehyde and 50% acetic acid) 
on a siliconised coverslip. Next, the coverslip was picked up with a poly-L-lysine- 
treated slide, and the salivary gland cells broken up by tapping the coverslip with an 
eraser and applying a firm pressure with the thumb. After examination of the polytene 
chromosome preparations under the light microscope to check that the chromosome 
arms are well spread, the slides frozen in liquid nitrogen and the coverslips were 
removed using a razor blade. Next, slides were washed in lxPBS, the polytene 
chromosome preparations were permeabilised in PBS containing 1 % Triton X-100 for 
10 minutes, blocked for 2 hrs in 5% milk in PBS ,and incubated with anti-RNAP II and 
anti-dMCRS2 antibodies diluted 1/100 in 5% milk in PBS overnight at 4°C. The next 
day, slides were washed, blocked in 5% milk in PBS, and incubated with secondary 
antibodies for two hours at room temperature. The dilutions of the secondary antibodies 
are indicated in Table 2-3. After washes, polytene chromosome spreads were mounted
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in Vectashield. Fluorescence images were acquired using a Zeiss LSM510 Confocal 
Laser Scanning Microscope (40x objective) and processed using Adobe photoshop CS2.
2.2.3 Scanning electronic microscopy (SEM)
Adult female flies of the relevant genotypes were collected and transferred 
to fresh vials for 6  hours. They were then submerged in 10% ethanol for 30 minutes 
followed by consecutive incubations in ethanol solutions of increasing concentrations
(30%, 50%, 70%, 90%, and 100%). Samples were prepared and imaged by Anne
Weston of the Cancer Research UK electron microscopy (EM) facility using a Jeol JSM 
6700F Scanning electron microscope.
2.2.4 Mutagenesis by imprecise R-element excision
The G19491 P-element (Genexel Inc.) is inserted 798 bp into the open 
reading frame of dprp38 (dprp38019491). The dprp38E1 mutant was generated by 
imprecise excision of the G 19491 P-element. Below is shown the cross scheme used to 
obtain the dprp38E1 mutant:
Po 8  8  w ; G19291(mv) /  CyO X w ; Sp/CyO; A2-3, Sb /  TM6B ?  $
F itfc J  w ; G19291 (mv) /  CyO; A2-3, Sb /  + X w ;S p /C y O  ?  $
F2 Single 8  w ; G1929J*/CyO  X w; Sp/C yO  ?  ?
In the first cross, the P-element line (G19491) was crossed to the transposase source 
(A2-3). Hybrid males (mosaic orange and white eyes) were selected from the Fi and 
crossed en masse to second chromosome balancer virgins (Sp /  CyO). In the F2 
generation, white-eyed excision males (G19291*) were selected and crossed 
individually to (Sp /  CyO) virgins. Males were lifted from this cross after four days and 
screened for deletions by PCRs using genomic DNA as a template and the dPrp38-5.03 
and dPrp38-3.3 primers. The genomic DNA from individual adult flies was prepared 
using the DNeasy kit (Qiagen) by following manufacturers directions. Once mutant 
chromosomes had been identified, the relevant crosses to Sp /  CyO were kept and 
progeny were mated inter se to obtain balanced mutant stocks.
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2.2.5 Generation of recombinant chromosomes
For generation of all recombinant chromosomes, similar crossing schemes 
were used. Shown below as an example is the crossing scheme used to recombine the 
dmcrs2rG166 mutation onto the FRT80B, Ubi-GFP chromosome:
Po 8  8  w;dmcrs2rG166/TM 3,Sb  X w ; FRT80B Ubi-GFP /  TM6B
Fi 8  8  w ; TM3, Sb/ TM6B X w ; dmcrs2rGI66/ FRT80B Ubi-GFP ? ?
F2 8  w ; FRT80B Ubi-GFP (?) , dm crsl0166(?)/ TM6B X w ; TM3, Sb /  TM6B 2 ?
In the first cross, dmcrs2rGl66 /  TM3, Sb flies were crossed to FRT80B , Ubi-GFP /  
TM6B flies. Virgin females were selected in Fi that have both dmcrs2rG166 and FRT80B 
, Ubi-GFP by the absence of the dominantly marked balancer chromosomes, TM3, Sb 
and TM6B. These females were crossed en masse to TM3, Sb /  TM6B males, and the 
meiotic recombination event occured in the female germline. The F2 generation were 
crossed to third chromosome balancer virgins, then lifted after four days, and screened 
for the presence of both dmcrs2rGI66 and FRT80B , Ubi-GFP by PCRs of genomic 
DNA. Crosses from recombinant males were kept and the progeny mated inter se to 
obtain recombinant stocks.
2.2.6 Density controlled wing measurements
Crosses to obtain the relevant genotypes were initiated. Once females 
were laying eggs (1-2 days), the flies were transferred to a container, which was 
inverted over an agar and apple juice substrate. Eggs were collected for 4 hours before 
the flies were removed. The embryos were kept at 25°C until eclosion. When the flies 
eclosed from the density-controlled crosses, males of the relevant genotype were 
collected and put into 100% ethanol. Wings were removed with micro-dissection 
tweezers, dried on a piece of tissue, and mounted on slides in Euparal (Sigma). A 
coverslip was placed over the wings, and the slides were dried overnight on a 65°C 
hotplate. Wings were digitally photographed using a LeicaDC200 camera on a MFIII 
dissection microscope. Wing areas were then measured using the Polygonal Lasso tool 




The dmfapl D2-1 RNAi, UAS-dprp38, UAS-dmfapl, and UAS-dmcrs2 
transgenic lines were generated by the Fly facility at Cancer Research UK. The pMT- 
dMFAPl RNAi, pUAS-dPrp38, pUAS-dMFAPl, and pUAS-dMCRS2 constructs were 
introduced into the germline by injections in the presence of transposase as previously 
described (Brand and Perrimon, 1993; Rubin and Spradling, 1982). The dMFAPl 
(15610) and dPrp38 (21136) RNAi lines were obtained from the Vienna Drosophila 
RNAi Center (VDRC).
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3-3B-C’ hs-FLP; FRT80B, dmcrs2r<jlM/FRT80B, Ubi-GFP
3-4B-D hs-FLP; FRT80B, Ubi-GFP, dmcrs2njl66/FRT80B, M(3)67c4
3-4E-G hs-FLP; FRT80B, Ubi-GFP, dmcrsTumr/FRT80B, M(3)67c4
3-4H-J hs-FLP; FRT80B, Ubi-GFP, dmcrs2cllo" 4/FRT80B, M(3)67c4
3-10D-I w‘so; engrailed-Gal4, UAS-GFP/UAS-dmcrs2
4-1C-D w“°- engrailed-Gal4, UAS-GFP/UAS-dPrp38RNAi
4-2C-D wls°; hs-FLP; FRT42D, dprp38IJhm'/FRT42D, Ubi-GFP
4-2E-F,H w‘so; hs-FLP; FRT42D, Ubi-GFP, dprp38h:'/FRT42D, M(2)53‘
4-9A-C w'” ; hs-FLP; Act >cd2 > Gal4, UAS-GFP
4-9D-F W50; hs-FLP; UAS-RNAi-dmfapl/Act >cd2 >Gal4, UAS-GFP
4-9G-I wuo; hs-FLP; UAS-RNAi-dprp38/Act >cd2 >Gal4, UAS-GFP
4-9J w's°; engrailed-GaU, UAS-GFP/+; UAS-dPrp38/MKRS
4-9J w“°; engrailed-GaU, UAS-GFP/+; UAS-dMFAPl/+
128
Table 2-2: Primary antibodies used
Primary Antibody Species Concentration Source
Pixie Rabbit 1:5000 Cancer Research UK
Adam Rabbit 1:1000 Cancer Research UK
eIF3-S2 Rabbit 1:1000 Cancer Research UK
eIF3-S8 Rabbit 1:1000 Cancer Research UK
eIF3-S9 Rabbit 1:1000 Cancer Research UK
eIF3-S10 Rabbit 1:1000 Cancer Research UK
eIF2-a Rabbit 1:000 Eurogentec, Belgium
eIF4A Rabbit 1:1000 Gift from Chris Proud
Rpsl3 Rabbit 1:1000 Eurogentec, Belgium
Rps25 Rabbit 1:1000 Cancer Research UK
RpLP 1:500 ImmunoVision
dMFAPl Guinae Pig 1:1000 Eurogentec, Belgium
dPrp38 Rabbit 1:1000/1:500 (WB/IF) Eurogentec, Belgium
dMCRS2 Guinae Pig 1:1000/1:500 (WB/IF) Eurogentec, Belgium
Cleaved Caspase 3 Rabbit 1:500 Cell signalling
phospho-Histone H3 Rabbit 1:1000 Upstate
(3-tubulin Mouse 1:2000 Developmental Studies 
Hybridoma Bank
a-tubulin Mouse 1:1000 Sigma
BrdU Mouse 1:1 Becton Dickinson
DIAP1 Mouse 1:500 Bruce Hay
CycE Rat 1:500 Helen McNeill
Pitslre Rabbit 1:1000 Eurogentec, Belgium
RNAPII serum Goat 1:2000 Amo L. Greenleaf
RNAPII (7G5) Mouse 1:100 Lazslo Tora
Myc Mouse 1:000 Santa Cruz
HA (3F10) Rat 1:000 Roche
FLAG Rabbit 1:1000 Sigma
GST Rabbit 1:1000 Sigma
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Table 2-3: Secondary antibodies used
Secondary antibody Species Concentration Source
Anti-GpRRX Guinae Pig 1:500 Jackson
Anti-RbRRX Rabbit 1:500 Jackson
Anti-MouseRRX Mouse 1:500 Jackson
Anti-RatRRX Rat 1:500 Jackson
Anti-GpAlexa633 Guinae Pig 1:500 Molecular Probes
Anti-RbFITC Rabbit 1:500 Jackson
IRdye800-labelled Rabbit 1:6000 Rockland
IRdye700DX-labelled Rabbit 1:6000 Rockland
IRdye700DX-labelled Mouse 1:6000 Rockland
Anti-mouseHRP Mouse 1:5000 Amersham
Anti-RabbitHRP Rabbit 1:5000 Amersham
Anti-RatHRP Rat 1:5000 Amersham
Anti-GpHRP Guinae Pig 1:5000 Sigma
Anti-goatHRP Goat 1:5000 Sigma
Anti-mouseFITC Mouse 1:10 DAKO
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Table 2-4: Primers used














Pits Ire K5 8 7 RA CTCCATTTTCAGACGCCTAAGAGCCACAATCTC
Pi t s l reRNAiS CGCTGAATTTCACATTTCCA





G F P R N A i S GGTGGTGCCCATCCTGGT
G F P R N A i A TCGCGCTTCTCGTTGGGG
dPrp38_RNAi_S AGCGTGTCTGCGACATTATACTGCCCC
dPrp38_RNAi_A AGCCTCGCGAGTCCCGTTCCC
d M F A P l G S T S CCGGAATTCATGAGTGCAGCCACCGCCGCCG
d M F A P l G S T A CCGGTCGACTTACTCCATCTTTTTTCGCTTCG
dPrp38_His_S CGTGGTACCATATGGCCAACCGCACGGTGAAGG
dPrp38_His_A AACAAGCTTTTAGTAGCGTCGTCGGTCACGC
d M F A P l A N S CACCATGGACAACGAACCCCGCCTGAAG
d M F A P l A N A TTACTCCATCTTTTTTCGCTTCG
d M F A P l A C S CACCATGAGTGCAGCCACCGCCGCCG








y-tubu 1 in_pre_m RN A S GCGCCAAACCTACTATTAACTC
y-tubu lin_pre_mRN A_A CTACATCACTGATCTCGTCCTG
dMCRS2_mRNA_S GCAGCTGCGAGCACACTAATC
dMCRS2 mRNA A CTGGATAATTCTGGGAGGTGG
dMCRS2_pre_mRN A S GGAGGCATCAAGAATAACCG
dMCRS2_pre_mRNA_A GTTTCGATGCAAAAGGAGCTG
Hi p p o mRNAS CGGTGAATACCAACAGAGCTC
H i p p o mR N A A CGCCACGGCCATCTCCCGC
Hi p p o p r e m R N A S GGAAAACGGAATGCAACAAC
H i ppopremRN A_ A CAATAACAAATGGCCAGCCCTTTC
eIF3-S 1 O m R N A S GGCCCGCTATACGCAACGTC














CG32604/prp 16_RN Ai_S CTCCTCCTTTCTCTTGGCCT
CG32604/prp 16_RNAi_A GCCGGAATCGATAACGTAGA
CG6015/prp 17_RN Ai_S CATTGATGTGGGCCTTCTCT
CG6015/prp 17_RN Ai_A C ACG C ACC AT CCCT AGTTTT
CG601 l/prp!8_RNAi_S GATGTCTCGCAGACTGTCCA





dMF AP1 _RN Ai_S AGGGAGCACAGGGAGCGATTCAGCGG
dMFAPl_RNAi_A AGCATTCGCTTGAGTTCACGCAGCTTC
132















eIF3-S 1 O R N A i A GTAGTTGGCCATGGTTTTGG
P i x i e R N A i S GGAGAAGCACACAACGCATCG
P i x i e R N A i A TGATCGAATGGTCAAGGCAGC
A d a m R N A i S l CGACGATTGGGAATCCGCA
















Chapter 3 -  Results and discussion part I
3.1 A putative role of dMCRS2 in RNAP II transcription
3.1.1 Background to the project
Over the past five years, much of the research in Dr. Tapon’s laboratory 
has been aimed at obtaining a better understanding of the Hippo (Hpo) signalling. The 
Hpo signalling pathway plays a key role in restricting organ size by controlling both cell 
cycle exit and apoptosis (Harvey and Tapon, 2007). In brief, the Hpo pathway 
comprises the two kinases Hpo (Harvey et al., 2003; Jia et al., 2003; Pantalacci et al., 
2003; Udan et al., 2003; Wu et al., 2003a) and Warts (Wts) (Justice et al., 1995; Xu et 
al., 1995), the adaptors Salvador (Sav) (Kango-Singh et al., 2002; Tapon et al., 2002) 
and Mobl as a tumour suppressor (Mats) (Lai et al., 2005), the transcriptional co­
activator Yorkie (Yki) (Huang et al., 2005), and the transcription factor Scalloped (Sd) 
(Goulev et al., 2008; Wu et al., 2008; Zhang et al., 2008) (Figure 3-1). Activation of the 
Hpo kinase results in phosphorylation of Wts, which in turn phosphorylates and 
inactivates the co-activator Yki. This switches off transcription of Yki target genes 
including the cell cycle regulator cyclin E (cycE) and and the anti-apoptotic gene diapl 
(Drosophila inhibitor o f apoptosis protein 1) (Huang et al., 2005). Thus, activation of 
the Hpo pathway restricts tissue growth by repressing the cell cycle and promoting 
apoptosis. The Hpo signalling pathway is activated by unknown signals, but the 
protocadherin, Fat (Bennett and Harvey, 2006; Cho et al., 2006; Cho and Irvine, 2004; 
Silva et al., 2006; Willecke et al., 2006), and the FERM (Four point one Ezrin Radixin 
Merlin) domain proteins, Expanded and Merlin (Hamaratoglu et al., 2006), appear to be 
involved. Expanded and Merlin are themselves transcriptional targets of Yki, leading to 
an inhibitory feedback loop on the Hpo network.
In 2003, Paul Langton initiated a candidate-based screen in the laboratory 
to identify novel components of the Hpo pathway. At this time, Hpo, Sav, and Wts were 
the only known members of the pathway. He used the rough-eye phenotype caused by 
over-expression of Sav and Wts using the eye-specific GMR (Glass Multimer Reporter) 
promoter as a sensitised background to screen for novel components of the Hpo 
pathway. Candidates were selected based on a protein-protein interaction map of the 
Drosophila proteome generated from yeast 2-hybrid data (Curagen Inc.), and included
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Figure 3-1: The Hippo signalling pathway. Fat, Expanded, and Merlin function upstream of 
Hippo (Hpo) to regulate its kinase activity. Hpo bound to Salvador (Sav) phophorylates and 
activates Warts (Wts) kinase, which in turn phosphorylates Yorkie (Yki). Phosphorylation of Yki 
results in its association with 14-3-3 and retention in the cytoplasm. Upon loss of Hpo signalling, 
Yki shuttles to the nucleus where it binds to the transcription factor Scalloped (Sd) and stimulates 
transcription of target genes like diapl, cycE, and ex. Figure adapted from (Zhang et al. 2008).
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primary, secondary, and tertiary interactions with Hpo, Sav, and Wts. Thus, the aim was 
to use genetics to filter the large-scale two-hybrid data. Transposons (P-elements) 
inserted in the loci of the majority of the candidate genes were obtained from Genexel 
Inc.. Since P-element insertions potentially disrupt gene expression, the Genexel lines 
are putative LOF mutants. These lines were crossed to GMR-sav,wts and tested for their 
ability to suppress or enhance the rough-eye phenotype. A P-element insertion 
(l(3)rG166) in the dmcrs2 locus (dmcrs2rG166) was found to suppress the rough-eye 
phenotype.
3.1.2 The dmcrsrGf66 mutant allele suppresses the rough-eye phenotype 
caused by elevated levels of Hpo signalling
To document the suppression of the rough-eye phenotype in GMR-sav,wts 
animals carrying one copy of the dmcrs2rGI66 mutant allele, Julien Colombani, acquired 
scanning electron micrographs (SEMs) of wt, GMR-sav,wts/+, and GMR- 
sav,wts/dmcrs2rG166 eyes (Figure 3-2A-C’). As expected, over-expression of Sav and 
Wts using the eye-specific GMR driver results in a small rough-eye phenotype 
(compare B with A). High magnification (1x1000) SEMs of GMR-sav,wts eyes reveal 
that neighbouring ommatidia are frequently fused together and bristles are missing 
(Figure 3-2B’). SEMs of GMR~sav,wts/dmcrs2rG166 eyes show a rescue of the size and 
the roughness of the GMR-sav,wts eye (compare C with B). Moreover, high 
magnification SEMs of GMR-sav,wts/dmcrs2rG166 eyes reveal an intermediate 
phenotype with fewer fused ommatidia and only occasional missing bristles (Figure 3- 
2C’). This confirms that one copy of the dmcrs2rGI66 mutant allele is sufficient to 
partially rescue the rough-eye phenotype of GMR-sav,wts animals.
3.1.3 The l(3)rG166 P-element insertion is a dmcrs2 LOF mutation
dMCRS2 is encoded by three exons, and the insertion point of the 
l(3)rG166 P-element is predicted to be in the third exon. To verify the approximate 
position of the P-element, I carried out PCRs using primers that anneal to the inverted 
repeat of the P-element and approximately 500 bps upstream or downstream of the 
predicted insertion point (data not shown). Subsequent sequence analysis of the PCR 
products identified the exact insertion point. My analysis confirmed that the l(3)rG166 
P-element is inserted in the third exon and revealed that the exact insertion point is 




Figure 3-2: The rough-eye phenotype is suppressed in flies heterozygous for the 
dmcrs2rS,## mutation. (A-C’) Scanning electron micrographs (SEMs) of adult control (A-A’), 
GMRsav,wts (B-B’), and GMRsav,wts/dmcrs2rG,6e (C-C’) eyes. GMR-driven expression of Sav 
and Wts in the eye results in a small rough-eye phenotype (compare B with A), which is 
suppressed in flies heterozygous for the dmcrsZ0166 mutation. (A’) High magnification (1000x) 
SEM of a control eye show the regular arrangement of bristles. (B’) High magnification (1000x) 
SEM of a GMRsav,wts eye reveals the fusion of neighbouring ommatidia and the loss of many 
bristles. (C’) High magnification (1 OOOx) SEM of a GMRsav,wts/dmcrs2fGf6e eye show fewer fused 
ommatidia and only a few missing bristles (compare C’ with B’). These images were generated by 
Julien Colombani.
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of the dMCRS2 protein (Figure 3-3A). Moreover, Julien Colombani found that flies 
homozygous for the mcrs2rG166 mutation die as third instar larvae, but can be rescued to 
viability by GAL4/UAS-driven ubiquitous expression of dMCRS2. This demonstrates 
that dMCRS2 is an essential protein and that the l(3)rG166 P-element insertion indeed 
represents a dMCRS2 LOF mutation.
3.1.4 dMCRS2 LOF does not affect CycE and DIAP1 protein levels or Yki 
activity
As previously mentioned, the Hpo signalling pathway negatively regulates 
the transcription of diapl and cycE to promote apoptosis and cell cycle exit (Figure 3- 
1). Thus, inactivation of the Hpo pathway results in derepression of Yki activity and 
increased levels of DIAP1 and CycE (Pantalacci et al., 2003). The ability of the 
dmcrs2rG166 mutant allele to suppress the rough-eye phenotype caused by hyper­
activation of the Hpo signalling pathway suggests that dMCRS2 might have a pro- 
apoptotic function downstream of Sav and Wts. To test this idea, Julien Colombani used 
the FLP/FRT system to generate mitotic clones of dmcrs2rG166 mutant tissue in eye 
imaginal discs (the larval precursor of the adult eye) (Figure 3-3B-C’). By inducing 
FLP/FRT-mediated recombination in early eye-imaginal discs, it is possible to generate 
homozygous mutant clones (no GFP), corresponding wild-type twin-spots (two copies 
of GFP), while heterozygous tissue has one copy of GFP. Only small dmcrs2rG166 
mutant clones could be recovered in heterozygous animals, indicating that dMCRS2 is 
required for normal growth and proliferation (Figures 3-3B, C). Staining of discs with 
anti-DIAPl (Figure 3-3B’) or anti-CycE (Figure 3-3C’) antibodies revealed that DIAP1 
and CycE protein levels are not affected in dmcrs2rGI66 mutant clones. This suggests 
that dMCRS2 does not function downstream of Sav and Wts to regulate Yki activity. To 
confirm this observation, I studied the effect of dMCRS2 depletion on Yki activity in 
Drosophila S2 cells using previously established reporter assay as a read-out for Yki 
activity (Huang et al., 2005) (Figure 3-3D). In brief, Yki fused to the DNA binding 
domain (DB) of the yeast Gal4 transcription factor (Gal4DB-Yki) is a potent 
transcriptional activator, and Yki activity can be assayed by co-transfection of Gal4DB- 
Yki with a Gal4-responsive reporter (UAS-luciferase). Thus, transfection of S2 cells 
with Gal4DB-Yki results in a robust induction of luciferase activity relative to cells 
transfected with the DB domain alone (Huang et al., 2005). As previously reported, I 
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Figure 3-3: dMCRS2 LOF does not affect DIAP and CycE protein levels or Yki activity. (A)
Schematic of the dmcrs2 locus. dMCRS2 is encoded by three exons (indicated in black). The 
C-terminal part of the third exon encodes a Forkhead Associated (FHA) domain (indicated in red). 
The position of the rG166 P-element inserted in dmcrs2 is indicated. (B-C’) High magnification of 
an area of the eye imaginal disc from third instar larvae. The posterior is to the right. Mitotic clones 
of dmcrs2rG166 mutant tissue marked by the absense of GFP (B, C) and stained with the anti- 
DIAP1 (B’) and anti-CycE (C’) antibodies. Close up view of dmcrs2rG166 mutant clone shows that 
DIAP1 levels are unchanged in the dmcrs2rG166 mutant tissue (B-B’). (D) RNAi-mediated depletion 
of dMCRS2 protein levels does not derepress the loss of Gal4DB-Yki activity caused by Hpo, Sav, 
and Lats gain of function. S2 cells were treated with dsRNA targeting eGFP  (black and grey bars) 
or dmcrs2 (white bar). The next day, cells were transfected the indicated plasmids and 3 days 
later, luciferase acitivities were m easured and relative activity levels were calculated.
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of Hpo, Sav, and Wts (Figure 3-3D and (Huang et al., 2005)). Notably, I did not observe 
any derepression of Yki activity in dMCRS2-depleted cells expressing Hpo, Sav, and 
Wts (Figure 3-3D). This result is consistent with the initial observation that DIAP1 and 
CycE protein levels are unaffected in dmcrs2rG166 mutant tissue (Figure 3-3B-C’), and 
shows that dMCRS2 does not function downstream of Sav and Wts to regulate Yki 
activity. However, my results do not rule out that dMCRS2 has a pro-apoptotic function 
independent and/or further downstream of Yki.
3.1.5 The m crs^ 166 allele is likely to encode a dominant negative 
dMCRS2 mutant protein lacking the FHA domain
At this time during the project, I acquired two additional transposon 
(PiggyBac) insertions in the dmcrs2 locus, c07041 and c00114. The insertion points of 
both P-elements at the 5’end of exon 2 were verified by PCRs (Figure 3-4A). The 
dmcrs2c07041 and dmcrs2c00U4 mutant alleles are likely to represent dMCRS2 LOF 
mutations, since transheterozygous combinations of the dmcrs2c00114, dmcrs2c07041, and 
dmcrs2rG166 alleles are lethal.
To analyse the abilities of the two putative dMCRS2 LOF mutations to 
suppress the rough-eye phenotype, I crossed the dmcrs2c07041 and dmcrs2c00114 mutant 
alleles into the GMRsav,wts background. Unexpectedly, I found that neither of the two 
putative dmcrs2 LOF alleles was able to suppress the rough-eye phenotype (data not 
shown). This suggests that the dmcrsT07041 and dmcrs2c00] 14 alleles represent weaker 
dMCRS2 LOF mutations. Alternatively, the dmcrs2rG166 allele may carry additional 
mutations in non-essential genes outside of the dmcrs2 locus that interact with Sav/Wts 
signalling. The rG166 P-element insertion in dmcrs2 is predicted to cause a deletion of 
the last 84 amino acids of dMCRS2, which includes most of the FHA domain. Since the 
FHA domain is likely to be important for dMCRS2 function (see Introduction), the 
dmcrs2rGl66 mutant allele could potentially encode a dominant negative dMCRS2 
mutant protein. In contrast, the c07041 and cOOl 14 P-element insertions are predicted to 
cause a deletion of approximately 84% of the dMCRS2 protein and are more likely to 
represent null mutations. To study the nature of the dmcrs2c00114, dmcrs2c07041, and 
dmcrs2rG166 mutations in more details, I generated an antibody that recognises a stretch 
of amino acids in the central part of the dMCRS2 protein. I used the FLP/FRT system to 
generate mitotic clones of dmcrs2e00114, dmcrs2°07041, and dmcrs2rG166 mutant tissue in 
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Figure 3-4: The dmcrs2rG,M allele is likely to encode a truncated dMCRS2 product. (A) Sche­
matic of the dmcrs2 locus. The positions of the C07041, c00114 , and rG166 P-elem ents inserted 
in dmcrs2 are indicated. (B-J) dMCRS2 protein levels are significantly reduced mitotic clones of 
dmcrs2c001u (B-D) and dmcrs2a07041 (E-G), but not dmcrs2fG166 (H-l) mutant tissue. Eye imaginal 
discs from third instar larvae. Posterior is to the left. Mitotic clones of dmcrs?G166 (B-D), 
dmcrs2c07041 (E-G), and dmcrs2c001u (H-l) mutant tissue marked by two copies of GFP (B, E, H) 
and stained with the anti-dMCRS2 antibody (C, F, I).
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small dmcrs2c00114, dmcrs2c07041, and dmcrs2rG166 mutant clones could be recovered in 
heterozygous animals (data not shown). The difficulty of obtaining dMCRS2 LOF 
mutant clones in heterozygous animals might in part be due to their elimination by the 
surrounding wt tissue. In developing Drosophila imaginal discs, slow-growing cells are 
generally eliminated by a process known as cell competition, whereby fast-growing 
cells actively kill their slower neighbours (Diaz and Moreno, 2005). Minute mutations, 
which are dominantly-acting mutations in ribosomal components, are widely used to 
alleviate the effects of cell competition (Diaz and Moreno, 2005). By creating mutant 
clones in a Minute background, the proliferation rate of the surrounding heterozygous 
tissue is slowed down, allowing unhealthy mutant cells to survive. Thus, GFP-labelled 
dmcrs2c00114, dmcrs?07041, and dmcrs?0166 mutant clones were generated in eye 
imaginal discs that are heterozygous for a mutation in a Minute gene (Figure 3-4B-J). 
Staining discs with the anti-dMCRS2 antibody revealed a significant reduction in 
dMCRS2 protein levels in mitotic clones of dmcrs2°00114 and dmcrs?07041 mutant tissue 
(Figure 3-4F, I). In contrast, I observed no reduction in dMCRS2 protein levels in 
homozygous dmcrs?0166 mutant clones (Figure 3-4B). Since the anti-dMCRS2 
antibody recognises a stretch of amino acids encoded by a region 5’ to the l(3)rG166 P- 
element insertion point (amino acids 119-133), this shows that the dmcrs?0166 mutation 
causes a truncation rather than an ablation of the dmcrs2-encoded product. Thus, the 
dmcrs2r° 166 mutation could potentially behave as a dominant negative mutation. 
Consistent with this idea, dmcrs2r0166 mutant tissue grows and proliferates slower than 
dmcrs?00114 and dmcrs2c07041 mutant tissue (compare the sizes of GFP-labelled clones in 
Figure 3-4B with those in 4E and 4H). This might explain the difference in the ability of 
the dmcrs2r° 166 versus the dmcrs?00114 and dmcrs?07041 mutant alleles to rescue the 
rough-eye phenotype in GMRsav,wts flies.
3.1.6 dMCRS2 might not be physically linked with the Hpo pathway
According to the data derived from the Drosophila genome-wide yeast 2- 
hybrid screen (Curagen Inc.), dMCRS2 is predicted to form a tertiary interaction with 
Hpo via its primary and secondary interactions with the CG1017-encoded product and 
Rep2, respectively (Figure 3-5A). To verify these interactions, recombinant Rep2-HA, 
CG1017-myc and dMCRS2-Flag proteins were expressed in Drosophila cells, and the 
predicted interactions were tested by co-immunoprecipitation experiments (Figure 3- 




















Figure 3-5: dMCRS2 might not be physically linked with Hpo pathway. (A) Schematic of 
protein-protein interactions based on the data derived from the genome-wide yeast 2-hybrid 
screen in Drosophila (Curagen Inc.). (B) Small amounts of dMCRS2 co-immunoprecipitates with 
the CG1017-encoded protein. dMCRS2-Flag, CG1017-Myc, and control immunoprecipitates 
were blotted for the presense of dMCRS2-Flag using an anti-Flag antibody (top panel) and 
CG1017-Myc using an anti-Myc antibody (bottom panel). (C) CG1017-Myc does not 
co-immunoprecipiate with Rep2-HA. CG1017-Myc, Rep2-HA and control immunoprecipitates 
were blotted for the presence of CG1017-Myc using an anti-Myc antibody (top panel) and Rep2- 
HA using an anti-HA antibody (bottom panel).
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the CG1017-Myc precipitate (Figure 3-5B, top panel), no CG1017-Myc protein could 
be detected in the dMCRS2-Flag precipitate (Figure 3-5B, bottom panel) suggesting 
that the association of dMCRS2-Flag with CG1017-Myc is rather weak. Moreover, the 
CG/0/7-encoded product did not co-immunoprecipitate with Rep2-HA (Figure 3-5C). 
Thus, my co-immunoprecipitation data do not provide solid evidence for the predicted 
tertiary interaction between dMCRS2 and Hpo. Given the difficulties of interpreting the 
genetic interaction between dMCRS2 LOF and Sav/Wts gain of function alleles and the 
lack of evidence for a physical link between dMCRS2 and the Hpo pathway, I decided 
to continue my characterisation of dMCRS2 outside the context of the Hpo signalling 
pathway.
3.1.7 dMCRS2 is required for normal progression through S phase
As previously mentioned, dmcrs2 is an essential gene required for growth 
during development. Moreover, dmcrs2 clones grow poorly in heterozygous animals 
(compare the size of dmcrs2 clones (no GFP) with that of wild-type twin-spots (two 
copies of GFP) in Figure 3-3C). To further investigate the growth/proliferation defect 
observed in dmcrs2 mutant tissue, I recorded DNA profiles from Drosophila S2 cells 
treated with dsRNA targeting eGFP (control) or dmcrs2 for the indicated number of 
days (Figure 3-6A-D’) by FACS analysis. In parallel, aliquots were removed to 
calculate the total number of cells (Figure 3-6E) and to analyse dMCRS2 protein levels 
(Figure 3-6F). The DNA profiles showed that cells treated with dsRNA targeting 
dmcrs2 begin to accumulate in S phase after 5-7 days (Figure 3-6B-D’). Consistent with 
this, dsRNA-mediated depletion of dMCRS2 slows down proliferation after about 5 
days (Figure 3-6E). Immuno-blotting with my anti-dMCRS2 antibody confirmed that 
dMCRS2 protein levels are significantly reduced at day 6 when cell proliferation has 
slowed down and cells have started accumulating in S phase (Figure 3-6F). Thus, 
dMCRS2 is required for normal S phase progression and for proliferation and growth 
during development.
3.1.7.1 dMCRS2-depleted cells spend longer time in S phase
DNA profiles offer a snapshot of the percentage of cells in a particular 
phase of the cell cycle at a given time point, but do not provide any information 
regarding the kinetics of cell cycle progression. A BrdU pulse can be used to 

































Figure 3-6: dMCRS2 is required for proliferation and normal progression through S phase.
(A-D’) Cells depleted of dMCRS2 accumulate in S phase. S2 cells were treated with dsRNA 
targeting GFP (control) or dmcrs2 for the indicated number of days. Cells were fixed, stained with 
propidium iodide, and analysed by flow cytometry. The peaks corresponding to the G1 (2N) and 
G2/M (4N) populations are indicated on the X-axis. (E-F) Cells were counted and dMCRS2 
protein levels measured in a parallel set-up. (E) Proliferation of dMCRS2-depleted cells (red) 
slows down after 5-6 days. Control treated (blue) or dMCRS2-depleted (red) cells were counted 
once a day from day 2-7 (D2-D7). (F) Immuno-blotting confirms that dMCRS2 protein levels are 
reduced in cells in S2 cells treated with dsRNA corresponding to dmcrs2 after 6-61/2 days. Cell 
extracts prepared from S2 cells treated with dsRNA corresponding to GFP (control) or dmcrs2 for 










and BrdU-positive cells can then be followed by flow cytometry through the different 
phases of the cell cycle. This provides a method for estimating the rate at which cells 
progress through each phase of the cell cycle. To study the kinetics of dMCRS2- 
depleted cells as they progress through the cell cycle, an aliquot of cells treated with 
dsRNA targeting eGFP (control) or dmcrs2 for 6 days (Figure 3-7C-C’) was BrdU 
pulse-labelled for 15 minutes. Cells were collected at the indicated time points after the 
BrdU pulse, and BrdU-labelled cells were recorded by flow cytometry (Figure 3-7A- 
F’). At the 3-hour time point, the majority of control cells have left S phase (Figure 3- 
7B) and after six hours about 50% of the cells have progressed through mitosis and 
entered G1 (Figure 3-7C). After 9-12 hours, the majority of control cells have 
progressed through mitosis and entered G1 (Figure 3-7D, E), and at the 15-hour time 
point a few cells start to re-enter S phase (Figure 3-7F). Whereas some dMCRS2- 
depleted cells exit S phase, progress through mitosis, and enter Gl, a significant 
proportion of dMCRS2-depleted cells remain in S phase at all time point (Figure 3-7 A’- 
F’). Thus, at the 6-, 9-, and 12-hour time points when all control cells are in G2/M or 
Gl, some dMCRS2-depleted cells remain in S phase (Figure 3-7C-E’). This shows that 
dMCRS2 is required for normal rates of progression through S phase. Interestingly, 
expression levels of the human homologue of dMCRS2 (MSP58) fluctuate in a cell 
cycle-dependent manner with a peak of expression in early S phase (Ren et al., 1998; 
Song et al., 2004). Together with my data, this suggests that dMCRS2/MSP58 function 
is required during S phase.
3.1.8 dMCRS2 associates with proteins that function in RNAP II 
transcription and translation
As an approach to place dMCRS2 in a functional context, I next sought to 
identify proteins that form a complex with tandem affinity-purified Glutionine S 
transferase (GST)-Tobacco etch virus (TEV)-Calmodulin binding peptide (CBP)-tagged 
dMCRS2 (GTC-dMCRS2) protein. For this purpose, I generated S2 cells stably 
expressing GTC-dMCRS2 under the control of the inducible methallothionein (MT) 
promoter (Figure 3-8A). The tandem affinity purification (TAP) technique, which was 
originally developed in yeast and later adapted to metazoan cells, involves two 
sequential purifications steps and aims to minimise contamination by abundant or 
“sticky” proteins in the final eluate. In the first purification step, GTC-dMCRS2 is 
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Figure 3-7: dMCRS2-depleted cells progress through S phase with slower kinetics. (A-F’) 
S2 cells were treated with dsRNA targeting GFP (control, A-F) or dmcrs2 (A’-F’) for 6 days. Cells 
were reseeded at a density of 1x106 cells/ml and pulse-labelled with BrdU for 15 min. Cells were 
fixed, stained with propidium iodide, and analysed by flow cytometry at the indicated time points 
after the BrdU pulse. The peaks corresponding to the G1 (2N) and G2/M (4N) populations are 
indicated on the X-axis.
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Figure 3-8: dMCRS2 associates with several proteins that function in transcription and 
translation. (A) Schematic of GTC-dMCRS2. (B) To identify dMCRS2-associated proteins, a 
two-step purification was performed from approximately 1x1010 S2 cells expressing GTC- 
dMCRS2 or the GTC-tag alone. The final eluates were resolved on a 4-12% Nupage Bis-Tris gel 
and stained with Brilliant Blue G-colloidal concentrate. Visible bands (indicated by asterisks) 
were excised and identified by MALDI-TOF mass spectrometry. The band corresponding to 
dMCRS2 is indicated by two asterisks.
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the second step, cleaved CBP-dMCRS2 and any associated proteins are bound to 
calmodulin beads, washed and eluted (see Materials and Methods). I carried out large- 
scale purification from approximately lxlO10 S2 cells expressing GTC-dMRS2 or the 
GTC tag alone (control). The samples from the purification procedures were subjected 
to SDS-PAGE, and individual protein bands were visualised by blue G-colloidal 
concentrate staining (Figure 3-8B). Bands that were present in the dMCRS2 sample, but 
absent in the control sample, were carefully excised and subjected to mass spectrometry 
to identify the proteins (bands marked with asterisks in Figure 3-8B). In the control 
sample two faint bands had a similar migration pattern to bands in the GTC-dMCRS2 
purification (bands marked with asterisks in Figure 3-8B, lane 2). To avoid false 
positives in my GTC-dMCRS2 purification, those contaminants were cut out and 
identified by mass spectrometry.
The majority of proteins that I identified by mass spectrometry analysis 
are known or predicted to function in translation (Table 3-1, in blue) or RNAP II 
transcription (Table 3-1, in red). As for the first category, my mass spectrometry 
analysis identified several proteins that function in translation initiation, including 5 out 
of the 13 components that make up Drosophila eIF3 complex, the ATP-dependent RNA 
helicase eIF-4A/eIF4A/Tip2p (Drosophila/humans/yeast), which facilitates 48S PIC 
assembly by unwinding secondary structures in the 5’-untranslated region (UTR) of the 
mRNA (see Introduction), Pabp/PABPCl/Pabp (Drosophila/humans/yeast), which 
positively regulates translation in vitro and in vivo (Tarun and Sachs, 1995), and 
Belle/DHX15/DBP1 (Z>oso/?/zz7tf/humans/yeast), which is functions in mRNA scanning 
in yeast (Berthelot et al., 2004) (Figure 3-9A). In addition, several small and large 
ribosomal subunit proteins co-purified with GTC-dMCRS2 (Table 3-1, in blue). This 
suggests that dMCRS2 might have a function in translation initiation.
As for the second category, my mass spectrometry analysis identified both 
subunits of the GTF, TFIIF, the FACT component SSRP/SSRPl/Pob3p 
(Drosophila/humans/yQasi), Pitslre/ C dkllpl,° (Drosophila/humans), 
CKIIa/CK2a/Cka2p (DrosopMa/humans/yeast), and Psr/JMJD6 (Drosophila/humans). 
Interestingly, many of these proteins have previously been reported to co-purify with 
each other and with RNAP II in humans (Figure 3-9B). Thus, Cdkl l pU0 has been found 
to associate with both subunits of TFIIF, CK2, the FACT complex, and hyper- 
phosphorylated RNAP II (Trembley et al., 2002), and CK2 has been isolated in complex 
with TFIIF, C dk llpll°, RNAP II, and SSRP1, all of which it is capable of
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Table 3-1
ID (Drosophila/Humans/Yeast1) Predicted function
d M C R S 2 / p 5 8 C h r o m a t i n  r e m o d e l i n g / R N A P  I t r a n s c r i p t i o n
P i t s l r e / C d k 1 1 p1i0 T  r a n s c r i p t i o n / s p l i c i n g
T F I I F a / G T F 2 F 1 / R a p 7 4 T r a n s c r i p t i o n
T F I I F p / G T F I I 2 F 2 / R a p 3 0 T r a n s c r i p t i o n
S S R P / S S R P 1 / P o b 3 p C h r o m a t i n  r e m o d e l i n g / t r a n s c r i p t i o n  r e g u l a t i o n
P s r / J M J D 6 C h r o m a t i n  r e m o d e l i n g / t r a n s c r i p t i o n  r e g u l a t i o n
C K I I a / C K 2 a / C k a 2 p S u r v i v a l / T r a n s c r i p t i o n
e  IF  3 - S 9 / e l  F 3 S 9 / P r t  1 T r a n s l a t i o n  i n i t i a t i o n
e l F 3 - S 8 / e l F 3 S 8 / N i p 1 T r a n s l a t i o n  i n i t i a t i o n
l n t 6 / e l F 3 S 6 T r a n s l a t i o n  i n i t i a t i o n / n o n s e n s e  m e d i a t e d  d e c a y
e l F 3 - S 2 / e l F 3 S 2 / T i f 3 4 T r a n s l a t i o n  i n i t i a t i o n
e l F 3 - S 1 2 / e l F 3 S 1 2 T r a n s l a t i o n  i n i t i a t i o n
e l F - 4 A / e l F 4 A 2 / T i f 2 p T r a n s l a t i o n  i n i t i a t i o n
P a b p / P A B P C 1 / p a b p T r a n s l a t i o n  i n i t i a t i o n
B e l l e / D H X 1 5 / D B P 1 m R N A  s c a n n i n g
R p S 3 / R p S 3 / R p S 3 T r a n s l a t i o n
R p S 4 / R p S 4 / R p S 4 T r a n s l a t i o n
R p S 6 / R p S 6 / R p S 6 B p T r a n s l a t i o n
R p S 7 / R p S 7 / R p S 7 A p T r a n s l a t i o n
R p S 9 / R p S 9 / R p S 9 A p T r a n s l a t i o n
R p L P O / R p L P O / R p p O p T r a n s l a t i o n
R p L 4 / R p L 4 / R p L 4 T r a n s l a t i o n
R p L 5 / R p L 5 / R p L 5 T r a n s l a t i o n
R p L 1 3 A / R p L 1 3 A / R p L 1 3 A T r a n s l a t i o n
R p L 1 7 / R p L 2 3 / R p L 1 7 A T r a n s l a t i o n
R p L 1 8 A / R p L 1 8 A / R p L 1 8 A T r a n s l a t i o n
R p L 2 3 A / R p L 2 3 / R p L 2 5 T r a n s l a t i o n
C B P 8 0 / N C B P 1 / S T O 1 R N A  c a p  b i n d i n g / n o n s e n s e  m e d i a t e d  d e c a y
C G 8 6 1 1 / D D X 3 1 / D B P 7 r R N A  p r o c e s s i n g
P i t / D D X 1 8 / H a s  1 p r R N A  p r o c e s s i n g
B 5 2 / S r p 5 5 S p l i c i n g / A l t e r n a t i v e  s p l i c i n g
H f p / P U F 6 0 S p l i c i n g / A l t e r n a t i v e  s p l i c i n g
P a s h a / D G C R 8 m i R N A  b i o g e n e s i s
C G 7 8 4 3 / A R S 2 U n k n o w n
C G 4 8 8 7 / R B M 1 0 U n k n o w n
D m o r c 2 / h o r c 2 L / O r c 2 p D N A  r e p l i c a t i o n
R F C 4 0 / R F C 2 / R F C 4 D N A  r e p l i c a t i o n
N C D / K I F C 1 / K A R 3 p C h r o m o s o m e  s e g r e g a t i o n
C G 6 9 0 4 / g l y c o g e n  s y n t h a s e  1 / U D P -  
g l u c o s e - s t a r c h  g l u c o s y l t r a n s f e r a s e G l y c o g e n  s y n t h e s i s
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Figure 3-9: Predicted protein-protein interactions among two functional groups of proteins 
that co-purify with GTC-dMCRS2. (A-B) Schematics of predicted protein-protein interactions 
among proteins purified in complex with GTC-dMCRS2 based on previous reports in the litera­
ture. (A) Proteins purifed in complex with dMCRS2, which are predicted to function in translation 
initiation. (B) Proteins purifed in complex with dMCRS2, which are predicted to be associated with 
elongating RNAP II.
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phosphorylating (Egyhazi et al., 1999; Li et al., 2005b; Payne et al., 1989; Trembley et 
al., 2003). The identification of several proteins in my GTC-dMCRS2 purification, 
which have known or predicted functions in RNAP II transcription, suggests that 
dMCRS2 might also have a function in regulating RNAP II transcription.
dMCRS2 was previously found to be part of a MOF-containing chromatin 
remodelling complex (Mendjan et al., 2006). Whereas I did not recover this complex in 
my purification, I was able to verify the interaction between dMCRS2 and MOF in co- 
immunoprecipitation experiments (see later in Results part I, Figure 3-14B). Though it 
has been shown that MOF is required for normal levels of RNAP II transcription of a 
large number of genes (Kind et al., 2008), no physical connection between MOF and 
RNAP II complexes has been established so far. Hence, I decided to study the putative 
association of dMCRS2 with RNAP II complexes in more details.
3.1.9 dMCRS2 is mainly localised in the nucleus
If dMCRS2 plays a role in regulation of RNAP II transcription, a 
significant proportion of dMCRS2 would be expected to localise to the nucleus. To 
study the localisation of dMCRS2 in wild-type tissue, I dissected salivary glands from 
third instar larvae (Figure 3-10A-C). Stainings of salivary glands with my anti-dMCRS2 
antibody revealed that the majority of dMCRS2 protein is in the nucleus (Figure 3- 
10A). I also examined the localisation of dMCRS2 in the epithelial tissue of wing 
imaginal discs (the larval precursor of the wing) (Figure 3-10D-I). The engrailed- 
Gal4, UAS-GFP driver line was crossed to an UAS~dmcrs2 transgenic line generated by 
Julien Colombani to over-express in dMCRS2 in the engrailed domain of the wing 
(marked by GFP in E and H). Stainings of wing imaginal discs from engrailed- 
Gal4,GFP/UAS-dmcrs2 third instar larvae with my anti-dMCRS2 antibody confirmed 
that most dMCRS2 co-localises with nuclear GFP in the engrailed domain of the wing 
(compare Figure 3-10G with Figure 3-1 OH). These data show that the in vivo 
localisation of dMCRS2 is mostly nuclear and are consistent with a possible function of 
dMCRS2 in regulation of RNAP II transcription.
3.1.10 The dMCRS2 FHA domain is required for its association with Cdk11
Pitslre/Cdkllpll° (Drosophila/humans), which I recovered in my GTC- 
dMCRS2 purification, associates with hyper-phosphorylated RNAP II and is required 






















Figure 3-10: dMCRS2 is a nuclear protein. (A-C) Wild-type salivary glands from third instar 
larvae stained with the anti-dMCRS2 antibody in red (A) or a nuclear dye in blue (B). dMCRS2 is 
mainly localised in the nucleus. (D-l) Wing imaginal discs from third instar larvae. Posterior is to 
the right. (G-l) Close up view of area inside white square in D-F. Expression of dMCRS2 in the 
posterior compartment of the wing using the engrailed-Gal4 driver (marked by GFP in E and H). 
Wing imaginal discs stained with the anti-dMCRS2 antibody reveals that a significant fraction of 
dMCRS2 protein is in the nucleus (D, G).
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of dMCRS2 in RNAP II transcription in more details, I initially sought to verify the 
association of dMCRS2 with Pitslre. I expressed recombinant HA-Pitslre protein in S2 
cells, and tested its ability to co-immunoprecipitate with endogenous dMCRS2 (Figure 
3-11 A). Immuno-blotting of HA-Pitslre, dMCRS2, and control (anti-V5) precipitates 
with an anti-HA antibody revealed the presence of HA-Pitslre in the dMCRS2 
precipitate (Figure 3-11 A, top panel). In contrast, I was not able to detect any dMCRS2 
protein in the HA-Pitslre precipitate (Figure 3-11 A, bottom panel). One possible 
explanation for this is that binding of an antibody to the N-terminal HA-tag in HA- 
Pitslre interferes with its association with dMCRS2. Attempts to generate C-terminally 
tagged Pitslre were unsuccessful, suggesting that the C-terminus might be post- 
translational modified. Nevertheless, I was able to show that HA-Pitslre associates with 
endogenous dMCRS2.
I next wanted to analyse which part of dMCRS2 mediates its association 
with HA-Pitslre. For this purpose I generated full-length Flag-tagged dMCRS2 
(dMCRS2-Flag) and dMCRS2 lacking its C-terminal FHA domain (dMCRS2AFHA- 
Flag). I found that deletion of the FHA domain abolished the ability of dMCRS2 to 
associate with HA-Pitslre (Figure 3-11C). This was not due to the presence of the Flag- 
tag at the C-terminus of dMCRS2AFHA, since full-length dMCRS2-Flag retains its 
ability to associate with HA-Pitslre (Figure 3-1 IB). These data suggest that the FHA 
domain of dMCRS2 is required for its association with HA-Pitslre. However, my data 
do not rule out the possibility that deletion of the FHA domain results in aberrant 
folding of the dMCRS2AFHA-Flag protein. Attempts to express the FHA domain alone 
were not successful, suggesting that high levels of the FHA domain might be lethal to 
the cells. I next wished to examine whether the kinase activity of HA-Pitslre is 
important for its interaction with dMCRS2. To generate a kinase inactive HA-Pitslre, I 
mutated Lysine 587 to Arginine (HA-PitslreK587R). This point mutation was selected 
based on previous studies of serine/threonine kinase structure and function, which have 
demonstrated a specific requirement for this highly conserved Lysine residue for 
enzymatic activity (De Bondt et al., 1993; Taylor et al., 1993). Co-immunoprecipitation 
studies revealed that similar amounts of HA-PitslreK587R and HA-Pitslre co-purify 
with dMCRS2-Flag (compare Figure 3-1 ID with Figure 3-1 IB), suggesting that the 

































Figure 3-11: The dMCRS2 FHA domain is required for its association with Pitslre. (A)
HA-Pitslre associates with endogenous dMCRS2. dMCRS2, HA-Pitslre, and control (anti-V5) 
immunoprecipitates were blotted for the presense of HA-Pitslre using an anti-HA antibody (top 
panel) and dMCRS2 using the anti-dMCRS2 antibody (bottom panel). (B-C) HA-Pitslre associ­
ates with dMCRS2-Flag, but not dMCRS2AFHA-Flag. HA-Pitslre, dMCRS2-Flag (B), 
dMCRS2AFHA-Flag (C), and control (anti-V5) immunoprecipitates were blotted for the presence 
of HA-Pitslre (top panels) using an anti-HA antibody, dMCRS2-Flag (B, bottom panel) and 
dMCRS2AFHA-Flag (C, bottom panel) using an anti-Flag antibody. (D) The HA-PitslreK587R 
mutant, which is predicted to lack kinase activity, retains its ability to interact with dMCRS2-Flag. 
HA-PitslreK587R, dMCRS2-Flag, and control (anti-V5) immunoprecipitates were blotted for the 
presence of HA-PitslreK587R using an anti-HA antibody (top panel) or dMCRS2-Flag using an 
anti-Flag antibody (bottom panel).
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3.1.11 dMCRS2 co-sediments with Pitslre and RNAP II on glycerol and 
sucrose gradients
The human Pitslre/Cdkl l pll° (Drosophila/humans) protein was previously 
found to associate with hyper-phosphorylated RNAP II. My data show that Pitslre can 
be purified in complex with dMCRS2 (Table 3-1 and Figure 3-11A-B). To analyse 
whether dMCRS2, Pitslre, and RNAP II might exist as part of the same complex, I 
examined the velocity sedimentation profiles of all three proteins on sucrose and 
glycerol gradients (Figure 3-12A-B). Extract from S2 cells expressing HA-Pitslre was 
resolved by velocity sedimentation on a 7.5-35% glycerol gradient, and fractions were 
collected and immuno-blotted for the presence of dMCRS2, HA-Pitslre, and RNAP II. 
To detect RNAP II, I used a goat anti-Drosophila RNAP II serum, which was 
previously shown to recognise several of the Drosophila RNAP II subunits (Weeks et 
al., 1982). Westem-blot analysis revealed similar velocity sedimentation profiles for 
dMCRS2, HA-Pitslre, and three different RNAP II subunits (Figure 3-12A). Velocity 
sedimentation on glycerol gradients generates high-resolution profiles of intermediate 
sized complexes, whereas dense complexes, e.g. ribosomal subunits, are pelleted. To 
examine whether dMCRS2 and Pitslre co-sediment with more dense complexes, I next 
analysed their velocity sedimentation profiles on a sucrose gradient (Figure 3-12B). To 
study the sedimentation profile of endogenous Pitslre, I generated an antibody, which 
recognises a C-terminal region of Pitslre (aa 884-898). To test the specificity of 
antibody, extracts from cells treated with dsRNA targeting eGFP (control) or pitslre for 
four days were probed with my anti-Pitslre antibody. Immunoblot analysis revealed a 
band of the expected size (130 kDa), which was greatly reduced in Pitslre-depleted 
extracts (Figure 3-12C, lane 1-2). Moreover, my antibody detected two bands in 
extracts from cells expressing HA-Pitslre corresponding to the sizes of endogenous and 
HA-Pitslre (Figure 3-12C, lane 3). Having confirmed the specificity of the anti-Pitslre 
antibody, I examined the profiles of endogenous dMCRS2, Pitslre, and RNAP II 
resolved by velocity sedimentation on a sucrose gradient (Figure 3-12B). For 
comparison, the 40S ribosomal subunit fractions were marked using an anti-RpS25 
antibody. I found that the majority of dMCRS2 protein co-sediments with Pitslre and 
RNAP II in fractions slightly higher up the gradient than the 40S ribosomal subunit 
fractions (Figure 3-12B). These data suggest that dMCRS2 and Pitslre might both be 
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Figure 3-12: dMCRS2 co-sediments with Pitslre and RNAPII on sucrose and glycerol gradi­
ents. (A-B) Cell extracts were resolved by velocity sedimentation on a 7.5-35% glycerol gradient 
for 7 hours at 37.000 rpm (A) or on a 7.5-30% sucrose gradient for four hours at 39,000 rpm (B). 
The presence or absence of dMCRS2, Pitslre, and RNAPII in the different fractions was revealed 
by Western-blotting. Fractions containing the 40S subunit were identified by probing for the small 
ribosomal subunit protein RpS25 (B). (C) The specificity of the anti-Pitslre antibody was 
confirmed by immuno-blotting on cell extracts prepared from S2 cells treated with dsRNA corre­
sponding to eGFP  (control) or dmcrs2 for four days. Anti-ptubulin was used as a loading control.
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present in the 40S ribsosomal subunit containing fractions. This observation and the 
identification of translation initiation factors and small ribosomal proteins in my GTC- 
dMCRS2 purification (Table 3-1) suggest that dMCRS2 might have an additional 
function in translation initiation. However, I did not study this putative function of 
dMCRS2 in more details.
3.1.12 dMCRS2 co-localises with RNAP II complexes on polytene 
chromosomes
The observation that the velocity sedimentation profile of dMCRS2 on 
glycerol and sucrose gradients is similar to that of Pitslre and RNAP II, suggests that it 
might be associated with RNAP II complexes. The giant polytene chromosomes of the 
Drosophila salivary gland are generated by multiple rounds of endoreplication 
generating over 1,000 synapsed copies of the chromosomes (Zink and Paro, 1989). 
These have proved very useful to visualise the localisation of transcription factors on 
the chromosomes. To further analyse the putative association of dMCRS2 with RNAP 
II complexes, Nic Tapon co-stained polytene chromosomes spreads prepared from 
salivary glands of developing third instar larvae (see Materials and methods) with anti- 
dMCR2 (Figure 3-13A, in red) and anti-RNAP II antibodies (Figure 3-13B, in green). 
Staining with my anti-dMCRS2 antibody revealed the localisation of dMCRS2 in 
distinct bands on the polytene chromosomes, some of which co-localised with RNAP II 
(Figure 3-13C, white arrows). These data suggest that dMCRS2 is indeed associated 
with a sub-group of RNAP II complexes. Future experiments will address whether this 
sub-group of RNAP II complexes might be hyper-phosphorylated (elongating) RNAP II 
using a phospho-specific anti-RNAP II antibody.
Unfortunately, my anti-Pitslre antibody did not reveal a specific staining 
pattern when tested by immunofluorescence on mitotic clones of RNAi-depleted pitslre 
mutant tissue. Thus, I was not able to examine the distribution of Pitslre on polytene 
chromosomes. Instead I analysed the association of HA-Pitslre with RNAP II by co- 
immunoprecipitation experiments (Figure 3-12D). Immuno-blot analysis of HA-Pitslre, 
RNAP II, and control (anti-V5) precipitates using an anti-HA antibody revealed that a 
fraction of HA-Pitslre is associated with RNAP II (Figure 3-12D, top panel). I was not 
able to detect any RNAP II protein in the HA-Pitslre precipitate, suggesting that binding 
of an antibody to the N-terminal HA-tag might interfere with the association of RNAP 













Figure 3-13: dMCRS2 co-iocalises with RNAP II on polytene chromosomes. (A-C) A fraction 
of dMCRS2 co-localise with a sub-group of RNAP II complexes. Polytene chromosome spreads 
prepared from third instar larvae and stained with anti-dMCRS2 (A, in red) and anti-RNAP II (B, 
in green) antibodies. White arrows indicate regions of co-localisation of dMCRS2 and RNAP II 
complexes (C). (D) HA-Pitslre, RNAP II, control 1 (anti-V5, Protein A beads), and control 2 (anti- 
V5, Protein G beads) immunoprecipitates were blotted for the presense of HA-Pitslre using an 
anti-HA antibody (top panel) and RNAP II subunits using the goat anW-Drosophila RNAP II serum 
(bottom panel).
detectable fraction of RNAP II, e.g. hyper-phosphorylated RNAP II, may associate with 
HA-Pitslre. However, attempts to immunoprecipitate hyper-phosporylated RNAP II 
using a commercial antibody were unsuccessful (data not shown).
3.1.13 The association of dMCRS2 with Pitslre is regulated in response to 
activation of the Hpo pathway
The initial observation that introduction of one copy of the dmcrs2rG166 
mutant allele into a GMRsav,wts background suppressed the rough-eye phenotype of 
those animals, prompted my to investigate the whether Hpo signalling might regulate 
the association of dMCRS2 with Pitslre. I examined the ability of dMCRS2-Flag to co- 
immunoprecipitate with HA-Pitslre in control cells (Figure 3-14A, left panels) and cells 
expressing Hpo-Myc and Wts-Myc (Figure 3-14A, right panels). As previously, I found 
that a significant proportion of HA-Pitslre co-purified with dMCRS2-Flag in control 
cells (Figures 3-1 IB and 3-14A, left middle panel). Interestingly, the association of 
dMCRS2-Flag with HA-Pitslre was completely abolished in cells over-expressing Hpo 
and Wts (Figure 3-14B, left middle panel). Importantly, dMCRS2-Flag and HA-Pitslre 
protein levels were unchanged in these cells, showing that it is indeed the association of 
dMCRS2-Flag with HA-Pitslre, which is regulated in response to Hpo signalling. Since 
over-expression of Hpo and Wts induces apoptosis, it is not clear from these data 
whether the association of dMCRS2-Flag with HA-Pitslre is regulated specifically by 
Hpo signalling or in more generally in response to apoptosis. Future studies will aim to 
resolve this issue.
3.1.14 The association of dMCRS2 with the MOF complex is not regulated 
in response to activation of the Hpo pathway
dMCRS2 was previously shown to be part of a chromatin-remodelling 
complex containing NSL1-3, MBDR2, and the histone methylase MOF (I will refer to 
this complex as the MOF complex) (Mendjan et al., 2006). Unexpectedly, I did not 
recover any of those components in my purification (Table 3-1). Since one potential 
role of dMCRS2 could be to link chromatin remodelling with regulation of RNAP II 
transcription via its ability to associate with Pitslre/RNAP II and the MOF complex, I 
wished to confirm the association of dMCRS2 with the MOF complex. For this 
purpose, I generated HA-tagged MOF and analysed its ability to co-immunoprecipitate 
with dMCRS2 (Figure 3-14B, left panels). As previously described, I found that a
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Figure 3-14: The association of dMCRS2 with Pitslre, but not MOF, is regulated in response 
to excess Hpo signalling. (A) The association of HA-Pitslre with dMCRS2-Flag is disrupted in 
response to Hpo and Lats gain of function. (A) dMCRS2-Flag, HA-Pitslre, and control (anti-V5) 
immunoprecipitates from control cells (left) or cells transfected with Hpo and Wts (right) were 
blotted for the presence of HA-Pitslre using an anti-HA antibody (top panels) and dMCRS2-Flag 
using an anti-Flag antibody (bottom panels). (B) The association of dMCRS2-Flag with MOF-HA 
is not affected by Hpo gain of function. dMCRS2-Flag, HA-MOF, and control (anti-V5) immuno­
precipitates from control cells (left) or cells transfected with Hpo (right) were blotted for the pres­
ence of HA-MOF using an anti-HA antibody (top panels) and dMCRS2-Flag using an anti-Flag 
antibody (bottom panels).
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fraction of HA-MOF co-purifies with dMCRS2-Flag (Figure 3-14B, left middle panel).
I was not able to detect any HA-MOF protein in the dMCRS2-Flag immunoprecipitate 
(Figure 3-14B, left bottom panel). One possible explanation for this is that only a small 
fraction of dMCRS2 is associated with HA-MOF under these conditions. I next wished 
to examine whether the association of dMCRS2 with MOF is regulated in response to 
over-expression of Hpo (Figure 3-14B, right panels). I found that whereas the amount 
of HA-MOF protein that co-purifies with dMCRS2-Flag is slightly lower in Hpo over­
expressing cells (compare right and left middle panels in Figure 3-14B), the dMCRS2- 
Flag immunoprecipitation was equally less efficient in these cells (compare right and 
left bottom panels in Figure 3-14B). Thus, the association of dMCRS2 with the MOF 
complex appear not to be significantly affected by excess Hpo signalling. Similarly, I 
found that the association of dMCRS2 with another component of the MOF complex, 
MBDR2, was unaffected by Hpo signalling (data not shown). In conclusion, the 
association of dMCRS2 with Pitslre, but not the MOF complex, is regulated by the Hpo 
signalling pathway and perhaps more generally in response to apoptosis.
3.2 Discussion -  part I
3.2.1 Does dMCRS2 function downstream of the Hpo signalling pathway?
The initial observation that the rough-eye phenotype caused by Sav and 
Wts gain of function in the eye is suppressed in animals heterozygous for a P-element 
insertion in the dmcrs2 locus (diners?0166) (Figure 3-1) suggested that dMCRS2 might 
function downstream of Sav and Wts. Surprisingly, I did not observe a rescue of the 
rough-eye phenotype in GMR-sav,wts animals heterozygous for two other dMCRS2 
LOF mutations, dmcrs2c07041 and dmcrs2c00114 (data not shown). My in vivo analysis 
revealed that dMCRS2 protein levels are significantly reduced in mitotic clones of 
dmcrs2e07041 and dmcrs2c00114 mutant tissue, but unchanged in clones of dmcrs2rGl66> 
mutant tissue (Figure 3-4). This indicates that the dmcrs2r° 166 mutation causes a 
truncation rather than an ablation of the dmcrs2-encoded product. Consistent with this, 
the 1(3)rG 166 P-element insertion is predicted to cause a truncation of dMCRS2, which 
retains the epitope of dMCRS2 recognised by my anti-dMCRS2 antibody, but lacks 
most of the FHA domain (Figure 3-3 A). Since the FHA domain is likely to be essential 
for dMCRS2 function, dmcrs2r0166 might encode a dominant negative form of 
dMCRS2. Consistent with this idea, mitotic clones of dmcrs2r° 166 mutant tissue exhibit
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a more severe growth defect than those of dmcrs2c07041 and dmcrs2°00114 mutant tissue 
(compare Figure 3-4B with 3-4E and 3-4H). Thus, dmcrs2rG166 is likely to represent a 
strong dMCRS2 LOF mutation. This might explain the observed rescue of the rough- 
eye phenotype in GMRsav,wts animals heterozygous for the dmcrs2rG166, but not the 
dmcrs2c07041 and dmcrs2c00114, mutant alleles (Figure 3-2 and data not shown).
The ability of one copy of dmcrs2rG166 to partially rescue the rough-eye 
phenotype of GMRsav,wts animals suggests that dMCRS2 has a pro-apoptotic function 
downstream of Sav and Wts. However, Julien Colombani found that CycE and DIAP 
protein levels were unchanged in clones of dmcrs2rG166 mutant tissue (Figure 3-3B-C’), 
indicating that dMCRS2 does not function immediately downstream of Sav and Wts. 
Consistent with this, RNAi-mediated depletion of dMCRS2 does not restore Yki 
activity in cells expressing Hpo, Sav, and Wts (Figure 3-3D). Thus, if dMCRS2 is 
required for apoptotic signalling downstream of Sav and Wts, it appears to be in parallel 
with or further downstream of Yki. Since the data presented here suggest that dMCRS2 
might have a function in regulation of RNAP II transcription, it is tempting to speculate 
that dMCRS2 is required for Yki-independent transcription of pro-apoptotic genes. 
Alternatively, dMRCS2 may have a general rather than Hpo-specific pro-apoptotic 
function. This could be analysed genetically by testing the ability of dmcrs2rGI66 to 
modifiy other apoptosis-related phenotypes, such as that elicited by expression of the 
IAP inhibitors Hid, Grim of Reaper.
3.2.2 dMCRS2 is required for normal rates of S phase progression and 
for growth during development
My in vivo characterisation of dmcrs2 revealed that it is an essential gene 
required for normal growth during development. Thus, larvae homozygous lethal for 
mutations in dmcrs2 exhibit severe growth defects and die as third instar larvae (data 
not shown). A more detailed analysis of the growth defect in cultured cells revealed that 
dMCRS2-depleted cells progress through S phase with slower kinetics than control 
cells. Consistent with dMCRS2 function being required in S phase, expression levels of 
the human homologue of dMCRS2 (MSP58) fluctuate in a cell cycle dependent manner 
with a peak of expression in early S phase (Ren et al., 1998; Song et al., 2004).
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3.2.3 dMCRS2 can be purified in complex with proteins that function in 
translation initiation and RNAP II transcription
To place dMCRS2 in a functional context, I carried out a large-scale 
tandem affinity purification of GTC-dMCRS2 followed by mass spectrometry analysis 
to identify dMCRS2-associated proteins (Figure 3-8 and Table 3-1). My mass 
spectrometry analysis revealed a number of proteins, most of which fell into one of two 
groups of functionally related proteins. The first group contained several proteins that 
are predicted to function in translation initiation including five components of the eIF3 
complex, eIF4-A/eIF4A2/Tif2p, Pabp/PABPCl/Pabp, Belle/DHX15/DBP1 
(Z>0S0/?/n7a/humans/yeast), and small ribosomal 40S subunit proteins. Interestingly, 
MSP58, the human homologue of dMCRS2, was previously found to associate with 
fragile mental retardation protein (FMRP) and polyribosomal poly(A)+ messenger 
ribonucleoprotein (mRNPs) in the cytoplasmic compartment of neurons (Davidovic et 
al., 2006). FMRP is a component of mRNPs complexes (Feng et al., 1997; Khandjian et 
al., 2004; Stefani et al., 2004) and is required for both transport (Estes et al., 2008) and 
translation of target mRNAs (Zalfa et al., 2003). The purification of GTC-dMCRS2 in 
complex with translation initiation factors and ribosomal proteins suggests that 
dMCRS2, like MSP58, might be associated with mRNPs. Consistent with this idea, my 
velocity sedimentation data revealed that a small fraction of dMCRS2 might be 
associated with the translation machinery (Figure 3-12B). However, I did not study this 
putative function of dMCRS2 in more details.
The second group of proteins recovered in my GTC-dMCRS2 purification 
are known or predicted to function in RNAP II transcription and/or chromatin 
remodelling. These included, both subunits of the GTF, TFIIF, CKIIa/CK2aCka2p, 
Pitslre/Cdkllpll°, Psr/JMJD6, and the FACT component, SSRP/SSRPl/Pob3p 
(Drosophila/humans/yeast) (Table 3-1). Several of these have previously been 
functionally linked. Thus, Cdkl l pU0 has been found to associate with both subunits of 
TFIIF, CK2, the FACT complex, and RNAP II (Trembley et al., 2002), and CK2 has 
been isolated in complex with TFIIF, C dkllpU0, RNAP II, and SSRP1, all of which it 
phosphorylates (Egyhazi et al., 1999; Li et al., 2005b; Payne et al., 1989; Trembley et 
al., 2003). This suggests that dMCRS2 might also have a function in RNAP II 
transcription. Consistent with this, I found that the majority of dMCRS2 protein is
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localised in the nucleus in various tissues from developing third instar larvae (Figure 4- 
10).
3.2.4 dMCRS2 associates with the Pitslre/ Cdk11p11° protein kinase
The Pitslre/Cdkllpll° protein kinase {Drosophila!humans), which I 
recovered in my large-scale purification of GTC-dMCRS2 (Table 3-1), was previously 
shown to be required for RNAP II transcription in humans (Trembley et al., 2002). To 
further analyse a putative function of dMCRS2 in RNAP II transcription, I characterised 
the association of dMCRS2 with Pitslre. My co-immunoprecipitation analyses showed 
that Pitslre associates with full-length dMCRS2, but not dMCRS2 lacking the C- 
terminal FHA domain (Figure 3-11A-C). This suggests that dMCRS2 rely on its FHA 
domain for its association with Pitslre. Future experiments will include GST pull-downs 
of bacterial produced dMCRS2 and Pitslre proteins to establish whether the interaction 
between dMCRS2 and Pitslre is direct. I also found that a putative kinase dead version 
of Pitslre, PitslreK587R, retained its ability to associate with dMCRS2, indicating that 
intrinsic kinase activity of Pitslre might not be not required for its association with 
dMCRS2 (Figure 3-1 ID). However, additional experiments will be required to 
determine whether the PitslreK587R mutant is indeed inactive.
3.2.5 dMCRS2 co-localises with a sub-group of RNAP II complexes on 
polytene chromosomes in vivo
My co-immunoprecipitation analyses revealed that Pitslre, like its human 
homologue C dk llpll°, associates with RNAP II (Figure 3-13D and (Trembley et al., 
2002)). The observation that Pitslre associates with both dMCRS2 and RNAP II 
suggests that dMCRS2 might also be associated with RNAP II complexes. Consistent 
with this idea, my velocity sedimentation experiments showed that dMCRS2 and Pitslre 
co-sediment with RNAP II complexes on glycerol and sucrose gradients (Figure 3-12A- 
B). Moreover, co-staining of polytene chromosome spreads with anti-RNAP II and anti- 
dMCRS2 antibodies revealed that dMCRS2 co-localises with a sub-group of RNAP II 
complexes on polytene chromosomes in vivo (Figure 3-13A-C). Since the anti-RNAP II 
antibody recognises both phosphorylated (elongating) and hypo-phosphorylated RNAP 
II complexes (Figure 3-12B), it is possible that this sub-group of RNAP II complexes 
represents elongating RNAP II. Consistent with this idea, CK2 and TFIIF, which were 
recovered in my GTC-dMCRS2 purification, co-localise with elongating RNAP II
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complexes on polytene chromosomes in vivo (Egyhazi et al., 1999). The presence of 
TFIIF and absence of other GTFs in my GTC-dMCRS2 purification is also consistent 
with a role of dMCRS2 in RNAP II elongation, since TFIIF is the only GTF, which re­
associates with RNAP II complexes following their release from the initiation complex 
(Zawel et al., 1995). Future experiments will address whether dMCRS2 associates with 
elongating RNAP II complexes by co-stainings of polytene chromosome spreads with 
antibodies that recognise phosphorylated RNAP II and dMCRS2. Moreover, I have 
acquired antibodies against several of the proteins that I identified in my GTC-dMCRS2 
purification including CKII and TFIIFa, and I am currently generating a new anti- 
Cdkl 1 antibody. This will allow me to examine the distribution of these proteins along 
polytene chromosomes and their co-localisation with dMCRS2.
3.2.6 dMCRS2 might provide a link between the MOF complex and RNAP 
II
dMCRS2 was previously isolated in complex with NLS1-3, MBDR2, and 
MOF (Mendjan et al., 2006), suggesting that it might function in chromatin 
remodelling. Whereas I did not recover any of the components of the MOF complex in 
my GTC-dMCRS2 purification, I was able to confirm the association of dMCRS2 with 
MOF (Figure 3-14B) and MBDR2 (data not shown) by co-immunoprecipitation 
analysis. Whereas microarray analyses have shown that MOF activity is required for 
normal levels of RNAP II transcription of a wide range of genes (Kind et al., 2008), a 
molecular link between MOF and RNAP II has yet to be established. The observations 
that dMCRS2 associates with Pitslre/Cdkllpll° (Figure 3-11A-B) and co-localises with 
RNAP II complexes on polytene chromosomes (Figure 3-13A-C), suggest that 
dMCRS2 might bridge an interaction between the chromatin remodelling MOF 
complex (Figures 3-14 and (Mendjan et al., 2006)) and Pitslre/RNAP II complexes 
(Table 3-1 and Figures 3-11-14). Whereas this model is consistent with the data 
presented here, it needs further validation. Future experiments will aim at establishing a 
connection between dMCRS2, the MOF complex, and Pitlsre/RNAP II complexes by 
examining their distribution along polytene chromosomes and by chromatin 
immunoprecipitation (ChIP) experiments. In particular, it will be interesting to test 
whether dMCRS2, Pitslre and MOF are associated with the same genes, or whether 
dMCRS2 is present in separate pools associated with either partner. If Pitslre and MOF 
are present in the same complex, what are their relative contributions to gene
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transcription? This can be analysed both using microarray analysis in cultured cells 
depleted of dMCRS2, Pitslre and MOF, and in vivo by examining the expression of 
enhancer trap lines in mutant clones. How the MOF complex is recruited to sites of 
transcription remains mysterious. It is tempting to speculate that dMCRS2, through its 
ability to bind RNAP II components, may act as a docking site for the MOF complex.
3.2.7 dMCRS2 might regulate RNAP II transcription in response to Hpo 
signalling and/or apoptosis
Interestingly, I found that the association of dMCRS2 with Pitslre, but not 
the MOF complex, is disrupted in response to excess Hpo signalling (Figure 3-14). This 
might suggest that the link between MOF-dMCRS2 and Pitslre/RNAP II complexes is 
disrupted in response to activation of the Hpo pathway, and could provide a mechanism 
for down-regulation of RNAP II transcription in response to Hpo signalling and/or 
apoptosis. One possible way of testing this idea will be to analyse the extent of co­
localisation between dMCRS2/MOF and RNAP II in Hpo gain of function salivary 
glands. Since the association of dMCRS2 with the MOF complex appear to be 
unaffected in response to Hpo signalling (Figure 3-14B and data not shown), their co­
localisation could potentially serve as an internal negative control for these analyses.
3.2.8 Does dMCRS2 have an additional function in DNA damage repair?
dMCRS2 contains a FHA domain, which is found almost exclusively in 
nuclear proteins that function in transcription regulation, DNA repair, and/or cell cycle 
progression (Durocher et al., 1999; Hofmann and Bucher, 1995; Li et al., 2000). 
Consistent with this, my data show that dMCRS2 is mainly nuclear and might play a 
role in regulation of RNAP II transcription. Interestingly, some of the GTC-dMCRS2- 
associated proteins identified in my large-scale purification are thought to have dual 
functions in RNAP II transcription and DNA damage repair. These include 
CKIIa/CK2a/Cka2p and the FACT component SSRP1. Thus, a complex consisting of 
CK2 and the two FACT components, SSRP1 and Sptl6, was found to stimulate p53 
activity in response to UV-induced DNA damage (Keller et al., 2001). Due to the 
crucial role of the FACT complex in chromatin remodelling, it has been suggested that 
the activated CK2-FACT complex functions as a sensor of DNA damage. Consistent 
with this idea, CK2-mediated phosphorylation of maize SSRP1 enhances the 
association of SSRP1 with UV irradiation damaged DNA (Krohn et al., 2003). The
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chromatin remodelling factor, hMOF/MOF, is another MSP58/dMCRS2-associated 
protein, which has been reported to function in DNA damage repair (Mendjan et al., 
2006). Thus, hMOF-depleted cells exhibit a delay in the kinetics of the DNA repair 
process (Taipale et a l, 2005), and expression of dominant negative MOF results in less 
efficient repair of double-strand breaks (Gupta et al., 2005). Moreover, it has been 
suggested that hMOF-mediated H4K16 acetylation, which increases upon IR-induced 
DNA damage, might label sites of DNA damage and activate and/or recruit the DNA 
repair machinery (Gupta et al., 2005). Thus, it is possible that dMCRS2 could have an 
additional function in DNA damage repair. Consistent with this idea, I noticed that 
dMCRS2 protein levels were stabilised in S2 cells exposed to IR-induced DNA damage 
(data not shown). However, I did not further pursue a role of dMCRS2 in DNA damage 
repair.
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Chapter 4 -  Results and discussion part II
4.1 dPrp38 and dMFAPI are required for pre-mRNA processing 
and G2/M progression
4.1.1 The starting point of the project
As previously discussed, we were originally interested in the CG30342- 
and CG/0/7-encoded proteins due to their potential link with the Hpo pathway (Figure 
3-5A and (Giot et al., 2003)). Data from the Drosophila genome-wide yeast two-hybrid 
screen suggested that the protein encoded by the CGI 017 gene might be linked with the 
Hpo pathway via its interaction with Rep2 (Figure 3-5 and (Giot et al., 2003)). 
However, my initial protein-protein interaction data did not confirm the reported 
interaction between the CG1017-Qncoded protein and Rep2 (Figure 3-5B-C). Consistent 
with the yeast 2-hybrid data, I did find that the proteins encoded by the CGI 017 and 
CG30342 genes associate with each other as discussed later (Figure 4-6). For that 
reason, a link between the CGI 017- and CG30342-cncoded proteins and the Hpo 
pathway was not further pursued. Instead, I focused on the characterisations of the 
CG30342- and CG/077-encoded products outside the context of the Hpo signalling 
pathway.
4.1.2 The CG30342 gene encodes the Drosophila Prp38 protein
My project initially focused on the CG30342-encoded protein. Since this 
protein has not previously been studied, I carried out homology searches against other 
genomes to identify functional domains or homologues that might provide a clue to the 
function of the CG30342-encoded protein. Homology searches revealed that the protein 
encoded by the CG30342 gene is homologous to the yeast Prp38p splicing factor and 
the human Prp38 protein (Prpf38). Thus, the Drosophila protein is 75% identical to the 
human Prp38 protein (Prpf38a) and 22% identical to yeast Prp38p (Chen et al., 2006b). 
Moreover, the CG30342-encodQd protein contains a conserved 180 amino acid Prp38 
homology domain at its N-terminus, which is found in both Prpf38 and Prp38p, and 150 
additional amino acids that are found in the human, but not the yeast, Prp38 protein 
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Figure 4-1: dPrp38 is a nuclear protein. (A) Schematic of the dprp38 locus. dPrp38 is encoded 
by a single exon. The N-terminal part encodes a region with homology to Prp38 (red). (B) 
Immuno-blots on cell extracts prepared from S2 cells treated with dsRNA corresponding to GFP 
(control) or dprp38 with antibodies recognising the C- (dPrp38_C) and N-terminal (dPrp38_N) 
part of dPrp38. (C-D) RNAi-mediated depletion of dPrp38 in wing imaginal discs from third instar 
larvae. Posterior is to the left. Expression of a dprp38 inverted repeat in the posterior compart­
ment of the wing using the engrailed-Gal4 driver (marked by GFP in C) results in reduced levels 
of dPrp38 as detected with the anti-dPrp38_C antibody (D). (E-F) dPrp38 is localised in the 
nucleus. Wild-type salivary glands from third instar larvae stained with the anti-dPrp38_C 
antibody in red (E) or a nuclear dye (F). The anti-dPrp38_C antibody also revealed a nuclear 
localisation of dPrp38 in the fat body (indicated by white arrows E).
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As mentioned in the introduction, budding yeast Prp38p is an U4/U6.U5- 
tri-snRNP component that plays an important role in the maturation of the spliceosome. 
Prp38p activity is dispensable for the initial assembly of the spliceosome, but is 
required in a later step for the release of U4 snRNP and activation of the spliceosome 
(Xie et al., 1998). Intriguingly, the mammalian Prp38p homologue does not appear to 
be stably associated with the tri-snRNPs and has been recovered in surprisingly few 
spliceosomal purifications (Jurica and Moore, 2003). This apparent discrepancy 
between yeast and higher eukaryotes prompted me to study dPrp38 in more details.
4.1.3 dPrp38 is a nuclear protein
To characterise dPrp38 in vitro and in vivo, I raised two antibodies 
against the N- and C-terminus of dPrp38 (dPrp38_N and dPrp38_C). The antibodies 
were tested by Western-blotting on extracts from cultured Drosophila S2 cells treated 
with dsRNA targeting eGFP (control) or dprp38. In control treated cells, both 
antibodies recognised a band of the expected size (35 kDa), which was greatly reduced 
upon RNAi treatment (Figure 4-IB). The specificity of the anti-dPrp38_C antibody was 
also tested by immuno-fluorescence on larval tissue. For this purpose a \JAS-dprp38 
RNAi line was obtained from Vienna Drosophila RNAi Centre (VDRC). dPrp38 was 
depleted in the posterior compartment of the wing by engrailed-Gal4 driven expression 
of a UAS-dprp38 RNAi transgene obtained from the Vienna Drosophila RNAi Centre 
(VDRC, marked by GFP in Figure 4-1C). Wing imaginal discs were dissected from 
third instar larvae and stained with the anti-dPrp38_C antibody (red in Figure 4-ID). 
Reduced staining in the posterior compartment of the wing confirmed the specificity of 
the antibody. Next, I wished to determine the cellular localisation of dPrp38. The 
salivary gland provides a convenient tissue to study cellular localisation, because of the 
large size of the cells. Staining of cells in the salivary glands or fat body tissue dissected 
with the salivary glands (marked by white arrows in Figure 4-IE) of a wild-type animal 
revealed that dPrp38 is localised exclusively in the nucleus (Figure 4-1E-F). This is the 
expected localisation for a splicing factor and consistent with a conserved function of 
yeast Prp38p in flies.
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4.1.4 dPrp38 is required for developmental growth and proliferation
4.1.4.1 Molecular and biochemical characterisation of the P(G19491) insertion
In vivo studies of core splicing factors have mostly been carried out in 
unicellular organisms like yeast. Drosophila provides a convenient system for studying 
loss-of-function phenotypes in a multi-cellular organism. To study dprp38 loss-of- 
function, I obtained a stock bearing a P-element insertion in the open reading frame of 
dprp38 (dprp38G19491) (Figure 4-2A). The position of the P-element was verified by 
PCRs using primers that anneal to the inverted repeat of the P-element and 
approximately 500 bps upstream or downstream of the predicted insertion point (data 
not shown). Subsequent sequence analysis of the obtained PCR products identified the 
exact insertion point. The P-element insertion is predicted to give rise to a deletion of 
the last 65 amino acids of dPrp38, and a replacement of this region with two amino 
acids encoded by the P-element. To examine the nature of the product encoded by the 
dPrp38Ql949[ mutant allele, fly extracts from dprp38GI9491 animals were generated and 
immuno-blotted with the anti-dPrp38_N and anti-dPrp38_C antibodies. As a control, 
extracts were generated from animals where the P-element had been precisely excised. 
Both antibodies detected a band of the expected size (35 kDa) in extracts from control 
animals (Figure 4-2B, top and middle panel). Consistent with the P-element insertion 
causing a deletion of the C-terminal part of dPrp38, immuno-blotting of extracts from 
dprp38G19491 animals with my anti-dPrp38_C antibody did not reveal any product 
(Figure 4-2B, middle panel). Westem-blots of the same extracts using the anti- 
dPrp38_N antibody detected a product migrating slightly above the wild-type band 
(Figure 4-2B, top panel). This suggests that the dprp38°19491 mutation is not a protein 
null.
4.1.4.2 Characterisation of the P(G19491) insertion in dPrp38 in vivo
To study the dprp38G19491 mutation in vivo, I used the FLP/FRT system 
(Xu and Rubin, 1993) to induce mitotic clones of dprp38G1949J mutant tissue in the eye- 
imaginal discs of heterozygous animals (Figure 4-2C-D). Staining discs with the anti- 
dPrp38_C antibody revealed that dPrp38 expression levels are affected by gene dosage. 
Thus, the anti-dPrp38_C staining was brighter in homozygous wild-type (two copies of 
GFP) than heterozygous tissue (one copy of GFP), while mutant tissue (no GFP) had 
















Figure 4-2: dPrp38 is required for developmental growth and proliferation. (A) Schematic of 
the dprp38 locus. The position of the P-element inserted in dprp38G19491 and the imprecise 
excision deletion mutant (dprp38E1) are indicated. (B) Whole extracts from control adult flies or 
flies homozygous mutant for dprp38G19491 were used for immuno-blotting with anti-dPrp38_N (top 
panel), anti-dPrp38_C (middle panel), and anti-p-tubulin (bottom panel). (C-F, H) Eye imaginal 
discs from third instar larvae. Posterior is to the left. Mitotic clones of dprp38G19491 (C-D) or 
dprp3&E1(E-F, H) mutant tissue marked by the absence of GFP (C) or two copies of GFP (E, H) 
and stained with the dPrp38_C antibody in red (D, F, H). The inset in E is a blow-up of a region of 
the image, with dp/p38-mutant areas circled in red and homozygous Minute clones in white. (G) 
is a schematic representation of the eye-antennal disc with the area in E-F, H boxed.
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clones are generated simultaneously from the same mitotic recombination event, the 
relative growth rates of mutant and wild-type tissues can be inferred from the relative 
size of the clones. Notably, the dprp38G19491 insertion has no detectable effect on clone 
growth (compare the size of bright green and black areas in Figure 4-2C). The presence 
of a gene product in adult dprp38019491 animals as detected with the anti-dPrp38_N 
antibody (Figure 4-2B, top panel) and the wild-type growth behaviour of the 
dprp38GI9491 mutant tissue (Figure 4-2C) suggest that dprp38019491 might not be a 
complete loss of function mutant.
4.1.4.3 Generation of a dPrp38 deletion mutant
While the N-terminal half of dPrp38 contains the Prp38 homology 
domain, the C-terminal half of dPrp38 is much less conserved. Homozygous 
dprp38{019491 mutant flies are viable, indicating that either dprp38 is not an essential 
gene or the C-terminal region of dPrp38 is not essential for its function. To resolve this 
issue, I set out to generate a new dprp38 mutant allele by mobilisation of the P-element 
in dprp38019491. A cross scheme was set up to generate excisions (see Materials and 
Methods for cross scheme), and putative mutants were screened by PCRs for small 
deletions using primers that anneal 700 bps upstream and downstream of the P-element 
insertion points. PCR analysis revealed that one excision causes a deletion of a region 
upstream of the P-element insertion point (dprp38EI). Sequence analysis of the 
shortened PCR product revealed that in dprp3^ , a region of 370 bp is deleted from the 
dprp38 locus (Figure 4-2A). This deletion removes part of the Prp38 homology domain. 
Flies homozygous for dprp38E1 die as first instar larvae, but can be rescued to viability 
by Gal4-UAS-driven ubiquitous expression of dPrp38 (Brand et al., 1994). This 
demonstrates that dprp38 loss of function is indeed lethal. Due to the early stage of 
lethality, I was not able to determine whether dprp38s1 is a true protein null mutation, 
but the severity of the phenotype suggests that dprp38E1 is a functional null or a strong 
hypomorph.
4.1.4.4 Clonal analysis of the dprpSSF1 mutant
To study the dprp38EI mutant phenotype in vivo, I used the FLP/FRT 
system to generate mitotic clones of dprp38EI mutant tissue in wing and eye imaginal 
discs. Attempts to recover dprp38EI mutant clones in heterozygous animals were 
unsuccessful, indicating that dPrp38 is required for normal growth and/or proliferation
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(data not shown). Thus, GFP-labelled dprp38Ei mutant clones were generated in eye 
imaginal discs that are heterozygous for a mutation in a Minute gene (Figure 4-2E-F, H, 
and materials and methods). Even in this context, only small dprp38EI mutant clones 
could be recovered posterior to the mitotic furrow where cell proliferation has ceased 
(Figure 4-2E, mutant cells are labelled by two copies of GFP, red circles). Notably, the 
mutant clones were similar in size to clones homozygous for the Minute mutation 
(marked by absence of GFP, white circles). Since homozygous Minute clones are 
severely growth defective due to lack of functional ribosomes, this demonstrates that 
dPrp38 function is indeed essential for cell growth and proliferation.
4.1.5 dPrp38 is required for proliferation and G2/M progression
4.1.5.1 Cells depleted of dPrp38 accumulate in G2/M
To further investigate the growth/proliferation defect observed in dprp38 
mutant tissue, DNA profiles were recorded from Drosophila S2 cells treated with 
dsRNAs targeting eGFP (control) or dprp38 for the indicated number of days (Figure 4- 
3A-D’). In parallel, aliquots were removed to calculate the total number of cells (Figure 
4-3E) and to analyse dPrp38 protein levels (Figure 4-3F). The DNA profiles showed 
that cells treated with dsRNAs targeting dprp38 begin to accumulate in G2/M after 
three to four days (Figure 4-3A-B’). After five to six days, an increase in the sub-Gl 
(SGI) peak is evident, indicating that cells are becoming apoptotic (Figure 4-3C-D’). 
Consistent with this and the in vivo results (Figure 4-2), dsRNA-mediated depletion of 
dPrp38 slows down and eventually blocks proliferation after about four days (Figure 4- 
3E). Immuno-blotting confirmed that this correlates with a gradual decrease in dPrp38 
protein levels (Figure 4-3F). Thus, dPrp38 required for G2/M progression and for 
proliferation and growth during development.
4.1.5.2 dPrp38-depleted cells progress through S phase with normal kinetics, but 
slow down in G2/M
To study the kinetics of dPrp3 8-depleted cells as they progress through the 
cell cycle, an aliquot of cells treated with dsRNA targeting eGFP (control) or dPrp38 
for four days (Figure 4-3B-B’) was BrdU pulse-labelled for 15 minutes. Cells were 
collected at the indicated time points after the BrdU pulse, and BrdU-labelled cells were 
recorded by flow cytometry (Figure 4-4A-F’). After three hours, most dPrp38-depleted 
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Figure 4-3: dPrp38 is required for proliferation and G2/M progression. (A-D ) Cells depleted 
of dPrp38 accumulate in G2/M and eventually become apoptotic. S2 cells were treated with 
dsRNA targeting GFP (control) or dPrp38 for the indicated number of days. Cells were fixed, 
stained with propidium iodide, and analysed by flow cytometry. The ratio of cells in the G2/M 
relative to G1 phase is indicated for each treatment (G1:G2/M). The peaks corresponding to the 
sub-G1 (SG1), G1 (2N), and G2 (4N) populations are indicated on the X-axis. (E-F) Cells were 
counted and dPrp38 protein levels m easured in a parallel set-up. (E) Control treated (blue) or 
dPrp38-depleted (red) cells were counted once a day from day 2-7 (D2-D7). (F) Immuno-blotting 
confirms that dPrp38 protein levels are progressively reduced in cells in S2 cells treated with 
dsRNA corresponding to dprp38 compared to control cells. Cell extracts prepared from S2 cells 
treated with dsRNA corresponding to GFP  (control) or dprp38 after the indicated number of days 
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Figure 4-4: dPrp38-depleted cells progress through S phase with normal kinetics, but are 
slowed down in G/M. (A-F’) S2 cells were treated with dsRNA targeting GFP (control, A-F) or 
dPrp38 (A’-F’) for four days. Cells were reseeded at a density of 1x106 cells/ml and pulse-labelled 
with BrdU for 15 min. Cells were fixed, stained with propidium iodide, and analysed by flow cytom­
etry at the indicated time points after the BrdU pulse. dPrp38-depleted cells progress through S 
phase with similar kinetics as control cells, but accumulate in G2/M (compare C’ with C). Only a 
small proportion of dPrp38-depleted cells undergo mitosis and enter G1 compared with control 
cells (compare D’-F’ with D-F).
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depleted of dPrp38 progress through S phase with normal kinetics. After 6 hours, 
approximately 50% of control cells have entered Gl, whereas the majority of dPrp38- 
depleted cells are still in G2/M. At the 12-hour time point, the majority of control cells 
are in Gl and after 15 hours some start to re-enter S phase. In contrast, the majority of 
dPrp38-depleted cells remain in G2/M even at the 15-hour time point (Figure 4-4C’-F’). 
A small proportion of cells appear to enter Gl after 9-12 hours, but with severely 
delayed kinetics (Figure 4-4C’-F’). Thus, dPrp38 is required for normal rates of entry 
into and/or progression through mitosis.
4.1.6 dPrp38 forms a complex with multiple splicing factor homologues
Having characterised the requirement for dPrp38 in growth and 
proliferation in vitro and in vivo, I next wished to study the molecular function of 
dPrp38. While yeast Prp38p is an integral component of the tri-snRNP, its mammalian 
homologue remains poorly characterised and has been isolated in comparatively few 
spliceosome preparations (Jurica and Moore, 2003). I therefore wished to identify 
dPrp38 binding partners in order to shed light on its function in higher eukaryotes. Two 
large-scale affinity purifications of endogenous dPrp38 from Drosophila S2 cells were 
performed using my anti-dPrp38_N and anti-dPrp38_C antibodies. The samples from 
the purification procedures were subjected to SDS-PAGE, and individual protein bands 
were visualised by blue G-colloidal concentrate staining (Figure 4-5A). Bands that were 
present in one or both of the dPrp38 samples, but absent in the control sample, were 
carefully excised and subjected to mass spectrometry to identify the proteins (bands 
marked with asterisks in Figure 4-5A).
Consistent with a role of dPrp38 in splicing, more than half of the proteins 
identified by mass spectrometry represent homologues of yeast splicing factors (Table 
4-1). In agreement with the reported function of yeast Prp38p (Xie et al., 1998), several 
of the proteins identified as dPrp38 binding partners are homologues of proteins 
required for late maturation of the spliceosome in yeast. These include the two U5 
snRNP proteins CG8877/U5-220kD/Prp8p and CG10333/U5-100kD/Prp28p and the 
three NTc/Cdc5-Prpl9 components CG6905/Cdc5/Ceflp, CG5519/hPrpl9/Prpl9p, and 
CG6197/XAB2/Syflp (Drosophila/Humans/Yeast). The DEAD box helicase, Prp28, is 
essential for the displacement of U1 snRNP by U6 snRNP at the 5’-splice site (Chen et 
al., 2001b; Staley and Guthrie, 1998). Prp8 is a constituent component of the U5 snRNP 
(Lossky et al., 1987; Stevens et al., 2001) and like Prp38, it is required for release of U4
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Figure 4-5: dPrp38 associates with several splicing factors and a previously uncharacter­
ised protein dM FAPI. (A) To identify dPrp38-associated proteins, purifications were performed 
form S2 cells using anti-dPrp38_N, anti-dPrp38_C or anti-GFP (control) antibodies. The final 
eluates were resolved on a 4-12% Nupage Bis-Tris gel, and stained with Brilliant Blue G-colloidal 
concentrate. Visible bands (indicated by asterisks) were excised and identified by MALDI-TOF 
m ass spectrometry. The band corresponding to dPrp38 is indicated by two asterisks. The proteins 
isolated in complex with endogenous dPrp38 are summarised in Table 4-1. (B) The specificity of 
the anti-dMFAP1 antibody was confirmed by immuno-blotting on cell extracts prepared from S2 
cells treated with dsRNA corresponding to GFP  (control) or dmfapl for three days. Anti-p-tubulin 
was used as a loading control. (C) dMFAPI co-immunoprecipitates with dPrp38. dPrp38, 
dMFAPI, and control (anti-GFP) immunoprecipitates from S2 cells were blotted for dMFAPI (top 
panel) and dPrp38 (bottom panel). (D-E) dMFAPI depletion destabilises dPrp38 and vice versa. 
Cell extracts prepared from S2 cells treated with dsRNA corresponding to GFP (control, D-E), 
dmfapl (D), or dprp38 (E) for three days were blotted fordPrp38 and dMFAPI as indicated. Anti- 
p-tubulin was used as a loading control.
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Table 4-1




CG6905/Cdc5/Cef1 p Splicing/NTc/Cdc5-Prp19 complex
CG5519/hPrp19/Prp19p Splicing/NTc/Cdc5-Prp19 complex
CG9143/XAB2/Syf1 p Splicing/NTc/Cdc5-Prp19 complex




CG11198/Acetyl CoA carboxylase Fatty acid synthesis
CG5261/Dihydrolipoyl acetyltransferase Fatty acid synthesis
CG7430/Dihydrolipoyl dehydrogenase Fatty acid synthesis
CG7961/alpha-coatom er subunit Intercompartmental trafficking
CG6699/beta-coatom er subunit Intercompartmental trafficking
CG8264/Bx42 Transcription factor
CG8983/ERp60 Protein folding
1Protein does not have an obvious homologue in yeast, and the fly and the human IDs are indicated.
180
snRNP (Kuhn et al., 1999; Kuhn et al., 2002). Prpl9 and Cefl both belong to the NTc, 
which plays an important role in the activation step of the spliceosome by stabilising the 
interaction of U5 and U6 snRNPs with the pre-mRNA after the release of U1 and U4 
snRNPs (Chan and Cheng, 2005; Chan et al., 2003). Additional splicing factor 
homologues purified in complex with dPrp38 included CG9983, and CGI2749. 
CG9983 and CGI2749 are the two closest homologues of Hrplp/hnRNPAl 
(yeast/humans) in the Drosophila genome. Proteins belonging to this family have been 
reported to function as negative regulators of pre-mRNA splicing (Zhu et al., 2001).
In addition to splicing factors, I also identified a number of proteins 
involved in vesicle trafficking and fatty acid synthesis. Interestingly, mouse Prpl9p was 
recently found to be associated with lipid droplets and to have a putative role in lipid 
droplet biogenesis (Cho et al., 2007). It is possible that other splicing factors could have 
a similar additional function in lipid biogenesis. However, I did not further investigate a 
function of dPrp38 in lipid biogenesis and/or trafficking.
4.1.7 The CG1017-encoded protein, dMFAPI, forms a complex with 
dPrp38
As well as homologues of proteins with well-characterised functions, the 
mass spectrometry analysis identified the product of the predicted gene CGI 017, which 
was previously found to interact with dPrp38 in a genome-wide yeast 2-hybrid screen 
(Table 4-1, and (Giot et al., 2003)). This protein is 52% identical to the human Micro- 
fibrillar-associated protein 1 (MFAP1). MFAP1 and its homologues contain no 
recognisable domain; the name refers to the fact that chicken MFAP1 (also known as 
AMP for Associated Microfibril protein) was initially identified through a screen for 
proteins detected by an antiserum raised against a crude microfibril preparation 
(Horrigan et al., 1992). MFAP1 was recovered in a number of purifications of various 
spliceosomal complexes (Bessonov et al., 2008; Deckert et al., 2006; Makarov et al., 
2002; Makarova et al., 2004; Neubauer et al., 1998) although its presumed function as 
an extracellular matrix component initially led to its classification as a purification 
artefact (Neubauer, 2005; Neubauer et al., 1998). However, my observation that 
dMFAPI forms a complex with dPrp38 and the Drosophila yeast 2-hybrid data, which 
suggests that the interaction might be direct, prompted me to further characterise the 
function of dMFAPI.
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To verify the interaction between dPrp38 and dMFAPI, I generated an 
antibody against dMFAPI (see Materials and Methods). The antibody was tested on 
extracts from cells treated with dsRNA targeting eGFP (control) or dmfapl (Figure 4- 
5B). The antibody detects a band in control extracts that migrates at the expected size of 
75 kDa. The intensity of this band is strongly reduced in extracts from cells depleted of 
dMFAPI, confirming the specificity of the antibody (Figure 4-5B). This antibody and 
an anti-dPrp38 antibody were used to immunoprecipitate endogenous dMFAPI and 
dPrp38. Western blotting revealed the presence of dPrp38 in the dMFAPI immuno­
precipitate and vice versa (Figure 4-5C). These data confirm that dMFAPI forms a 
complex with dPrp38.
The stabilities of many proteins are increased upon their incorporation 
into complexes. Consistent with this idea, I found that depletion of dMFAPI affects 
dPrp38 protein levels (Figure 4-5D) and vice versa (Figure 4-5E). Thus, dPrp38 
proteins levels are substantially decreased in cells depleted of dMFAPI (Figure 4-5D), 
and vice versa (Figure 4-5E). Importantly, {3-tubulin levels were not affected in either 
sample, suggesting that dPrp38 and dMFAPI indeed stabilise each other by forming a 
complex (Figure 4-5D-E).
4.1.8 dPrp38 interacts directly with dMFAPI
To examine whether the interaction between dPrp38 and dMFAPI is 
direct, I used bacterial produced GST-dMFAPl and His-dPrp38 proteins (Figure 4-6A- 
B). GST pull-downs of GST-dMFAPl or GST alone (control) were carried out in the 
presence of His-dPrp38 (Figure 4-6A). I found that His-dPrp38 is present in the GST- 
dMFAPl, but not the GST precipitate (Figure 4-6A). Similarly, cleaved GST-dMFAPl 
co-purifies with His-dPrp38, but not an unrelated His-tagged peptide (Figure 4-6B). 
This shows that the interaction between dPrp38 and dMFAPI is direct.
Next, I wished to determine the domain in dMFAPI, which mediates its 
interaction with dPrp38 and vice versa. dMFAPI does not contain any recognisable 
functional domains, though the C-terminal half of dMFAPI is highly conserved in 
humans. Thus, I tested the ability of N-terminal (amino acids 1-229, HA-dMFAPlAC) 
and C-terminal (amino acid 229-478, HA-dMFAPlAN) domains of dMFAPI to interact 
with endogenous dPrp38 (Figure 4-6C-D). I found that HA-dMFAPlAN (Figure 4-6C), 
but not HA-dMFAPlAC (Figure 4-6D), co-immunoprecipitates with dPrp38. This 










































Figure 4-6: dPrp38 interacts directly with dMFAPI. (A) Bacterially expressed GST-dMFAP1 or 
GST alone was incubated with bacterially expressed His-dPrp38, and GST pull-downs were 
probed for the presence of His-dPrp38 using one of my dPrp38 antibodies (middle lane) or GST- 
dMFAPl (top panel) and GST (bottom panel) using and anti-GST antibody. (B) Bacterially 
expressed His-dPrp38 or an unrelated His-tagged peptide (control) was incubated with cleaved 
GST-dMFAP1, and His pull-downs were probed for the presence of dMFAPI using my anti- 
dMFAPI antibody (top panel) or His-dPrp38 using one of my dPrp38 antibodies (bottom lane). 
(C-D) dPrp38 interacts with the C-terminal part of dMFAPI. dPrp38 (C-D), HA-dMFAP1AN (C), 
HA-dMFAP1 AC (D), and control (C-D, anti-V5) immunoprecipitates from S2 cells were blotted for 
dMFAPI (top panel) and dPrp38 (bottom panel). (E-F) dMFAPI interacts with the N-terminal part 
of dPrp38. dMFAPI (E-F), HA-dPrp38p (E), HA-dPrp38A (F), and control (E-F, anti-V5) immuno­
precipitates from S2 cells were blotted for dMFAPI (top panel) and dPrp38 (bottom panel).
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previously discussed, the dprp38019491 mutation, which is predicted to cause a deletion 
of the last 65 amino acids of dPrp38, has no effect on growth and proliferation in vivo 
(Figure 4-2C-D). If the ability of dPrp38 to interact with dMFAPI is linked with its 
essential function, deletion of the C-terminal part of dPrp38 would not be predicted to 
disrupt its interaction with dMFAPI. Indeed, I found that dPrp38 lacking the last 65 
amino acids (amino acids 1-266, HA-dPrp38p) retains its ability to interact with 
dMFAPI (Figure 4-6E). I also tested whether the Prp38 homology domain of dPrp38 
(amino acids 1-180, HA-dPrp38A) was sufficient to mediate its interaction with 
dMFAPI. While small amounts of dMFAPI are recovered in the HA-dPrp38PA 
precipitate, no HA-dPrp38PA protein can be detected in the dMFAPI precipitate 
(Figure 4-6F). Thus, whereas the Prp38 homology domain of dPrp38 might be sufficient 
for its interaction with dMFAPI, the presence of additional 86 amino acids in HA- 
dPrp38P appears to be required for full binding ability. In conclusion, dMFAPI binds to 
the N-terminus of dPrp38 via its C-terminus.
4.1.9 dMFAPI forms a complex with several splice factor homologues
Given the direct interaction between dMFAPI and dPrp38 and the fact 
that MFAP1 is present in several human spliceosomal fractions, I wanted to establish 
whether dMFAPI interacts with other components of the spliceosome. I performed a 
large-scale purification of endogenous dMFAPI from Drosophila S2 cells using the 
anti-MFAPl antibody (see materials and methods). Proteins isolated in complex with 
dMFAPI were subjected to SDS-PAGE, visualised by G-colloidal concentrate staining, 
and identified by mass spectrometry (Figure 4-7A).
The majority of proteins isolated in complex with dMFAPI are predicted 
or known to function in splicing (Table 4-2). These include dPrp38/Prpf38a/Prp38p, 
three U5 snRNP proteins CG8877/U5-220kD/Prp8p, CG5931/U5-200kD/Brr2p and 
CG3436/U5-40kD/Rsa4p, one component of the NTc/Cdc5-Prpl9 complex, 
CG6905/Cdc5/Ceflp, and CG2173/DDX27/Drslp (Drosophila/Humans/Yeast), which 
are conserved in yeast, and Hfp/Puf60, CG4602/Srp54, and CG6995/Safb2 
(flies/humans) that are conserved among higher eukaryotes. Notably, CG8877/U5- 
220kD/Prp8p and CG6905/Cdc5/Ceflp, which function in the activation step of the 
yeast spliceosome (Chan and Cheng, 2005; Chan et al., 2003; Kuhn et al., 1999; Kuhn 
et al., 2002), were isolated in complex with both dPrp38 and dMFAPI. Also recovered 
in the dMFAPI purification was the DExD/H-box RNA helicase CG5931/U5-
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Figure 4-7: dMFAPI associates with several splicing factors that are implicated in 
spliceosome activation. (A) To identify dMFAPI-associated proteins, purifications were 
performed form S2 cells using anti-dMFAP1 or anti-GFP (control) antibodies. The final eluates 
were resolved on a SDS-PAGE gel, and stained with Brilliant Blue G-colloidal concentrate. Visible 
bands (indicated by asterisks) were excised and identified by MALDI-TOF mass spectrometry. 
The band corresponding to dMFAPI is indicated by two asterisks. Proteins isolated in complex 
with endogenous dMFAPI are summarised in Table 4-2. (B) Schematic overview of some of the 
proteins isolated in comlex with dPrp38 and/or dMFAPI (red) and previously reported interactions 
of the homologues in yeast (blue) or humans (green) (www.thebiogrid.org). Both the Drosophila 
and human IDs are indicated in the schematic. A line connecting two proteins indicates that they 
have been purified together using one or both of them as bait.
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Table 4-2






CG6905/Cdc5/Cef1 p Splicing/NTc/Cdc5-Prp19 complex







CG7961/alpha-coatomer subunit Intercompartmental trafficking
CG6699/beta-coatom er subunit Intercompartmental trafficking
CG17927/Myosin heavy chain Cytoskeleton
CG1676/Cactin Unknown
1Protein does not have an obvious homologue in yeast, and the fly and the human IDs are indicated.
186
200kD/Brr2p, which in yeast is required for release of the U4 snRNP and activation of 
the spliceosome (Raghunathan and Guthrie, 1998). This suggests that dPrp38 and 
dMFAPI might both function during the activation step of the spliceosome cycle.
Based on my results (Table 4-1 and Table 4-2) and data in the literature, I 
have generated a schematic overview of putative protein-protein interactions between 
some of the proteins that were purified in complex with dPrp38 and/or dMFAPI (Figure 
4-7B). Interestingly, dPrp38 and dMFAPI are both associated with multiple U5 snRNP 
proteins and one or several components of the NTc/Cdc5-Prpl9 complex, suggesting 
that they might bridge an interaction between the two complexes.
4.1.10 dMFAPI is required for pre-mRNA processing
The observations that dMFAPI interacts directly with dPrp38 (Figure 4- 
6A-B) and can be isolated in complex with several splicing factor homologues (Table 4- 
2) suggest that dMFAPI might function in pre-mRNA processing. To further 
investigate this, I used the y-tubulin transcript as a read-out to study the requirement for 
dMFAPI in pre-mRNA processing. Using quantitative RT-PCR to measure y-tubulin 
pre-mRNA and mRNA levels, I observed a 70-84% decrease in y-tubulin mRNA levels 
accompanied by a 3.4-7.3-fold increase in y-tubulin pre-mRNA levels in cells depleted 
of dMFAPI, dPrp38 or the well-characterised splicing factor CG8877/Prp8p 
(Drosophila/yeast) compared with control cells (Figure 4-8A). I also examined the 
effect of reducing dMFAPI protein levels on pre-mRNA processing of other transcripts 
including hippo, dmcrs2, and eIF3-S10 (Figure 4-8B-C). For these transcripts, I 
observed an about 40% reduction in mRNA levels (Figure 4-8B) accompanied by a 7- 
10-fold increase in pre-mRNA levels (Figure 4-8C) in dMFAPI-depleted cells 
compared with control cells. Thus, dMFAPI is indeed required for pre-mRNA 
processing.
4.1.11 dmfapl is an essential gene
Having confirmed that dMFAPI is a spliceosome-associated protein, I 
next wanted to study the in vivo requirement for dMFAPI. Initially, I set out to generate 
a dmfapl deletion mutant by mobilisation of a P-element (GE5102) inserted 
approximately 1 kb upstream of the coding region of dmfapl. About one thousand 
putative dmfapl mutants were screened for imprecise excisions by PCRs, but no 
imprecise excisions of the P-element were recovered (data not shown). Instead I used a
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Figure 4-8: dMFAPI is required  for pre-mRNA processing . (A) Total RNA was extracted from 
S2 cells treated with dsRNA targeting eGFP  (control), dprp38, dmfapl, or CG8877/prp8 for four 
days, and y-tubulin mRNA (black) and pre-mRNA (grey) levels were measured after 1st strand 
synthesis by qPCRs (see materials and methods). (B-C) Total RNA was extracted from S2 cells 
treated with dsRNA targeting eGFP  (control) or dmfapl, and hippo (black), dmcrs2 (grey), or 
elF3-S10 (white) mRNA (B) and pre-mRNA (C) levels were measured after 1st strand synthesis 
by qPCRs. (A-C) mRNA and pre-mRNA levels were compared between different samples by 
normalisation to levels of the intronless his3 transcript.
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transgenic dmfapl RNAi line from VDRC to study dMFAPI loss of function 
phenotypes. Ubiquitous expression of the dmfapl RNAi construct caused lethality at the 
larval stage. The lethality is likely to be a consequence of the severe growth defect 
observed in larvae depleted of MFAP1 (data not shown). To confirm that the observed 
phenotype was not due to an off-target effect, I generated an independent RNAi line 
that targets a distinct region of the dmfapl transcript (D2-1, see materials and methods). 
Consistent with the phenotype I observed with the VDRC RNAi line, ubiquitous 
expression of the D2-1 dmfapl RNAi construct resulted in larval lethality (data not 
shown). Thus, dmfapl, like dprp38, is an essential gene.
4.1.12 dMFAPI is required for growth and proliferation during 
development
To further characterise the growth defect observed in larvae with reduced 
levels of dMFAPI, I generated GFP-marked dmfapl RNAi-expressing clones in wing 
imaginal discs using the Flipout/Gal4 technique (Figure 4-9D-F) (Pignoni et al., 1997). 
For comparison, wild-type clones and clones depleted of dPrp38 were generated in 
parallel (Figure 4-9A-C, G-I). Consistent with dMFAPI and dPrp38 being required for 
normal growth and proliferation, clones with reduced levels of dMFAPI or dPrp38 
(marked by GFP in Figure 4-9D, I) are markedly smaller than control clones (marked 
by GFP in Figure 4-9A) generated at the same time. Furthermore, depletion of dMFAPI 
or dPrp38 in the highly proliferating region of the wing pouch results in apoptosis, as 
measured by increased levels of cleaved-caspase 3 staining in the clones (Figure 4-9E, 
H). In comparison, no apoptosis could be detected in wild-type clones (Figure 4-9B). 
Thus, normal levels of dMFAPI and dPrp38 are required for clonal growth and survival 
in proliferating tissue.
4.1.12.1 dPrp38 and dMFAPI gain of function causes an overgrowth phenotype
To study dMFAPI and dPrp38 gain of function phenotypes, I used UAS- 
dprp38 and UAS-dmfapl transgenic animals that had been generated by Julien 
Colombani (see Materials and Methods). UAS-GFP (control), UAS-dprp38, and UAS- 
dmfapl transgenic animals were crossed to flies carrying the engrailed-Gal4 transgene 
to drive the expression of GFP (control), dPrp38 or dMFAPI in the posterior 
compartment of the wing. The crosses were carried out under density-controlled 









0  100 -  bN '</)




Figure 4-9: In vivo characterisation of dMFAPI. (A-l) Wing imaginal discs from third instar 
larvae. Posterior is to the right. Wild-type clones (A-C) or clones expressing dprp38 and dmfapl 
RNAi constructs (D-l) were generated using the FLPout technique (marked by GFP in A, D, G). 
Clones with reduced levels of dMFAPI (D-F) or dPrp38 (G-l) are smaller than control clones (A-C) 
generated at the sam e time and undergo apoptosis as measured by increased levels of cleaved- 
caspase 3 staining in the clones (red in E, H). (J) Ectopic expression of dPrp38 or dMFAPI in the 
posterior compartment of the wing results in an over-growth phenotype. dPrp38, dMFAPI, or 
GFP (control) were expressed in the posterior compartment of the wing using the engrailed-Gal4 
driver and the wing areas were m easured (see Materials and methods). The number of wing used 
for each genotype is indicated (n). ** Indicates that p<0.01, using a students t-test.
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during the larval growth phase and thus the final organ size in the adult fly. The area of 
the engrailed domain of female wings in the adult FI progeny was quantified in each 
cross (see Materials and Methods). dMFAPI and dPrp38 gain of functions cause 
modest overgrowth phenotypes (Figure 4-9J). Thus, Gal4-UAS-driven expression of 
dPrp38 and dMFAPI results in an 8% and 6% increase in the area of the engrailed 
domain. From these data, it cannot be concluded if the observed overgrowth is the result 
of increased proliferation or growth rates or and extended period of 
growth/proliferation. I did not study the overgrowth phenotypes in more detail.
4.1.13 dMFAPI is required forG2/M progression
To further investigate the growth/proliferation defect observed in dmfapl 
mutant tissue, I analysed the DNA profile from cultured Drosophila S2 cells depleted of 
dMFAPI. Consistent with my in vivo results, dsRNA-mediated depletion of dMFAPI 
slows down proliferation (data not shown) and cells eventually arrest in G2/M (Figure 
4-10A-B). Thus, in cells depleted of dMFAPI the ratio of cells in Gl and G2/M is 0.42 
(Figure 4-1 OB) compared with 1.20 for control treated cells (Figure 4-10A). Using my 
anti-dMFAPl antibody, I verified the depletion of dMFAPI (Figure 4-10C). Thus 
dMFAPI, like dPrp38, is required for G2/M progression and for proliferation and 
growth during development.
4.1.14 A general requirement for splicing factors in G2/M progression
Studies carried out with temperature-sensitive mutants in yeast suggest 
that several splicing factors are important for cell cycle progression (Boger-Nadjar et 
al., 1998; Hwang and Murray, 1997; Lundgren et al., 1996; Ohi et al., 1998; Potashkin 
et al., 1998; Stevens and Abelson, 1999; Urushiyama et al., 1997; Vaisman et al., 1995). 
The cell cycle arrest phenotypes observed with different splicing factor mutants seem to 
vary (Bums et al., 2002). This could reflect a difference in the severity of the splicing 
defects among those mutants or differential requirements for individual splicing factors. 
My data (Fig. 4J-L) and some evidence from mammalian cells suggest that in higher 
eukaryotes at least certain splicing factors are required for the G2/M transition 
(Bernstein and Coughlin, 1998; Li et al., 2005a; Pacheco et al., 2006). However, it is 
unclear whether this cell cycle arrest phenotype is general, or whether inactivation of 
different core components of the metazoan spliceosome would give rise to the same 
variability in cell cycle arrest phenotypes reported in yeast. To address this, I analysed
191
A C o n t r o l B A d M F A P I
G 1 : G 2 / M I 1 G 1 : G 2 / M
i
=  1 . 1 9
k )
I = 0 . 4 2
1 1 '
2N 4N 2N 4N







C o n t r o l  
G 1  : G 2 / M =  0 . 9 6
2N4N
G C G 8 8 7 7 / P r p 8 p  
G 1  : G 2 / M =  0 . 4 9
2N4N
J C G 6 0 1 1 / P r p 1 8 p  
G 1  : G 2 / M =  0 . 6 4
2N4N
E C G 6 0 4 9 / C u s 2 p  
|G 1  : G 2 / M =  0 . 8 2
<—>+  - F - -- --------
?N4N
H C G 3 2 6 0 4 / P r p 1 6 p
G 1  : G 2 / M =  0 . 8 4
i
.— i \ L
2N4N
K C G 5 5 1 9 / P r p 1 9 p  
G 1 : G 2 / M =  0 . 5 0
F C G 6 9 0 5 / C e f 1 p  
G 1  : G 2 / M =  0 . 4 8
2N4N
I C G 6 0 1 5 / P r p 1 7 p  
G 1  : G 2 / M =  0 . 3 9
2N4N
L C G 8 2 4 1 / P r p 2 2 p  
G 1  : G 2 / M =  0 . 5 0
2N4N2N4N
D N A  c o n t e n t
Figure 4-10: Depletion of dMFAPI and several core components of the spliceosome 
results in G2/M arrest. (A-L) Cells depleted of dMFAPI or other splicing factors arrest in G2/M. 
S2 cells were treated with dsRNA targeting GFP (control), dmfapl, or other splicing factors for 
three days. Cells were fixed, stained with propidium iodide, and analysed by flow cytometry. The 
ratio of cells in G2/M relative to G1 is indicated for each treatment (G1:G2/M). (C) Immuno- 
blotting confirms that dMFAPI protein levels are reduced in cells treated with dsRNA targeting 
dmfapl compared with control cells. Anti-p-tubulin is used as a loading control.
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the DNA profile from S2 cells treated with dsRNAs targeting a range of Drosophila 
homologues of yeast splicing factor (Figure 4-10D-L). These include Cus2p, which 
functions in the recruitment of U2 to the branch region (Perriman and Ares, 2000), 
Ceflp and Prpl9p, which are required for maturation of the spliceosome (Chan and 
Cheng, 2005; Chan et al., 2003; Tsai et al., 1999), Prp8p, Prpl6p, Prpl7p, and Prpl8p, 
which act in the second step of the splicing reaction (James et al., 2002a; Schneider et 
al., 2002; Umen and Guthrie, 1995a; Wang and Guthrie, 1998), and Prp22p, which is 
required for release of the spliced mRNA (Schneider et al., 2004). Depletion of any of 
these putative splicing factors led to an accumulation of cells in G2/M (Figure 4-10D- 
L). The degree to which cells arrested in G2/M varied between the different treatments 
and might reflect the efficiency of the dsRNA-mediated depletion. These data suggest 
that in higher eukaryotes, the G2/M arrest phenotype is a general outcome of interfering 
with the basic splicing machinery. It is not clear whether this phenotype is due to the 
depletion of a factor that is rate limiting for G2/M progression or to the activation of a 
cell cycle checkpoint.
4.1.15 Depletions of several different spliceosome components results in 
cell cycle arrest prior to the onset of mitosis
To explore the nature of the G2/M arrest in more details, cells depleted of 
dPrp38, dMFAPI, or the splicing factor homologues indicated in Figure 4-10D-L were 
stained with anti-y-tubulin and anti-phospho-Histone 3 (PH3) antibodies. The anti-PH3 
antibody labels the condensed chromatin from the onset of mitosis (Figure 4-11 A) 
through to cytokinesis (Figure 4-1 ID). To examine whether cells depleted of dPrp38, 
dMFAPI, or other splicing factors arrest in G2 or during mitosis, a minimum of 1200 
cells were examined for each treatment, and the percentage of PH3 positive cells was 
scored. Depletion of either of the tested splicing factors results in a 26-100% reduction 
in the number of PH3 positive cells relative to that of control cells (Figure 4-1 IE). I did 
not note the accumulation of cells at any stage of mitosis. This suggests that these 
splicing factor-deficient cells are arrested in G2, prior to chromosome condensation, 
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Figure 4-11: Depletion of several components of the spliceosome results in G2/M arrest.
(A-D) S2 cells stain positive for phospho-histone 3 (PH3) from the onset of mitosis (A), through 
metaphase (B) and anaphase (C) to cytokinesis (D). S2 cells were stained with anti-y-tubulin (in 
red) and anti-PH3 (in green) antibodies. (A) The scale bar is at 100 ^M. (E) Depletion of various 
splicing factor homologues results in a decrease in numbers of PH3-positive cells. Cells were 
treated with dsRNA targeting the indicated proteins for four days and stained with anti-y-tubulin 
and anti-PH3 antibodies. For each set-up, the percentage of PH3-positive cells relative to that of 
control cells was calculated by examining a minimum of 1200 cells. 1When a protein does not 
have an obvious homologue in yeast, the fly and human IDs are indicated.
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4.1.16 Depletion of dPrp38 or dMFAPI causes a reduction in stg/cdc25 
mRNA levels
In Drosophila, mitosis is triggered by a temporally controlled burst of 
string/cdc25 (stg) transcription (Edgar and O'Farrell, 1989). Stg is a phosphatase, which 
activates the mitotic kinase Cdkl and is essential for G2/M progression. In addition to 
the transcriptional regulation of stg mRNA levels, the presence of an intron in the stg 
transcript implies that stg mRNA levels are critically dependent on a functional 
spliceosome. Thus, the observation that depletion of dPrp38, dMFAPI, and a number of 
core splicing factor homologues cause cells to arrest in G2/M (Figure 4-10) suggests 
that stg mRNA levels might be affected under those conditions. To investigate this, I 
measured stg mRNA levels in cells depleted of dMFAPI, dPrp38, or the well- 
characterised splicing factor CG8877/Prp8p (flies/yeast). As expected, treating cells 
with dsRNA targeting dmfapl, dprp38, or CG8877/prp8 caused cells to arrest in G2/M 
(Figure 4-12A-F). Using quantitative RT-PCR to measure stg mRNA levels, I observed 
an 83-96% decrease in stg mRNA in cells depleted of dMFAPI, dPrp38 or 
CG8877/Prp8p compared with control cells (Figure 4-12G). The observed decrease in 
mRNA levels could be due to a defect in processing of the stg pre-mRNA or could be 
an indirect effect caused by interference of a factor required for regulation of stg 
transcription. Attempts to measure stg pre-mRNA levels by quantitative RT-PCR were 
unsuccessful (data not shown). This is most likely due to the low level and instability of 
stg pre-mRNA. Consistent with this idea, it has previously been reported that many pre- 
mRNAs do not accumulate in response to a defective spliceosome, but are degraded by 
the exosome complex (Bousquet-Antonelli et al., 2000).
4.2 Discussion part II
4.2.1 A conserved function of Prp38p in higher eukaryotes
The essential budding yeast protein, Prp38p, was the first protein shown to 
function in maturation of the spliceosome. Prp38p is dispensable for the initial assembly 
of the spliceosome, but is required for the release of the U4 snRNP and activation of the 
spliceosome (Xie et al., 1998). Homologues of Prp38p have been identified in higher 
eukaryotes, but the conservation of the primary sequence is poor. Thus, Prp38p is only 
24 and 22% identical to Prpf38a (humans) and dPrp38 (flies), respectively. In contrast,
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Figure 4-12: Depletion of dPrp38 or dMFAPI causes a reduction in stg  mRNA levels. (A-D) 
S2 cells were treated with dsRNA targeting GFP (control) or genes encoding the indicated prod­
ucts for three days. Cells were fixed, stained with propidium iodide, and analysed by flow cytom­
etry. The ratio of cells in G2/M relative to G1 is indicated for each treatment. (E-F) The effective­
ness of dPrp38 and dMFAPI depletions were assayed by immuno-blotting. (G) In parallel, total 
RNA was extracted from cells and stg mRNA levels were measured after 1st strand synthesis by 
quantitive PCR (see materials and methods), stg mRNA levels were compared between the 
different samples by normalisation to mRNA levels of a-tubulin.
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dPrp38 is 75% identical to Prpf38a. Despite the low level of homology between Prp38p 
and its homologues in higher eukaryotes, my data suggest that its function may be 
conserved in metazoans. Thus, mass spectrometry analysis of proteins isolated in 
complex with dPrp38 revealed a number of splicing factor homologues that have been 
implicated in maturation of the spliceosome (Table 4-1). These include two U5 snRNP 
proteins, dPrp8/U5-220kD/Prp8p and CG10333/U5-100kD/Prp28p, and three 
components of the NTc/Cdc5-Prpl9 complex CG6905/Cdc5/Ceflp, 
CG9143/XAB2/Syflp, and CG5519/hPrpl9/Prpl9p (flies/humans/yeast).
4.2.2 dPrp38 appears to be associated with the spliceosome during the 
activation step
The observation that dPrp38 associates with U5 snRNP proteins and 
components of the NTc/Cdc5-Prpl9 complex (Table 4-1), suggests that it might join the 
spliceosome concomitantly with or after the tri-snRNP. Consistent with this, 
purifications of human spliceosome intermediates have revealed that Prpf38a is 
associated with the B complex (Bessonov et al., 2008; Deckert et al., 2006), but not the 
A complex (Hartmuth et al., 2002; Urlaub et al., 2002). Surprisingly, in humans 
Prpf38p does not appear to be a stable component of the tri-snRNP (Makarov et al., 
2002), and it was not recovered in purifications of the BAU1 spliceosome intermediate 
(Makarova et al., 2004) or the activated spliceosome (complex B*) (Makarov et al., 
2002). As previously mentioned, the BAU1 complex represents an intermediate 
activation step after dissociation of the U 1 snRNP, but before unwinding of the U4/U6 
duplex (Makarova et al., 2004). This would argue that in contrast to its yeast 
counterpart, Prpf38a is not implicated in the activation step or it is very loosely 
associated with the spliceosome and lost during the purification procedures. My data 
favours the latter possibility. Thus, dPrp38 associates with several components of the 
Cdc5-Prpl9 complex, which in humans appear to be stably associated with the BA1U 
and B* complexes (Makarov et al., 2002; Makarova et al., 2004), but not the B complex 
(Makarova et al., 2004). Thus, my data suggest that, like yeast Prp38p, dPrp38 joins the 
spliceosome concomitantly with the tri-snRNP and stays associated with the 
spliceosome during at least part of the activation step.
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4.2.3 What is the molecular function of dPrp38 in spliceosome 
activation?
The integral U5 snRNP protein CG8877/Prp8p (Lossky et al., 1987; 
Stevens et al., 2001) was recovered in both my dPrp38 (Table 4-1) and dMFAPl (Table 
4-2) purifications. Consistent with the recovery of CG8877/Prp8p in my dPrp38 
purification, budding yeast prp38 and prp8 were previously found to interact 
genetically. Prp8p is the largest known nuclear yeast protein and it is thought to play a 
scaffold-like role in the spliceosome by forming numerous interactions with the pre- 
mRNA, snRNPs, and splice factors. Genetics suggest that Prp8p regulates unwinding of 
the U4/U6 duplex and plays a central role in the release of U4 snRNP and activation of 
the spliceosome. Consistent with this, Prp8p interacts physically and genetically with 
Brr2p, the RNA helicase that is thought to be responsible for the unwinding of the 
U4/U6 double helix.
Xie and co-workers have proposed a model in which Prp38p recruits (or 
activates) an RNA unwinding activity necessary for U4 snRNP release and U6 snRNA 
integration into the active site of the spliceosome. It is tempting to speculate that Brr2p 
might represent this RNA unwinding activity. The ability of Brr2p to interact directly 
with Prp8p would argue against a role of dPrp38 in recruitment of CG5931/Brr2p. 
However, dPrp38 could form a weak interaction with CG5931/Brr2p sufficient for its 
activation, or dPrp38 could recruit a factor required for activation of CG5931/Brr2p. As 
previously mentioned, Snul 14p is thought to function upstream of Brr2p to regulate its 
activity required for unwinding of the U4/U6 duplex (Small et al., 2006). However, 
CG4849/Snull4p is most likely not recruited to the spliceosome by dPrp38 since 
Snull4p, like Brr2p, interacts directly with Prp8p (Achsel et al., 1998; van Nues and 
Beggs, 2001a). Thus, it is not clear if/how dPrp38 might facilitate U4 snRNP release 
during spliceosome activation.
Interestingly, the NTc/Cdc5-Prpl9 complex components, CG5519/Prpl9p 
and CG6905/Ceflp, were both isolated in complex with dPrp38 (Table 4-1). In budding 
yeast, the NTc joins the spliceosome after U1 and U4 snRNP release, but before the 
first catalytic step and is required for spliceosome activation. Thus, dPrp38 might have 
an additional function after U4 snRNP release to facilitate NTc/Cdc5-Prpl9 complex 
recruitment and/or spliceosome activation.
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4.2.4 dMFAPI appears to be associated with the spliceosome during the 
activation step
In addition to homologues of known splicing factors, I identified a 
previously uncharacterised protein, dMFAPI, which binds directly to dPrp38 (Table 4-1 
and Figure 4-6A-B). Human MFAP1 has been recovered in a number of spliceosome 
purifications, but was initially discarded as a contaminant due to its proposed 
extracellular localisation (Neubauer, 2005; Neubauer et al., 1998). Here I show that 
dMFAPI, like dPrp38, functions in pre-mRNA processing (Figure 4-8) and is 
associated with several conserved splicing factors including dPrp38, the U5 snRNP 
proteins CG8877/U5-220kD/Prp8p, CG3436/U5-40kD/Rsa4p, and CG5931/U5- 
200kD/Brr2p and the NTc/Cdc5-Prpl9 core component, CG6905/Cdc5/Ceflp (Table 4- 
2). Consistent with the association of dMFAPI with U5 snRNP proteins and a 
component of the NTC/Cdc5-Prpl9 complex, human MFAP1 was previously recovered 
in purifications of B, BA1U and B* complexes (Bessonov et al., 2008; Deckert et al., 
2006; Makarov et al., 2002; Makarova et al., 2004), but not A complexes (Hartmuth et 
al., 2002). Thus, dMFAPl/MFAPl might join the spliceosome simultaneously with 
dPrp38/Prpf38a, but seems to be more tightly associated with the spliceosome during 
the activation step. Moreover, MFAP1 was not recovered in spliceosome complexes 
after the first catalytic step, suggesting that it functions during the activation step 
(Bessonov et al., 2008; Jurica et al., 2002).
4.2.5 A function of dMFAPI in alternative splicing?
In addition to highly conserved spliceosome components, dMFAPI also 
formed a complex with a number of splicing factors that have evolved more recently in 
metazoans. Unsurprisingly, most of these function in regulation of alternative splicing. 
Thus, CG4602/srp54, CG6995/saf-b, and hfp/puf60 were all recovered in a RNAi 
screen for regulators of alternative splicing, which included 70% of all genes encoding 
known Drosophila RNA-binding proteins (Park et al., 2004). This is consistent with the 
idea that additional splicing factors have evolved in metazoans to accommodate more 
complex splice patterns. As expected, very few core splicing components were found to 
regulate alternative splicing. An interesting exception is CG5931/Brr2p, which I 
isolated in complex with dMFAPI (Park et al., 2004). dMFAPI is highly conserved 
among higher eukaryotes, but not in yeast, indicating that it has evolved more recently. 
Notably, dMFAPI does not contain a conserved RNA-binding motif and was not
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included in the screen carried out by Park and co-workers (Park et al., 2004). Thus, it 
remains to be determined whether dMFAPI might regulate alternative splicing in higher 
eukaryotes.
4.2.6 dPrp38 and dMFAPI protein levels affect growth and proliferation 
during development
My in vivo studies revealed that dPrp38 is required for growth and 
proliferation (Figure 4-2 and 4-9A-I). Thus, flies homozygous for the dprp38E1 
mutation die as first instar larvae, but can be rescued to viability by Gal4-UAS-driven 
ubiquitous expression of dPrp38 (Brand et al., 1994). Moreover, dprp3tfl mutant tissue 
fail to grow in a wild-type background, suggesting that the dprp38E1 mutation is a 
functional null or a strong hypomorph. The inability of d p r p 3 ^  mutant tissue to grow 
in a wild-type background is not only the due to elimination by cell competition, since 
only small dprp38El mutant clones are recovered in a growth compromised (.Minute) 
background (Figure 4-2). This shows that dPrp38 is intrinsically required for growth 
and proliferation and is consistent with an essential function dPrp38 in splicing. My in 
vivo studies also showed that dMFAPI is an essential protein required for normal 
growth during development. Thus, flies with reduced levels of dMFAPI are severely 
growth compromised and die at the larval stage. Consistent with this, clones of mutant 
tissue with reduced levels of dMFAPI exhibit proliferation and growth defects and 
undergo apoptosis (Figure 4-9A-F). Thus, dMFAPI and dPrp38 might both perform 
essential functions in pre-mRNA processing.
Interestingly, dPrp38 and dMFAPI gain of functions result in modest 
overgrowth phenotypes (Figure 4-9J). It is not clear though if/how the overgrowth 
phenotypes are linked with a role of dPrp38 and dMFAPI in splicing. Moreover, it 
cannot be concluded whether excess growth is due to an extended period of growth or 
to increased proliferation/growth rates (Figure 4-9J). Future experiments will provide a 
more detailed analysis of the overgrowth phenotypes. First, by counting the number of 
cells within fixed areas of wild-type and dPrp38 or dMFAPI gain of function tissue, it 
can be determined whether the overgrowth phenotype is due to an increase in cell size 
or excess proliferation. Second, the proliferation rates of dPrp38 and dMFAPI gain-of- 
function cells can be analysed by inducing Flipout-GAL4 clones at fixed time points 
and comparing clonal growth rates with those of control clones.
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4.2.7 dPrp38 is required for G2/M progression
As mentioned above, my in vivo data show that dPrp38 LOF results in a 
severe growth and proliferation defect. A more detailed analysis in cultured cells shows 
that dPrp38 is required for G2/M progression (Figure 4-3). Thus, dPrp38-depleted cells 
gradually accumulate in G2/M in response to decreased levels of dPrp38. BrdU pulse- 
labelling experiments confirm that the majority of dPrp38-depleted cells fail to progress 
through mitosis (Figure 4-4). Importantly, dPrp38-depleted cells progress through S 
phase with normal kinetics, indicating that dPrp38 only becomes rate-limiting upon 
entry into mitosis. Though it cannot be excluded that the transition from G1 to S phase 
occurs with slower kinetics in cells depleted of dPrp38, the gradual accumulation of 
dPrp38-depleted cells in G2/M in response to decreasing levels of dPrp38 (Figure 4-3) 
and the severe delay or lack of progression through mitosis (Figure 4-4) strongly 
suggest that G2/M progression is the main rate-limiting step.
4.2.8 A general requirement for splicing factors in G2/M progression in 
higher eukaryotes?
In yeast, a subset of genes with known functions in splicing has also been 
implicated in cell cycle progression. These include PRP3, PRP17, PRP8, CEF1, PRP22 
(S. cerevisiae) (Boger-Nadjar et al., 1998; Hartwell et al., 1973; Hwang and Murray, 
1997; Johnston and Thomas, 1982; Ohi et al., 1998; Shea et al., 1994; Vaisman et al., 
1995) and PRP1, PRP2, PRP5, PRP6, CDC28/PRP8, CDC5, and PRP12 (S. pombe) 
(Habara et al., 2001; Lundgren et al., 1996; Nurse et al., 1976; Ohi et al., 1994; 
Potashkin et al., 1998; Takahashi et al., 1994; Urushiyama et al., 1997). Whereas 
mutations in some genes encoding splicing factors cause cells to arrest heterogeneously 
throughout the cell cycle, cefl-13, prpl7A, andprp22-l mutants arrest homogenously in 
G2/M (Bums et al., 2002). A model has been put forward to explain the variability of 
the timing of cell cycle arrest, which suggests that splicing factors are differentially 
required for efficient splicing of single transcripts or a subset of transcripts (Bums et al., 
2002). Consistent with this idea, removal of a single intron from the a-tubulin encoding 
TUB1 gene alleviates both the G2/M arrest and cell division defect observed in the cefl- 
13 mutant, but only partially rescues the cell division defect observed in prpl7A , and 
prp22-l (Bums et al., 2002; Chawla et al., 2003). Instead, the G2/M arrest and growth 
defect in the prp l 7A mutant can be rescued by removal of an intron from the ANC1
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gene (Dahan and Kupiec, 2004). The molecular basis for this specificity remains 
unclear.
The range of cell cycle phenotypes observed with different splicing factor 
mutants in yeast prompted me to study the requirement for various Drosophila splicing 
factors in cell cycle progression. I analysed the effect of individual depletions of 
splicing factors that are predicted to function at various stages of the spliceosome cycle. 
Depletion of any of those splicing factors caused cells to arrest in G2/M (Figure 4-10D- 
L), suggesting that it is a general consequence of interfering with spliceosome activity. 
Consistent with this, a genome wide screen RNA interference screen in HeLa cells for 
factors required for mitosis identified a number of genes encoding splicing factors 
(Kittler et al., 2004). However, it cannot be concluded whether the observed G2/M 
arrest results from of a failure to splice a pre-mRNA encoding a factor that is rate 
limiting for entry into mitosis, or whether a defect in splicing activates a mitotic 
checkpoint that causes cells to arrest in G2.
4.2.9 dPrp38 and dMFAPI are required for normal stg mRNA levels
As mentioned above, the G2/M arrest observed in cells depleted of 
dPrp38, dMFAPI, and other splicing factors might be the consequence of a failure to 
splice a pre-mRNA encoding a factor that is rate limiting for entry into mitosis. In 
Drosophila, Stg activity is essential for G2/M progression and seems to be regulated at 
the transcriptional level. Thus, mitosis is triggered by a temporally controlled burst of 
stg transcription (Edgar and O'Farrell, 1989). This fluctuation in stg mRNA levels 
suggests that de novo transcription and/or processing of stg pre-mRNA is important and 
possibly rate-limiting for G2/M transition. Consistent with this idea, although not 
excluding other explanations, I found that depletion of dPrp38, dMFAPI or 
CG8877/Prp8p cause a 83-96% reduction in stg mRNA levels and a G2/M arrest 
(Figure 4-12). Importantly, this decrease in stg mRNA levels could be due to a defect in 
splicing of stg pre-mRNAs or reduced levels of stg transcription. However, the 
observation that dPrp38 and dMFAPI are both required for pre-mRNA processing 
(Figure 4-8) favours the idea that the reduction in stg mRNA levels is caused directly or 
indirectly by a defect in pre-mRNA processing. The presence of an intron in the stg pre- 
mRNA suggests that dPrp38, dMFAPI or CG8877/Prp8p could be directly required for 
splicing o f stg pre-mRNAs. However, attempts to detect stg pre-mRNA products in 
cells depleted o f dPrp38, dMFAPI or CG8877/Prp8p by RT-PCR were unsuccessful
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(data not shown). This is most likely due to the low level and instability of stg pre- 
mRNA.
Chapter 5 -  Results and discussion part III
5.1 Pixie associates with the 40S ribosomal subunit in an ATP-  
dependent manner and functions in transiation initiation
5.1.1 Background to the Pixie project
pixie (pix) was identified in a genetic screen for molecules that regulate 
growth and interact with PI3K signalling (Coelho et al., 2005b). Female flies with a 
small-wing phenotype elicited by MS1096-Gal4 driven expression of a dominant 
negative form of the catalytic subunit of PI3K (Dpi 10KD) in the wings, were crossed to 
male flies that had been fed Ethyl methanesulfonate (EMS) to randomly mutagenise 
their genomes (Figure 5-1). The resultant progeny were screened for dominant
t/ri
suppression or enhancement of the Dpi 10 small wing phenotype. One group of 7 
mutant chromosomes isolated as enhancers in the screen exhibited lethality or reduced 
body size when placed in trans with each other and displayed a complex 
complementation pattern. The gene corresponding to two of these mutations (pix3c2 and 
pix3c3, Figure 5-2), which are lethal in trans to each other, was mapped by meiotic 
recombination using visible markers and Single Nucleotide Polymorphisms (SNPs), and 
named pixie (Coelho et al., 2005b).
Carmen Coelho carried out a detailed in vivo study of different pixie loss 
of function mutations (Figure 5-2). This study showed that mutations in pixie have an 
unusual effect on fly growth that is similar to the effect of mutations in genes encoding 
ribosomal proteins. For example, weak pixie mutant combinations (pix135/pix124 and 
pixL35/pixLI?) and some heterozygous ribosomal protein mutants {Minutes) have slender 
bristles and show developmental delay, yet their final adult body size is near normal 
(Coelho et al., 2005a; Lambertsson, 1998). In addition, pixie and ribosomal protein 
mutant wing imaginal discs show complex defects in growth and cell survival that vary 
spatially and temporally (Coelho et al., 2005a). This phenotypic similarity suggested 
that the pixie growth phenotype might arise via an effect on translation. Consistent with 
this, depletion of Pixie was found to reduce global translation as measured by levels of 
[35S]-cysteine and -methionine incorporation (Coelho et al., 2005a).
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Dp110*°
DpHO*0 + pixie
Figure 5-1: A screen for novel growth regulators identified a loss of function mutation in 
Pixie (pixie3*2). (A) Expression of a kinase dead version of the catalytic subunit of PI3K (Dp110KD) 
in the Drosophila wing using the MS1096-Gal4 driver results in a small-wing phenotype. (B) The 
pixie3*2 mutation enhances the small-wing phenotype caused by expression of Dp110KD in the 
wing. Flies with a small-wing phenotype due to the expression of Dp110KD in the wing were 
crossed to flies that had been fed EMS to randomly m utagenise their genomes. The offspring 
were screened for flies, in which the small-wing phenotype was either enhanced or suppressed 
(Coelho et al, 2005b).
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L24 L17 L49L35 3c2 3c3
RLIU Fe/S ABC ABC
Walker A Sig Walker B Walker A Sig Walker B
Figure 5-2: pixie missense mutations. A schematic of the predicted functional domains of Pixie 
and the positions of characterised mis-sense mutations. Pixie contains two ABC domains with 
Walker A and B motifs that are found in most ATPases, and an ABC domain signature motif (Sig), 
which distinguishes ABC domain proteins from other ATPases. At the N-terminus, Pixie has an 
iron-sulfur cluster domain (Fe/S), and a domain with high homology to its human homologue, RLI. 
The positions of previously characterised mutations in pixie is indicated; pix1-24 (Pro38Leu), pixf-17 
(Ala77Thr), pix1-35 (Pro146Leu), pix302 (Gln231Leu), and pix303 (Ala77Thr) (Coelho et al, 2005b). 
The pix302 and pix303 alleles, which were recovered in the screen for modifiers of the small-wing 
phenotype, are dominant negative, pix1-49, pix1-24 and pix1-17 are strong LOF alleles, and pix1-35 is a 
hypomorphic allele (Coelho et al, 2005a; Coelho et al, 2005b).
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5.1.2 The starting point of my project
At the time when I joined the Leevers laboratory, the molecular function 
of Pixie had not been further studied. The only Pixie ortholog that had been 
characterised in any details was human RNAse L inhibitor (RLI). As the name implies, 
RLI was identified due to its ability to inhibit the antiviral activity of RNAse L (Bisbal 
et al., 1995). Importantly, RNAse L is only found in mammals, whereas Pixie/RLI is 
conserved in all eukaryota and archaea sequenced so far (Gabaldon and Huynen, 2004). 
Thus, the reported function of RLI in viral infection does not account for the 
conservation of RLI/Pixie in non-mammalian species. The initial in vivo and in vitro 
data, which hinted that Pixie might function in translation (Coelho et al., 2005a), would 
better explain the high level of conservation of the Pixie/RLI protein. This prompted me 
to study the function of Pixie and its role in translation in more details. During the 
course of my studies, three independent studies provided evidence that the yeast 
homologue of Pixie, Rlilp, functions in translation initiation and ribosome biogenesis 
(Dong et al., 2004; Kispal et al., 2005; Yarunin et al., 2005).
5.1.3 Pixie associates with elF3 components and proteins of the 40S 
subunit
My first approach to place Pixie in a functional context was to use mass 
spectrometry to identify proteins that co-purify with tandem affinity-purified GST- 
TEV-CBP-tagged Pixie (GTC-Pixie) protein. For this purpose, I generated S2 cells 
stably expressing GTC-Pixie under the control of the inducible methallothionein (MT) 
promoter (Figure 5-3A). To test GTC-Pixie expression levels, cells expressing GTC- 
Pixie were grown in the presence of increasing concentrations of Q 1SO4 for 16 hours 
(Figure 5-3B). As expected, increasing concentrations of Q 1SO4 induces increasing 
levels of GTC-Pixie expression. Moreover, in the absence of CuSC>4 , leakage from the 
MT promoter results in low GTC-Pixie expression levels that are comparable with those 
of endogenous Pixie protein. To avoid any impact that massive over-expression of 
GTC-Pixie might have on cell signalling, I carried out large-scale purification from 
non-induced cells expressing GTC-Pixie at low levels (Figure 5-3B). GTC-Pixie was 
affinity-purified from approximately lx l0 10 S2 cells on glutathione-sepharose beads 
and cleaved with TEV protease. CBP-Pixie and any associated proteins were bound to 
calmodulin beads were then washed and eluted (see Materials and Methods). Control
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Figure 5-3: Pixie associates with elF3 components and proteins of the 40S ribosomal 
subunit. (A) Schematic of GTC-Pixie. (B) Anti-Pixie immuno-blots of extracts prepared from S2 
cells expressing GTC-Pixie under the control of the inducible MT promoter, incubated for 16 hours 
with increasing concentrations of C uS 04. (C) The specificities of the anti-elF3-S2, -elF3_S8, and 
-elF3-S9 antibodies were tested on control extracts or extracts from cells depleted of elF3-S2, 
elF3-S8 or elF3-S9. (D-E) A two-step purification was performed from approximately 1x1010 S2 
cells expressing GTC-Pixie or the GTC-tag alone. The final eluates were resolved on a 4-12% 
Nupage Bis-Tris gel and stained with Brilliant Blue G-colloidal concentrate (D) or blotted onto a 
PVDF membrane and probed with antibodies against the indicated translation initiation factors 
(E). Visible bands were excised and identified by MALDI-TOF m ass spectrometry (C). Two bands 
that were visible, but could not be identified by MALDI-TOF m ass spectrometry (marked with * in 
C), have sizes corresponding to other elF3 components, elF3-S9 and elF3-S8.
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purifications were carried out from cells expressing the GTC tag alone. The final eluates 
were resolved by SDS-PAGE, and individual protein bands were stained with Brilliant 
Blue G-colloidal concentrate, cut out, and identified by MALDI-TOF mass 
spectrometry (Figure 5-3C).
My mass spectrometry analysis identified two components of translation 
initiation factor 3, eIF3-S10 and Adam (Tif32p and Hcrlp in yeast). In addition, two 
proteins, which co-purify with Pixie, but could not be identified by mass spectrometry, 
have sizes that correspond approximately to other eIF3 components (eIF3-S9 and eIF3- 
S8 (Prtlp and N iplp in yeast), marked with asterisks in Figure 5-3C). To test the 
identity of these proteins, I generated antibodies against eIF3-S8, eIF3-S9, and another 
eIF3 component, eIF3-S2 (Tif34p in yeast). The specificity of the three antibodies were 
tested by Western blotting on extracts from control cells or cells depleted of eIF3-S8, 
eIF3-S9, or eIF3-S2 by dsRNA treatment. Immuno-blot analysis revealed the presence 
of single bands in control extracts corresponding to the predicted sizes of eIF3-S8 (105 
kDa), eIF3-S9 (78 kDa), and eIF3-S2 (34 kDa) that are greatly reduced in extracts from 
cells depleted of the respective proteins (Figure 5-3D). Having confirmed the 
specificities of the anti-eIF3-S8, anti-eIF3-S9, and anti-eIF3-S2 antibodies, aliquots of 
the GTC-Pixie and control purifications were resolved by SDS-PAGE and probed for 
the presence of eIF3-S8, eIF3-S9, and eIF3-S2 (Figure 5-3E). Immuno-blotting revealed 
that all three eIF3 components co-purify with GTC-Pixie, but not the GTC-tag alone. 
Moreover, I did not detect any interaction between Pixie and another translation 
initiation factor, eIF4A. Thus, all eIF3 components tested, but not eIF4A, co-purify with 
Pixie. In addition to eIF3 components, my mass spectrometry analysis also identified 
two 40S subunit proteins, Rps25 and Rpsl7, and the product of the predicted gene 
CG4975 (Figure 5-3C). The CG4975-Qncoded protein has no identifiable domains and 
is found only in flies, so it was not studied further. The observation that Pixie interacts 
with eIF3 components and 40S ribosomal proteins (Figure 5-3C, E) suggests that it 
might function in translation initiation. Consistent with this idea, yeast Rlilp interacts 
with several translation initiation factors including eIF3 and is required for normal 
levels of translation initiation (Dong et al., 2004; Kispal et al., 2005; Yarunin et al., 
2005).
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5.1.4 Pixie is required for optimal stability of an elF3 sub-core complex
The observation that Pixie can be purified in complex with various eIF3 
components prompted me to examine the nature of the eIF3-Pixie interaction in more 
detail. For this purpose, I generated an antibody against Adam. The specificity of the 
antibody was tested on control extracts and extracts from Adam-depleted cells. 
Immuno-blot analysis revealed the presence of a single band of the predicted size (35 
kD) in control extracts that is markedly reduced in Adam-depleted extracts (Figure 5- 
4A). Having confirmed the specificity of the Adam antibody, I examined the effect that 
eIF3-S 10-depletion has on Pixie and various eIF3 components including Adam. I found 
that depletion of eIF3-S10 reduces protein levels of eIF3-S8 and eIF3-S9, but not those 
of the loosely associated eIF3 component Adam (Figure 5-4B). Thus, eIF3-S10, eIF3- 
S8 and eIF3-S9 seem to be required in stoichiometric amounts to stabilise each other 
and might form a sub-complex. Consistent with this, their yeast homologues, Tif32p, 
N iplp, and Prtlp, have been shown to form a sub-complex, in which Tif32p bridges an 
interaction between N iplp and Prtlp  (Phan et al., 2001). eIF3-S10 depletion has no 
effect on Pixie protein levels suggesting that Pixie is not a stoichiometric component of 
this sub-complex (Figure 5-4B). Importantly, maximum depletion of Pixie reduces the 
stability of some eIF3 components (Figure 5-4C). Thus, in cells efficiently depleted of 
Pixie, eIF3-S10, eIF3-S9, and eIF3-S8 protein levels are significantly reduced, Adam 
proteins levels slightly affected, and eIF3-S2 protein levels unaffected. In contrast, 
partial (90%) depletion of Pixie has no impact on eIF3-S10 levels (Figure 5-5C). Thus, 
Pixie may play a catalytic rather than structural role in stabilizing some eIF3 core 
components, perhaps by promoting their assembly into translation initiation-competent 
complexes. Consistent with the idea, the abundance of the yeast homologue of Pixie, 
Rlilp, is relatively low compared with that of several translation initiation factors 
including eIF3 (Dong et al., 2004).
5.1.5 Pixie is required for normal levels of translation initiation
The observation that Pixie can be isolated in complex with eIF3 and 
proteins from the 40S subunit suggests that Pixie, like Rlilp, may have a role in 
translation initiation. To further analyse this, I studied the A254 (for absorbance at 254 
nm wavelength) profiles from control cells and cells depleted of Pixie. An A254  
(polysome) profile depicts the concentrations of RNA over the length of a gradient and 




















Figure 5-4: Pixie is required for optimal stability of elF3 core components. (A) Immuno-blot 
analysis confirms the specificity of the anti-Adam antibody. Cytoplasmic extracts from cells 
treated with dsRNA targeting eGFP  or adam for 8 days were probed with the anti-Adam antibody. 
(B) Depletion of elF3-S10 causes a reduction in protein levels of elF3-S8 and elF3-S9, but not 
those of Pixie and Adam. Cell extracs were prepared from cells treated with dsRNA targeting 
eGFP (control) or elF3-S10 for five days and analysed by immuno-blotting with the indicated 
antibodies. (C) Depletion of Pixie causes a reduction in protein levels of elF3-S8, elF3-S9, and 
elF3-S10, but not those of Adam or elF3-S2.Cell lysates were prepared from cells treated with 
dsRNA targeting eGFP  (control) or pixie for five days and analysed by immuno-blotting with the 
indicated antibodies.
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subunits, the 80S ribosome, and mRNAs containing multiple ribosomes (polysomes) 
(Figure 5-5A). By measuring the areas underneath the 80S and polysome peaks, it is 
possible to estimate the relative abundance of 80S ribsosomes and polysomes under 
different conditions. To generate the polysome profiles, control and Pixie-depleted 
extracts were resolved by velocity sedimentation on 7.5-60% sucrose gradients, and a 
polysome profile was recorded for each gradient (Figure 5-5A-B). Importantly, I used 
an intermediate Pixie RNAi regime that did not impact on eIF3-S10 protein levels so 
that any changes in the polysome profile could be attributed specifically to Pixie rather 
than eIF3 depletion (Figure 5-5C). The polysome profiles revealed that depletion of 
Pixie causes a decrease in the polysome fraction relative to the 80S ribosome peak 
(Figure 5-5A-B). Thus, the polysome to 80S ribosome ratio decreases from 2.6 in 
control cells (Figure 5-5A) to 1.0 in Pixie-depleted cells (Figure 5-5B). Similarly, 
depletion of eIF3-S10 dramatically reduces the fraction of actively transcribed mRNAs 
relative to 80S ribosomes (Figure 5-5D-E). The observed increase in the 80S ribosome 
peak in cells depleted of Pixie and eIF3-S10 is a hallmark of a defect in translation 
initiation and mostly represents an accumulation of empty ribosomes. Thus, binding 
eIF3 and other translation initiation factors to the 40S subunit is required to prevent the 
spontaneous assembly of 40S and 60S subunits into empty ribosomes lacking mRNAs 
(reviewed in (Hinnebusch, 2006)). To test this idea, polysome profiles were resolved 
under high salt conditions, to dissociate empty but not mRNA-bound ribosomes (Foiani 
et al., 1991). Under these conditions, the 80S peak in cells depleted of Pixie is greatly 
reduced and similar in size to that in control cells. Furthermore, there is a dramatic 
increase in the amount of free 40S and 60S subunits in cells depleted of Pixie (Figure 5- 
5G-H). This confirms that depletion of Pixie results in accumulation of empty 
ribosomes. As expected, the polysome fraction is reduced in cells depleted of Pixie 
(Figure 5-5G-H). Thus, Pixie, like eIF3, is required for the formation of mRNA-bound 
ribosomes.
5.1.6 Pixie is not associated with elongating ribosomes
Next, I wished to study the association of Pixie with eIF3 and the 
translational machinery in more details by examining their sedimentation profiles on 
sucrose gradients. For this purpose, I generated an antibody against the 40S subunit 
ribosomal protein Rps25 that I had previously purified in complex with GTC-Pixie. The 





























Figure 5-5: Reducing levels of Pixie inhibits translation initiation. S2 cells were treated with 
dsRNA targeting eGFP  (control), pixie, or elF3-S10 for five (D-F) or eight (A-C, G-l) days. Prior 
to harvesting, cells were starved in PBS containing 2 mg/mL glucose for one hour, stimulated with 
1 pM insulin in complete Drosophila Schneider medium for three hours, and treated with 100 
pg/mL cycloheximide for 10 mins. (A-B, D-E, G-H) Cytoplasmic extracts were resolved by velocity 
sedimentation on 7.5-60% sucrose gradients for two hours at 39,000 rpm, then the A ^  profile 
was recorded for each gradient. (G-H) cytoplasmic extracts were resolved by velocity sedimenta­
tion in the presence of 0.7M NaCI to dissociate empty 80S ribosomes lacking mRNA. The 
positions of different ribosomal species on the ribosomal profiles are indicated (A, G-H). (C,F,I) an 
aliquot of each cytoplasmic extract was resolved by SDS-PAGE and immuno-blotted with the 
indicated antibodies.
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dsRNA targeting eGFP or rps25 for five days. Immuno-blotting revealed the presence 
of a single band of the expected size (13 kD) in control extracts that was greatly reduced 
in Rps25-depleted extracts (Figure 5-6A). Next, cytoplasmic extract from S2 cells was 
resolved by velocity sedimentation on a 7.5-60% sucrose gradient and fractions were 
collected and immuno-blotted for the presence of Pixie and eIF3 proteins. My anti- 
Rps25 antibody was used to identify fractions containing the 40S subunit, and a 
commercially available antibody, which recognise the 60S subunit protein ribosome P 
antigen (termed RpLP), marked the fractions containing the 60S subunit, 80S ribosome 
and polysomes (Figure 5-6B). As expected for an initiation factor, immuno-blot 
analysis revealed that eIF3 does not bind to assembled or elongating 80S ribosomes. 
Instead a proportion of eIF3 localises to the fractions containing the 40S subunit. Pixie 
is present in the low-density fractions at the top of the gradient and possibly in the 
fractions containing the 40S subunit, but not in the fractions containing the 60S 
subunits, 80S ribosomes, or polysomes (Figure 5-6B). This is consistent with the idea 
that Pixie functions in translation initiation rather than elongation.
5.1.7 Pixie, unlike elF3, does not stably associate with the 40S subunit
Having established that Pixie does not associate with elongating 
ribosomes, I wished to resolve whether Pixie binds to the 40S subunit. To obtain a 
better resolution around the 40S-containing fractions, cytoplasmic extract was resolved 
on a 7.5-30% sucrose gradient. Fractions were collected and analysed by Western blots. 
Immuno-blotting with antibodies against RpS25 and RpLP identified the fractions 
containing the small and large ribosomal subunits, respectively (Figure 5-7A). Under 
the conditions used in this experiment, I found that the majority of Pixie is localised in 
the soluble fractions at the top of the gradient rather than co-sedimenting with core eIF3 
components or the 40S subunit. Instead, the distribution of Pixie is rather similar to that 
of Adam, which was affinity purified with Pixie (Figure 5-3C). Thus, although in large- 
scale affinity purifications Pixie can be isolated with small amounts of core eIF3 
components and 40S subunit proteins, the association of Pixie and/or Adam with eIF3 
and the 40S subunit might be too weak to withstand the velocity sedimentation 
conditions. Consistent with this idea, the mammalian homologue of Adam, eIF3j, is lost 
from the 40S subunit upon velocity sedimentation (Fraser et al., 2004; Unbehaun et al.,













Figure 5-6: Pixie does not associate with elongating ribosomes. (A) The specificity of the 
anti-Rps25 andtibody was confirmed by immuno-blotting of cytoplasmic extracts prepared from 
cells treated with dsRNA targeting eGFP  or rps25 for five days. An unspecific band was used as 
a loading control. (B) Cytoplasmic extracts were prepared from 5x10s S2 cells and resolved by 
velocity sedimentation on 7.5-60% sucrose gradients for two hours at 39,000 rpm. Gradients 
were collected and polysome profiles simultaneously recorded (data not shown). The presence 
or absence of Pixie and two elF3 components in the different fractions was revealed by Western- 
blotting. Fractions containing the 40S and 60S subunits were identified by probing for the small 

























Figure 5-7: Pixie, unlike elF3, does not associate with the 40S subunit under standard 
conditions. (A) Cytoplasmic extracts were prepared from 5x10® S2 cells and resolved by velocity 
sedimentation on 7.5-30% sucrose gradients for 4.5 hours at 39,000 rpm. Gradients were 
collected and probed for the presence of Pixie, elF2a, and various elF3 components. The pres­
ence of the 40S and 60S ribsomal subunits was revealed by probing for the small and large 
ribosomal proteins, RpS25 and RpLP. The asterisk indicates an elF3- and elF2-containing com­
plex that may correspond to the Drosophila equivalent of the yeast MFC.(B) The specificity of the 
anti-elF2-a antibody was tested on extracts from cells treated with dsRNA targeting eGFP 
(control) or elF2-a for four days, p-tubulin was used as a loading control.
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sedimentation at low salt concentrations or upon cross-linking (Dong et al., 2004; 
Kispal et al., 2005; Yarunin et al., 2005).
5.7.7.7 eIF3 exists in a large complex that might be the fly  equivalent of the yeast 
MFC
As expected, immuno-blot analysis revealed that a fraction of eIF3 is 
bound to the 40S subunit. Notably, though, the majority of eIF3 exists in a less dense 
complex slightly higher up the gradient (marked by an asterisk in Figure 5-7A). This 
complex might represent the fly equivalent of an important translation initiation 
intermediate in yeast, the MFC, which consists of the TC and elFs 1,3, and 5 (Asano et 
al., 2000). To test this hypothesis, I generated an antibody against the a-subunit of eIF2 
(eIF2-a). The specificity of the antibody was tested on extracts from cells treated with 
dsRNA targeting eGFP (control) or eIF2-a for four days. Immuno-blotting with the 
anti-eIF2-a antibody revealed a single band of the expected size (40 kD) in the control 
extracts that was significantly reduced in the eIF2-a-depleted extract (Figure 5-7B). 
Having confirmed the specificity of the anti-eIF2-a antibody, the sucrose gradient 
fractions were probed for the presence of eIF2-a. Immuno-blot analysis revealed that 
the eIF2-a behaves in a similar way to eIF3 (Figure 5-7A). Thus, whereas some eIF2-a 
is bound to the 40S subunit, a significant amount of eIF2-a protein is found in the less 
dense el F3-containing fractions slightly higher up the gradient (marked by an asterisks 
in Figure 5-7A). This supports the idea that eIF3 and eIF2, like their yeast counterparts, 
might exist in a MFC with elFs 1 and 5. Notably, a small fraction of eIF2-a is found in 
the soluble fractions at the top of the gradient. This might represent free eIF2 or eIF2 
bound Met-tRNAjMet and GTP in the TC (Figure 5-7A).
5.1.8 Pixie associates with the 40S subunit in an ATP-dependent manner
Although in my large-scale purifications Pixie associates with small 
amounts of eIF3 and 40S subunit proteins (Figure 5-3C, E), these interactions are lost 
upon velocity sedimentation (Figure 5-7). This suggests that the interactions between 
Pixie and eIF3 and/or the 40S subunit are weak and possibly regulated in some way. 
The presence of two ABC domains in Pixie, which are predicted to bind and hydrolyse 
ATP, suggests that the association of Pixie with eIF3 and/or the 40S subunit might be 
regulated in an ATP-dependent manner. Consistent with these domains being important 
for Pixie function, several strong loss-of-function mutations in pixie are in conserved
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residues of the ABC domains (Coelho et al., 2005a). For example, pix3c2 disrupts the 
nucleotide-binding ABC domain signature motif of the first ABC domain, and pix149 
(Glyl23Ser) is in the third conserved glycine of the Walker A loop of the first ABC 
domain that is predicted to bind to the nucleotide phosphate groups (Figure 5-2) 
(Coelho et al., 2005a). Moreover, a mutation in yeast Rlilp that is predicted to allow 
ATP binding, but not hydrolysis, is non-functional and inhibits growth when over­
expressed (Dong et al., 2004).
To test whether Pixie associates with eIF3 and/or the 40S subunit in an 
ATP-dependent manner, I examined the sedimentation profile of Pixie on 7.5-30% 
sucrose gradients in the presence of ADP (control), ATP or a non-hydrolysable version 
of ATP (ADP-N-P). Immuno-blotting showed that addition of ADP, ATP or ADP-N-P 
to these extracts does not dramatically alter the distribution of eIF3-S2, eIF3-S8, eIF3- 
S9, eIF3-S10, RpLP and RpS25 on the sucrose gradients (Figure 5-8). Similarly, the 
addition of ADP or ATP has no effect on the distribution of Pixie on the sucrose 
gradients. In contrast, in the presence of ADP-N-P, a substantial proportion of Pixie 
protein redistributes to the 40S subunit-containing fractions (Figure 5-8). Given the 
similar distribution of Pixie and Adam on the initial sucrose gradients (Figure 5-7), I 
also examined the effect of ADP-N-P on the distribution of Adam. However, I did not 
observe a consistent redistribution of Adam under these conditions (data not shown). 
However, this result is not conclusive, since the association of Adam/eIF3j with the 40S 
subunit might be too weak to withstand velocity sedimentation irrespective of whether 
Pixie promotes its recruitment to the 40S subunit in the first place.
The presence of Pixie in the 40S subunit-containing fractions suggests that 
Pixie binds to the 40S subunit under these conditions. However, it cannot be ruled out 
that the presence of Pixie in these fractions is the result of its association with a 
different complex of similar size. To distinguish between these two possibilities, I 
examined the effect that depletion of two 40S subunit proteins, Rps25 and Rpsl3, has 
on the ATP-dependent redistribution of Pixie into the 40S subunit-containing fractions. 
The rationale behind this approach was that depletion of Rps25 and Rpsl3 is likely to 
affect 40S subunit levels, since 40S subunit ribosomal proteins are required in 
stoichiometric amounts. Extracts from cells treated with dsRNA targeting eGFP 
(control) or rps25 and rpsl3 were resolved on 7.5-30% sucrose gradients in the 
presence of ADP-N-P, and fractions were collected and analysed by immuno-blotting. 






















Figure 5-8: Pixie redistributes into the 40S subunit-containing fractions in the presence of 
ATP-N-P. The presence of ADP-N-P redistributes a significant proportion of endogenous Pixie 
protein into the 40S subunit-containing fractions, but does not affect the distribution of elF3 com­
ponents on the gradient. Cytoplasmic extracts were prepared 5x10® S2 cells, then 5 mM ADP, 
ATP, or ADP-N-P was added prior to their resolution on 7.5-30% sucrose gradients for 4.5 hours 
at 39,000 rpm. Gradients were collected and probed for the presence of Pixie and various elF3 
components. Fractions containing the 40S and 60S subunits were identified by probing for the 
small and large ribosomal subunit proteins, RpS25 and RpLP.
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containing fractions of the control gradient (Figure 5-9A). In contrast, depletion of 
Rps25 and Rpsl3 blocks the ATP-dependent redistribution of Pixie into more dense 
fractions (Figure 5-9A-B). The failure to detect Pixie in these fractions is not due to an 
effect on Pixie protein levels. Thus, immuno-blotting confirmed that Pixie protein levels 
are unaffected in cells depleted of Rps25 and Rpsl3 (Figure 5-9B). These data show 
that Pixie indeed binds to the 40S subunit in the presence of ADP-N-P.
5.1.9 The C-terminal ABC domain of Pixie is required for its association 
with the 40S subunit
I next wished to determine whether it is the binding of ATP to Pixie itself 
that allows its association with the 40S subunit. The recently solved structure of p. 
furiosus RLI reveals that the two ABC domains of RLI are arranged in a head-to-tail 
fashion (Karcher et al., 2005; Karcher et al., 2008). This arrangement creates two 
composite nucleotide-binding sites formed by Walker A/B and Q-loops from one ABC 
domain and the signature motifs from the opposing ABC domain (Karcher et al., 2008). 
Thus, deletion of one ABC domain is predicted to abolish both nucleotide-binding sites. 
I therefore examined the ability of a truncated Pixie mutant protein, which lacks the 
second ABC domain (GTC-PixieAABC), to bind the 40S subunit in the presence of 
ADP-N-P. This involved the generation of a stable cell line that expresses the GTC- 
PixieAABC. Cytoplasmic extract from cells expressing PixieAABC was resolved on a 
7.5-30% sucrose gradient in the presence of ADP-N-P and analysed by immuno- 
blotting (Figure 5-10). As a control, extracts from cells expressing GTC-Pixie were 
resolved on gradients in the absence or presence of ADP-N-P. As expected, endogenous 
Pixie redistributes to the 40S subunit-containing fractions in the presence of ADP-N-P. 
In contrast, GTC-PixieAABC remains in the soluble fractions at the top of the gradient, 
indicating that GTC-PixieAABC is unable to bind the 40S subunit. This is not due to the 
presence of the GTC-tag, since GTC-Pixie behaves similarly to endogenous Pixie. 
Thus, the C-terminal ABC domain of Pixie is necessary for its binding to the 40S 
subunit.
5.1.10 The PixieE501Q mutant is constitutively associated with the 40S 
subunit
The observation that GTC-PixieAABC is unable to bind the 40S subunit is 
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Figure 5-9: Pixie a sso c ia te s  with the 40S subunit in an ATP-dependent manner. The ATP- 
dependent redistribution of Pixie into denser fractions depends on its association with the 40S 
subunit. (A) 5x10s S2 cells treated with dsRNA targeting eGFP  (control), or rps25 and rps13 for 
five days were collected, cytoplasmic extracts were prepared, and 5 mM ADP-N-P was added 
prior to their resolution on 7.5-30% sucrose gradients for 4.5 hours at 39,000 rpm. (B) An aliquot 
of each cytoplasmic extract as resolved by SDS-PAGE and immuo-blotted with the indicated 
antibodies. Immuno-blotting confirms that RpS25 and RpS13 protein levels are reduced in cells 
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Figure 5-10: The C-terminal ABC domain of Pixie is required for its association with the 
40S subunit. GTC-Pixie and endogenous Pixie, but not GTC-PixieAABC, redistributes to the 
40S subunit-containing fractions in the presence of ADP-N-P. Cytoplasmic extracts were 
prepared from 5x10® S2 cells stably expressing GTC-Pixie or a truncated GTC-Pixie protein 
lacking the C-terminal ABC domain (GTC-PixieAABC). 5 mM ADP-N-P was added to the extracts 
as indicated prior to their resolution on 7.5-30% sucrose gradients for 4.5 hours at 39,000 rpm. 
The presence of GTC-Pixie, GTC-PixieAABC, and endogenous Pixie protein was revealed by 
immuno-blotting with an anti-Pixie antibody recognising the N-terminal part of Pixie.
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with the 40S subunit. However, it does not rule out the possibility that the ABC domain 
is required for the binding of Pixie to another protein that associates with the 40S 
subunit in an ATP-dependent manner. Furthermore, deletion of the C-terminal ABC 
domain might interfere with the folding of the rest of the Pixie protein. I therefore 
wished to generate a gain of function mutation in Pixie that would mimic the binding of 
Pixie to ADP-N-P. I chose to mutagenise Glutamate 501 in the conserved Walker B 
motif of the second ABC domain to Glutamine (PixieE501Q). This mutation is 
predicted to allow ATP binding, but not hydrolysis. To study the sedimentation profile 
of the PixieE501Q mutant on a sucrose gradient, I generated stable cell lines expressing 
GTC-PixieE501Q under the control of an inducible promoter. Cytoplasmic extracts 
from these cells were resolved by velocity sedimentation on 7.5-30% sucrose gradients 
in the presence or absence of ADP-N-P (Figure 5-11 A). As expected, endogenous Pixie 
only binds to the 40S subunit in the presence of ADP-N-P (Top panel, induced + ADP- 
N-P). In contrast, immuno-blot analysis revealed that a significant proportion of GTC- 
PixieE501Q is constitutively associated with the 40S subunit in the absence of ADP-N- 
P (Top panel, induced). The distribution of GTC-PixieE501Q, much like eIF3, does not 
change in the presence of ADP-N-P (Top panel, induced + ADP-N-P). In fact, the 
distribution of GTC-PixieE501Q is rather similar to that of eIF3-S10 and eIF2-a. These 
data show that ATP-binding by Pixie itself results in its association with the 40S subunit 
and possibly eIF3. Moreover, Pixie is released from the 40S subunit and possibly eIF3 
upon ATP-hydrolysis, indicating that these interactions are transient. This is consistent 
with the idea that Pixie provides a catalytic rather than a structural function.
5.1.11 The association of Pixie with the 40S ribosome subunit is 
insensitive to elF3 depletion
The observations that Pixie co-purifies with eIF3 and that a proportion of 
eIF3 is constitutively bound to the 40S subunit, prompted me to investigate whether 
eIF3 is required for the ATP-dependent recruitment of Pixie to the 40S subunit.
o
Cytoplasmic extracts were prepared from 5x10 cells treated with dsRNA targeting 
eGFP or eIF3-S10 for five days and resolved on 7.5-30% sucrose gradients (Figure 5- 
12B). As expected, depletion of eIF3-S10 protein levels reduces the stability of eIF3- 
S9, but has no effect on Pixie levels (Figure 5-4B and 5-12B). Importantly, reduced 
levels of 40S subunit-bound eIF3-S10 and eIF3-S9 do not affect ATP-dependent 
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Figure 5-11: GTC-PixieE501Q, which is predicted to bind, but not hydrolyse ATP, is consti- 
tutively associated with the 40S subunit. (A) A proportion of GTC-PixieE501Q, much like 
elF3-S10, is constitutively associated with the 40S subunit. Cytoplasmic extracts were prepared 
from 5x108 S2 cells stably expressing GTC-Pixie or the GTC-PixieE501Q mutant protein, and 
where indicated 5 mM ADP-N-P was added to the extracts prior to their resolution on 7.5-30% 
sucrose gradients for 4.5 hours at 39,000 rpm. GTC-PixieE501Q expression was induced by 
addition of 175 ng/ml_ (Induced + ADP-N-P, panel 3) or 700 pg/mL (Induced, panel 2) C uS04 for 
16 hours. High levels of GTC-PixieE501Q over-expression do not affect the association of elF3- 
S10 and elF2-a with the 40S subunit (Induced, panel 2). (B) Immuno-blotting revealed that high 
levels of GTC-PixieE501Q over-expression (induced by 700 pg/mL CuSO^ do not affect the 
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Figure 5-12: The association of Pixie with the 40S subunit is insensitive to elF3 depletion.
(A) Reduced levels of 40S subunit-bound elF3 does not affect the ATP-dependent association of 
Pixie with the 40S subunit. Cells were treated with dsRNA targeting eGFP  (control) or elF3-S10 
for five days. Cytoplasmic extracts were prepared from 5x108 control or elF3-S10-depleted cells 
and resolved on 7.5-30% sucrose gradients for 4.5 hours at 39,000 rpm in the presence or 
absence of 5 mM ADP-N-P. (B) Immuno-blotting confirms the depletion of elF3-S10 and shows 
that elF3-S9 levels are also reduced, whereas Pixie protein levels are unaffected.
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remaining eIF3-S10 is responsible for the association of Pixie with the 40S subunit, the 
fact that there is no detectable reduction in 40S-bound Pixie strongly implies that the 
ability of Pixie to bind the 40S subunit is independent of its ability to interact with eIF3.
5.1.12 Depletion of Pixie does not affect the association of elF2 and elF3 
with the 40S ribosome subunit
Whereas the association of Pixie with the 40S subunit is transient, a 
significant proportion of eIF3 core components and eIF2 is stably associated with the 
40S subunit (Figure 5-7). This would argue against a role of Pixie in bridging an 
interaction between eIF3 core components and/or eIF2 and the 40S subunit. However, 
Pixie might still provide a catalytic function required for the recruitment of eIF3 and/or 
eIF2 to the 40S subunit. To investigate this, I examined whether depletion of Pixie 
affects the association of eIF2 and eIF3 with the 40S subunit. Cytoplasmic extracts from 
cells treated with dsRNA targeting eGFP (control) or pixie were resolved on 7.5-30% 
sucrose gradients and analysed by immuno-blotting with antibodies against eIF3-S10 
eIF2-a (Figure 5-13A). As previously, I used an intermediate RNAi regime that did not 
impact on eIF3-S10 protein levels (Figure 5-13B). Reducing Pixie protein levels with 
approximately 90%, did not affect the levels of 40S subunit-bound eIF3-S10 and eIF2- 
a  (Figure 5-13 A). Whereas it is possible that the remaining Pixie activity is sufficient to 
promote the assembly of eIF3-S10 and eIF2-a onto the 40S subunit, the same 90% 
depletion of Pixie is able to reduce the polysome content of cells (Figure 5-5A-B). 
Thus, the defect in translation initiation observed in cells partially depleted of Pixie 
(Figure 5-5A-B) is unlikely to be caused by a lack of recruitment of eIF3 or eIF2 to the 
40S subunit (5-13 A).
5.2 Discussion -  Part III
5.2.1 Pixie interacts with elF3
I initially carried out a large-scale TAP purification to identify proteins 
that co-purify with GTC-tagged Pixie. My mass spectrometry analysis of GTC-Pixie- 
associated proteins identified two eIF3 components, Adam and eIF3-S10, and two 40S 
subunit ribosomal proteins (Figure 5-3C). Subsequent immuno-blot analysis of proteins 
isolated in complex with GTC-Pixie revealed the identity of a further three eIF3 
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Figure 5-13: Depletion of Pixie does not affect recruitment of elF2 and elF3 to the 40S 
subunit. (A) Cytoplasmic extracts were prepared from 5x108 S2 cells treated with dsRNA target­
ing eGFP  or pixie for 8 days, and 5 mM ADP-N-P was added to the extracts prior to their resolu­
tion on 7.5-30% sucrose gradients for 4.5 hours at 39,000 rpm. (B) Immuno-blotting confirms that 
Pixie protein levels are 90% reduced in Pixie-depleted extracts compared with control extracts.
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fundamental function in translation initiation, eIF3-S2, eIF3-S8, eIF3-S9, and eIF3-S10 
are all highly conserved, and their yeast counterparts, Tif34p, Niplp, Prtlp, and Tif32p, 
are essential for viability. Adam is also well conserved though its yeast homologue 
Hcrlp is dispensable for viability. The observation that sufficient amounts of Adam and 
eIF3-S10 protein were recovered in my GTC-Pixie purification to allow identification 
by mass spectrometry might indicate that they interact directly with Pixie (Figure 5-3C). 
Consistent with this idea, the yeast homologues of Pixie and Adam, Rlilp and Hcrlp, 
were found to interact directly by yeast two-hybrid analysis (Kispal et al., 2005).
5.2.2 Pixie is required for normal levels of translation initiation
My polysome profile analysis revealed that depletion of Pixie, like that of 
eIF3-S10, results in an accumulation of 80S ribosomes and a decrease in the polysome 
fraction (Figure 5-5A-F). The dramatic increase in the 80S peak is a hallmark of a 
defect in translation initiation and mostly represents the spontaneous assembly of free 
40S and 60S subunits into empty ribosomes lacking mRNA. Alternatively, it could 
reflect stalled mRNA-bound 80S ribosomes. To distinguish between these two 
possibilities, I examined the polysome profile from cells depleted of Pixie under 
conditions that dissociate empty, but not mRNA containing, 80S ribosomes (Figure 5- 
5G-I). This revealed that the observed increase in the 80S subunit peak indeed is due to 
an accumulation of empty ribosomes. Thus, Pixie interacts with the eIF3 complex and 
40S subunit ribosomal proteins and is required for assembly of 48S pre-initiation 
complexes and normal levels of translation initiation. Similarly, three independent 
studies in yeast have provided evidence that Rlilp interacts with eIF3 and ribosomal 
proteins and functions in translation initiation (Dong et al., 2004; Kispal et al., 2005; 
Yarunin et al., 2005), indicating that this function of Pixe/Rlilp is conserved from yeast 
to metazoans.
5.2.3 Pixie is not constitutively associated with the 40S subunit
The initial observations that Pixie binds to eIF3 (Figure 5-3C, E) and is 
required for normal levels of translation initiation (Figure 5-5A-C), prompted me to 
analyse the association of Pixie and eIF3 with the translational machinery in more 
details. I was initially surprised to find that most Pixie is localised in the soluble 
fractions at the top o f  the gradient rather than co-sedimenting with the core eIF3 
components or the 40S subunit (Figure 5-7). This suggests that the interactions between
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Pixie and eIF3 and/or the 40S subunit, which I initially identified in my GTC-Pixie 
purification, might be too weak to withstand the velocity sedimentation conditions or 
possibly regulated. Consistent with this idea, the interaction of yeast Rlilp with the 40S 
subunit only withstands velocity sedimentation under low salt conditions or upon cross- 
linking (Dong et al., 2004; Kispal et al., 2005; Yarunin et al., 2005).
Interestingly, my velocity sedimentation analyses revealed that whereas a 
proportion of eIF3 is bound to the 40S subunit, a significant amount of eIF3 exists in a 
less dense complex further up the gradient (Figure 5-7). This complex might be the fly 
equivalent of the yeast MFC, which consists of the TC and elFs 1, 3, and 5 (Asano et 
al., 2000). Consistent with this idea, I found that a significant proportion of eIF2-a is 
present in these eIF3-containing fractions (Figure 5-7).
5.2.4 Pixie associates with the 40S subunit in an ATP-dependent manner
Pixie possesses two ABC domains, the integrity of which is essential for 
its biological function (Coelho et al., 2005a). This, prompted me to examine whether 
the binding of Pixie to the 40S subunit might be ATP-dependent. Indeed, I found that 
binding of Pixie to the 40S subunit is transient and ATP-dependent (Figures 5-8 and 5- 
9). Thus, Pixie is detected in the 40S subunit fractions only in the presence of ADP-N- 
P. Moreover, a point mutation in the ATP-binding center of Pixie, which is predicted to 
allow Pixie to bind, but not hydrolyse, ATP, results in constitutive association of Pixie 
with the 40S subunit (Figure 5-11). This indicates that Pixie associates with the 40S 
subunit in its ATP-bound form and is released upon ATP hydrolysis. Given the similar 
distribution of Pixie and Adam on sucrose gradients, I examined whether redistribution 
of Pixie to the 40S subunit fractions in the presence of ADP-N-P had an effect on the 
sedimentation profile of Adam. ATP-dependent binding of Pixie to the 40S subunit did 
not increase levels of 40S subunit-bound Adam protein (data not shown). This might 
not be expected, since Pixie is likely to provide a catalytic function rather than bridging 
an interaction between Adam and the 40S subunit. Given the direct interaction between 
the yeast homologues of Pixie and Adam, Rlilp and Hcrlp, it is still possible that Pixie 
promotes recruitment of Adam to the 40S subunit (Kispal et al., 2005). However, due to 
the loose association of Adam with the 40S subunit, it is not possible to address this by 
velocity sedimentation analysis.
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5.2.5 Pixie binds to the 40S subunit independent of core components of 
elF3
The ability of Pixie to interact with eIF3 and the observation that a 
proportion of eIF3 is constitutively bound to the 40S subunit prompted me to examine 
whether ATP-dependent interaction of Pixie with the 40S subunit is mediated by eIF3. 
Treatment of cells with dsRNA targeting eIF3-S10 reduced levels of 40S subunit-bound 
eIF3-S10 and eIF3-S9, but had no impact on ATP-dependent binding of Pixie to the 
40S subunit (Figure 5-12). These data suggests that Pixie binds to the 40S subunit 
independent of core eIF3 components. My data do not exclude that binding of Pixie to 
the 40S subunit could be mediated by other eIF3 components that are not affected by 
eIF3-S10 depletion. However, the mammalian homologue of Adam, eIF3j, is the only 
eIF3 component that is thought to bind to the 40S subunit independent of the rest of the 
eIF3 complex (Fraser et al., 2007; Fraser et al., 2004; Nielsen et al., 2006; Unbehaun et 
al., 2004). Given that a substantial fraction of Pixie is recruited to the 40S subunit under 
conditions where only a small proportion of Adam is 40S subunit-bound, my data 
favour the idea that Pixie binds the 40S subunit independent of eIF3.
5.2.6 Pixie might promote the assembly of elF3 core components into 
translation initiation competent complexes
Interestingly, I found that dsRNA-mediated depletion of eIF3-S10 reduces 
levels of eIF3-S8 and eIF3-S9, but has no impact on Adam and Pixie levels (Figure 5- 
4A). This observation suggests that the optimal stability of eIF3-S8, eIF3-S9 and eIF3- 
S10 depends on the presence of all three proteins in stoichiometric amounts and their 
assembly into a complex. Consistent with this, the yeast homologues of eIF3-S8, eIF3- 
S9 and eIF3-S10, Niplp, Prtlp, and Tif32p, form an eIF3 sub-complex, in which Tif32p 
bridges an interaction between Niplp and Prtlp (Phan et al., 2001). I also found that 
extensive dsRNA-mediated depletion of Pixie causes a reduction in the protein levels of 
eIF3-S8, eIF3-S9, and eIF3-S10, whereas levels of Adam are slightly affected and those 
of eIF3-S2 are unaffected (Figure 5-4B). Thus, Pixie may aid the assembly of the eIF3- 
S8-eIF3-S10-eIF3-S9 sub-complex into stable translation initiation competent 
complexes. The observation that partial (90%) depletion of Pixie has no impact on eIF3- 
S10 protein levels suggests that Pixie provides a catalytic rather than a structural 
function. Consistent with this idea, I only detected significant amounts of Pixie in the 
eIF3-containing fractions of the gradient in the presence of ADP-N-P.
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5.2.7 Pixie depletion results in reduced translation initiation, but does not 
affect recruitment of elFs 2 and 3
Given the fact that Pixie can bind both to both eIF3 and ribosomal 
proteins, and the effect that ADP-N-P has on its distribution on sucrose gradients, Pixie 
may play a catalytic role in the assembly of translation pre-initiation complexes onto the 
40S subunit. To investigate whether Pixie promotes the recruitment of eIF3 to the 40S 
subunit, I compared levels of 40S-bound eIF3-S10 in cells depleted of Pixie with that in 
control cells. I found that a 90% depletion of Pixie does not affect levels of 40S subunit- 
bound eIF3-S10 (Figure 5-13), either because Pixie is not essential for its recruitment to 
the 40S subunit, or because the remaining Pixie is still able to provide that catalytic 
function. Consistent with my data, depletion of Rlilp also has no impact on the 
proportion of 40S subunit-bound eIF3 in yeast (Dong et al., 2004). Instead, Rlilp 
depletion reduces levels of 40S subunit-bound elFl, eIF2, and eIF5 (Dong et al., 2004). 
In contrast, I found that depletion of 90% of Pixie has no impact on recruitment of eIF2- 
a  to the 40S subunit (Figure 5-13). This discrepancy between my data and the data 
published by Dong and co-workers might reflect a difference in the efficiency of the 
Pixie versus the Rlilp depletion. Notably, though, the same 90% depletion of Pixie is 
able to reduce the polysome content of cells (Figure 5-5A-C), indicating that the 
observed defect in translation initiation is unlikely to be caused by a lack of recruitment 
of eIF2-a or eIF3 core components to the 40S subunit.
5.2.8 A function of Pixie between 43S and 48S pre-initiation complex 
assembly
As previously mentioned, the eIF3 complex functions as a platform that 
coordinates multiple events during translation initiation. For instance, activation of the 
insulin-signalling pathway results in the replacement of eIF3-bound S6K by mTOR and 
the recruitment of eIF4B to the eIF3 complex (Holz et al., 2005). Moreover, mTOR- 
dependent signalling stimulates the assembly of 48S pre-initiation complexes by 
promoting the association of 40S subunit-bound eIF3 with mRNA-bound eIF4G (Harris 
et al., 2006). Thus, it is possible that Pixie, rather than recruiting eIF3 to the 40S 
subunit, interacts with 40S subunit-bound eIF3 at a later step o f translation initiation to 
promote assembly of 48S pre-initiation complexes.
Interestingly, the mammalian homologue o f Adam, eIF3j, was recently 
found to reduce the affinity of the 40S subunit for mRNA by binding to the mRNA
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entry channel. Thus, high affinity for mRNA is only restored upon recruitment of the 
TC to the 40S subunit and positioning of Met-tRNAiMet in the P site (Fraser et al.,
2007). Given the potential direct interaction between Pixie and Adam (Kispal et al.,
2005), Pixie might modulate Adam activity at this stage of translation initiation to 
promote 48S pre-initiation complex assembly.
5.2.9 pixie mutant flies have a Minute-like phenotype, suggesting that 
ribosome levels might be affected.
Insulin signalling regulates several aspects of translation including 
translation initiation and elongation. In addition to mutations in the pixie gene, the 
screen carried out in the Leevers laboratory also identified mutations genes encoding 
ribosomal proteins (Coelho et al., 2005b). This indicates that mutations in the genes 
encoding the building blocks of the translational machinery interact genetically with 
mutations that reduce insulin signalling. Interestingly, phenotypic analyses carried out 
by Carmen Coelho showed that the pixie mutant phenotype is similar to that displayed 
by the Minute class of mutations, several of which have been shown to correspond to 
mutations in ribosomal genes (Coelho et al., 2005a; Lambertsson, 1998). Like flies 
heterozygous for Minute mutations, flies trans-heterozygous for weak pixie mutant 
combinations or flies carrying a dominant negative pixie allele show developmental 
delay and have slender bristles (Coelho et al., 2005a). Thus, pixie has a ‘Minute-like’ 
phenotype, consistent with it being required for normal levels of translation. To date, no 
translation initiation factors have been reported to have Minute-like phenotypes and 
eIF4A mutations do not have the same effect on clonal growth as pixie mutations 
(Coelho et al., 2005a). Thus, although my biochemical data demonstrate that Pixie plays 
a role in translation initiation, its mutant phenotypes are more akin to those of ribosomal 
protein mutants than those of translation initiation factors. The Minute-like aspects of 
the pixie mutant phenotype may reflect the fact that Pixie, like yeast Rlilp, has an 
additional role in ribosome biogenesis (Dong et al., 2004; Kispal et al., 2005; Yarunin et 
al., 2005). Consistent with this idea, my data demonstrate that Pixie can bind the 40S 
ribosomal subunit (Figure 5-3C), and that it does so in dependently of core eIF3 
components (Figure 5-13). Future experiments might shed light on whether the reported 
function of R lilp in ribosome biogenesis is conserved in flies. In yeast, conditional 
knockout of Rlip results in nuclear accumulation of recombinant GFP-tagged small and 
large ribosomal subunit proteins, and this is likely to be caused by a defect in ribosome
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biogenesis (Kispal et al., 2005; Yarunin et al., 2005). To address the putative function 
of Pixie in ribosome biogenesis, the cellular localisation of GFP-tagged small and large 
ribosomal proteins could be examined in control and Pixie-depleted cells. The small and 
large ribosomal subunit rRNAs are generated from the same pre-rRNA by multiple 
consecutive cleavage events. Since a defect in pre-rRNA processing is likely to result in 
the accumulation of pre-rRNA or partially processed pre-rRNA intermediates, the 
requirement for Pixie in rRNA maturation could be addressed by Nortem-blot analysis, 
using probes that recognise different rRNA intermediates, in control and Pixie-depleted 
cells.
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Chapter 6 - Concluding Remarks
Gene expression is regulated at multiple stages including transcription, 
pre-mRNA processing, and translation. The first regulated step in gene expression is 
transcription. For all protein-encoding genes, this is initiated by the recruitment of 
RNAP II and a number of general and gene-specific transcription factors to the 
promoter region of the gene. Once the RNAP II PIC has assembled onto the promoter 
region, phosphorylation of RNAP II on its CTD is required for transcription elongation 
to take place. This is carried out by various kinases including Cdks 7 and 9. Efficient 
RNAP II transcription elongation also relies on the coordinated action of positive 
elongation factors and chromatin remodelling factors. The data presented here suggest 
that the FHA domain protein dMCRS2 might have a previously uncharacterised 
function in RNAP II transcription. Thus, dMCRS2 can be purified in complex with 
RNAP II-associated proteins and co-localises with a subset of RNAP II complexes on 
polytene chromosomes. However, it is not clear which role dMCRS2 might play in 
RNAP II transcription. The association of dMCRS2 with TFIIF, Pitslre, CK2, and the 
FACT component SSRP1 suggests that dMCRS2 might function in early and/or late 
transcription elongation. dMCRS2 was previously shown to form a complex with the 
histone acetyl transferase MOF (Mendjan et al., 2006), which mediates H4K16Ac at the 
5’-end of genes and has been shown to regulate RNAP II-dependent transcription of a 
number of genes (Kind et al., 2008). How the MOF complex is recruited to sites of 
active transcription remains mysterious, and a physical link between the chromatin 
remodelling MOF-complex and RNAP II has yet to be established. It is tempting to 
speculate that dMCRS2 might provide a physical link between the MOF-complex and 
RNAP II via its ability to associate with Pitslre. Thus, RNAP II-associated dMCRS2 
and/or Pitslre could function as a docking site for the remainder of the MOF complex, 
which in turn might stimulate early or late RNAP II elongation by modulating the 
chromatin structure. Interestingly, the association of dMCRS2 with Pitslre is abolished 
in response to hyper-activation of the Hpo signalling pathway. Thus, the association of 
dMCRS2 and/or the MOF complex with RNAP II could be regulated in response to 
apoptotic stimuli. Whereas the above model is consistent with the data presented here, it 
requires further validation. First, it remains to be determined whether dMCRS2 function
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is indeed required for normal levels of RNAP II transcription. Second, it will be 
interesting to resolve whether dMCRS2 associates with initiating or elongating RNAP 
II complexes. Third, it will be important to clarify whether dMCRS2 and/or Pitslre are 
required for the recruitment of the MOF complex to sites of active transcription. 
Finally, if RNAP II-associated dMCRS2 functions as a docking site for the MOF 
complex, it will be interesting to determine whether association of dMCRS2 and/or the 
MOF complex with RNAP II regulated in response to apoptosis?
Once a gene has been transcribed, the next step in gene expression is 
splicing of the pre-mRNA to generate mature mRNA. This process is carried out by the 
spliceosome, a highly conserved ribonucleoprotein complex that consists of five 
snRNAs and more than 200 proteins. Whereas much of the mechanistic insight into the 
spliceosome has been derived from yeast genetics, the isolation and comparison of 
different mammalian spliceosome intermediates have revealed that excision of an intron 
from a pre-mRNA occurs largely by the same sequential path in yeast and higher 
eukaryotes (Bessonov et al., 2008; Jurica et al., 2002; Makarov et al., 2002; Makarova 
et al., 2004). Importantly, purifications of mammalian spliceosomes have added a vast 
array of elements to the pre-existing list of conserved core splicing factors. Many of 
these have no previous connection to splicing and require functional validation (Jurica 
and Moore, 2003). One example is MFAP1, which was recovered in a number of 
purifications of various mammalian spliceosomal complexes (Bessonov et al., 2008; 
Deckert et al., 2006; Makarov et al., 2002; Makarova et al., 2004; Neubauer et al., 
1998). The supposed function of MFAP1 as an extra-cellular matrix component initially 
led to its classification as a purification artefact (Neubauer, 2005; Neubauer et al., 
1998). Here I provide evidence that the Drosophila homologue MFAP1, dMFAPl, is 
indeed required for pre-mRNA processing (Andersen and Tapon, 2008). Moreover, I 
show that dMFAPl binds directly to dPrp38 (Andersen and Tapon, 2008), the 
Drosophila homologue of the yeast tri-snRNP protein Prp38p that was previously 
shown to be dispensable for spliceosome assembly, but required for spliceosome 
activation (Xie et al., 1998). In addition to dPrp38, dMFAPl is associated with several 
other splicing factors that function during the activation step, suggesting that dMFAPl, 
like dPrp38, plays a role in the activation step of the spliceosome (Andersen and Tapon,
2008). Consistent with this, human MFAP1 associates with fully assembled and 
activated spliceosomes, but is absent from spliceosomes purified after the first catalytic 
reaction (Bessonov et al., 2008; Deckert et al., 2006; Makarov et al., 2002; Makarova et
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al., 2004; Neubauer et al., 1998). dMFAPl is well conserved among higher eukaryotes, 
but has no recognisable homologue in yeast, indicating that it has evolved more recently 
in metazoans. This might suggest that dMFAPl, like many other metazoan-specific 
splicing factors, plays a role in alternative splicing. It would be interesting to include 
dMFAPl in future RNAi screens for regulators of alternative splicing.
In agreement with their fundamental functions, I found that dPrp38 and 
dMFAPl are essential proteins required for growth and proliferation during 
development (Andersen and Tapon, 2008). A more detailed analysis of this growth 
defect shows that dMFAPl and dPrp38 are required for G2/M progression (Andersen 
and Tapon, 2008). Interestingly, dsRNA-mediated depletion of a wide range of core 
splicing factors elicits a similar phenotype, suggesting that the observed G2/M arrest 
might be a general consequence of interfering with spliceosome function (Andersen and 
Tapon, 2008). In agreement with this, a genome-wide screen RNA interference screen 
in HeLa cells for factors required for mitosis identified a number of genes encoding 
splicing factors (Kittler et al., 2004). Future studies might resolve whether the observed 
G2/M arrest results from of a failure to splice a pre-mRNA encoding a factor that is rate 
limiting for entry into mitosis (e.g. stg/cdc25), or whether a defect in splicing activates a 
mitotic checkpoint that causes cells to arrest in G2.
Once pre-mRNAs have been processed into mRNAs, they are exported 
into the cytoplasm where they engage with translation initiation factors and ribosomal 
subunits to form translation initiation competent complexes. This is another step in gene 
expression, which is tightly regulated in accordance with extra-cellular insulin levels 
and intra-cellular energy and amino acid levels. Leevers and co-workers carried out a 
genetic screen to identify molecules that regulate growth and interact with PI3K- 
signalling (Coelho et al., 2005b). One of the genes identified in this screen, pixie, was 
found to enhance the small-wing phenotype elicited by expression of a dominant 
negative form of the catalytic subunit of PI3K in the wing. Subsequently, Pixie was 
found to be required for normal global levels of translation (Coelho et al., 2005a). The 
data presented here provide a more detailed characterisation of role of Pixie in 
translation. I show that Pixie associates with eIF3 and small ribosomal proteins and is 
required for the assembly of translation initiation competent complexes (Andersen and 
Leevers, 2007). Thus, depletion of Pixie results in the accumulation of empty 80S 
ribosomes lacking mRNAs and reduces translation initiation levels (Andersen and 
Leevers, 2007). Moreover, Pixie associates with the 40S subunit in an ATP-dependent
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manner, suggesting that Pixie plays a catalytic role in the assembly of complexes 
required for translation initiation (Andersen and Leevers, 2007). It is not clear at which 
stage of translation initiation Pixie is required. Thus, depletion of Pixie does not appear 
to affect the recruitment of eIF3 and eIF2 to the 40S subunit (shown here and (Andersen 
and Leevers, 2007)). This suggests that Pixie is dispensable for 43S PIC assembly and 
might be required at a later stage of translation initiation, e.g. for assembly of 48S PICs. 
Interestingly, eIF3, which Pixie was co-purified with, seems to provide a platform to 
coordinate a dynamic sequence of events required for 48S PIC assembly in response to 
insulin signalling (Holz et al., 2005). Thus, insulin signalling recruits the mTORCl 
complex to eIF3, which results in the activation and release of S6K1 (Holz et al., 2005). 
Following activation and dissociation from the translational machinery, S6K1 
phosphorylates and activates eIF4B. Phosphorylation of eIF4B promotes its recruitment 
to the translational machinery via its association with eIF3 (Holz et al., 2005). Insulin 
signalling also stimulates the association of eIF4G with eIF3 and thereby promotes 48S 
PIC assembly. It is tempting to speculate that Pixie provides a catalytic function 
downstream of insulin signalling to assist and/or coordinate the association of some of 
these factors with eIF3. It would be interesting to examine the effect of Pixie depletion 
on the association of mTOR, S6K, eIF4B, and eIF4G with 40S-bound eIF3. This might 
provide a better understanding of the mechanism by which Pixie promotes 48S PIC 
assembly and translation initiation.
Although my biochemical analysis demonstrates a role of Pixie in 
translation initiation (Andersen and Leevers, 2007), the pixie mutant phenotypes are 
more akin those of ribosomal protein mutants than those of translation initiation factors 
(Coelho et al., 2005a). This suggests that Pixie might have an additional function 
required to maintain normal levels of ribosomes. Consistent with this idea, the yeast 
homologue Rlilp has dual functions in translation initiation and ribosome biogenesis 
(Kispal et al., 2005; Yarunin et al., 2005). Whereas the function of Pixie/Rlilp in 
translation initiation seems to be well conserved, it remains to be determined whether 
the function of Rlilp in ribosome biogenesis is also conserved in higher eukaryotes.
Organism growth relies on gene expression and is therefore crucially 
dependent on the basic cellular machineries that are responsible for gene transcription, 
pre-mRNA processing, nuclear export, and protein synthesis. Moreover, each step of 
gene expression must be tightly regulated in accordance with nutrient availability and 
developmental programming. In multicellular organisms, developmental programming
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ensures that the transcription of specific subsets of genes is triggered at the appropriate 
stage of development. During early development, growth is often exponential, and 
genes encoding molecules required for protein synthesis and organelle biogenesis are 
actively transcribed. At later stages of development different subsets of genes are turned 
on to restrict proliferation and promote differentiation of progenitor cells into 
specialised cells. This shift in gene expression is mainly achieved by highly controlled 
epigenetic mechanisms including covalent modifications of histones such as acetylation, 
phosphorylation, and methylation (Agger et al., 2008; Berger, 2007; Panning and 
Taatjes, 2008; Thomas and Voss, 2007). The importance of keeping those mechanisms 
in check is evident from the observation that many human cancers are caused by 
changes in the epigenetic landscape that result in silencing of tumour suppressor genes. 
Thus, loss of hMOF, which specifically acetylates histone 4 on lysine 16, leads to 
nucleosome repositioning and silencing of the TMS1 (target o f  methylation-mediated 
silencing) tumour suppressor gene (Kapoor-Vazirani et al., 2008). In contrast to other 
histone modifications, H4K16Ac is restricted to a more select set of target genes, 
suggesting that the dMCRS2-MOF complex might regulate a limited subset of genes 
required for specific cellular processes, e.g., apoptosis.
Regulation of alternative splicing is another mechanism by which gene 
expression is fine-tuned to meet cellular needs at different stages of development in 
multicellular organisms. In contrast to unicellular organisms, where alternative splicing 
is almost non-existent, alternative splicing represents a key regulatory step in higher 
eukaryotes. Thus, a recent study estimates that at least 74% of multi-exon transcripts are 
alternatively spliced in humans (Johnson et al., 2003). To accommodate more complex 
splice patterns, additional splicing factors have evolved in metazoans. These include the 
family of SR proteins, which function in splice site selection. Genes encoding SR 
proteins are frequently mutated in various types of cancer (Ghigna et al., 2005; Kami et 
al., 2007; Sjoblom et al., 2006). One possible explanation for this is that mutations in 
SR proteins are likely to affect the expression of only a subset of genes and could 
potentially target oncogenes or tumour suppressor genes specifically. The finding that 
dMFAPl is required for pre-mRNA processing adds another protein to the list of 
splicing factors that have evolved more recently in metazoans. It will be interesting to 
learn more about the contribution of dMFAPl to alternative splicing and whether 
mutations in the dmfapl gene is associated with human diseases.
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Protein synthesis is the last step in gene expression and is subject to 
regulation by multiple signalling pathways. During early development mass 
accumulation is often exponential and this puts a high demand on the translational 
machinery to synthesise proteins required for organelle biogenesis. Importantly, protein 
synthesis and ribosome biogenesis are among the most energetically demanding cellular 
processes and must be kept in check and coordinated with nutrient availability. The 
TOR kinase represents a major node for the integration of multiple signals representing 
the metabolic state of the cell and regulates protein synthesis according to amino acid 
and energy levels. The observation that mutations in pixie interact genetically with 
mutations altering the activity of the insulin signalling pathway suggests that Pixie 
could function as a downstream effector of insulin signalling to regulate translation 
levels (Coelho et al., 2005). Interestingly, the presence of two iron-sulfur clusters (ISCs) 
at the N-terminus of Pixie implies that Pixie activity could be regulated by other means, 
e.g., in response to reactive oxygen species (ROS). Thus, Nitric Oxide (NO) is known 
to alter the activity of iron regulatory protein 1 (IRP1) by promoting disassembly of its 
ISCs in response to immunological or inflammatory stimuli (reviewed in (Bouton and 
Drapier, 2003)). Similarly, Pixie activity might be modulated in response to stress. It is 
tempting to speculate that Pixie could function as a sensor of ROS to regulate protein 
synthesis and growth in response to various types of environmental stress. In addition, 
the main source of ROS in the cell is the mitochondria, where ROS are generated as 
part of the respiratory process. Thus, Pixie could sense the energy status of the cell and 
thus couple mitochondrial ATP generation with the energy-intensive process of protein 
synthesis. Since Pixie/RLI proteins are extraordinarily conserved, this might represent 
an ancient mechanism for regulating growth of unicellular organisms in response to 
environmental clues (Gabaldon and Huynen, 2004). Interestingly, the human 
homologue of Pixie, RLI, was originally identified as an inhibitor of the antiviral 2- 
5A/RNAse L system, which is induced by interferon in response to viral infection 
(Bisbal et al., 1995). Interferon signalling increases levels of NO, which in turn might 
alter the activity of RLI to promote the antiviral action of the 2-5A/RNAse L system. 
Thus, it is possible that in mammals, deregulation of RLI activity in response to 
immunological and/or inflammatory stimuli would support immune defence processes 
by simultaneously slowing down metabolism and promoting antiviral action.
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